{
  "meta": {
    "title": "44_Inicet_Nov_2024_Mock_Test-1_-_19-10-2024",
    "url": "https://brainandscalpel.vercel.app/44-inicet-nov-2024-mock-test-1-19-10-2024-280dc582.html",
    "scrapedAt": "2025-11-29T17:23:46.550Z"
  },
  "questions": [
    {
      "id": 61462,
      "choices": [
        {
          "id": 245125,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C5a</span></span></p>"
        },
        {
          "id": 245126,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C3b</span></span></p>"
        },
        {
          "id": 245127,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C3d</span></span></p>"
        },
        {
          "id": 245128,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C4d</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient underwent a kidney transplant and presents with signs of graft dysfunction two weeks post-operation. A biopsy is performed, and staining reveals the presence of a specific complement factor in the peritubular capillaries. Which of the following complement factors is most indicative of this acute humoral (antibody-mediated) rejection?</span></span></p>",
      "unique_key": "Q6302620",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) C4d</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">C4d deposition in the peritubular capillaries is a hallmark of acute antibody-mediated rejection (AMR) in organ transplantation, particularly in kidney transplants. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is part of the classical complement pathway and indicates the presence of donor-specific antibodies (DSAs) binding to the graft endothelium, leading to complement activation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The detection of C4d in biopsy samples helps confirm the diagnosis of humoral rejection, guiding appropriate management to reduce immune-mediated damage.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. C5a:</span></strong><span style=\"font-size:14.0pt\"> C5a is an anaphylatoxin involved in the recruitment of neutrophils and other inflammatory cells. While it plays a role in the inflammatory response, it is not specifically used as a marker for antibody-mediated rejection in transplant settings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. C3b:</span></strong><span style=\"font-size:14.0pt\"> C3b is an opsonin that tags pathogens for phagocytosis and is involved in complement activation, but its presence is not a specific marker of humoral rejection in transplant biopsies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. C3d:</span></strong><span style=\"font-size:14.0pt\"> C3d is a product of C3 cleavage and can be associated with complement activation. While C3d may be present in various immune responses, it is less specific for humoral rejection compared to C4d, which directly indicates classical complement activation in the context of transplant rejection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">C4d is a key marker of acute humoral (antibody-mediated) rejection in organ transplants, particularly kidneys, as it indicates the presence of donor-specific antibodies and complement activation through the classical pathway.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245128,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61243,
      "choices": [
        {
          "id": 244253,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nesbit operation</span></span></span></span></p>"
        },
        {
          "id": 244254,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Grayhack shunt</span></span></span></span></p>"
        },
        {
          "id": 244255,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Roving operation</span></span></span></span></p>"
        },
        {
          "id": 244256,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Buccal mucosa flap urethroplasty</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these procedures is done for correction of abnormal curvature of the&nbsp;penis (chordee)? </span></span></p>",
      "unique_key": "Q3935246",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Nesbit operation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the penis is of adequate length, it is possible to plicate the tunica albuginea on the side opposite to the maximum curvature. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The plication can be done by Nesbit&rsquo;s technique.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Grayhack shunt:</strong> The <strong>Grayhack shunt</strong> involves creating a connection between the <strong>corpora cavernosa</strong> and the <strong>saphenous vein</strong> and is used for treating refractory ischemic priapism when other shunting techniques have failed.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Rovsing operation</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Deroofing of polycystic kidney disease</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Buccal mucosa flap urethroplasty</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Done for urethral stricture</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nesbit technique is used for correction of abnormal penile curvature like in Peyronie&rsquo;s disease.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244253,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61303,
      "choices": [
        {
          "id": 244493,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Voltage clamp</span></span></p>"
        },
        {
          "id": 244494,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patch clamp</span></span></p>"
        },
        {
          "id": 244495,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iontophoresis</span></span></p>"
        },
        {
          "id": 244496,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Microelectrode recording</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which technique is best for measuring current flow through a single ion channel?</span></span></p>",
      "unique_key": "Q1960099",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Patch clamp</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Patch clamp</span></strong><span style=\"font-size:14.0pt\"> is the ideal method to study the current flow across a single ion channel. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This technique allows for the precise measurement of ionic currents through individual ion channels by isolating a small patch of membrane. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is particularly useful for understanding the function of ion channels under various physiological and pathological conditions.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Voltage clamp:</span></strong><span style=\"font-size:14.0pt\"> This technique is used to measure the ionic currents across a cell membrane by holding the membrane potential constant. However, it is typically used for studying the collective current through multiple ion channels rather than individual ones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Iontophoresis:</span></strong><span style=\"font-size:14.0pt\"> This technique involves the movement of ions through tissues using an electric current and is more relevant for drug delivery rather than measuring ion channel currents.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Microelectrode recording:</span></strong><span style=\"font-size:14.0pt\"> While microelectrode recording can measure electrical activity in neurons, it lacks the precision required to isolate and measure currents from a single ion channel, unlike the patch clamp technique.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patch clamp technique is the gold standard for studying the activity of individual ion channels, allowing for the detailed analysis of ionic currents at the single-channel level.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244494,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61227,
      "choices": [
        {
          "id": 244189,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytokine release</span></span></p>"
        },
        {
          "id": 244190,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased hepatic protein synthesis</span></span></p>"
        },
        {
          "id": 244191,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased portal venous pressure</span></span></p>"
        },
        {
          "id": 244192,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced estrogen metabolism</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old man presents with a 3-month history of increased abdominal girth, bloating, and fatigue. He has a long-standing history of heavy alcohol consumption, averaging more than 30 units per week since he was 16. On physical examination, he has gynecomastia, visibly red palms, and a distended abdomen with a positive fluid wave. Laboratory studies show elevated liver enzymes, a prolonged prothrombin time, and low serum albumin. Given his clinical presentation, which pathophysiological mechanism most likely explains the development of gynecomastia and palmar erythema in this patient?<strong> </strong></span></span></p>",
      "unique_key": "Q6662018",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D) Reduced estrogen metabolism</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s long-standing history of heavy alcohol consumption suggests the development of chronic liver disease, likely cirrhosis. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cirrhosis, the liver&#39;s ability to metabolize hormones, including estrogen, is significantly impaired. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This reduced estrogen metabolism leads to higher circulating levels of estrogen, which can cause secondary effects such as gynecomastia (due to the increased stimulation of breast tissue) and palmar erythema (a result of vascular changes associated with elevated estrogen). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These signs are characteristic physical findings in patients with chronic liver disease.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Cytokine release:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While cytokine release is involved in the inflammatory response seen in liver disease, it does not directly account for the gynecomastia and palmar erythema. These symptoms are more specifically linked to hormonal imbalances rather than inflammation alone.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decreased hepatic protein synthesis:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic liver disease leads to decreased production of proteins like albumin and clotting factors, resulting in hypoalbuminemia and coagulopathy. However, this is not the direct cause of gynecomastia or palmar erythema.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Increased portal venous pressure:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased portal pressure is associated with complications like ascites, splenomegaly, and varices. It does not directly cause gynecomastia or palmar erythema; these findings are more related to hormonal changes due to impaired liver metabolism.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic liver disease, particularly cirrhosis, can lead to impaired estrogen metabolism. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This hormonal imbalance is responsible for the development of gynecomastia and palmar erythema, classic signs seen in patients with advanced liver disease.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244192,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61309,
      "choices": [
        {
          "id": 244517,
          "text": "<p><span style=\"font-size:18px;\">Respectful maternal care</span></p>"
        },
        {
          "id": 244518,
          "text": "<p><span style=\"font-size:18px;\">GATHER approach</span></p>"
        },
        {
          "id": 244519,
          "text": "<p><span style=\"font-size:18px;\">Counselling for cervical cancer screening</span></p>"
        },
        {
          "id": 244520,
          "text": "<p><span style=\"font-size:18px;\">PPIUCD counselling</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 32-year-old woman comes to the clinic seeking advice on family planning options. During the session, the clinician uses a structured guide for the discussion, ensuring that the patient's concerns are addressed, providing accurate information, and helping her make an informed decision. Which structured method is most likely being used in this scenario?&nbsp;</span></p>",
      "unique_key": "Q5310716",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) GATHER approach</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The GATHER approach is a structured counselling method commonly used in <strong>contraceptive counselling</strong>.</span></li><li><span style=\"font-size:18px;\">It stands for <strong>Greet, Ask, Tell, Help, Explain, and Return/Refer</strong>, and it guides healthcare providers through a step-by-step process to ensure that patients receive personalized and comprehensive information.</span></li><li><span style=\"font-size:18px;\">It helps ensure that the patient’s needs and concerns are addressed while providing appropriate and accurate information about various contraceptive options, allowing the patient to make an informed choice.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Respectful maternal care:&nbsp;</strong>This focuses on ensuring dignity, respect, and compassionate care during childbirth but is not specific to the structured approach of contraceptive counselling.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Counselling for cervical cancer screening:&nbsp;</strong>This is related to educating women about screening tests like Pap smears and HPV tests but is not specifically associated with the GATHER approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. PPIUCD counselling:&nbsp;</strong>This is specific to providing information about postpartum intrauterine contraceptive devices, but the structured GATHER approach is broader and applies to general contraceptive counselling.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The GATHER approach is a structured counselling technique used to provide comprehensive and personalized contraceptive counselling, ensuring that the patient’s concerns are addressed and accurate information is given to help them make informed decisions.</span></li></ul>",
      "correct_choice_id": 244518,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61321,
      "choices": [
        {
          "id": 244565,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cranial Nerve X</span></span></p>"
        },
        {
          "id": 244566,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cranial Nerve IX</span></span></p>"
        },
        {
          "id": 244567,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cranial Nerve XII</span></span></p>"
        },
        {
          "id": 244568,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cranial Nerve XI</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presents with difficulty swallowing and hoarseness of voice. During the physical examination, when the posterior pharyngeal wall is touched with a tongue depressor, she exhibits a gag reflex.&nbsp; Which of the following cranial nerves is responsible for the sensory component of the gag reflex? </span></span></p>",
      "unique_key": "Q3697745",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Cranial Nerve IX</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>gag reflex</strong> is a protective reflex involving the <strong>sensory</strong> and <strong>motor innervation</strong> of the <strong>pharynx</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cranial Nerve IX (Glossopharyngeal nerve)&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">provides the <strong>sensory innervation</strong> to the <strong>posterior third of the tongue</strong> and the <strong>pharyngeal mucosa</strong>, which is stimulated during the <strong>gag reflex</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When the <strong>posterior pharyngeal wall</strong> is touched, <strong>Cranial Nerve IX</strong> senses the touch and sends sensory signals to the <strong>brainstem</strong>. The <strong>motor response</strong> of the gag reflex is then mediated by <strong>Cranial Nerve X (Vagus nerve)</strong>, causing the <strong>elevation of the palate</strong> and <strong>pharyngeal contraction</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Cranial Nerve X (Vagus nerve)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. While <strong>Cranial Nerve X</strong> mediates the <strong>motor response</strong> of the <strong>gag reflex</strong> (i.e., <strong>palate elevation</strong> and <strong>pharyngeal contraction</strong>), it does not provide the <strong>sensory input</strong> that initiates the reflex.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Cranial Nerve XII (Hypoglossal nerve)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. <strong>Cranial Nerve XII</strong> controls <strong>motor function</strong> of the <strong>tongue</strong> muscles, but it is not involved in the <strong>sensory or motor components</strong> of the <strong>gag reflex</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cranial Nerve XI (Accessory nerve)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. <strong>Cranial Nerve XI</strong> primarily innervates the <strong>sternocleidomastoid</strong> and <strong>trapezius muscles</strong>, playing no role in the <strong>gag reflex</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>gag reflex</strong> involves the <strong>sensory limb</strong> carried by the <strong>Glossopharyngeal nerve (CN IX)</strong> and the <strong>motor limb</strong> carried by the <strong>Vagus nerve (CN X)</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulating the <strong>posterior pharyngeal wall</strong> activates <strong>Cranial Nerve IX</strong>, leading to a reflexive <strong>pharyngeal contraction</strong> through <strong>Cranial Nerve X</strong>. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244566,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61233,
      "choices": [
        {
          "id": 244213,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized cardioversion</span></span></span></span></p>"
        },
        {
          "id": 244214,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous diltiazem</span></span></span></span></p>"
        },
        {
          "id": 244215,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Correct underlying electrolyte abnormalities</span></span></span></span></p>"
        },
        {
          "id": 244216,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous amiodarone</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 76-year-old woman with a history of chronic obstructive pulmonary disease (COPD) and heart failure presents to the emergency department with worsening shortness of breath over the past 3 days. She denies chest pain or palpitations. On examination, her temperature is 99.5&deg;F, blood pressure is 145/85 mm Hg, pulse is irregular at 135/min, and oxygen saturation is 88% on room air. Jugular venous distention and bilateral wheezing are noted. An ECG is taken and shown below. Which of the following is the most appropriate next step in management?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162515.png\" style=\"height:160px; width:300px\" /></span></span></p>",
      "unique_key": "Q8263498",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Correct underlying electrolyte abnormalities</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multifocal atrial tachycardia (MAT) is commonly associated with chronic lung diseases like COPD and is often triggered by hypoxemia or electrolyte disturbances. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The management of MAT primarily involves correcting the underlying causes, such as hypoxemia, hypokalemia, or hypomagnesemia, rather than using traditional antiarrhythmic medications. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Addressing these triggers can help stabilize the arrhythmia and improve overall clinical status.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Synchronized cardioversion</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cardioversion is not indicated in MAT as it is not effective in arrhythmias arising from multiple atrial foci, unlike atrial fibrillation or flutter.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Intravenous diltiazem</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While rate control may be beneficial, diltiazem is not the first-line treatment in MAT since treating the underlying condition (e.g., electrolyte imbalances or hypoxemia) is more effective.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Intravenous amiodarone</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Amiodarone is used for various arrhythmias, but in MAT, it is less effective compared to correcting the precipitating factors like electrolyte disturbances.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The primary management of multifocal atrial tachycardia involves correcting the underlying causes such as hypoxemia and electrolyte imbalances, especially in patients with chronic pulmonary conditions.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244215,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61288,
      "choices": [
        {
          "id": 244433,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulates cell cycle progression</span></span></p>"
        },
        {
          "id": 244434,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Regulates apoptosis</span></span></p>"
        },
        {
          "id": 244435,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repairs double-strand DNA breaks</span></span></p>"
        },
        {
          "id": 244436,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Encodes a cell surface receptor for growth factors</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 51-year-old woman with a significant family history of early-onset breast and ovarian cancer undergoes genetic screening. The results reveal a pathogenic variant in the BRCA1 gene. Which of the following best describes the primary role of the BRCA1 gene in cellular function?</span></span></p>",
      "unique_key": "Q6503483",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Repairs double-strand DNA breaks</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>BRCA1</strong> gene is critical in maintaining genomic stability by facilitating the repair of <strong>double-strand DNA breaks</strong> through homologous recombination, a high-fidelity repair mechanism. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutations in the BRCA1 gene result in impaired DNA repair, leading to an accumulation of genetic damage, which increases the risk of breast and ovarian cancers. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This function distinguishes BRCA1 as a key player in preventing malignancies.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Stimulates cell cycle progression</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: BRCA1 is not directly involved in stimulating cell cycle progression. Instead, it acts more as a safeguard, halting cell cycle progression to allow for DNA repair when damage is detected.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Regulates apoptosis</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Although BRCA1 is indirectly involved in the regulation of apoptosis as a response to DNA damage, its primary function is DNA repair, not directly inducing or regulating apoptosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Encodes a cell surface receptor for growth factors</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This function is more characteristic of genes like <strong>HER2</strong>, which encode growth factor receptors involved in cell signalling. BRCA1 is primarily involved in the DNA damage response and repair.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA1 is a tumor suppressor gene crucial for <strong>repairing double-strand DNA breaks</strong> through homologous recombination. A mutation in BRCA1 disrupts this repair process, increasing susceptibility to breast and ovarian cancers.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244435,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61486,
      "choices": [
        {
          "id": 245221,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T8, T9</span></span></p>"
        },
        {
          "id": 245222,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">L1, L2</span></span></p>"
        },
        {
          "id": 245223,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">L3, L4</span></span></p>"
        },
        {
          "id": 245224,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S1, S2</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 14-year-old boy is brought to the emergency department after experiencing trauma to the right groin area while playing sports. On physical examination, the physician lightly strokes the inner thigh, leading to a reflex contraction of the cremaster muscle, causing elevation of the right testis. Which of the following spinal nerve roots is responsible for this cremasteric reflex?</span></span></p>",
      "unique_key": "Q3178209",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) L1, L2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>cremasteric reflex</strong> is mediated by the <strong>genitofemoral nerve</strong>, which originates from the <strong>L1 and L2</strong> nerve roots. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This reflex involves the <strong>afferent limb</strong> from the <strong>ilioinguinal nerve</strong> (L1) and the <strong>efferent limb</strong> via the <strong>genitofemoral nerve</strong> (L1-L2). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Stroking the inner thigh activates sensory fibers, leading to contraction of the <strong>cremaster muscle</strong> and resulting in <strong>elevation of the testis</strong> on the same side.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. T8, T9</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The <strong>T8-T9 nerve roots</strong> are primarily associated with the <strong>upper abdominal muscles</strong> and the <strong>cutaneous innervation</strong> of the upper abdominal wall, not with the cremasteric reflex.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. L3, L4</span></strong><span style=\"font-size:14.0pt\">: Incorrect. While <strong>L3 and L4</strong> are involved in <strong>patellar reflexes</strong> and <strong>leg innervation</strong>, they do not contribute to the <strong>genitofemoral nerve</strong> or the <strong>cremasteric reflex</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D. S1, S2</strong>: Incorrect. The <strong>S1 and S2 nerve roots</strong> are typically involved in <strong>lower extremity reflexes</strong> such as the <strong>Achilles reflex</strong> and do not play a role in the <strong>cremasteric reflex</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>cremasteric reflex</strong> is mediated by the <strong>L1 and L2 spinal nerve roots</strong>, specifically involving the <strong>genitofemoral nerve</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This reflex is tested by gently stroking the inner thigh, leading to contraction of the <strong>cremaster muscle</strong> and <strong>elevation of the testis</strong>. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245222,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61267,
      "choices": [
        {
          "id": 244349,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, and 4</span></span></span></span></p>"
        },
        {
          "id": 244350,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, and 3</span></span></span></span></p>"
        },
        {
          "id": 244351,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3, and 4</span></span></span></span></p>"
        },
        {
          "id": 244352,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3, and 4</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 5-year-old child presents with suspected hearing loss. The otolaryngologist wants to conduct objective tests to evaluate the child&#39;s hearing ability. Which of the following tests are considered objective methods for assessing hearing?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brainstem-evoked response audiometry (BERA)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Otoacoustic emissions (OAE)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pure tone audiometry</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tympanometry</span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q5463774",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1, 2, and 4</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Objective hearing tests&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">do not rely on the patient&#39;s subjective responses and can provide accurate assessments, especially in young children or patients who may not reliably respond to subjective tests like pure tone audiometry.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>objective tests</strong> include:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brainstem-evoked response audiometry (BERA)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This test measures electrical activity in the brainstem in response to sound stimuli. It is particularly useful in diagnosing hearing loss in infants and young children, as it does not require active participation from the patient.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Otoacoustic emissions (OAE)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This test measures sounds that are generated by the inner ear (cochlea) in response to an auditory stimulus. The presence or absence of these emissions can help assess cochlear function, making it useful for newborn hearing screenings.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tympanometry</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This test measures the movement of the tympanic membrane (eardrum) in response to changes in air pressure in the ear canal. It helps evaluate middle ear function and detect conditions such as middle ear effusion or eustachian tube dysfunction.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pure tone audiometry&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>subjective test</strong>, as it requires the patient&#39;s active response to hearing different tones at varying frequencies and intensities, and thus is not considered an objective measure.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect, as pure tone audiometry is not an objective test.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Objective hearing tests&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">such as <strong>BERA</strong>, <strong>OAE</strong>, and <strong>tympanometry</strong> are essential tools for diagnosing hearing loss in children, especially when patient cooperation may be limited. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These tests provide reliable information about the auditory pathway and middle ear function without requiring subjective feedback from the patient.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244349,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61340,
      "choices": [
        {
          "id": 244641,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of a non-human reservoir</span></span></span></span></p>"
        },
        {
          "id": 244642,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dormant or latent phase in human hosts</span></span></span></span></p>"
        },
        {
          "id": 244643,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transovarian transmission of the virus in mosquitoes</span></span></span></span></p>"
        },
        {
          "id": 244644,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Poor community sanitation and hygiene</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In India, the dengue virus persists during inter-epidemic periods through a direct man-mosquito-man transmission cycle. Which of the following mechanisms best explains the virus&#39;s survival during these periods of low human infection? </span></span></p>",
      "unique_key": "Q1187380",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Transovarian transmission of the virus in mosquitoes</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transovarian transmission&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a mechanism through which the <strong>dengue virus</strong> is passed from an infected female mosquito to its offspring through its eggs. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This allows the virus to persist in mosquito populations even during periods when there is a reduction in human cases. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This method of survival helps maintain the presence of the virus in regions like India during the inter-epidemic periods, ensuring that the virus can re-emerge when conditions are favorable for another outbreak.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Presence of a non-human reservoir:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. Unlike some other arboviruses, the dengue virus does not rely on non-human animal reservoirs for its survival. The <strong>primary vector</strong> is the <em>Aedes</em> mosquito, and the <strong>cycle</strong> is primarily between <strong>humans and mosquitoes</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Dormant or latent phase in human hosts:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. The dengue virus does not establish a latent phase in humans. Once infected, humans can carry the virus for a limited period during the acute phase of the illness, but they are not long-term carriers of the virus.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Poor community sanitation and hygiene:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. While poor sanitation can contribute to <strong>increased breeding sites for mosquitoes</strong> and higher transmission rates, it does not explain how the virus survives during periods when human infection rates are low. The <strong>transovarian transmission in mosquitoes</strong> is the key factor in virus persistence.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>dengue virus</strong> survives during the <strong>inter-epidemic periods</strong> through <strong>transovarian transmission</strong> within mosquito populations, where infected female <em>Aedes</em> mosquitoes pass the virus to their offspring. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This ensures the persistence of the virus even when human infection rates are low.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244643,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61467,
      "choices": [
        {
          "id": 245145,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">McArdle disease</span></span></p>"
        },
        {
          "id": 245146,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tarui&#39;s disease</span></span></p>"
        },
        {
          "id": 245147,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pompe disease</span></span></p>"
        },
        {
          "id": 245148,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Von Gierke disease</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old boy presents with muscle cramps and fatigue after moderate physical activity such as running or playing sports. Laboratory studies reveal elevated creatine kinase levels during episodes of muscle pain. Additionally, blood tests reveal mild chronic anemia and signs of red blood cell breakdown.&nbsp; Further analysis shows reduced activity of phosphofructokinase-1 (PFK-1) in muscle cells and red blood cells. Which of the following is the most likely diagnosis?<strong> </strong></span></span></p>",
      "unique_key": "Q7114405",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Tarui&#39;s disease</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tarui&#39;s disease, or Glycogen Storage Disease type VII, is caused by a deficiency in phosphofructokinase-1 (PFK-1), an essential enzyme in glycolysis. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The deficiency affects both muscle cells and red blood cells. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During physical activity, muscle cells cannot adequately use glucose for energy, leading to muscle cramps, fatigue, and elevated creatine kinase due to muscle damage. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additionally, because PFK-1 is also involved in glycolysis in red blood cells, the deficiency can cause hemolysis, leading to mild chronic anemia.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. McArdle disease:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is characterized by a deficiency in muscle glycogen phosphorylase, leading to muscle cramps and exercise intolerance. However, McArdle disease does not involve hemolytic anemia, which is a distinguishing feature of Tarui&#39;s disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pompe disease:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pompe disease (Glycogen Storage Disease type II) is due to a deficiency in acid alpha-glucosidase and primarily affects cardiac and skeletal muscles, leading to cardiomegaly, muscle weakness, and respiratory failure. It does not present with exercise-induced muscle cramps and is not associated with PFK-1 deficiency.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Von Gierke disease:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Von Gierke disease (Glycogen Storage Disease type I) is caused by a deficiency of glucose-6-phosphatase, leading to severe hypoglycemia, lactic acidosis, and hepatomegaly. It is not associated with muscle cramps or hemolytic anemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tarui&#39;s disease (Glycogen Storage Disease type VII) is caused by a deficiency of phosphofructokinase-1 (PFK-1) in muscle cells and red blood cells, leading to exercise-induced muscle cramps, myoglobinuria, and hemolytic anemia.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245146,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61319,
      "choices": [
        {
          "id": 244557,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Articular hyaline cartilage</span></span></p>"
        },
        {
          "id": 244558,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-articular hyaline cartilage</span></span></p>"
        },
        {
          "id": 244559,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">White fibrocartilage</span></span></p>"
        },
        {
          "id": 244560,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Yellow cartilage</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man presents with chronic joint pain and reduced mobility in his knee. Imaging reveals degenerative changes in the knee joint, prompting a biopsy of the joint cartilage. The histopathological image of the cartilage is shown below. Based on the microscopic appearance, which of the following types of cartilage is most likely present?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-173633.png\" style=\"height:227px; width:300px\" /></span></span></p>",
      "unique_key": "Q7411066",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) White fibrocartilage</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows <strong>prominent collagen fibers</strong> arranged in bundles with <strong>intervening rows of chondrocytes</strong>, characteristic of <strong>white fibrocartilage</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fibrocartilage&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is found in structures that require <strong>tensile strength and shock absorption</strong>, such as the <strong>intervertebral discs</strong>, <strong>pubic symphysis</strong>, and <strong>menisci</strong> of the knee. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>dense collagenous matrix</strong> helps resist <strong>compression and shear forces</strong>, making it ideal for <strong>supporting weight</strong> and <strong>maintaining joint integrity</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Articular hyaline cartilage</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. <strong>Hyaline cartilage</strong> is characterized by a <strong>smooth, glassy matrix</strong> with <strong>scattered chondrocytes</strong> in <strong>lacunae</strong> and minimal visible collagen fibers. It forms the <strong>articular surfaces</strong> of most joints, providing a <strong>smooth surface</strong> for <strong>joint movement</strong>. The image does not show the typical <strong>homogeneous appearance</strong> of <strong>hyaline cartilage</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Non-articular hyaline cartilage</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. <strong>Non-articular hyaline cartilage</strong> is similar in appearance to <strong>articular hyaline cartilage</strong> but is found in locations like the <strong>trachea</strong> and <strong>nasal septum</strong>. The given image shows <strong>collagen fiber bundles</strong>, which are not characteristic of <strong>hyaline cartilage</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Yellow cartilage</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. <strong>Yellow cartilage</strong>, also known as <strong>elastic cartilage</strong>, contains <strong>elastic fibers</strong> in addition to <strong>collagen</strong>. It is found in the <strong>external ear</strong>, <strong>epiglottis</strong>, and <strong>eustachian tube</strong>. The image does not show the characteristic <strong>elastin network</strong> seen in <strong>yellow cartilage</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">White fibrocartilage&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by <strong>dense collagen bundles</strong> and is found in structures that require <strong>high tensile strength</strong>, such as the <strong>menisci</strong> and <strong>intervertebral discs</strong>. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244559,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61300,
      "choices": [
        {
          "id": 244481,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">WAGR syndrome; wt 1 gene (11p13)</span></span></span></p>"
        },
        {
          "id": 244482,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Denys-drash syndrome: wt 1 gene (11p13)</span></span></span></p>"
        },
        {
          "id": 244483,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Beckwith Wiedmann syndrome; wt 2 gene (11p15.5)</span></span></span></p>"
        },
        {
          "id": 244484,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Downs syndrome. (21 Trisomy)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A mother brings her 2-year-old child with complaints of his large tongue which is not completely accommodated in his mouth as shown in the image and enlargement of only one side of the body and limbs. On further evaluation earlobe creases were noted. Identify the syndrome the baby is presenting with and its gene responsible?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-163302.jpg\" style=\"height:351px; width:400px\" /></span></span></p>",
      "unique_key": "Q5472957",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Beckwith Wiedmann syndrome; wt 2 gene (11p15.5)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Beckwith-Wiedemann syndrome (BWS) is characterized by features such as <strong>macroglossia</strong> (large tongue), <strong>hemihyperplasia</strong> (enlargement of one side of the body), and <strong>earlobe creases or pits</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These features are indicative of an overgrowth disorder present from birth. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">BWS is associated with mutations or alterations in the <strong>WT2 gene locus on chromosome 11p15.5</strong>, which regulates growth. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Other features of BWS may include abdominal wall defects, hypoglycemia in infancy, and an increased risk of tumors such as Wilms&#39; tumor.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. WAGR syndrome; WT1 gene (11p13):&nbsp;</span></strong><span style=\"font-size:14.0pt\">WAGR syndrome includes <strong>Wilms&#39; tumor</strong>, <strong>Aniridia</strong> (absence of the iris), <strong>Genitourinary abnormalities</strong>, and <strong>mental Retardation</strong>. It is associated with deletions in the <strong>WT1 gene on chromosome 11p13</strong>, not 11p15.5, and does not typically present with macroglossia or hemihyperplasia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Denys-Drash syndrome; WT1 gene (11p13):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Denys-Drash syndrome is characterized by <strong>Wilms&#39; tumor</strong>, <strong>pseudohermaphroditism</strong>, and <strong>glomerulopathy</strong> leading to kidney failure. It is linked to mutations in the <strong>WT1 gene</strong>. Unlike BWS, it does not present with macroglossia or hemihyperplasia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Down syndrome (Trisomy 21):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Down syndrome is characterized by features such as a <strong>single palmar crease</strong>, <strong>sandal gap</strong>, <strong>upslanting palpebral fissures</strong>, and <strong>hypotonia</strong>. It results from an extra copy of chromosome 21 (Trisomy 21). It does not present with macroglossia, hemihyperplasia, or earlobe creases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Beckwith-Wiedemann syndrome is a congenital overgrowth disorder characterized by features like macroglossia, hemihyperplasia, and ear creases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is associated with genetic changes in the WT2 gene locus on chromosome 11p15.5, leading to abnormal regulation of growth. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244483,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61493,
      "choices": [
        {
          "id": 245249,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta neuron</span></span></p>"
        },
        {
          "id": 245250,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gamma neuron</span></span></p>"
        },
        {
          "id": 245251,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha neuron</span></span></p>"
        },
        {
          "id": 245252,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delta neuron</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following types of neurons innervates the intrafusal fibers of the muscle spindle?<strong> </strong></span></span></p>",
      "unique_key": "Q1956865",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Gamma neuron</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gamma motor neurons innervate the intrafusal fibers within muscle spindles.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;These neurons regulate the sensitivity of muscle spindles to stretch, ensuring that the spindle can adjust to changes in muscle length.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Activation of gamma neurons causes contraction of intrafusal fibers, maintaining tension and sensitivity to muscle stretch, which is essential for proprioception and fine-tuning muscle activity.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Beta neuron</span></strong><span style=\"font-size:14.0pt\">: Beta motor neurons primarily innervate extrafusal muscle fibers and have a role in muscle contraction. They do not play a significant role in directly modulating the sensitivity of the muscle spindle.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Alpha neuron</span></strong><span style=\"font-size:14.0pt\">: Alpha motor neurons innervate extrafusal muscle fibers, which are responsible for the actual contraction of muscles. While crucial for muscle movement, they do not directly influence the sensitivity of the muscle spindle.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Delta neuron</span></strong><span style=\"font-size:14.0pt\">: Delta neurons (A-delta fibers) are sensory neurons that transmit pain and temperature sensations rather than motor control. They do not have a role in the regulation of muscle spindle function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gamma motor neurons provide the motor supply to intrafusal muscle fibers of the muscle spindle, allowing adjustment of spindle sensitivity to muscle stretch, which is crucial for proprioception.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245250,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61480,
      "choices": [
        {
          "id": 245197,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Carcinoma cervix</span></span></span></p>"
        },
        {
          "id": 245198,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Carcinoma endometrium</span></span></span></p>"
        },
        {
          "id": 245199,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Carcinoma vulva</span></span></span></p>"
        },
        {
          "id": 245200,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Carcinoma vagina</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old woman is diagnosed with a gynecological malignancy that has a risk of lymphatic spread. She is scheduled for a sentinel lymph node biopsy to evaluate potential metastasis. In which of the following cancers is this procedure most useful for determining lymph node involvement? </span></span></p>",
      "unique_key": "Q7507537",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Carcinoma vulva</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sentinel lymph node biopsy (SLNB) is most useful in patients with early-stage <strong>carcinoma of the vulva</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It helps determine if the cancer has spread to the lymph nodes without the need for a more extensive lymph node dissection, thereby reducing morbidity. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The sentinel lymph node is the first lymph node to which cancer cells are likely to spread from the primary tumor. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If this node is negative for cancer, it is likely that the remaining lymph nodes are also free of cancer, allowing for less invasive treatment.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Carcinoma cervix:</span></strong><span style=\"font-size:14.0pt\"> Although lymph node involvement is significant in carcinoma of the cervix, the use of SLNB is not the standard of care for this cancer type. More extensive lymph node dissection or imaging studies are typically used for staging.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Carcinoma endometrium:</span></strong><span style=\"font-size:14.0pt\"> Sentinel lymph node biopsy can be used in certain cases of endometrial cancer, especially in early stages, but it is not as well-established as it is in vulvar cancer. Traditional staging procedures often involve a more extensive lymph node dissection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Carcinoma vagina:</span></strong><span style=\"font-size:14.0pt\"> SLNB is not typically used in the management of vaginal cancer. This cancer type is rare, and the standard approach usually involves other methods for assessing lymph node involvement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Sentinel lymph node biopsy (SLNB)&nbsp;</span></strong><span style=\"font-size:14.0pt\">is most valuable in <strong>early-stage carcinoma of the vulva</strong> to assess lymph node involvement while minimizing the need for extensive lymph node dissection. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It helps determine the spread of cancer to lymph nodes and guides further treatment.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245199,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61226,
      "choices": [
        {
          "id": 244185,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased renin release and aldosterone secretion</span></span></span></span></p>"
        },
        {
          "id": 244186,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated atrial natriuretic peptide (ANP) due to central volume expansion</span></span></span></span></p>"
        },
        {
          "id": 244187,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enhanced proximal tubular sodium reabsorption</span></span></span></span></p>"
        },
        {
          "id": 244188,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suppression of the hypothalamic-pituitary-adrenal (HPA) axis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man is brought to the emergency department 30 minutes after falling through the ice while skating on a frozen lake. He presents with confusion and disorientation. His temperature is 93.2&deg;F, pulse is 120/min, and respirations are 22/min. Physical examination reveals cold, pale extremities, and numbness of the fingers. His blood pressure is 110/70 mm Hg. Laboratory results show mildly elevated serum creatinine, normal electrolyte levels, and an increased urine output over the next several hours. Further evaluation reveals a decrease in serum antidiuretic hormone (ADH) levels. Which of the following additional findings would be most consistent with the underlying physiological mechanism of this patient&rsquo;s presentation?</span></span></p>",
      "unique_key": "Q3463951",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Elevated atrial natriuretic peptide (ANP) due to central volume expansion</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In hypothermia, peripheral vasoconstriction occurs as a compensatory response to conserve heat, which leads to an increase in central blood volume. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The body perceives this volume shift as an excess, leading to increased atrial stretch and subsequent release of atrial natriuretic peptide (ANP). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The increase in ANP contributes to natriuresis and diuresis. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additionally, the perceived central volume expansion causes a decrease in ADH secretion, further promoting urine production, known as cold-induced diuresis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Increased renin release and aldosterone secretion</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Increased central blood volume and elevated ANP typically suppress the renin-angiotensin-aldosterone system (RAAS). Thus, renin release and aldosterone secretion would be decreased, not increased.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Enhanced proximal tubular sodium reabsorption</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Increased ANP promotes natriuresis by inhibiting sodium reabsorption in the collecting ducts rather than enhancing proximal tubular reabsorption.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Suppression of the hypothalamic-pituitary-adrenal (HPA) axis</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hypothermia triggers a stress response, leading to activation, not suppression, of the HPA axis. This response is aimed at increasing glucocorticoid production to manage metabolic demands.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In hypothermia, cold-induced diuresis is driven by an increase in central blood volume due to peripheral vasoconstriction. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This leads to elevated ANP levels, suppression of ADH, and increased urine production. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding these interrelated physiological changes is crucial in managing hypothermic patients.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244186,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61249,
      "choices": [
        {
          "id": 244277,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1</span></span></p>"
        },
        {
          "id": 244278,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.6</span></span></p>"
        },
        {
          "id": 244279,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.7</span></span></p>"
        },
        {
          "id": 244280,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.9</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man is being evaluated for metabolic concerns, and during the assessment, the clinician is comparing the metabolic characteristics of various body tissues. When discussing the energy production of the lens, the clinician emphasizes that the respiratory quotient (RQ) is distinct due to its predominant metabolic process. What is the respiratory quotient of the lens?</span></span></p>",
      "unique_key": "Q1365124",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) 1</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>respiratory quotient (RQ)</strong> of the <strong>lens</strong> is <strong>1</strong>, which indicates that the lens primarily metabolizes glucose through anaerobic glycolysis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The RQ of 1 is characteristic of carbohydrate metabolism, which means that the volume of carbon dioxide produced is equal to the volume of oxygen consumed. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Since the lens relies predominantly on glycolysis due to its avascular nature, glucose is its primary energy source.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>respiratory quotient (RQ)</strong> of <strong>1</strong> for the lens indicates that it primarily relies on carbohydrates for energy production. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244277,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61285,
      "choices": [
        {
          "id": 244421,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pulmonary edema</span></span></span></p>"
        },
        {
          "id": 244422,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute renal failure</span></span></span></p>"
        },
        {
          "id": 244423,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Active cerebral bleeding</span></span></span></p>"
        },
        {
          "id": 244424,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cerebral edema</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following conditions is not a contraindication for the use of osmotic diuretics?<strong> </strong></span></span></p>",
      "unique_key": "Q6024265",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Cerebral edema</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Cerebral edema&nbsp;</span></strong><span style=\"font-size:14.0pt\">is an indication, not a contraindication, for the use of osmotic diuretics such as <strong>mannitol</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Osmotic diuretics can reduce intracranial pressure by drawing water out of the brain tissue into the bloodstream, which helps decrease cerebral swelling and pressure.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Pulmonary edema</span></strong><span style=\"font-size:14.0pt\">: Osmotic diuretics can exacerbate pulmonary edema by increasing intravascular volume, which can worsen respiratory distress. Therefore, they are contraindicated in this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Acute renal failure</span></strong><span style=\"font-size:14.0pt\">: Osmotic diuretics may be contraindicated in acute renal failure because they require functioning kidneys to eliminate the excess fluid and can potentially worsen fluid overload if the kidneys are not functioning adequately.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Active cerebral bleeding</span></strong><span style=\"font-size:14.0pt\">: Osmotic diuretics are contraindicated in patients with active cerebral bleeding, as they can increase blood flow to the brain and potentially worsen the bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Osmotic diuretics&nbsp;</span></strong><span style=\"font-size:14.0pt\">are <strong>indicated</strong> for conditions like <strong>cerebral edema</strong> to reduce intracranial pressure.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are <strong>contraindicated</strong> in conditions like <strong>pulmonary edema</strong>, <strong>acute renal failure</strong>, and <strong>active cerebral bleeding</strong> due to the risk of worsening fluid overload or exacerbating bleeding.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244424,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61273,
      "choices": [
        {
          "id": 244373,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberous sclerosis</span></span></span></span></p>"
        },
        {
          "id": 244374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neurofibromatosis type 2</span></span></span></span></p>"
        },
        {
          "id": 244375,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neurofibromatosis type 1</span></span></span></span></p>"
        },
        {
          "id": 244376,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sturge-Weber syndrome</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 31-year-old woman presents with persistent headaches and a progressive decrease in hearing. She undergoes an MRI of the brain, which is shown below. Based on these findings, which of the following conditions is most likely responsible for this presentation? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-170119.png\" style=\"height:303px; width:300px\" /></p>",
      "unique_key": "Q2602706",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B) Neurofibromatosis type 2</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The MRI of image shows bilateral cerebellopontine angle masses, which are characteristic of vestibular schwannomas. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vestibular schwannomas, especially when bilateral, are highly suggestive of Neurofibromatosis type 2 (NF2). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NF2 is an autosomal dominant disorder characterized by the presence of bilateral vestibular schwannomas, meningiomas, and other CNS tumors. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of these findings in a young patient with decreased hearing points strongly towards this diagnosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Tuberous sclerosis:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberous sclerosis typically presents with cortical tubers, subependymal nodules, and renal angiomyolipomas. It does not typically present with bilateral vestibular schwannomas, making this answer incorrect in the context of the presented imaging and symptoms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Neurofibromatosis type 1:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NF1 is more commonly associated with neurocutaneous manifestations such as caf&eacute;-au-lait spots, neurofibromas, and optic gliomas. It does not typically involve vestibular schwannomas, especially not bilaterally.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Sturge-Weber syndrome:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is characterized by a port-wine stain and leptomeningeal angiomas leading to seizures and neurological deficits. It is not associated with vestibular schwannomas or findings in the cerebellopontine angle.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral vestibular schwannomas seen on brain imaging are pathognomonic for Neurofibromatosis type 2 (NF2). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NF2 is an autosomal dominant disorder characterized by multiple central nervous system tumors, including bilateral vestibular schwannomas, which can lead to hearing loss and other neurological symptoms.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244374,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61346,
      "choices": [
        {
          "id": 244665,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bhore Committee</span></span></p>"
        },
        {
          "id": 244666,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mudaliar Committee</span></span></p>"
        },
        {
          "id": 244667,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chadha Committee</span></span></p>"
        },
        {
          "id": 244668,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kartar Singh Committee</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A public health consultant is evaluating the staffing structure of rural sub-centers in India to ensure they meet the recommended guidelines for primary healthcare delivery. She finds that one of the historical committees emphasized that each sub-center should be equipped with one male health worker and one female health worker to provide balanced care to the community. Which of the following committees made this specific recommendation to enhance the accessibility and quality of healthcare in rural areas?</span></span></p>",
      "unique_key": "Q1418956",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Kartar Singh Committee</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kartar Singh Committee (1973):</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also known as &lsquo;Committee on Multipurpose Workers under Health and Family Planning&rsquo;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ANMs to be replaced by &lsquo;Female Health Workers&rsquo;; Basic health workers, Malaria surveillance workers, Vaccinators, Health education assistants and family planning health assistants be replaced by &lsquo;Male Health Workers&rsquo;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 PHC for 50,000 population, 15&ndash;16 subcentres each for 3,000&ndash;3,500 population</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Each subcentre be staffed by team of one male and one female health worker</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 Male Health Supervisor per 3&ndash;4 male health workers and 1 Female Health Supervisor per 4 female health workers</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lady Health Visitors be designated as Female Health Supervisors</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doctor in charge of PHC should have overall charge of supervisors and health workers in his area</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bhore Committee: Health Survey &amp; Development Committee</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mudaliar Committee: Health Survey &amp; Planning Committee</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Jungalwallah Committee: Committee on Integration of Health Services</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kartar Singh Committee: Committee on MPWs under Health &amp; Family Planning</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244668,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61252,
      "choices": [
        {
          "id": 244289,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To examine the posterior nasal cavity</span></span></p>"
        },
        {
          "id": 244290,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To visualize the larynx and vocal cords</span></span></p>"
        },
        {
          "id": 244291,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To remove foreign bodies from the ear canal</span></span></p>"
        },
        {
          "id": 244292,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To perform nasal septal surgery</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A physician uses the instrument shown in the image during a clinical examination. Which of the following is the primary use of this instrument?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162449.jpg\" style=\"height:298px; width:400px\" /></span></span></p>",
      "unique_key": "Q1896630",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) To visualize the larynx and vocal cords</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The instrument shown is a <strong>laryngeal mirror</strong>. It is primarily used for <strong>indirect laryngoscopy</strong> to visualize the <strong>larynx</strong>, including the <strong>vocal cords</strong>, epiglottis, and surrounding structures. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The mirror is gently placed at the back of the throat, and the reflection helps the physician view the laryngeal area without the need for invasive procedures.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. To examine the posterior nasal cavity</span></strong><span style=\"font-size:14.0pt\">: This procedure is typically done using a <strong>post-nasal mirror</strong>, which is smaller and angled differently to access the back of the nasal cavity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. To remove foreign bodies from the ear canal</span></strong><span style=\"font-size:14.0pt\">: This requires specialized ear instruments like <strong>ear forceps</strong> or an <strong>ear curette</strong>, not a laryngeal mirror.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. To perform nasal septal surgery</span></strong><span style=\"font-size:14.0pt\">: Surgical procedures on the nasal septum require <strong>surgical tools</strong> like <strong>septal elevators</strong> or <strong>nasal speculums</strong>, not a laryngeal mirror.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A <strong>laryngeal mirror</strong> is used for <strong>indirect visualization</strong> of the <strong>larynx and vocal cords</strong>, allowing clinicians to assess the structures of the throat without invasive procedures.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244290,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61455,
      "choices": [
        {
          "id": 245097,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cataract</span></span></p>"
        },
        {
          "id": 245098,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Corectopia</span></span></p>"
        },
        {
          "id": 245099,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iris cysts</span></span></p>"
        },
        {
          "id": 245100,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iris atrophy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old female presents with progressive changes in her right eye, including blurred vision and an abnormal pupil position. After slit-lamp examination, the patient is diagnosed with Iridocorneal Endothelial (ICE) syndrome. Which of the following findings is not typically associated with ICE syndrome?<strong> </strong></span></span></p>",
      "unique_key": "Q3669615",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Cataract</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Cataract&nbsp;</span></strong><span style=\"font-size:14.0pt\">is&nbsp;<strong>not</strong> typically associated with Iridocorneal Endothelial (ICE) syndrome. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ICE syndrome is characterized by changes primarily affecting the cornea, iris, and the angle structures of the eye.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Corectopia</strong>: Displacement of the pupil is a classic feature of ICE syndrome and is due to abnormal contraction of the iris tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Iris cysts</strong>: Although less common than other features, <strong>iris cysts</strong> can be seen in ICE syndrome due to irregularities in the iris stroma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Iris atrophy</strong>: <strong>Iris atrophy</strong> is a common feature of ICE syndrome and often appears as progressive thinning and loss of iris tissue, resulting in changes in pupil shape and appearance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Iridocorneal Endothelial (ICE) syndrome&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a rare ocular condition characterized by <strong>corectopia</strong>, <strong>iris atrophy</strong>, and corneal endothelial abnormalities. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The exact mechanism is unknown, however there appears to be a component of abnormal corneal endothelium that proliferates onto the iris forming a membrane that then obstructs the trabecular meshwork, leading to iris distortion. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nodule formation can also occur when the abnormal corneal endothelium causes contractions around the iris stroma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Herpesvirus DNA has been identified in some patients following keratoplasty, suggesting the possibility that herpes simplex virus may induce the abnormal endothelialization in the anterior chamber angle and on the surface of the iris.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Cataracts</span></strong><span style=\"font-size:14.0pt\"> are not a typical feature of ICE syndrome, and distinguishing these findings is essential in recognizing and managing this rare disorder effectively.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245097,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61258,
      "choices": [
        {
          "id": 244313,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cooperative Binding</span></span></span></span></p>"
        },
        {
          "id": 244314,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Michaelis-Menten Kinetics</span></span></span></span></p>"
        },
        {
          "id": 244315,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allosteric Activation</span></span></span></span></p>"
        },
        {
          "id": 244316,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sigmoid Curve</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the graph provided, which type of enzyme kinetics is most likely demonstrated in this scenario?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-165115.png\" style=\"height:289px; width:300px\" /></p>",
      "unique_key": "Q6583511",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>B) Michaelis-Menten Kinetics</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The graph displays a <strong>hyperbolic curve,</strong> which is characteristic of enzymes following <strong>Michaelis-Menten kinetics</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this type of enzyme reaction, as the substrate concentration increases, the reaction velocity (v) rises rapidly until it reaches a maximum velocity (Vmax), beyond which increasing the substrate concentration does not significantly increase the reaction rate. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Michaelis constant (Km) represents the substrate concentration at which the reaction velocity is half of Vmax, providing insight into the enzyme&#39;s affinity for its substrate.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Cooperative Binding:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cooperative binding typically results in a sigmoidal (S-shaped) curve, not a hyperbolic one. This type of curve is seen with enzymes or proteins like hemoglobin, where substrate binding increases the affinity for subsequent substrate molecules.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Allosteric Activation:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allosteric enzymes often display sigmoidal curves due to changes in enzyme conformation upon binding of an allosteric activator. The provided graph lacks the S-shape characteristic of allosteric enzyme activity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Sigmoid Curve:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The graph in the question is hyperbolic, not sigmoidal. Sigmoidal curves are seen in cooperative enzyme binding, where the initial binding of the substrate alters the affinity of the enzyme for additional substrate molecules.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Michaelis-Menten kinetics is characterized by a hyperbolic relationship between reaction velocity and substrate concentration, where Vmax represents the maximum rate of the reaction, and Km indicates the substrate concentration at which the reaction velocity is half of Vmax. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This model is typical for many enzymes under steady-state conditions.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-165144.png\" style=\"height:194px; width:300px\" /></span></span></span></span></p>",
      "correct_choice_id": 244314,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61466,
      "choices": [
        {
          "id": 245141,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute tubular necrosis</span></span></p>"
        },
        {
          "id": 245142,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor lysis syndrome</span></span></p>"
        },
        {
          "id": 245143,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Syndrome of inappropriate antidiuretic hormone (SIADH)</span></span></p>"
        },
        {
          "id": 245144,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypercalcemia of malignancy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male with a history of high-grade non-Hodgkin lymphoma begins chemotherapy. Within 24 hours, he develops nausea, vomiting, and muscle weakness. Laboratory studies reveal hyperkalemia, hyperphosphatemia, hypocalcemia and elevated uric acid levels. Which of the following is the most likely underlying pathology?<strong> </strong></span></span></p>",
      "unique_key": "Q6925685",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Tumor lysis syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tumor lysis syndrome (TLS) occurs when rapidly dividing cancer cells are lysed, releasing intracellular contents into the bloodstream. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This leads to hyperkalemia (due to potassium release), hyperphosphatemia (from cell breakdown), and secondary hypocalcemia (due to phosphate binding calcium). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevated uric acid levels result from the breakdown of purines. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The symptoms of nausea, vomiting, and muscle weakness, along with these laboratory findings, are classic indicators of TLS.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Acute tubular necrosis:</span></strong><span style=\"font-size:14.0pt\"> While acute tubular necrosis (ATN) can cause renal dysfunction and elevated creatinine levels, it does not typically cause the specific combination of electrolyte imbalances (hyperkalemia, hyperphosphatemia, and hypocalcemia) seen in TLS. ATN would also not directly cause hyperuricemia in the context of rapid tumor cell breakdown.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Syndrome of inappropriate antidiuretic hormone (SIADH):</span></strong><span style=\"font-size:14.0pt\"> SIADH typically leads to hyponatremia due to water retention and is not associated with the hyperkalemia, hyperphosphatemia, or hyperuricemia characteristic of TLS. SIADH is not a common consequence of chemotherapy for hematologic malignancies like lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Hypercalcemia of malignancy:</span></strong><span style=\"font-size:14.0pt\"> Hypercalcemia of malignancy is often seen with certain cancers, but it is associated with elevated calcium levels, not hypocalcemia as seen in TLS. It also does not present with hyperphosphatemia and hyperuricemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tumor lysis syndrome is characterized by the rapid release of intracellular contents into the blood following the destruction of malignant cells, leading to hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia.</span> </span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition is often triggered by chemotherapy in patients with high-grade malignancies, making close monitoring essential.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245142,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61284,
      "choices": [
        {
          "id": 244417,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ploucquet&rsquo;s test</span></span></span></span></p>"
        },
        {
          "id": 244418,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fodere&rsquo;s test</span></span></span></span></p>"
        },
        {
          "id": 244419,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gettler&rsquo;s test</span></span></span></span></p>"
        },
        {
          "id": 244420,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wreden&rsquo;s test</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old forensic expert is called to investigate the suspicious death of a newborn found in a remote area near a community health center. The body is partially decomposed, and the primary concern is to determine whether the newborn had been alive at birth. The forensic expert decides to use several tests that are historically known to help distinguish live birth from stillbirth. Which of the following tests is not used to determine live birth?</span></span></p>",
      "unique_key": "Q1272948",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Gettler&rsquo;s test</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gettler&#39;s test is historically used to determine the level of chloride concentration in the heart blood to distinguish between freshwater and saltwater drowning, not to assess whether a birth was live. This test does not help in determining live birth and is therefore not relevant in scenarios where the determination of live versus stillbirth is necessary.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Ploucquet&rsquo;s Test:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This test is used to determine live birth by checking whether the lungs of the deceased infant float in water, suggesting the infant breathed air (i.e., was born alive).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fodere&rsquo;s Test:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Similar to Ploucquet&rsquo;s, this test also examines lung flotation but includes additional examination of lung tissue under a microscope to confirm air inhalation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Wreden&rsquo;s test:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This test involves examining the middle ear to determine live birth. During fetal life, the middle ear contains gelatinous embryonic connective tissue, which disappears and is replaced by air after live birth. If air is found in the middle ear, it supports the idea that the newborn was alive and had taken a breath.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tests like Ploucquet&rsquo;s, Fodere&rsquo;s, and Wreden&rsquo;s are commonly used to assess whether a newborn was alive at birth by evaluating the lungs or middle ear. Gettler&rsquo;s test, used to determine drowning, is not relevant in assessing live birth.</span></span></span></span></p>",
      "correct_choice_id": 244419,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61469,
      "choices": [
        {
          "id": 245153,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&alpha;</span></span><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">-Ketoglutarate</span></span></p>"
        },
        {
          "id": 245154,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinyl CoA</span></span></p>"
        },
        {
          "id": 245155,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fumarate</span></span></p>"
        },
        {
          "id": 245156,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxaloacetate</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman presents to the emergency department with confusion and lethargy. Her history is significant for a recent episode of gastroenteritis, which led to decreased oral intake. Blood tests reveal significantly elevated ammonia levels. Which of the following substrates of the TCA cycle is most likely decreased as a result of hyperammonemia, contributing to its neurotoxicity?</span></span></p>",
      "unique_key": "Q2261748",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) &alpha;-Ketoglutarate</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hyperammonemia causes a shift in the balance between glutamate and glutamine in the brain, leading to the consumption of &alpha;-ketoglutarate. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ammonia is detoxified in the brain by combining with glutamate to form glutamine, a process that is catalyzed by glutamine synthetase. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This reaction depletes &alpha;-ketoglutarate, an essential substrate in the TCA cycle. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The loss of &alpha;-ketoglutarate results in impaired energy production in neurons, contributing to the neurotoxic effects of ammonia and leading to symptoms such as confusion and lethargy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Succinyl CoA:</span></strong><span style=\"font-size:14.0pt\"> Succinyl CoA is a TCA cycle intermediate but is not directly affected by the elevated levels of ammonia. The reduction of &alpha;-ketoglutarate due to ammonia-induced conversion of glutamate to glutamine occurs upstream of succinyl CoA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Fumarate:</span></strong><span style=\"font-size:14.0pt\"> Fumarate is downstream in the TCA cycle and is not directly influenced by hyperammonemia. The neurotoxicity of hyperammonemia is more closely related to the reduction of &alpha;-ketoglutarate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Oxaloacetate:</span></strong><span style=\"font-size:14.0pt\"> While oxaloacetate is a key intermediate in the TCA cycle, it is not the primary substrate affected by elevated ammonia levels. The depletion of &alpha;-ketoglutarate due to its role in glutamine synthesis is the central issue in hyperammonemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hyperammonemia leads to the depletion of &alpha;-ketoglutarate in the brain as ammonia is detoxified through its conversion to glutamine. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This depletion disrupts the TCA cycle, reducing energy production in neurons and contributing to the neurotoxic effects of elevated ammonia levels, such as lethargy and confusion. </span></span></li>\r\n</ul>",
      "correct_choice_id": 245153,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61323,
      "choices": [
        {
          "id": 244573,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5</span></span></span></span></p>"
        },
        {
          "id": 244574,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4</span></span></span></span></p>"
        },
        {
          "id": 244575,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2</span></span></span></span></p>"
        },
        {
          "id": 244576,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A baby assessed at 5 minutes after birth had blue extremities and irregular gasping respiration. Heart rate was 40/min, and there was a grimace with some flexion of extremities. APGAR score for this newborn is _______. </span></span></p>",
      "unique_key": "Q9374833",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A) 5</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>APGAR score</strong> in this baby is <strong>5</strong>, based on the following criteria:</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle; margin-left:40px\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Color</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Blue extremities (acrocyanosis) = <strong>Score 1</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart Rate</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 40 beats/min (less than 100/min) = <strong>Score 1</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reflex Irritability</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Grimace when stimulated = <strong>Score 1</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle Tone</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Some flexion of extremities = <strong>Score 1</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory Effort</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Irregular gasping respiration = <strong>Score 1</strong></span></span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The total APGAR score is <strong>5</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>APGAR score</strong> is assessed at <strong>1 minute</strong> and <strong>5 minutes</strong> after birth. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It evaluates five objective signs: <strong>Appearance (Color), Pulse (Heart Rate), Grimace (Reflex Irritability), Activity (Muscle Tone),</strong> and <strong>Respiration (Respiratory Effort)</strong>. Each parameter is scored from <strong>0 to 2</strong>, with <strong>2</strong> being the best score.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>APGAR score</strong> is used to quickly assess the health of a newborn immediately after birth, evaluating <strong>Appearance, Pulse, Grimace, Activity,</strong> and <strong>Respiration</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A score between <strong>0-3</strong> indicates the need for immediate resuscitation, while <strong>4-6</strong> suggests moderate difficulty, and <strong>7-10</strong> indicates a generally healthy newborn.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244573,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61457,
      "choices": [
        {
          "id": 245105,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 and 2</span></span></p>"
        },
        {
          "id": 245106,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 and 4</span></span></p>"
        },
        {
          "id": 245107,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 and 3</span></span></p>"
        },
        {
          "id": 245108,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 and 5</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A 29-year-old man presents with a painless ulcer on his penis that has been present for 2 weeks. He also has painless inguinal lymphadenopathy. The patient reports unprotected sexual activity and is concerned about a sexually transmitted infection. Serologic testing is performed. Which of the following statements about syphilis are true?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">VDRL test detects antibodies.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Jarisch-Herxheimer reaction is IgE mediated.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In primary and secondary syphilis, the treatment preferred is penicillin.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RPR is done for CSF.</span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treponema pallidum can be easily cultivated in artificial culture media.</span></span></li>\r\n</ol>",
      "unique_key": "Q5536922",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) 1 and 3</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement 1. VDRL test detects antibodies:&nbsp;</span></strong><span style=\"font-size:14.0pt\">This statement is correct. The <strong>Venereal Disease Research Laboratory (VDRL)</strong> test is a <strong>nontreponemal test</strong> used to detect <strong>reagin antibodies</strong> produced in response to cellular damage due to <strong>Treponema pallidum</strong>. It is used for screening purposes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement 3. In primary and secondary syphilis, the treatment preferred is penicillin:&nbsp;</span></strong><span style=\"font-size:14.0pt\">This is also true. The <strong>treatment of choice</strong> for <strong>primary and secondary syphilis</strong> is <strong>benzathine penicillin G</strong>, which is highly effective at eradicating the infection and preventing complications. It is recommended for all patients, including those with penicillin allergy, for whom desensitization is considered.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement 2. Jarisch-Herxheimer reaction is IgE mediated:&nbsp;</span></strong><span style=\"font-size:14.0pt\">This statement is incorrect. The <strong>Jarisch-Herxheimer reaction</strong> is an inflammatory response occurring after the start of <strong>syphilis treatment</strong> (often with penicillin), characterized by fever, chills, and myalgia, and is <strong>not IgE-mediated</strong>. It occurs due to the release of endotoxins from dying spirochetes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement 4. RPR is done for CSF:&nbsp;</span></strong><span style=\"font-size:14.0pt\">This is incorrect. The <strong>RPR (Rapid Plasma Reagin)</strong> test is a nontreponemal test used for <strong>serologic screening</strong> of syphilis in the blood, not for <strong>cerebrospinal fluid (CSF)</strong> testing. <strong>VDRL</strong> is the preferred test for CSF analysis in suspected neurosyphilis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Statement 5. Treponema pallidum can be easily cultivated in artificial culture media:&nbsp;</span></strong><span style=\"font-size:14.0pt\">This statement is false. <strong>Treponema pallidum</strong>, the bacterium causing syphilis, cannot be grown in artificial culture media. It is highly fastidious and requires specialized conditions to be studied.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Syphilis&nbsp;</span></strong><span style=\"font-size:14.0pt\">is diagnosed using <strong>nontreponemal tests</strong> such as <strong>VDRL</strong> and <strong>RPR</strong> for screening. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>preferred treatment</strong> for <strong>primary and secondary syphilis</strong> is <strong>benzathine penicillin G</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>Jarisch-Herxheimer reaction</strong> is a common inflammatory response to treatment but is <strong>not IgE-mediated</strong>. <strong>Treponema pallidum</strong> cannot be cultured in artificial media, and <strong>RPR</strong> is not used for <strong>CSF analysis</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245107,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61445,
      "choices": [
        {
          "id": 245057,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enterotoxigenic E. coli (ETEC)</span></span></span></span></p>"
        },
        {
          "id": 245058,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enteroinvasive E. coli (EIEC)</span></span></span></span></p>"
        },
        {
          "id": 245059,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enteropathogenic E. coli (EPEC)</span></span></span></span></p>"
        },
        {
          "id": 245060,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enterohemorrhagic E. coli (EHEC)</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old child presents with severe abdominal cramps, initial watery diarrhea, followed by grossly bloody diarrhea. The parents deny any fever, and there is a concern for possible hemolytic-uremic syndrome. Which strain of Escherichia coli is most likely responsible for this presentation?<strong> </strong></span></span></p>",
      "unique_key": "Q3854358",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D) Enterohemorrhagic E. coli (EHEC)</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&rsquo;s presentation of <strong>severe abdominal cramps</strong>, <strong>initial watery diarrhea</strong>, followed by <strong>grossly bloody diarrhea</strong> with little or no fever is consistent with <strong>Enterohemorrhagic E. coli (EHEC)</strong> infection. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The specific strain <strong>O157 </strong>is often associated with this presentation, which may also lead to <strong>hemolytic-uremic syndrome (HUS)</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pathogenesis involves the production of a <strong>verocytotoxin (Shiga toxin)</strong>, which <strong>inhibits protein synthesis</strong> in host cells, leading to epithelial damage in the colon and bloody diarrhea.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Enterotoxigenic E. coli (ETEC):&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Typically causes <strong>watery diarrhea, cramps, and low-grade fever</strong> in travellers and infants. It affects the <strong>small intestine</strong> and does not cause bloody diarrhea or HUS.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Enteroinvasive E. coli (EIEC):&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes <strong>dysentery-like illness</strong> with <strong>fever, cramping, and watery diarrhea</strong> that progresses to <strong>scant, bloody stools</strong>. It involves the <strong>large intestine</strong>, but fever is usually present, and the bloody diarrhea is not as prominent as in EHEC.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Enteropathogenic E. coli (EPEC):&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes <strong>copious watery diarrhea</strong> with <strong>fever, nausea, vomiting, and mucus-filled stools</strong> in infants. It is mainly associated with <strong>small intestine involvement</strong> and does not typically present with bloody diarrhea or cause HUS.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-100949.png\" style=\"height:833px; width:1000px\" /></span></span></strong></span></span></p>",
      "correct_choice_id": 245060,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61448,
      "choices": [
        {
          "id": 245069,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histamine release</span></span></p>"
        },
        {
          "id": 245070,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased bradykinin levels</span></span></p>"
        },
        {
          "id": 245071,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mast cell activation</span></span></p>"
        },
        {
          "id": 245072,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autoimmune reaction</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old woman with a history of hypertension presents to the emergency department with a sudden onset of swelling in her face, lips, and tongue. She denies difficulty breathing but mentions a tingling sensation in her mouth. She recently started taking a new antihypertensive medication. On physical examination, there is marked facial and lip swelling without urticaria or rash. Her vital signs are stable, and there is no evidence of anaphylaxis. Laboratory tests show normal serum tryptase levels. Which of the following pathophysiological mechanisms most likely explains this patient&#39;s presentation?</span></span></p>",
      "unique_key": "Q6888831",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B) Increased bradykinin levels</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms suggest <strong>angioedema</strong>, a known side effect of certain antihypertensive medications, particularly angiotensin-converting enzyme inhibitors (ACE inhibitors). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACE inhibitors lead to increased levels of bradykinin because they inhibit the enzyme responsible for bradykinin breakdown. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated bradykinin levels result in increased vascular permeability and fluid leakage into the tissues, causing swelling. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This type of angioedema typically presents with sudden onset of facial and lip swelling without urticaria and is not mediated by histamine or mast cell activation, as evidenced by normal serum tryptase levels.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Histamine release:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histamine release is associated with allergic reactions, often presenting with urticaria, pruritus, and, sometimes, anaphylaxis. The absence of these symptoms and the normal serum tryptase levels make histamine release unlikely in this scenario.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Mast cell activation:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mast cell activation, as seen in allergic reactions or anaphylaxis, leads to histamine and other mediator release, resulting in urticaria and potentially respiratory symptoms. This patient&#39;s presentation lacks these characteristics, and normal serum tryptase levels further rule out mast cell involvement.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Autoimmune reaction:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autoimmune reactions typically involve a gradual onset and may present with systemic symptoms. Angioedema from ACE inhibitor use is a more acute, bradykinin-mediated event, unrelated to autoimmune mechanisms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angioedema associated with ACE inhibitors is mediated by increased bradykinin levels, leading to sudden swelling without urticaria. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognizing this mechanism is crucial for appropriate management, which includes discontinuing the offending medication.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245070,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61328,
      "choices": [
        {
          "id": 244593,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-4, B-3, C-2, D-1</span></span></p>"
        },
        {
          "id": 244594,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-4, B-1, C-3, D-2</span></span></p>"
        },
        {
          "id": 244595,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1, B-4, C-3, D-2</span></span></p>"
        },
        {
          "id": 244596,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-2, C-4, D-1</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most appropriate kit to use for the symptom mentioned?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-174416.jpg\" style=\"height:315px; width:700px\" /></span></span></p>",
      "unique_key": "Q4294045",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) A-4, B-1, C-3, D-2</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Lower abdominal pain</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct Kit: <strong>4.</strong>&nbsp;<strong>Yellow, Kit 6</strong>. This kit is used for <strong>lower abdominal pain</strong>, typically associated with conditions like <strong>pelvic inflammatory disease (PID)</strong>. It includes <strong>Cefixime, Metronidazole, and Doxycycline</strong>, targeting common pathogens involved in PID.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Urethral discharge</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct Kit: <strong>1.&nbsp;Grey, Kit 1</strong>. <strong>Kit 1</strong> is used for symptoms like <strong>urethral discharge</strong>, indicative of <strong>gonorrhea or chlamydia infections</strong>. It contains <strong>Azithromycin and Cefixime</strong>, effective against these pathogens.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Non-herpetic genital ulcer</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct Kit: <strong>3.</strong>&nbsp;<strong>White, Kit 3</strong>. <strong>Kit 3</strong> is used for <strong>non-herpetic genital ulcers</strong>, such as those caused by <strong>syphilis or chancroid</strong>. It includes <strong>Azithromycin and Penicillin</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Vaginal discharge</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Correct Kit: <strong>2.</strong>&nbsp;<strong>Green, Kit 2</strong>. <strong>Kit 2</strong> is recommended for <strong>vaginal discharge</strong>, which can result from <strong>bacterial vaginosis or candidiasis</strong>. It contains <strong>Secnidazole and Fluconazole</strong> to treat these infections.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The National Aids Control Organization (NACO has provided color-coded kits for the syndromic management of sexually transmitted diseases:</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-174504.jpg\" style=\"height:736px; width:900px\" /></span></span></span></span></p>",
      "correct_choice_id": 244594,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61438,
      "choices": [
        {
          "id": 245029,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></span></span></p>"
        },
        {
          "id": 245030,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral acetazolamide</span></span></span></span></p>"
        },
        {
          "id": 245031,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide</span></span></span></span></p>"
        },
        {
          "id": 245032,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dipivefrine</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 75-year-old woman is seen for a routine eye examination. She has a history of open-angle glaucoma and has been using glaucoma eye drops for the past 15 years to control her intraocular pressure. Her current intraocular pressures are well maintained at 17 mm Hg in both eyes. On examination, you note the presence of black pigments deposits on the lower tarsal conjunctiva bilaterally. Which of the following medications is most likely causing this finding?<strong> </strong></span></span></p>",
      "unique_key": "Q2031635",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D) Dipivefrine</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dipivefrine&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">prodrug of adrenaline (epinephrine)&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">that is occasionally used in the treatment of glaucoma. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One of the side effects of dipivefrine is the formation of&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">adrenochrome</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, an oxidation product of adrenaline that can result in black deposits in the conjunctiva. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although this medication is not commonly used nowadays, such deposits are a known side effect of its oxidation.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong> <strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This beta-blocker is widely used in glaucoma treatment but does not produce black pigmented deposits on the conjunctiva.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></span></strong> <strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral acetazolamide</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This carbonic anhydrase inhibitor is taken systemically to lower intraocular pressure but does not cause conjunctival pigmentation.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></span></strong> <strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A topical carbonic anhydrase inhibitor that also does not lead to black conjunctival deposits.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dipivefrine</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, a prodrug of adrenaline, can lead to&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">black conjunctival deposits&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">due to the formation of&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">adrenochrome</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Recognizing medication side effects, particularly with older anti-glaucoma medications, is essential for managing patients who present with unusual ocular findings after prolonged treatment.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245032,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61296,
      "choices": [
        {
          "id": 244465,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tensor fasciae latae</span></span></p>"
        },
        {
          "id": 244466,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gluteus minimus</span></span></p>"
        },
        {
          "id": 244467,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Piriformis</span></span></p>"
        },
        {
          "id": 244468,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gluteus medius</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following muscles is most likely not innervated by the superior gluteal nerve?</span></span></p>",
      "unique_key": "Q7887350",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Ans. C) Piriformis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>superior gluteal nerve</strong> (L4-S1) innervates the <strong>gluteus medius</strong>, <strong>gluteus minimus</strong>, and <strong>tensor fasciae latae</strong> muscles, which are involved in <strong>hip abduction</strong> and <strong>stabilizing the pelvis</strong> during walking. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>piriformis muscle</strong>, however, is innervated by the <strong>nerve to the piriformis</strong> (branches of <strong>S1 and S2</strong>). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, any muscle dysfunction not related to these three muscles suggests the involvement of a muscle like the <strong>piriformis</strong>, which has a different innervation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-163216.jpg\" style=\"height:430px; width:700px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Option A. Tensor fasciae latae</span></strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">: Incorrect. </span><span style=\"font-size:14.0pt\">This muscle is innervated by the <strong>superior gluteal nerve</strong> and contributes to <strong>hip abduction</strong> and <strong>internal rotation</strong>. It is not the muscle excluded from innervation by this nerve.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Gluteus minimus</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The <strong>gluteus minimus</strong> is supplied by the <strong>superior gluteal nerve</strong> and assists in <strong>hip abduction</strong> and <strong>internal rotation</strong>. It is innervated by the superior gluteal nerve, making it an incorrect choice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Gluteus medius</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The <strong>gluteus medius</strong> is also innervated by the <strong>superior gluteal nerve</strong> and plays a key role in <strong>stabilizing the pelvis</strong> during <strong>walking</strong> and <strong>hip abduction</strong>. This makes it the wrong choice as well.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>superior gluteal nerve</strong> provides innervation to the <strong>gluteus medius</strong>, <strong>gluteus minimus</strong>, and <strong>tensor fasciae latae</strong>, but <strong>not the piriformis</strong>, which is supplied by the <strong>nerve to the piriformis</strong>. </span></span></li>\r\n</ul>",
      "correct_choice_id": 244467,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61326,
      "choices": [
        {
          "id": 244585,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right superior lobe</span></span></span></span></p>"
        },
        {
          "id": 244586,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right middle lobe</span></span></span></span></p>"
        },
        {
          "id": 244587,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Upper part of right inferior lobe</span></span></span></span></p>"
        },
        {
          "id": 244588,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lingula</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 67-year-old man with a history of dysphagia due to a recent stroke is admitted to the hospital after aspirating food during a meal. He is found lying supine when the aspiration occurs. A chest X-ray reveals consolidation in one of the lobes of the lung. In the supine position, which of the following lobes is most likely affected by the aspiration in this patient?<strong> </strong></span></span></p>",
      "unique_key": "Q3875092",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Upper part of right inferior lobe</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When <strong>aspiration</strong> occurs in a <strong>supine</strong> patient, the <strong>upper part of the right inferior lobe</strong> is most commonly affected. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is due to the anatomical structure of the <strong>right main bronchus</strong>, which is <strong>shorter, wider</strong>, and more <strong>vertical</strong> than the <strong>left main bronchus</strong>, making it more susceptible to <strong>aspirated materials</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the <strong>supine position</strong>, the <strong>posterior segments</strong> of the <strong>right upper lobe</strong> and <strong>superior segments</strong> of the <strong>right lower lobe</strong> are the most gravity-dependent areas, and thus more likely to collect aspirated material.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-174339.png\" style=\"height:318px; width:400px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Right superior lobe</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Although the <strong>right main bronchus</strong> is the most common site for aspiration, in the <strong>supine position</strong>, the <strong>superior segments</strong> of the <strong>lower lobe</strong> are more likely to be affected than the <strong>superior lobe</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Right middle lobe</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The <strong>middle lobe</strong> may be affected by aspiration in certain positions, like when sitting or standing, but is less commonly impacted in the <strong>supine position</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Lingula</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The <strong>lingula</strong> is part of the <strong>left lung</strong> and thus is not typically involved in aspiration in the <strong>supine position</strong>, as the right lung&#39;s anatomy makes it more prone to aspiration.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a <strong>supine patient</strong>, aspiration is most likely to affect the <strong>upper part of the right inferior lobe</strong> due to the anatomy of the <strong>right main bronchus</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the <strong>gravity-dependent regions</strong> of the lungs is crucial for identifying potential areas of <strong>aspiration-related consolidation</strong> on imaging studies.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244587,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61228,
      "choices": [
        {
          "id": 244193,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Closed reduction and assessment of hip stability</span></span></span></span></p>"
        },
        {
          "id": 244194,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT and 3D reconstruction</span></span></span></span></p>"
        },
        {
          "id": 244195,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High weight skeletal traction</span></span></span></span></p>"
        },
        {
          "id": 244196,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Open reduction and posterior pillar of acetabulum reconstruction</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15-year-old boy was brought to the ER following a motor vehicle collision, complaining of pain over the hip. The x-ray is given below. What is the next step of management? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162038_ggOylzr.png\" style=\"height:166px; width:300px\" /></p>",
      "unique_key": "Q7943351",
      "difficulty_level": "beginner",
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Closed reduction and assessment of hip stability</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hip<strong> </strong>dislocation, particularly posterior hip dislocation, is a common injury following high-energy trauma like motor vehicle accidents. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a posterior hip dislocation, the femoral head is displaced from the acetabulum (typically posteriorly) but remains within the joint capsule.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Closed reduction is the initial treatment for a hip dislocation, where the joint is manually realigned without making an incision. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This should be performed as soon as possible (ideally within 6 hours) to reduce the risk of complications such as avascular necrosis of the femoral head.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After performing the closed reduction, hip stability should be assessed. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the reduction is successful and the hip remains stable (i.e., the joint remains in place without further dislocation or instability), conservative management with monitoring may be sufficient.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indications for closed reduction include a straightforward dislocation where there is no associated fracture of the acetabulum or femoral head, and the hip joint is stable after reduction.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Closed reduction and assessment of hip stability</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is the correct next step because it involves addressing the dislocation and assessing whether the hip joint is stable after realignment. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the hip is stable, further intervention may not be necessary.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. CT and 3D reconstruction:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT and 3D reconstruction are typically used for evaluating complex fractures, especially acetabular fractures or femoral head fractures. CT scans provide detailed information about the bone anatomy and fracture patterns, especially in complex pelvic injuries. However, if the issue is a dislocation without significant fracture involvement, the immediate need is for closed reduction to relieve pain and restore normal joint function. The CT scan would only be necessary if there is a concern for fractures of the acetabulum or femoral head that are not visible on plain x-rays.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. High weight skeletal traction:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skeletal traction is typically used for certain types of long bone fractures, particularly femoral shaft fractures, where it is used to realign the bones and provide stability while the fracture heals. It can also be used for pelvic fractures or for certain complex fractures, but it is not commonly used for managing hip dislocations. After a hip dislocation, the main focus is on closed reduction and stabilization of the joint.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Open reduction and posterior pillar of acetabulum reconstruction:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Open reduction is required when closed reduction fails or when the dislocation is associated with a complex fracture (such as an acetabular fracture) that cannot be addressed non-surgically. A posterior pillar of the acetabulum reconstruction refers to a specific surgical procedure for addressing fractures involving the posterior part of the acetabulum. However, if the dislocation is not associated with a complex fracture, surgical reconstruction (open reduction) is generally not required immediately. Only if there is a significant fracture of the acetabulum or the femoral head would surgery become necessary after the initial dislocation management.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The first step in managing a hip dislocation (likely posterior dislocation in this case) is to perform a closed reduction. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Following this, the stability of the joint should be assessed to determine if further intervention is required.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244193,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61257,
      "choices": [
        {
          "id": 244309,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Observation with regular follow-up</span></span></span></span></p>"
        },
        {
          "id": 244310,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholecystectomy with adjuvant chemotherapy</span></span></span></span></p>"
        },
        {
          "id": 244311,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radical cholecystectomy with lymphadenectomy with chemotherapy</span></span></span></span></p>"
        },
        {
          "id": 244312,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Palliative chemotherapy and radiation</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old woman presents with abdominal discomfort and weight loss. An ultrasound shows a mass in the gallbladder. Further imaging confirms a 2.5 cm tumor confined to the gallbladder with no invasion into surrounding structures, but lymph nodes near the bile duct are enlarged. A diagnosis of gallbladder adenocarcinoma is made. What is the most appropriate treatment at this stage? </span></span></p>",
      "unique_key": "Q1179480",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Radical cholecystectomy with lymphadenectomy with chemotherapy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The staging and treatment of <strong>gallbladder cancer</strong> are determined based on tumor size, invasion into surrounding structures, and lymph node involvement. This patient&rsquo;s tumor is 2.5 cm, confined to the gallbladder, and shows evidence of lymph node involvement, which indicates at least <strong>operable</strong> stage disease. For gallbladder cancer with local lymph node involvement, the best treatment option is <strong>radical cholecystectomy with lymphadenectomy</strong>, which involves removing the gallbladder along with surrounding tissues, including the cystic duct, portions of the liver, and regional lymph nodes. Adjuvant chemotherapy may be given. This offers the best chance of survival in cases of locally advanced but resectable disease.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Observation with regular follow-up</strong>: This is not appropriate for gallbladder cancer, especially when the tumor is larger than 2 cm and there is lymph node involvement. Early-stage gallbladder cancer (T1a) might be managed with simple cholecystectomy, but more advanced stages require more aggressive management.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Cholecystectomy with adjuvant chemotherapy</strong>: This may be considered for very early-stage gallbladder cancer confined to the mucosa (T1a). However, for larger tumors with lymph node involvement, radical surgery with lymphadenectomy is necessary.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Palliative chemotherapy and radiation</strong>: Palliative care is reserved for unresectable or metastatic gallbladder cancer (e.g., distant metastases). This patient&rsquo;s cancer is likely resectable, making radical surgery a better option.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Radical cholecystectomy with lymphadenectomy with chemotherapy&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the standard treatment for <strong>gallbladder cancer</strong> that is locally advanced but resectable, particularly when there is lymph node involvement.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244311,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61244,
      "choices": [
        {
          "id": 244257,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Kienbock&#39;s disease</span></span></span></p>"
        },
        {
          "id": 244258,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Kohler&#39;s Disease </span></span></span></p>"
        },
        {
          "id": 244259,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Wartenberg Syndrome</span></span></span></p>"
        },
        {
          "id": 244260,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Preiser&#39;s Disease</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This Radiographic Image could be a risk factor for:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162330.jpg\" style=\"height:294px; width:300px\" /></span></span></p>",
      "unique_key": "Q6422797",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Kienbock&#39;s disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Kienbock&#39;s disease is a condition that affects the lunate bone in the wrist, leading to avascular necrosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This occurs when the blood supply to the lunate is compromised, resulting in bone death.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Risk Factors</span></strong><span style=\"font-size:14.0pt\">:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Trauma</span></strong><span style=\"font-size:14.0pt\">: Previous wrist injuries can disrupt blood flow.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Anatomical Variations</span></strong><span style=\"font-size:14.0pt\">: Certain wrist structures can predispose individuals to this condition.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Repetitive Stress</span></strong><span style=\"font-size:14.0pt\">: Activities that involve repetitive wrist motions may increase risk.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">On imaging, you may see a sclerotic lunate with varying degrees of flattening, cyst formation, and eventual collapse of the bone, indicating avascular necrosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Kohler&#39;s Disease:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Kohler&#39;s disease is a rare condition affecting the navicular bone in children, typically ages 2 to 9. It involves avascular necrosis, but unlike Kienbock&rsquo;s, it usually has a good prognosis.<strong> </strong>Primarily occurs in children. Some familial predisposition might exist. X-rays will show a flattened, sclerotic navicular bone. The condition is self-limiting and usually resolves without significant intervention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162401.jpg\" style=\"height:286px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Wartenberg Syndrome:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Wartenberg syndrome, also known as Wartenberg&#39;s sign, is characterized by pain and sensory disturbances due to compression of the superficial branch of the radial nerve. It can lead to numbness or tingling on the back of the hand and is often associated with wrist injuries or conditions that cause swelling. Wrist injuries or repetitive strain can compress the nerve. Conditions that lead to edema can predispose individuals. This condition does not typically show specific changes on standard radiographs, as it is more about nerve entrapment rather than bony changes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162415.jpg\" style=\"height:203px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Preiser&#39;s Disease:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Preiser&#39;s disease is similar to Kienbock&#39;s in that it involves avascular necrosis, but it specifically affects the scaphoid bone. It occurs when there is insufficient blood supply to the scaphoid, often following a fracture. A history of scaphoid fracture is a significant risk. Variations in blood supply can predispose some individuals. X-rays may initially show a normal scaphoid; however, later stages can show bone collapse, sclerosis, or cyst formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162428.jpg\" style=\"height:403px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Kienbock&#39;s disease is most directly related to the risk factors of avascular necrosis of the lunate and is characterized by specific radiographic changes.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244257,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61479,
      "choices": [
        {
          "id": 245193,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mifepristone</span></span></span></span></p>"
        },
        {
          "id": 245194,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flutamide</span></span></span></span></p>"
        },
        {
          "id": 245195,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finasteride</span></span></span></span></p>"
        },
        {
          "id": 245196,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metyrapone</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient with Cushing&#39;s syndrome is being evaluated for a drug that can reduce the synthesis of cortisol. Which of the following medications works by inhibiting the synthesis of glucocorticoids?<strong> </strong></span></span></p>",
      "unique_key": "Q2301370",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Metyrapone</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metyrapone&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">inhibits the enzyme&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">11&beta;-hydroxylase</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, which is essential for the final step in cortisol synthesis in the adrenal cortex.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;By blocking this enzyme, metyrapone decreases the production of cortisol, making it useful in the&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">diagnosis&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">management&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s syndrome</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is particularly used in testing the integrity of the hypothalamic-pituitary-adrenal (HPA) axis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"color:#0f4761\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Mifepristone</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Mifepristone is an anti-progestogen and also acts as a glucocorticoid receptor antagonist but does not inhibit the synthesis of glucocorticoids.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Flutamide</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Flutamide is an androgen receptor antagonist used primarily in the treatment of prostate cancer. It does not affect glucocorticoid synthesis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Finasteride</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Finasteride is a 5-&alpha; reductase inhibitor used in the treatment of benign prostatic hyperplasia (BPH) and androgenic alopecia. It inhibits the conversion of testosterone to dihydrotestosterone (DHT) and has no effect on glucocorticoid synthesis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mifepristone is an Anti-Progestogen.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flutamide is an androgen receptor antagonist.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Finasteride is a 5-&alpha; Reductase inhibitor.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metyrapone is enzyme 11&szlig;-hydroxylase inhibitor.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245196,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61308,
      "choices": [
        {
          "id": 244513,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 and 4</span></span></span></span></p>"
        },
        {
          "id": 244514,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 and 3</span></span></span></span></p>"
        },
        {
          "id": 244515,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, and 3</span></span></span></span></p>"
        },
        {
          "id": 244516,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3, and 4</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man presents with a persistent fear of social situations and avoids public speaking. His psychiatrist diagnoses social anxiety disorder. Which of the following statements about social anxiety disorder are true? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is more common in males than females.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cognitive-behavioral therapy is an effective treatment.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-blockers can be used for symptom management.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Onset is typically in late adulthood.</span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q8205091",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 2 and 3</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statement 2: Cognitive-behavioral therapy is an effective treatment.</span></span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True.&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cognitive-behavioral therapy (CBT) is considered a first-line treatment for social anxiety disorder. It helps individuals challenge and change their negative thoughts and behaviors related to social situations.</span></span></span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statement 3: Beta-blockers can be used for symptom management.</span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True.&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-blockers, such as propranolol, are sometimes used to manage physical symptoms of anxiety (like tremors and tachycardia) in performance or specific social situations, such as public speaking.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statement 1: It is more common in males than females.</span></span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False.&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Social anxiety disorder is actually more common in females than in males. However, males may be more likely to seek treatment.</span></span></span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statement 4: Onset is typically in late adulthood.</span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False.&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Social anxiety disorder usually has an onset in adolescence or early adulthood, not late adulthood.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Social anxiety disorder is often treated effectively with CBT and beta-blockers can be used for performance-related anxiety, but it is more common in females and typically begins in adolescence.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244514,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61256,
      "choices": [
        {
          "id": 244305,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glutaraldehyde</span></span></p>"
        },
        {
          "id": 244306,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethylene oxide</span></span></p>"
        },
        {
          "id": 244307,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formaldehyde</span></span></p>"
        },
        {
          "id": 244308,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benzalkonium chloride</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A healthcare facility is performing routine sterilization and disinfection of medical equipment to ensure complete removal of all microbial life, including bacterial spores. Which of the following disinfectants is not considered a sporicidal agent?</span></span></p>",
      "unique_key": "Q3390384",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) Benzalkonium chloride</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Benzalkonium chloride&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>quaternary ammonium compound</strong> (QAC) that is commonly used as a surface disinfectant. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is effective against a wide range of microbes including bacteria, fungi, and some viruses. However, it is <strong>not sporicidal</strong> and does not effectively destroy bacterial spores, which are highly resistant forms of microbial life.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Glutaraldehyde</span></strong><span style=\"font-size:14.0pt\">: This is a high-level disinfectant that is <strong>sporicidal</strong> and used for cold sterilization of heat-sensitive medical equipment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Ethylene oxide</span></strong><span style=\"font-size:14.0pt\">: This is a gaseous sterilant that can be used for <strong>low-temperature sterilization</strong> and is effective against spores, although it requires prolonged exposure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Formaldehyde</span></strong><span style=\"font-size:14.0pt\">: Formaldehyde is a <strong>sporicidal agent</strong> that is used for sterilizing instruments and disinfecting environments, particularly in vapor form.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162516.jpg\" style=\"height:559px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 244308,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61306,
      "choices": [
        {
          "id": 244505,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bezold-Jarisch reflex</span></span></p>"
        },
        {
          "id": 244506,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hering-Breuer reflex</span></span></p>"
        },
        {
          "id": 244507,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bainbridge reflex</span></span></p>"
        },
        {
          "id": 244508,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s reflex</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man presents with a head injury following a fall. On examination, he is found to have elevated blood pressure, a heart rate of 45 beats per minute, and irregular breathing patterns. Which of the following reflexes is most likely responsible for this presentation?</span></span></p>",
      "unique_key": "Q5404762",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Cushing&#39;s reflex</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cushing&#39;s reflex is a physiological response to increased intracranial pressure (ICP).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;It is characterized by the classic triad of hypertension, bradycardia, and irregular respiration. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This reflex aims to maintain cerebral perfusion in the face of rising ICP by increasing systemic blood pressure.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;The bradycardia results from baroreceptor-mediated responses to the increased systemic pressure, and the irregular respiration is due to brainstem dysfunction caused by the elevated ICP.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-163334.jpg\" style=\"height:355px; width:700px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Bezold-Jarisch reflex</span></strong><span style=\"font-size:14.0pt\">: This reflex involves a decrease in heart rate and blood pressure triggered by stimulation of receptors in the heart, often seen in response to myocardial ischemia. It does not cause hypertension and irregular breathing patterns.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Hering-Breuer reflex</span></strong><span style=\"font-size:14.0pt\">: This reflex is involved in regulating the depth and frequency of breathing and is triggered by lung inflation. It is not associated with changes in blood pressure or bradycardia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Bainbridge reflex</span></strong><span style=\"font-size:14.0pt\">: This reflex is triggered by increased venous return and results in an increase in heart rate to accommodate the greater blood volume. It is not related to the triad seen in Cushing&#39;s reflex.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cushing&#39;s reflex is a critical response to elevated intracranial pressure, presenting with hypertension, bradycardia, and irregular respiration. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding this reflex is important for diagnosing conditions that increase intracranial pressure.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244508,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61441,
      "choices": [
        {
          "id": 245041,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delivering compressions at a rate of 80-100 compressions per minute</span></span></p>"
        },
        {
          "id": 245042,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allowing full chest recoil after each compression</span></span></p>"
        },
        {
          "id": 245043,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minimizing compression depth to avoid rib fractures</span></span></p>"
        },
        {
          "id": 245044,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interrupting chest compressions every 2 minutes for pulse checks</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man collapses at a shopping mall, and a bystander starts cardiopulmonary resuscitation (CPR) while waiting for emergency medical services (EMS) to arrive. Which of the following is the most important component of high-quality CPR?</span></span></p>",
      "unique_key": "Q4207701",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Allowing full chest recoil after each compression</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allowing full chest recoil&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">after each compression is a key element of <strong>high-quality CPR</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Full chest recoil enables the heart to refill with blood between compressions, ensuring effective circulation and maximizing the amount of blood delivered to vital organs, including the brain and heart. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Without complete recoil, the effectiveness of each compression is reduced, which can negatively impact outcomes.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other important aspects of high-quality CPR include:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Compression rate</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: 100-120 compressions per minute.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Compression depth</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: At least <strong>2 inches (5 cm)</strong> for adults, avoiding excessive depth that could cause injury.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minimizing interruptions</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Chest compressions should be continuous with minimal interruptions to maintain blood flow.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Delivering compressions at a rate of 80-100 compressions per minute</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This rate is too slow. High-quality CPR requires a compression rate of <strong>100-120 compressions per minute</strong> to maintain adequate perfusion.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Minimizing compression depth to avoid rib fractures</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: High-quality CPR emphasizes compressions of at least <strong>2 inches (5 cm)</strong> in depth for adults. While rib fractures can occur, they are a lesser concern compared to ensuring adequate depth for effective blood circulation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Interrupting chest compressions every 2 minutes for pulse checks</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While pulse checks are necessary, frequent interruptions can decrease the effectiveness of CPR. It is crucial to minimize pauses and focus on continuous, effective chest compressions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High-quality CPR&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">involves allowing <strong>full chest recoil</strong> after each compression, maintaining a <strong>compression rate of 100-120 compressions per minute</strong>, ensuring a <strong>depth of at least 2 inches</strong>, and minimizing interruptions to maximize blood flow during cardiac arrest.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245042,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61447,
      "choices": [
        {
          "id": 245065,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lunate</span></span></p>"
        },
        {
          "id": 245066,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Capitate</span></span></p>"
        },
        {
          "id": 245067,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trapezoid</span></span></p>"
        },
        {
          "id": 245068,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scaphoid</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a post-mortem examination of unidentified remains found at a remote site, a forensic expert is tasked with estimating the age of the deceased, a crucial factor in helping to identify the individual. Among the skeletal findings, the expert notes the developmental stage of the carpal bones, which is significant in narrowing down the age range. Based on the ossification patterns observed, which carpal bone would the forensic expert expect to have ossified first, suggesting it appears as early as 2 months of age in a normally developing infant?<strong> </strong></span></span></p>",
      "unique_key": "Q5437871",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B) Capitate</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Capitate is the first carpal bone to begin ossifying, typically around 2 months of age. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This early ossification is significant in pediatric forensics, especially when estimating the age of deceased infants or young children. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ossification sequences are a crucial part of skeletal analysis in forensic cases where age estimation can provide vital clues to identity.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong> <strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lunate</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ossifies around 4 years of age and could be useful in estimating the age of older children.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Trapezoid</strong>: The Trapezoid bone begins ossifying later in age, around&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5.5 years of age</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></span></strong> <strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scaphoid</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ossifies later, around 5 years of age, and helps in determining age in the middle childhood range.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Age of appearance of carpal bones is given below:</span></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-101720.png\" style=\"height:678px; width:800px\" /></span></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Mnemonic:</span></span></span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Capitate is captain</span></span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, hence comes first</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ham<strong>ate</strong> sound like capit<strong>ate, </strong>so comes immediately after it</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Tri</span></span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">quetral: Tri implies 3 </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pisiform is Laziform so comes last</span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245066,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61241,
      "choices": [
        {
          "id": 244245,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dynamic hip screw fixation</span></span></span></span></p>"
        },
        {
          "id": 244246,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intramedullary nail fixation</span></span></span></span></p>"
        },
        {
          "id": 244247,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Open reduction and internal fixation with plates</span></span></span></span></p>"
        },
        {
          "id": 244248,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemiarthroplasty</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old female presents with a history of hip pain and a recent fall resulting in a fracture. She has a known history of osteoporosis. MRI of the hip reveals a subtrochanteric femur fracture. During surgical planning, you note that the fracture is associated with a significant loss of cortical bone integrity. What is the most appropriate surgical management for this condition? </span></span></p>",
      "unique_key": "Q7616995",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B) Intramedullary nail fixation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is often the preferred method for treating subtrochanteric fractures. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intramedullary nails provide excellent stability and can better accommodate the forces experienced in the subtrochanteric region, particularly in osteoporotic bone.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Dynamic Hip Screw Fixation</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option is typically used for extracapsular femoral neck fractures and intertrochanteric fractures but is not ideal for subtrochanteric fractures, especially with significant loss of bone integrity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Open Reduction and Internal Fixation with Plates</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While this may be considered, it is less common for subtrochanteric fractures due to the higher risk of non-union and complications in osteoporotic bone.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hemiarthroplasty</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is generally reserved for cases involving femoral neck fractures in older patients with severe osteoarthritis or when there is significant bone loss in the femoral head. It is not the first choice for subtrochanteric fractures.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intramedullary nail fixation is the most appropriate surgical management for a subtrochanteric femur fracture in a patient with significant bone integrity loss.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244246,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61410,
      "choices": [
        {
          "id": 244917,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Podocyte foot process effacement</span></span></span></span></p>"
        },
        {
          "id": 244918,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immune complex deposition in the glomerular basement membrane</span></span></span></span></p>"
        },
        {
          "id": 244919,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sclerosis of some glomeruli affecting only a portion of each glomerulus</span></span></span></span></p>"
        },
        {
          "id": 244920,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deposition of IgA in the mesangium</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man presents with a one-month history of leg swelling, fatigue, and dark-colored urine. His medical history includes chronic hepatitis C infection. Physical examination reveals bilateral pitting edema in the lower extremities. Laboratory tests show a serum creatinine of 2.1 mg/dL, serum albumin of 3.0 g/dL, and 24-hour urine protein excretion of 4.5 g. Renal biopsy was done and HPE image is shown below. What is the underlying pathophysiological mechanism most likely responsible for this patient&#39;s condition?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-092155.png\" style=\"height:226px; width:300px\" /></span></span></p>",
      "unique_key": "Q3518483",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B) Immune complex deposition in the glomerular basement membrane</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation, laboratory findings, and renal biopsy results are consistent with <strong>membranoproliferative glomerulonephritis (MPGN)</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MPGN is characterized by immune complex deposition in the glomerular basement membrane and mesangium, leading to complement activation, resulting in low levels of C3 and C4. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The classic &quot;tram-track&quot; appearance seen on renal biopsy is due to the duplication of the glomerular basement membrane, which occurs as a result of mesangial cell proliferation and immune complex deposition. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MPGN can be associated with chronic infections, such as hepatitis C, which contributes to the formation of circulating immune complexes.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Podocyte foot process effacement</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is characteristic of <strong>minimal change disease</strong>, which typically presents with nephrotic syndrome and a normal complement level. Renal biopsy in minimal change disease does not show the &quot;tram-track&quot; appearance.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sclerosis of some glomeruli affecting only a portion of each glomerulus</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This describes <strong>focal segmental glomerulosclerosis (FSGS)</strong>, which presents with nephrotic syndrome but does not typically involve hypocomplementemia or the &quot;tram-track&quot; appearance on biopsy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Deposition of IgA in the mesangium</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This finding is characteristic of <strong>IgA nephropathy</strong>, which often presents with episodic hematuria following respiratory infections. IgA nephropathy does not typically show the &quot;tram-track&quot; appearance or low complement levels.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Membranoproliferative glomerulonephritis (MPGN) is characterized by immune complex deposition in the glomerular basement membrane, leading to complement activation (low C3 and C4) and distinctive pathological features, such as the &quot;tram-track&quot; appearance on renal biopsy. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic infections, including hepatitis C, are common contributing factors.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244918,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61338,
      "choices": [
        {
          "id": 244633,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Children aged 6-59 months</span></span></span></span></p>"
        },
        {
          "id": 244634,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Children aged 5-9 years</span></span></span></span></p>"
        },
        {
          "id": 244635,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pregnant women from the fourth month onward</span></span></span></span></p>"
        },
        {
          "id": 244636,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Women aged 20-49 years</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An ANM is tasked with administering iron and folic acid supplements, under AMB program to various groups in a rural community. Which of the following beneficiary groups has the same daily dosage of iron and folic acid but differs in frequency of administration compared to adolescents aged 10-19 years?</span></span></p>",
      "unique_key": "Q3968558",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Pregnant women from the fourth month onward</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both <strong>adolescents aged 10-19 years</strong> and <strong>pregnant women starting from the fourth month</strong> receive <strong>60 mg of iron</strong> and <strong>500 mcg of folic acid</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, the <strong>frequency</strong> differs: <strong>adolescents receive it weekly</strong>, while <strong>pregnant women take it daily</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This difference in frequency is due to the higher iron and folic acid demands during pregnancy to support maternal and fetal health.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-180135.png\" style=\"height:530px; width:1000px\" /></span></span></span></span></p>",
      "correct_choice_id": 244635,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61465,
      "choices": [
        {
          "id": 245137,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Poly A tail</span></span></span></span></p>"
        },
        {
          "id": 245138,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">tRNA</span></span></span></span></p>"
        },
        {
          "id": 245139,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guanyl Cap</span></span></span></span></p>"
        },
        {
          "id": 245140,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shine-Dalgarno Sequence</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is most likely responsible for mediating the attachment of eukaryotic mRNA to the ribosome?<strong> </strong></span></span></p>",
      "unique_key": "Q3278669",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Guanyl Cap</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In eukaryotic cells, the attachment of mRNA to the ribosome is mediated by the 5&#39; Guanyl cap (5&#39; cap). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This cap structure is recognized by the eukaryotic initiation factors, which help in the recruitment of the ribosome to the mRNA, allowing translation to proceed. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The cap also protects mRNA from degradation.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Poly A tail:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The poly A tail stabilizes mRNA and facilitates transport out of the nucleus but does not directly mediate ribosomal attachment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. tRNA:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">tRNA is involved in translating the mRNA code into amino acids but does not facilitate the attachment of mRNA to the ribosome.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Shine-Dalgarno Sequence:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This sequence is found in prokaryotic mRNA and is not relevant to eukaryotic ribosome binding.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In eukaryotic translation, the 5&#39; Guanyl cap is essential for the recognition and binding of mRNA to the ribosome, allowing efficient protein synthesis.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245139,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61332,
      "choices": [
        {
          "id": 244609,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wound management only</span></span></p>"
        },
        {
          "id": 244610,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wound management and anti-rabies vaccine</span></span></p>"
        },
        {
          "id": 244611,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-rabies vaccine only, no need for rabies immunoglobulin</span></span></p>"
        },
        {
          "id": 244612,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wound management, rabies immunoglobulin, and anti-rabies vaccine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old boy is brought to the clinic after being bitten by a stray dog. The child has a deep bite wound on his leg that is actively bleeding. His mother reports that the dog appeared aggressive, and there is no information about its vaccination status. Which of the following is the most appropriate post-exposure prophylaxis (PEP) for this patient?</span></span></p>",
      "unique_key": "Q1510088",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Wound management, rabies immunoglobulin, and anti-rabies vaccine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The child has sustained a <strong>Category III</strong> exposure, which includes <strong>single or multiple transdermal bites</strong>, deep scratches, or contamination of mucous membranes with saliva. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Category III exposures are considered high risk because they involve a direct breach of the skin. The recommended PEP for <strong>Category III</strong> includes:</span></span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wound management</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Immediate and thorough washing and disinfection of the wound.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rabies immunoglobulin (RIG)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Provides passive immunity until the vaccine induces an active immune response.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-rabies vaccine</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Induces the production of antibodies against the rabies virus for long-term protection.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Wound management only:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. While wound management is essential, <strong>Category III</strong> exposures require <strong>rabies immunoglobulin</strong> and <strong>anti-rabies vaccine</strong> due to the high risk of rabies transmission.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Wound management and anti-rabies vaccine:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. Although the <strong>anti-rabies vaccine</strong> is part of the required PEP, <strong>rabies immunoglobulin</strong> is also necessary for <strong>Category III</strong> exposures to provide immediate passive immunity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Anti-rabies vaccine only, no need for rabies immunoglobulin:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. <strong>Rabies immunoglobulin</strong> is crucial in <strong>Category III</strong> exposures, as it provides immediate passive immunity at the site of the wound before the vaccine-induced active immunity takes effect.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type of Contact, Exposure and Recommended Post-exposure Prophylaxis (PEP)</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-175100.jpg\" style=\"height:348px; width:700px\" /></span></span></strong></p>",
      "correct_choice_id": 244612,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61232,
      "choices": [
        {
          "id": 244209,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1, B-2, C-3, D-4</span></span></span></span></p>"
        },
        {
          "id": 244210,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-1, C-4, D-3</span></span></span></span></p>"
        },
        {
          "id": 244211,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-3, C-4, D-1</span></span></span></span></p>"
        },
        {
          "id": 244212,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-1, C-3, D-4</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following triage color codes with their correct descriptions during a mass casualty event: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-122707.png\" style=\"height:239px; width:700px\" /></p>",
      "unique_key": "Q4426166",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) A-2, B-1, C-3, D-4</span></span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Red &rarr; 2. Immediate life-threatening injuries, requires urgent intervention<br />\r\nB. Yellow &rarr; 1. Non-urgent injuries, can be delayed<br />\r\nC. Green &rarr; 3. Minor injuries, &quot;walking wounded&quot;<br />\r\nD. Black &rarr; 4. Deceased or injuries so severe that survival is unlikely</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Red (Immediate)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These patients have life-threatening injuries that require immediate intervention to survive (e.g., severe bleeding, airway compromise).</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Yellow (Delayed)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These patients have serious but non-life-threatening injuries. Treatment can be delayed without significant risk to life or limb (e.g., fractures, large wounds).</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Green (Minor)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These patients have minor injuries that can wait for extended periods before receiving treatment, or may not require treatment at all (e.g., small cuts, bruises).</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Black (Deceased/Expectant)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These individuals are either deceased or have injuries so severe that survival is not possible, even with immediate medical attention (e.g., massive head trauma, no pulse).</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a mass casualty event, <strong>triage color codes</strong> are used to prioritize care based on the severity of injuries, with <strong>Red</strong> for immediate intervention, <strong>Yellow</strong> for delayed care, <strong>Green</strong> for minor injuries, and <strong>Black</strong> for deceased or expectant patients.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244212,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61454,
      "choices": [
        {
          "id": 245093,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calcium oxalate stones</span></span></span></p>"
        },
        {
          "id": 245094,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Struvite stones</span></span></span></p>"
        },
        {
          "id": 245095,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cystine stones</span></span></span></p>"
        },
        {
          "id": 245096,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Uric acid stones</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presents with flank pain, fever, and dysuria. She has a history of recurrent urinary tract infections. Urinalysis reveals alkaline urine and urine microscopy shows the crystals in the image below. What is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-175939.jpg\" style=\"height:319px; width:300px\" /></span></span></p>",
      "unique_key": "Q8298802",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Struvite stones</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Struvite stones&nbsp;</span></strong><span style=\"font-size:14.0pt\">(magnesium ammonium phosphate) form in the presence of <strong>alkaline urine</strong>, which is often caused by <strong>urease-producing bacteria</strong> like Proteus or Klebsiella. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These bacteria split urea into ammonia, increasing the urine pH, which promotes the formation of struvite crystals. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The crystals are typically <strong>rectangular and &quot;coffin-lid&quot; shaped</strong>, as seen in the provided image. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Struvite stones are often associated with <strong>recurrent urinary tract infections</strong> and can lead to <strong>staghorn calculi</strong>, which are large stones that can fill the renal pelvis and calyces.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Calcium oxalate stones</span></strong><span style=\"font-size:14.0pt\">: These stones can form in any pH of urine and are more commonly found in acidic to neutral pH. The crystals are <strong>envelope-shaped</strong> or <strong>dumbbell-shaped</strong>, not the rectangular shape seen in struvite crystals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Cystine stones</span></strong><span style=\"font-size:14.0pt\">: Cystine stones form in <strong>cystinuria</strong>, a genetic disorder leading to increased excretion of cystine in the urine. The crystals are typically <strong>hexagonal</strong> and form in <strong>acidic urine</strong>, which does not match the appearance or the pH described here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Uric acid stones</span></strong><span style=\"font-size:14.0pt\">: These form in <strong>acidic urine</strong> and are associated with conditions like gout. Uric acid crystals are typically <strong>rhomboid</strong> or <strong>rosette-shaped</strong>, and the stones are radiolucent on imaging, which differs from the rectangular shape of struvite crystals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Struvite stones&nbsp;</span></strong><span style=\"font-size:14.0pt\">are associated with <strong>urease-producing bacteria</strong>, which raise the urine pH and lead to the formation of characteristic <strong>coffin-lid shaped crystals</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are typically seen in patients with recurrent <strong>urinary tract infections</strong> and form in <strong>alkaline urine</strong>.</span></span></li>\r\n</ul>",
      "correct_choice_id": 245094,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61501,
      "choices": [
        {
          "id": 245281,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.45</span></span></p>"
        },
        {
          "id": 245282,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.65</span></span></p>"
        },
        {
          "id": 245283,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.55</span></span></p>"
        },
        {
          "id": 245284,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0.35</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A study is conducted to evaluate the agreement between two radiologists in diagnosing lung nodules using chest X-rays. The results of their assessments are shown in the table below:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-120037.jpg\" style=\"height:187px; width:700px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calculate the kappa statistic for the agreement between the two radiologists.</span></span></span></p>",
      "unique_key": "Q1494784",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) 0.35</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Observed Agreement (p<sub>observed</sub></span></strong><span style=\"font-size:14.0pt\">):</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Observed agreement is when both radiologists agree (positive or negative):</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Positive agreement: 50 (both positive)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Negative agreement: 20 (both negative)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">p<sub>observed</sub>= (50+20)/100=0.70 </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Expected Agreement (p<sub>expected</sub>​)</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calculate the expected probability of positive agreement:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">p<sub>positive</sub>= (70/100)</span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Cambria Math&quot;,serif\">&lowast;</span></span><span style=\"font-size:14.0pt\">(60/100)=0.42</span></span></span>\r\n\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">(70/100) is the proportion of Radiologist 1&rsquo;s positive results.</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">(60/100) is the proportion of Radiologist 2&rsquo;s positive results.</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calculate the expected probability of negative agreement:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">p<sub>negative</sub>= (30/100)</span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Cambria Math&quot;,serif\">&lowast;</span></span><span style=\"font-size:14.0pt\">(40/100)=0.12</span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">(30/100) is the proportion of Radiologist 1&rsquo;s negative results.</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">(40/100) is the proportion of Radiologist 2&rsquo;s negative results.</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">p<sub>expected</sub>=0.42+0.12=0.54</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Calculate Kappa</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/untitled-1222.jpg\" style=\"height:139px; width:529px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This suggests <strong>fair agreement</strong> between the radiologists.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Kappa coefficient (K)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Indicates the extent of agreement between frequencies of two sets of data collected on two different occasions</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"ES\" style=\"font-size:14.0pt\">Formula: K = O-E/(1 &ndash; E)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Interpretation:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">0 = agreement equivalent to chance.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">0 &ndash; 0.20 = slight agreement.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">0.21 &ndash; 0.40 = fair agreement.</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">0.41 &ndash; 0.60 = moderate agreement.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">0.61 &ndash; 0.80 = substantial agreement.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">0.81 &ndash; 0.99 = near perfect agreement</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1 = perfect agreement.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 245284,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61268,
      "choices": [
        {
          "id": 244353,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbamazepine</span></span></span></span></p>"
        },
        {
          "id": 244354,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamotrigine</span></span></span></span></p>"
        },
        {
          "id": 244355,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium</span></span></span></span></p>"
        },
        {
          "id": 244356,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproate</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old male with a history of bipolar disorder presents for a follow-up visit. He has been hospitalized twice in the past year for severe depressive episodes, during which he expressed suicidal ideation. His psychiatrist is considering a medication that can help stabilize his mood and reduce his risk of future suicide attempts. Which of the following medications is most appropriate for reducing suicidality in this patient?<strong> </strong></span></span></p>",
      "unique_key": "Q3322361",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Lithium</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium is the only mood stabilizer that has demonstrated a consistent anti-suicidal effect in patients with bipolar disorder and major depressive disorder.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Numerous studies have shown that lithium significantly reduces the risk of suicide and suicide attempts in these populations. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This makes it the preferred choice for patients with bipolar disorder who are at an increased risk of suicide.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Lithium&rsquo;s effectiveness extends beyond mood stabilization, as it has been observed to reduce impulsivity, aggression, and the overall risk of self-harm.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Carbamazepine</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While carbamazepine is effective as a mood stabilizer, particularly for bipolar disorder with mixed or rapid-cycling episodes, it has not shown the same level of efficacy in reducing suicidal behavior as lithium.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Lamotrigine</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lamotrigine is particularly effective in preventing depressive episodes in bipolar disorder, but it does not have a proven anti-suicidal benefit. It is more commonly used as an adjunct in mood stabilization rather than a primary agent for reducing suicidality.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Valproate</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Valproate is another mood stabilizer used in the treatment of bipolar disorder, particularly for managing manic symptoms. However, it lacks the consistent evidence of anti-suicidal effects that lithium has demonstrated.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium is the only mood stabilizer that has consistently shown anti-suicidal properties in patients with bipolar disorder and major depressive disorder.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is considered the gold standard for mood stabilization due to its efficacy in preventing both manic and depressive episodes and reducing the risk of suicide.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium&rsquo;s potential benefits include neuroprotective effects and reduction of impulsivity and aggression.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244355,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61507,
      "choices": [
        {
          "id": 245305,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increasing the allocation of resources for MNS disorders</span></span></p>"
        },
        {
          "id": 245306,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enhancing the development of new psychiatric medications</span></span></p>"
        },
        {
          "id": 245307,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Improving access to affordable, quality care</span></span></p>"
        },
        {
          "id": 245308,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Helping people with MNS disorders lead normal lives</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The World Health Organization&#39;s Mental Health Gap Action Programme (mhGAP) focuses on reducing the treatment gap for mental, neurological, and substance use (MNS) disorders, particularly in low and lower-middle-income countries. Which of the following is not one of the primary goals of the mhGAP program? </span></span></p>",
      "unique_key": "Q7395564",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Enhancing the development of new psychiatric medications</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>mhGAP</strong> program by the <strong>World Health Organization (WHO)</strong> focuses on reducing the treatment gap for <strong>mental, neurological, and substance use (MNS) disorders</strong> in low- and lower-middle-income countries. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The goals include <strong>increasing resources</strong>, <strong>improving access to affordable and quality care</strong>, <strong>helping people with MNS disorders lead normal lives</strong>, and <strong>preventing MNS disorders</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The development of new psychiatric medications is <strong>not a direct focus</strong> of the mhGAP program, which is more concerned with <strong>scaling up existing evidence-based treatments</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Increasing the allocation of resources for MNS disorders:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. This is a key goal of the mhGAP program, aiming to ensure that sufficient resources are directed toward mental health care in resource-limited settings.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Improving access to affordable, quality care:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. Improving access to care is central to mhGAP, aiming to make mental health services more available to populations in low- and middle-income countries.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Helping people with MNS disorders lead normal lives:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. A primary goal of mhGAP is to provide interventions that allow individuals with MNS disorders to achieve better quality of life and social functioning.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>mhGAP program</strong> by WHO aims to reduce the treatment gap for <strong>mental, neurological, and substance use (MNS) disorders</strong> in low- and lower-middle-income countries by <strong>increasing resources, improving access to care, and enabling better quality of life</strong> for those affected. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It does not focus on the <strong>development of new medications</strong> but rather on scaling up existing evidence-based interventions.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additional Information </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The mnemonic <strong>&quot;MESSI DAD&quot;</strong> can be used to remember the disorders included in the mhGAP program:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Mental disorders in children (Option A)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">E</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Epilepsy</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Suicide</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Schizophrenia and other psychotic disorders (Option B)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">I</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Illicit drug use disorders</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Depression (Option D)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Alcohol-related disorders</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Dementia</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245306,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61262,
      "choices": [
        {
          "id": 244329,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Troilism</span></span></p>"
        },
        {
          "id": 244330,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Algolagnia</span></span></p>"
        },
        {
          "id": 244331,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Masochism</span></span></p>"
        },
        {
          "id": 244332,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Frotteurism</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During the autopsy of an unidentified male victim at a district hospital, the medical officer notices signs of sexual assault and excessive violence on the body. The presence of these elements suggests a psychological component to the crime, where the assailant may have derived gratification from the victim&#39;s suffering. Recognizing the characteristics of the injuries, the medical officer consults forensic specialist to identify this paraphilia that involves deriving pleasure from inflicting pain. This condition is known as an extreme form of:</span></span></p>",
      "unique_key": "Q2202429",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) Algolagnia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Algolagnia involves deriving sexual pleasure from inflicting pain on others, which aligns with the observed characteristics of lust murder, also known as erotophonophilia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In cases like the one presented, the sexual component is intertwined with lethal violence, indicating a severe paraphilic disorder where the murderer is stimulated by the physical or psychological suffering of the victim.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Troilism</strong>: Involves sexual arousal from watching one&#39;s partner with another person, unrelated to violence or infliction of pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Masochism</strong>: Pertains to deriving pleasure from one&#39;s own pain or humiliation rather than inflicting pain on others.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">. <strong>Frotteurism</strong>: Involves the act of touching or rubbing against a non-consenting person, typically in a crowded place, and does not inherently involve violence or lethal outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lust murder is a grave manifestation of algolagnia where the perpetrator finds sexual satisfaction in the act of killing and associated acts of violence. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Awareness and understanding of such paraphilic disorders are crucial in forensic medicine for accurate profiling and investigation of violent sexual crimes.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244330,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61269,
      "choices": [
        {
          "id": 244357,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atheromatous plaque</span></span></p>"
        },
        {
          "id": 244358,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperparathyroidism</span></span></p>"
        },
        {
          "id": 244359,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Milk alkali syndrome</span></span></p>"
        },
        {
          "id": 244360,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary thyroid carcinoma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 37-year-old woman presents with sudden onset hemiplegia. Imaging and biopsy confirm the presence of a psammomatous meningioma, a subtype characterized by the presence of psammoma bodies. Psammoma bodies represent a type of calcification. Similar types of calcification are seen in which of the following conditions?</span></span></p>",
      "unique_key": "Q7471872",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Atheromatous plaque</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Atheromatous plaques can often contain areas of dystrophic calcification, similar to the psammoma bodies seen in psammomatous meningioma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These calcifications occur due to local tissue damage and are common in advanced atherosclerosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Psammoma bodies are a specific form of dystrophic calcification seen in certain tumors like meningiomas and papillary thyroid carcinoma.</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162708.jpg\" style=\"height:208px; width:400px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Hyperparathyroidism:</span></strong><span style=\"font-size:14.0pt\"> Hyperparathyroidism often results in hypercalcemia, which can lead to metastatic calcifications in tissues like the kidneys, lungs, and stomach. It is not typically associated with the formation of psammoma bodies or localized calcifications seen in tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Milk alkali syndrome:</span></strong><span style=\"font-size:14.0pt\"> This syndrome is due to excessive calcium intake, leading to hypercalcemia and possibly metastatic calcifications. These calcifications are diffuse, unlike the localized psammoma bodies seen in conditions like meningiomas or atheromatous plaques.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Medullary thyroid carcinoma:</span></strong><span style=\"font-size:14.0pt\"> Medullary thyroid carcinoma is not known for having psammoma bodies. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Psammoma bodies are a form of dystrophic calcification seen in certain tumors like meningiomas and papillary thyroid carcinoma, and similar calcifications can also be seen in atheromatous plaques. </span></span></li>\r\n</ul>",
      "correct_choice_id": 244357,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61237,
      "choices": [
        {
          "id": 244229,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-c, 3-b, 4-a</span></span></span></span></p>"
        },
        {
          "id": 244230,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-c, 3-d, 4-a</span></span></span></span></p>"
        },
        {
          "id": 244231,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-d, 3-b, 4-a</span></span></span></span></p>"
        },
        {
          "id": 244232,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-c, 3-a, 4-d</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following signs and the diseases in which they occur.<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162950.png\" style=\"height:368px; width:1000px\" /></p>",
      "unique_key": "Q7603354",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 1-b, 2-c, 3-d, 4-a</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correctly matched pairs are <strong>1-b, 2-c, 3-d, 4-a</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hennebert&#39;s sign in congenital syphilis</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hennebert&#39;s sign&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>false</strong> <strong>positive fistula sign</strong> seen in the absence of a fistula. It is seen in <strong>congenital syphilis</strong>. It occurs due to the formation of adhesions between the stapes footplate and the saccule. It can also be seen in some cases of <strong>Meniere&#39;s disease</strong>.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schwartz sign in otosclerosis</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schwartz sign&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>pink or reddish hue</strong> seen on the <strong>promontory</strong> through the tympanic membrane. It is seen in <strong>active otosclerosis</strong>, where increased vascularity occurs around the stapes.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hitzelberger sign in acoustic neuroma</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hitzelberger sign&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">refers to <strong>numbness in the posterosuperior meatal wall</strong> of the external auditory canal (innervated by the VII cranial nerve). This sign is often seen in <strong>acoustic neuroma</strong> due to the involvement of the facial nerve.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bryce&#39;s sign in laryngocele</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bryce&#39;s sign&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by a <strong>gurgling sound</strong> produced when pressing on a <strong>laryngocele</strong>. It is due to the air or mucus present within the laryngocele.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hennebert&#39;s sign&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is associated with <strong>congenital syphilis</strong>, <strong>Schwartz sign</strong> with <strong>otosclerosis</strong>, <strong>Hitzelberger sign</strong> with <strong>acoustic neuroma</strong>, and <strong>Bryce&#39;s sign</strong> with <strong>laryngocele</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognizing these signs helps in identifying their underlying conditions during clinical assessments.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244230,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61253,
      "choices": [
        {
          "id": 244293,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Toll-like receptors (TLRs)</span></span></span></span></p>"
        },
        {
          "id": 244294,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complement receptor</span></span></span></span></p>"
        },
        {
          "id": 244295,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammasome</span></span></span></span></p>"
        },
        {
          "id": 244296,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fc receptor</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is primarily responsible for detecting necrotic cells and initiating their clearance?<strong> </strong></span></span></p>",
      "unique_key": "Q8290494",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Inflammasome</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammasomes&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are intracellular multiprotein complexes that play a crucial role in the body&#39;s innate immune response. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They detect <strong>necrotic cell debris&nbsp;</strong>and damage-associated molecular patterns (DAMPs), leading to the activation of <strong>caspase-1&nbsp;</strong>and the secretion of pro-inflammatory cytokines like IL-1&beta;. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This process helps initiate the immune response to clear necrotic cells and maintain tissue homeostasis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Toll-like receptors (TLRs)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: TLRs recognize <strong>pathogen-associated molecular patterns (PAMPs)</strong>, such as components of bacterial or viral pathogens. They play a key role in the detection of infectious agents, not in recognizing necrotic cells specifically.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Complement receptor</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Complement receptors are involved in recognizing opsonized pathogens marked by complement proteins and aiding in their clearance. They do not play a direct role in recognizing necrotic cells.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Fc receptor</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fc receptors bind to antibodies and play a role in antibody-mediated phagocytosis. They do not directly recognize necrotic cells but rather help in the immune response against antibody-tagged antigens.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammasomes&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are responsible for detecting <strong>necrotic cell debris</strong> and initiating the inflammatory response, which is crucial for the clearance of necrotic cells and the maintenance of immune homeostasis.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244295,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61305,
      "choices": [
        {
          "id": 244501,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous glucagon</span></span></span></span></p>"
        },
        {
          "id": 244502,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intravenous calcium gluconate</span></span></span></span></p>"
        },
        {
          "id": 244503,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">N-acetylcysteine</span></span></span></span></p>"
        },
        {
          "id": 244504,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old woman presents to the emergency department with nausea, vomiting, tinnitus, and confusion after ingesting an unknown quantity of over-the-counter medication in a suicide attempt. Laboratory findings reveal a mixed metabolic acidosis and respiratory alkalosis. Which of the following treatment strategies would be most useful in this patient&#39;s condition?<strong> </strong></span></span></p>",
      "unique_key": "Q2574106",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D) Urinary alkalinization</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization is an effective treatment for aspirin (salicylate) toxicity. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin is a weak acid, and by alkalinizing the urine, salicylates become ionized and trapped in the urine, which prevents reabsorption and enhances their elimination. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This approach is particularly beneficial in patients with acute salicylate toxicity presenting with mixed metabolic acidosis and respiratory alkalosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Intravenous glucagon</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Intravenous glucagon is used in the treatment of beta-blocker overdose, as it helps increase heart rate and myocardial contractility. It is not effective for salicylate toxicity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Intravenous calcium gluconate</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Calcium gluconate is used to treat hyperkalemia and calcium channel blocker toxicity. It is not indicated in the management of salicylate poisoning.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. N-acetylcysteine</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: N-acetylcysteine (NAC) is used as an antidote for acetaminophen overdose by replenishing hepatic glutathione. It is not useful in the treatment of salicylate toxicity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary alkalinization is the treatment of choice for aspirin toxicity, as it increases the ionization and excretion of salicylates, reducing systemic toxicity. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This method is particularly useful in managing overdoses involving weak acids like aspirin.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244504,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61468,
      "choices": [
        {
          "id": 245149,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adipocytes</span></span></p>"
        },
        {
          "id": 245150,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brain cells</span></span></p>"
        },
        {
          "id": 245151,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatocytes</span></span></p>"
        },
        {
          "id": 245152,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Red Blood Cells (RBCs)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following tissues is most likely to show reduced levels of glucose transporters after an overnight fast?</span></span></p>",
      "unique_key": "Q5950169",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Adipocytes</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">After an overnight fast, insulin levels decrease, leading to a reduction in the number of insulin-sensitive glucose transporters (specifically GLUT4) on the surface of adipocytes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Insulin stimulates the translocation of GLUT4 to the cell membrane, facilitating glucose uptake into adipocytes and muscle cells. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the absence of insulin, such as during fasting, these GLUT4 transporters are internalized, resulting in decreased glucose uptake in adipose tissue.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Brain cells:</span></strong><span style=\"font-size:14.0pt\"> Brain cells primarily use GLUT1 and GLUT3 for glucose transport, which are not insulin-dependent and remain constant even during fasting. These transporters are crucial for maintaining glucose availability to the brain, especially during periods of low glucose levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hepatocytes:</span></strong><span style=\"font-size:14.0pt\"> Hepatocytes utilize GLUT2, which facilitates glucose transport bidirectionally based on concentration gradients. GLUT2 is not insulin-dependent and functions to release glucose during fasting. Its levels do not decrease after an overnight fast.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Red Blood Cells (RBCs):</span></strong><span style=\"font-size:14.0pt\"> RBCs use GLUT1 for glucose uptake, which is not regulated by insulin. GLUT1 ensures a continuous glucose supply to RBCs, making them unaffected by changes in insulin levels or fasting states.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">GLUT4 transporters are insulin-dependent and found in adipocytes and muscle cells. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During periods of fasting, such as overnight, insulin levels drop, causing a reduction in the translocation of GLUT4 to the cell surface, thereby decreasing glucose uptake in these tissues. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This adaptation conserves glucose for insulin-independent tissues, such as the brain and red blood cells.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245149,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61278,
      "choices": [
        {
          "id": 244393,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo E</span></span></p>"
        },
        {
          "id": 244394,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo AI</span></span></p>"
        },
        {
          "id": 244395,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo B100</span></span></p>"
        },
        {
          "id": 244396,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apo B48</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following apolipoproteins serves as an activator of lecithin-cholesterol acyltransferase (LCAT), an enzyme crucial for cholesterol esterification in HDL particles?</span></span></p>",
      "unique_key": "Q1279609",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) Apo AI</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Apo AI is the primary activator of lecithin-cholesterol acyltransferase (LCAT), an enzyme that is vital in the formation of cholesterol esters in high-density lipoprotein (HDL) particles. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">LCAT catalyzes the conversion of free cholesterol into cholesteryl esters, which are then sequestered in the core of HDL, allowing for the maturation of HDL and efficient reverse cholesterol transport. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This process is critical for maintaining HDL function and for the removal of excess cholesterol from peripheral tissues, ultimately transporting it to the liver.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Apo E:</span></strong><span style=\"font-size:14.0pt\"> Apo E is involved in the recognition of lipoproteins by liver receptors, facilitating the uptake of chylomicron remnants and intermediate-density lipoprotein (IDL). It does not directly activate LCAT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Apo B100:</span></strong><span style=\"font-size:14.0pt\"> Apo B100 is a structural protein found in low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL). It is important for LDL receptor binding but is not involved in the activation of LCAT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Apo B48:</span></strong><span style=\"font-size:14.0pt\"> Apo B48 is found in chylomicrons and is essential for their formation in the intestine. It plays a role in chylomicron secretion into the lymphatics but does not activate LCAT.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Apo AI is a critical activator of LCAT, facilitating the conversion of free cholesterol into cholesteryl esters within HDL particles. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This activation is essential for HDL maturation and the reverse cholesterol transport pathway, where excess cholesterol is transported from peripheral tissues back to the liver for excretion.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244394,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61477,
      "choices": [
        {
          "id": 245185,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angiotensin II inhibitor</span></span></span></span></p>"
        },
        {
          "id": 245186,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACE inhibitor</span></span></span></span></p>"
        },
        {
          "id": 245187,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renin inhibitor</span></span></span></span></p>"
        },
        {
          "id": 245188,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neutral endopeptidase inhibitor</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old male with chronic heart failure is prescribed a combination therapy that includes Sacubitril. Which of the following best describes the mechanism of action of Sacubitril?<strong> </strong></span></span></p>",
      "unique_key": "Q3980947",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Neutral endopeptidase inhibitor</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sacubitril is a&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">neprilysin inhibitor&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(also known as a neutral endopeptidase inhibitor).</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Neprilysin is an enzyme responsible for degrading various vasoactive peptides, including&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atrial Natriuretic Peptide (ANP)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, </span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brain Natriuretic Peptide (BNP)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, </span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">bradykinin</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, and&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">adrenomedullin</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;By inhibiting neprilysin, Sacubitril increases the levels of these peptides, promoting&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">natriuresis, vasodilation, and reduced blood pressure</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, which are beneficial in managing&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">chronic heart failure</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is commonly used in combination with&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">valsartan</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, an angiotensin receptor blocker (ARB), to provide dual action&mdash;blocking the RAAS system while increasing the levels of beneficial peptides.</span></span></span></span></li>\r\n</ul>\r\n\r\n<h3>&nbsp;</h3>\r\n\r\n<h3><span style=\"font-size:14pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"color:#0f4761\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Angiotensin II inhibitor:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sacubitril does not directly inhibit angiotensin II. However, valsartan, which is combined with sacubitril in the fixed-dose combination, blocks the effects of angiotensin II at its receptor.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. ACE inhibitor:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sacubitril is not an ACE inhibitor. ACE inhibitors work by inhibiting the angiotensin-converting enzyme, which decreases the production of angiotensin II. Sacubitril, on the other hand, inhibits neprilysin.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Renin inhibitor:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sacubitril is not a renin inhibitor. Renin inhibitors, such as aliskiren, work by directly inhibiting renin, an enzyme involved in the RAAS pathway.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sacubitril is a neprilysin (neutral endopeptidase) inhibitor used in combination with valsartan to treat chronic heart failure.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;By inhibiting neprilysin, sacubitril increases the levels of natriuretic peptides and other vasoactive substances, leading to beneficial cardiovascular effects.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245188,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61500,
      "choices": [
        {
          "id": 245277,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mo cells</span></span></span></span></p>"
        },
        {
          "id": 245278,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">I cells</span></span></span></span></p>"
        },
        {
          "id": 245279,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peptic cells</span></span></span></span></p>"
        },
        {
          "id": 245280,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G cells</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 57-year-old man with a history of chronic acid reflux presents with worsening symptoms of peptic ulcer disease. Which type of gastric mucosal cells is primarily responsible for secreting a hormone that stimulates the production of hydrochloric acid in the stomach, potentially exacerbating his condition?<strong> </strong></span></span></p>",
      "unique_key": "Q6794447",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) G cells</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G cells&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are specialized cells located in the antrum of the stomach that secrete the hormone <strong>gastrin.</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Gastrin plays a crucial role in stimulating the parietal cells of the stomach to produce hydrochloric acid (HCl).</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Elevated levels of gastrin can increase acid secretion, which can exacerbate symptoms of acid reflux and peptic ulcer disease by increasing the acidity of the stomach environment.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;This makes G cells particularly relevant in conditions involving hyperacidity.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Mo cells</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Mo cells secrete <strong>motilin</strong>, a hormone that regulates gastrointestinal motility, not acid secretion. They are unrelated to the direct regulation of gastric acid production.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. I cells</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: I cells are found in the duodenum and secrete <strong>cholecystokinin (CCK</strong>), which stimulates pancreatic enzyme secretion and gallbladder contraction. They do not have a role in the regulation of gastric acid secretion.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Peptic cells</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Also known as chief cells, these secrete <strong>pepsinogen</strong>, an inactive enzyme that becomes pepsin in the presence of stomach acid. They are not involved in stimulating hydrochloric acid production.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G cells in the stomach secrete gastrin, which stimulates parietal cells to produce hydrochloric acid (HCl), contributing to conditions like peptic ulcer disease and acid reflux by increasing gastric acidity.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245280,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61444,
      "choices": [
        {
          "id": 245053,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulmonary hypertension due to chronic hypoxemia</span></span></p>"
        },
        {
          "id": 245054,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrent airway infections causing permanent dilation of bronchi</span></span></p>"
        },
        {
          "id": 245055,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alveolar destruction with airspace enlargement and impaired gas exchange</span></span></p>"
        },
        {
          "id": 245056,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fibrotic changes in the lungs due to chronic asbestos exposure</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man presents with a year-long history of worsening shortness of breath and a productive cough. He has a history of asthma and has been a chronic smoker for 45 years. On examination, his respiratory rate is 26/min, and SpO₂ is 93% on room air. Auscultation reveals scattered expiratory wheezing and rhonchi throughout both lung fields. Spirometry shows an FEV1/FVC ratio of 63% and an FEV1 of 65% of the predicted value. His diffusing capacity for carbon monoxide (DLCO) is measured at 40% of the predicted value. Chest X-ray is shown below. What pathophysiological process best explains this patient&rsquo;s findings?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-175722.jpg\" style=\"height:470px; width:400px\" /></span></span></p>",
      "unique_key": "Q5212600",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) Alveolar destruction with airspace enlargement and impaired gas exchange</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s chronic smoking history, progressive shortness of breath, reduced FEV1/FVC ratio, and significantly decreased diffusing capacity for carbon monoxide (DLCO) are characteristic of <strong>emphysema</strong>, a subtype of chronic obstructive pulmonary disease (COPD). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emphysema involves destruction of the alveolar walls, leading to enlarged airspaces and a decrease in the lung&#39;s surface area for gas exchange, hence the low DLCO. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The physical findings of wheezing, rhonchi, and hyperinflated lungs with flattened diaphragms further support this diagnosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pulmonary hypertension due to chronic hypoxemia:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While pulmonary hypertension can develop as a consequence of COPD, it does not explain the primary findings of reduced FEV1/FVC ratio and low DLCO. Pulmonary hypertension is more often a complication of the underlying lung disease rather than the primary cause.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Recurrent airway infections causing permanent dilation of bronchi:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This describes <strong>bronchiectasis</strong>, which typically presents with a chronic productive cough, frequent respiratory infections, and bronchial wall thickening seen on imaging. While wheezing and a productive cough can occur in bronchiectasis, the spirometry findings and markedly low DLCO are more consistent with emphysema.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Fibrotic changes in the lungs due to chronic asbestos exposure:</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Asbestosis</strong> is characterized by restrictive lung disease with a normal or increased FEV1/FVC ratio and a decreased total lung capacity. The spirometry in this patient shows an obstructive pattern, and his smoking history points toward COPD rather than a fibrotic lung disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emphysema, commonly caused by chronic smoking, leads to alveolar destruction, airspace enlargement, and impaired gas exchange, resulting in obstructive spirometry findings and reduced DLCO. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognizing these features is crucial for the appropriate diagnosis and management of patients with chronic respiratory symptoms.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245055,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61291,
      "choices": [
        {
          "id": 244445,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myomectomy</span></span></p>"
        },
        {
          "id": 244446,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Watchful waiting due to absence of symptoms</span></span></p>"
        },
        {
          "id": 244447,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></p>"
        },
        {
          "id": 244448,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initiate hormonal therapy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman is incidentally found to have a 14-week-sized uterine fibroid during a routine physical examination. She reports no symptoms, including no abnormal bleeding or pain. What is the most appropriate next step in the management of this patient?</span></span></p>",
      "unique_key": "Q5996486",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) Watchful waiting due to absence of symptoms</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Uterine fibroids, also known as leiomyomas, are common benign tumors of the uterus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The decision to treat fibroids depends primarily on symptoms such as heavy menstrual bleeding, pelvic pain, or pressure symptoms like urinary frequency. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In asymptomatic patients with fibroids, especially those that are incidentally found, active intervention is not necessary. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Instead, <strong>watchful waiting</strong> or monitoring the patient with periodic exams and ultrasounds is appropriate to ensure the fibroid does not grow or become symptomatic over time.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Myomectomy:</span></strong><span style=\"font-size:14.0pt\"> Myomectomy, a surgical removal of the fibroid, is typically reserved for patients who are symptomatic (e.g., with pain or heavy bleeding) or when fertility preservation is desired. In an asymptomatic patient, this invasive procedure is not indicated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hysterectomy:</span></strong><span style=\"font-size:14.0pt\"> Hysterectomy is a definitive treatment for fibroids, but it is generally reserved for women with large symptomatic fibroids, recurrent fibroids, or when other management options fail. In this asymptomatic patient, it is not appropriate to pursue such an invasive and irreversible procedure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Initiate hormonal therapy:</span></strong><span style=\"font-size:14.0pt\"> Medical management, including hormonal therapy, is generally aimed at controlling symptoms such as heavy menstrual bleeding. Since this patient has no symptoms, there is no need for hormonal treatment at this time.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In asymptomatic patients with uterine fibroids, <strong>observation without intervention</strong> is the preferred approach. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Treatment is indicated only if the fibroid causes symptoms or if there is a rapid increase in size that raises concern for malignancy.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244446,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61334,
      "choices": [
        {
          "id": 244617,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Have a written breastfeeding policy</span></span></p>"
        },
        {
          "id": 244618,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Help mothers initiate breastfeeding within 3 hours of birth</span></span></p>"
        },
        {
          "id": 244619,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Counseling on formula milk</span></span></p>"
        },
        {
          "id": 244620,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Practice rooming in 24 hours a day</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following statements belong to the 10 steps of successful breastfeeding recommended by the Baby Friendly Hospital Initiative (BFHI), except _____. </span></span></p>",
      "unique_key": "Q4721669",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B) Help mothers initiate breastfeeding within 3 hours of birth</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Baby Friendly Hospital Initiative (BFHI)</strong>, developed by the WHO and UNICEF, aims to promote breastfeeding by implementing practices that support mothers in initiating and maintaining breastfeeding. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>10 steps to successful breastfeeding</strong> emphasize immediate and uninterrupted skin-to-skin contact, supporting mothers to initiate breastfeeding as soon as possible, ideally within the <strong>first hour</strong> after birth. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The recommendation to initiate breastfeeding within <strong>3 hours</strong> is not part of the BFHI guidelines, making option <strong>B</strong> incorrect.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The 10 steps include:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Having a <strong>written infant feeding policy</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Training staff to support breastfeeding.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discussing the importance of breastfeeding&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">with expectant mothers.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Facilitating <strong>immediate skin-to-skin contact</strong> and supporting mothers to breastfeed right after birth.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Encouraging <strong>rooming-in</strong> so that mothers and infants stay together 24 hours a day.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educating on the <strong>risks of formula feeding</strong> and avoiding formula unless medically indicated.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Have a written breastfeeding policy</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is part of the BFHI guidelines, aimed at ensuring a consistent approach to breastfeeding support in the hospital.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Counseling on formula milk</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: BFHI includes providing information about the risks of formula feeding and supporting mothers to exclusively breastfeed unless medically necessary.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Practice rooming in 24 hours a day</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Rooming-in is strongly encouraged by BFHI to support the bonding process and facilitate breastfeeding on demand.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>BFHI guidelines</strong> emphasize initiating breastfeeding as soon as possible after birth, ideally within the first <strong>hour</strong>, providing continuous mother-infant support through <strong>rooming-in</strong>, and ensuring all staff are trained to promote and support exclusive breastfeeding.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244618,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61342,
      "choices": [
        {
          "id": 244649,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate response &ndash; Risk reduction &ndash; Infrastructure rebuilding &ndash; Community recovery &ndash; Preparedness</span></span></span></span></p>"
        },
        {
          "id": 244650,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk reduction &ndash; Community recovery &ndash; Infrastructure rebuilding &ndash; Preparedness &ndash; Emergency response</span></span></span></span></p>"
        },
        {
          "id": 244651,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emergency response &ndash; Community recovery &ndash; Infrastructure rebuilding &ndash; Risk reduction &ndash; Preparedness</span></span></span></span></p>"
        },
        {
          "id": 244652,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk reduction &ndash; Preparedness &ndash; Infrastructure rebuilding &ndash; Community recovery &ndash; Emergency response</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After a devastating flood hits a small town, local authorities begin to stabilize the affected area and provide emergency aid. In the following weeks, they focus on restoring basic services and starting long-term rebuilding efforts. Which of the following sequences represents the correct order of phases in managing the aftermath of the disaster?</span></span></p>",
      "unique_key": "Q9343187",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Emergency response &ndash; Community recovery &ndash; Infrastructure rebuilding &ndash; Risk reduction &ndash; Preparedness</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct sequence after a disaster as per the general disaster management principles is:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Response:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate actions taken to ensure safety, provide emergency services, and stabilize the situation. This involves &ndash; </span></span></span></span></li>\r\n</ol>\r\n\r\n<ul style=\"margin-left:40px\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Search, rescue and first aid</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Field care</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triage</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tagging</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identification of dead</span></span></span></span></li>\r\n</ul>\r\n\r\n<ol start=\"2\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rehabilitation:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Short-term recovery and normalization of operations to restore basic services and functions in the affected area.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reconstruction:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Long-term rebuilding of infrastructure and restoration of a fully functional community.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitigation:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Efforts to reduce the risk and lessen the impact of future disasters.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preparedness:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Planning and preparation to improve response activities for future disasters.</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disaster Cycle</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-180524.png\" style=\"height:531px; width:500px\" /></span></span></strong></span></span></p>",
      "correct_choice_id": 244651,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61238,
      "choices": [
        {
          "id": 244233,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rickettsia rickettsii</span></span></span></span></p>"
        },
        {
          "id": 244234,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rickettsia conorii</span></span></span></span></p>"
        },
        {
          "id": 244235,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ehrlichia chaffeensis</span></span></span></span></p>"
        },
        {
          "id": 244236,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplasma</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old man presents with fever, headache, and myalgias. He reports recent travel to a rural area where he was exposed to tick bites. Laboratory studies reveal leukopenia and thrombocytopenia. A peripheral blood smear, as shown in the image below. The arrow indicates an intracellular inclusion inside a monocyte. Which of the following is the most likely organism?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-163235.png\" style=\"height:212px; width:300px\" /></p>",
      "unique_key": "Q2998007",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C) Ehrlichia chaffeensis</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The blood smear image shows a <strong>monocyte</strong> containing a <strong>morula</strong> (cluster of bacteria) inside its cytoplasm. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is characteristic of <strong>Ehrlichia chaffeensis</strong>, an obligate intracellular bacterium that infects <strong>monocytes</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ehrlichiosis&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is transmitted by the <strong>Lone Star tick (Amblyomma americanum)</strong> and typically presents with <strong>fever, headache, myalgias</strong>, leukopenia, and thrombocytopenia. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of morulae inside monocytes is a key diagnostic feature.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Rickettsia rickettsia</strong>: This organism causes <strong>Rocky Mountain spotted fever</strong>, which typically presents with fever, headache, and a petechial rash. Rickettsia species infect <strong>endothelial cells</strong>, not monocytes.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rickettsia conorii</strong>: Causes <strong>Mediterranean spotted fever</strong>, which also presents with fever and rash but does not typically form morulae inside monocytes.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anaplasma</strong>: <strong>Anaplasma phagocytophilum</strong> causes <strong>anaplasmosis</strong>, which presents similarly to ehrlichiosis but infects <strong>neutrophils</strong> instead of monocytes. On a blood smear, morulae would be seen inside neutrophils rather than monocytes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ehrlichia chaffeensis&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an intracellular bacterium that infects <strong>monocytes</strong>, forming <strong>morulae</strong> within the cytoplasm. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is transmitted by tick bites and presents with fever, leukopenia, and thrombocytopenia. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognition of morulae inside monocytes&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is crucial for diagnosis.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244235,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61487,
      "choices": [
        {
          "id": 245225,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevate the presenting part and proceed with emergency cesarean section</span></span></span></span></p>"
        },
        {
          "id": 245226,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perform an amniotomy to confirm the finding</span></span></span></span></p>"
        },
        {
          "id": 245227,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Attempt to manually reposition the cord above the presenting part</span></span></span></span></p>"
        },
        {
          "id": 245228,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue monitoring and await spontaneous vaginal delivery</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman is in active labor with a cervix dilated to 3 cm and 70% effaced. During a vaginal examination, a soft, pulsatile mass resembling a &quot;bag of worms&quot; is detected. What is the most appropriate next step in management? </span></span></p>",
      "unique_key": "Q1829141",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A) Elevate the presenting part and proceed with emergency cesarean section</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The description of a &quot;bag of worms&quot; during a vaginal examination suggests <strong>umbilical cord prolapse</strong>, a condition where the umbilical cord slips ahead of the presenting fetal part and can become compressed, leading to compromised blood flow to the fetus. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate intervention is required to prevent fetal hypoxia or death. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevating the presenting part helps to reduce pressure on the cord while preparing for an <strong>emergency cesarean section</strong>, which is the definitive management in this situation to ensure the safety of the fetus.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Perform an amniotomy to confirm the finding</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Performing an amniotomy in the presence of a suspected <strong>cord prolapse</strong> can exacerbate the condition by further increasing pressure on the prolapsed cord. This is not appropriate, as it could worsen fetal compromise.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Attempt to manually reposition the cord above the presenting part</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While attempting to relieve pressure on the cord is necessary, the definitive management of <strong>cord prolapse</strong> is an <strong>emergency cesarean section</strong>. Simply repositioning the cord without proceeding to immediate delivery is insufficient and unsafe for the fetus.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Continue monitoring and await spontaneous vaginal delivery</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Waiting for spontaneous delivery</strong> in the context of <strong>cord prolapse</strong> is inappropriate, as it places the fetus at significant risk of hypoxia and can lead to adverse outcomes. Immediate intervention is required to ensure fetal well-being.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of <strong>umbilical cord prolapse</strong>, characterized by the presence of a soft, pulsatile structure resembling a &quot;bag of worms&quot; on vaginal examination, the most appropriate management is to <strong>elevate the presenting part</strong> to reduce cord compression and proceed with an <strong>emergency cesarean section</strong> to prevent fetal compromise.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245225,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61478,
      "choices": [
        {
          "id": 245189,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iodixanol</span></span></p>"
        },
        {
          "id": 245190,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diatrizoate</span></span></p>"
        },
        {
          "id": 245191,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iohexol</span></span></p>"
        },
        {
          "id": 245192,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Omnipaque</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following contrast agents is classified as an ionic monomer? </span></span></p>",
      "unique_key": "Q3468311",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><strong>B) Diatrizoate</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Diatrizoate</span></strong><span style=\"font-size:14.0pt\"> is an ionic monomer contrast medium. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is a high-osmolar contrast agent (HOCM) that dissociates in solution, leading to increased osmolality. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This type of contrast medium is more likely to cause adverse reactions, such as nausea, vomiting, and allergic reactions, compared to nonionic agents. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diatrizoate is typically used in certain gastrointestinal studies due to its high radiodensity but is less favored for intravenous use in patients with higher risk profiles, like those with chronic kidney disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Iodixanol:</span></strong><span style=\"font-size:14.0pt\"> This is a nonionic, iso-osmolar contrast agent. It does not dissociate in solution, resulting in lower osmolality. Iodixanol is commonly used in patients at higher risk for contrast-induced nephropathy due to its lower osmolality.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Iohexol:</span></strong><span style=\"font-size:14.0pt\"> This is a nonionic monomer contrast medium with low osmolality. Like iodixanol, it does not dissociate in solution, leading to a lower likelihood of adverse reactions compared to ionic contrast agents like diatrizoate. It is often used for a wide range of contrast-enhanced imaging studies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Omnipaque:</span></strong><span style=\"font-size:14.0pt\"> Omnipaque is the trade name for iohexol, which is also a nonionic, low-osmolar contrast agent. It is used to minimize the risk of adverse reactions in patients, making it a preferred choice in various imaging procedures, especially when high-risk patients are involved.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ionic monomer contrast agents, such as diatrizoate, have a higher osmolality due to their dissociation into ions in solution, leading to a greater risk of adverse reactions. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In contrast, nonionic contrast agents, like iohexol and iodixanol, do not dissociate and have lower osmolality, making them safer for use in patients with a higher risk of contrast-induced complications.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245190,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61437,
      "choices": [
        {
          "id": 245025,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interrupted suture</span></span></span></span></p>"
        },
        {
          "id": 245026,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mattress suture</span></span></span></span></p>"
        },
        {
          "id": 245027,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continous suture</span></span></span></span></p>"
        },
        {
          "id": 245028,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sub-cuticular suture</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the type of suturing technique shown below: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-095129.png\" style=\"height:268px; width:300px\" /></span></span></p>",
      "unique_key": "Q3757241",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Interrupted suture</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows a </span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">series of individual suture knots&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">with each stitch tied separately. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is characteristic of an&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">interrupted suture technique</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interrupted sutures&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are placed individually, with each stitch having its own knot. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are commonly used for skin closure because they provide strong wound approximation and minimize the risk of dehiscence (wound reopening). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If one suture fails, the others remain intact, offering additional security to the wound closure.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Mattress suture</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Mattress sutures, such as horizontal or vertical mattress sutures, involve a looped suture pattern that takes a deeper bite of tissue. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-095138.png\" style=\"height:240px; width:300px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Continuous suture</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Continuous sutures involve a single piece of suture material running along the entire length of the wound without being tied off between each pass. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-095150.png\" style=\"height:201px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Sub-cuticular suture</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Sub-cuticular sutures are placed just under the skin surface, running parallel to the wound edges and do not create visible knots on the surface. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-095202.png\" style=\"height:251px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interrupted sutures&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are characterized by individual stitches that are tied separately, offering strong and secure wound closure with the advantage of maintaining wound integrity even if one suture fails.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245025,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61245,
      "choices": [
        {
          "id": 244261,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pT1a sN0 M0</span></span></p>"
        },
        {
          "id": 244262,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pT1(mic) sN0 M0</span></span></p>"
        },
        {
          "id": 244263,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pT1b sN0 M0</span></span></p>"
        },
        {
          "id": 244264,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pT1c sN0 M0</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 44-year-old unmarried female is diagnosed with a non-palpable breast lesion on routine investigations. A pathological specimen after breast-conserving surgery reveals a 0.9 cm tumor in its greatest dimension, with a negative sentinel lymph node biopsy and no distant metastasis. What is the stage of the disease?</span></span></p>",
      "unique_key": "Q6419319",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) pT1b sN0 M0</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The staging of this patient&#39;s breast cancer is <strong>pT1b sN0 M0</strong>, based on the following details:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Tumor staging (pT1b)</span></strong><span style=\"font-size:14.0pt\">:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A <strong>T1b</strong> tumor is defined as being more than 0.5 cm but less than 1 cm in its greatest dimension. Since the tumor size is 0.9 cm, it fits into this category.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The prefix &quot;p&quot; indicates that the staging is based on <strong>pathological examination</strong>.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Node staging (sN0)</span></strong><span style=\"font-size:14.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The tumor is node-negative, meaning there is no regional lymph node involvement (N0).</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The &quot;s&quot; prefix indicates that this was determined through a <strong>sentinel lymph node biopsy</strong>.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Metastasis staging (M0)</span></strong><span style=\"font-size:14.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Since there is no evidence of distant metastasis, the staging is <strong>M0</strong>.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thus, the complete stage is <strong>pT1b sN0 M0</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. pT1a sN0 M0</span></strong><span style=\"font-size:14.0pt\">: This would be for a tumor that is less than or equal to 0.5 cm, which is not applicable here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. pT1(mic) sN0 M0</span></strong><span style=\"font-size:14.0pt\">: This refers to <strong>microscopic invasion</strong>, which is less than 1 mm, and is not the case for this patient&rsquo;s tumor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. pT1c sN0 M0</span></strong><span style=\"font-size:14.0pt\">: This stage would apply to tumors larger than 1 cm but less than 2 cm, which also does not fit this patient&#39;s tumor size of 0.9 cm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In breast cancer staging, a <strong>pT1b</strong> designation refers to tumors that are between 0.5 cm and 1 cm, and the <strong>sN0</strong> refers to no regional lymph node involvement, confirmed by sentinel node biopsy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">M0</span></strong><span style=\"font-size:14.0pt\"> indicates no distant metastasis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244263,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61459,
      "choices": [
        {
          "id": 245113,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">E6, E7</span></span></p>"
        },
        {
          "id": 245114,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">L1</span></span></p>"
        },
        {
          "id": 245115,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">E1, E2</span></span></p>"
        },
        {
          "id": 245116,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DE3</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is studying the molecular components of Human Papilloma virus (HPV) type 16 as shown in the given diagram. The labelled segments represent different genes encoded by the viral genome. Which of the following viral proteins is used to develop an effective vaccine against HPV?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180122.jpg\" style=\"height:285px; width:300px\" /></p>",
      "unique_key": "Q2380600",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) L1</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>L1 protein</strong> of <strong>Human Papillomavirus (HPV)</strong> is the <strong>major capsid protein</strong> and serves as the <strong>primary antigen</strong> used in the development of HPV vaccines. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">L1 proteins can <strong>self-assemble</strong> into <strong>virus-like particles (VLPs)</strong> that resemble the natural virus structure but do <strong>not contain viral DNA</strong>, making them <strong>non-infectious</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These VLPs effectively elicit a strong <strong>immune response</strong> against HPV, providing <strong>protection against infection</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">HPV vaccines such as <strong>Gardasil</strong> and <strong>Cervarix</strong> use <strong>L1 VLPs</strong> to immunize individuals against common high-risk HPV types.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. E6, E7</span></strong><span style=\"font-size:14pt\"><strong>:</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>E6 and E7</strong> are <strong>oncogenes</strong> in HPV that interfere with <strong>tumor suppressor proteins</strong> (<strong>p53 and Rb</strong> respectively), promoting malignant transformation of infected cells. These proteins are <strong>not used</strong> in vaccine development, but they are key targets for HPV-related cancer research.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. E1, E2</span></strong><span style=\"font-size:14pt\"><strong>:</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>E1</strong> and <strong>E2</strong> are involved in <strong>viral replication and transcription regulation</strong>. These proteins are essential for the life cycle of HPV but are not involved in the vaccine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. DE3:&nbsp;</span></strong><span style=\"font-size:14.0pt\">There is <strong>no known DE3 protein</strong> associated with HPV. This is a distractor option with no relevance to HPV&#39;s functional proteins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180137.jpg\" style=\"height:728px; width:964px\" /></span></span></strong><br />\r\n&nbsp;</p>",
      "correct_choice_id": 245114,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61327,
      "choices": [
        {
          "id": 244589,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Koplik spots</span></span></span></span></p>"
        },
        {
          "id": 244590,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"DE\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nagayama spots</span></span></span></span></p>"
        },
        {
          "id": 244591,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Forchheimer spots</span></span></span></span></p>"
        },
        {
          "id": 244592,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conjunctivitis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old child presents to a pediatric outpatient department with a 3-day history of high fever, runny nose, red eyes, and small white spots inside the mouth. On examination, a red, blotchy rash is noted on the skin. The child&#39;s immunization history is incomplete. Based on the clinical presentation, which of the following is considered a pathognomonic sign of the suspected disease?</span></span><strong> </strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-174441.png\" style=\"height:349px; width:300px\" /></strong></p>",
      "unique_key": "Q1957468",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Koplik spots</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Koplik spots are small, white or bluish-white spots with a red halo that appear on the buccal mucosa opposite the lower molars. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are pathognomonic for measles (rubeola) and typically appear 1-2 days before the characteristic measles rash. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of these spots in a child with a high fever, runny nose (coryza), conjunctivitis, and a red, blotchy rash strongly suggests measles. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Koplik spots are a critical diagnostic clue, especially in cases where the child&rsquo;s immunization status is incomplete or unknown.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Nagayama spots</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nagayama spots are red papular lesions that appear on the uvula and soft palate in children with roseola infantum (also known as sixth disease), which is caused by Human Herpesvirus 6 (HHV-6). Roseola is characterized by a high fever that suddenly subsides, followed by a rash that appears as the fever resolves. Unlike Koplik spots, Nagayama spots are not associated with the classic symptoms of measles.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Forchheimer spots</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Forchheimer spots are pinpoint red macules or petechiae that appear on the soft palate and uvula in patients with rubella (German measles). Rubella typically presents with a mild fever, lymphadenopathy (especially postauricular), and a fine pink maculopapular rash that spreads from the face to the body. Forchheimer spots are not pathognomonic for rubella and are less specific than Koplik spots for any disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Conjunctivitis</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Conjunctivitis (red, inflamed eyes) is a common symptom of several viral infections, including measles. However, it is not pathognomonic for measles or any specific infection. Conjunctivitis is often seen as part of the prodrome in measles along with coryza and cough (the three C&rsquo;s: cough, coryza, conjunctivitis). It can also appear in other viral illnesses and allergic reactions, making it less specific than Koplik spots for diagnosing measles.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Koplik spots are a pathognomonic feature of measles, appearing on the buccal mucosa 1-2 days before the onset of the characteristic red, blotchy rash. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Their presence, particularly in an unvaccinated child with a fever, runny nose, and conjunctivitis, strongly suggests measles. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early recognition of these spots is crucial for timely diagnosis, isolation, and prevention of the spread of this highly contagious virus.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244589,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61223,
      "choices": [
        {
          "id": 244173,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Release of proinflammatory cytokines; anti-inflammatory therapy</span></span></span></span></p>"
        },
        {
          "id": 244174,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of fat in visceral tissue; weight loss through lifestyle changes</span></span></span></span></p>"
        },
        {
          "id": 244175,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resistance to insulin; initiation of insulin therapy</span></span></span></span></p>"
        },
        {
          "id": 244176,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of the sympathetic nervous system; use of beta-blockers</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">60-year-old man presents for evaluation of uncontrolled hypertension. Over the past 3 years, he has experienced significant weight gain and developed type 2 diabetes mellitus. His blood pressure is consistently elevated at 159/97 mm Hg, and his BMI is 42 kg/m&sup2;. Physical examination shows pronounced central obesity. Laboratory tests reveal a total cholesterol of 262 mg/dL, HDL cholesterol of 25 mg/dL, triglycerides of 230 mg/dL, and fasting glucose of 120 mg/dL. Despite lifestyle counseling, he struggles to follow a diet or exercise regimen. Given the patient&#39;s metabolic profile, which pathophysiologic mechanism is most critical in the development of his current condition, and which intervention would most effectively address the underlying issue?<strong> </strong></span></span></p>",
      "unique_key": "Q1757844",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B) Accumulation of fat in visceral tissue; weight loss through lifestyle changes</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient presents with metabolic syndrome, characterized by obesity (particularly central or visceral adiposity), hypertension, dyslipidemia, and insulin resistance. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The accumulation of fat in visceral tissue is a key driver of metabolic syndrome. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Visceral fat is metabolically active and releases free fatty acids, proinflammatory cytokines, and hormones that contribute to insulin resistance and atherogenic dyslipidemia. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This, in turn, leads to hypertension and other components of metabolic syndrome. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most effective intervention to address the root cause is weight loss through lifestyle modifications, which can reduce visceral fat, improve insulin sensitivity, and potentially normalize metabolic parameters.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Release of proinflammatory cytokines; anti-inflammatory therapy:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although proinflammatory cytokines are involved in the pathogenesis of metabolic syndrome, they are secondary to visceral adiposity. Anti-inflammatory therapy does not directly address the core problem, which is the accumulation of visceral fat.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Resistance to insulin; initiation of insulin therapy:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin resistance is indeed a key component of metabolic syndrome. However, initiating insulin therapy in this context addresses the hyperglycemia rather than the root cause, which is excessive visceral fat and its metabolic consequences.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Activation of the sympathetic nervous system; use of beta-blockers:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The sympathetic nervous system does contribute to hypertension, particularly in obesity. However, beta-blockers alone do not address the primary issue, which is visceral fat accumulation and its broader metabolic effects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The accumulation of visceral fat is a central factor in the development of metabolic syndrome, leading to insulin resistance, dyslipidemia, and hypertension. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Addressing visceral adiposity through lifestyle interventions such as diet and exercise is the most effective strategy to improve the patient&#39;s metabolic profile and control blood pressure.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244174,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61446,
      "choices": [
        {
          "id": 245061,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 5, 8</span></span></span></span></p>"
        },
        {
          "id": 245062,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6, 3, 8, 4</span></span></span></span></p>"
        },
        {
          "id": 245063,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">7, 8, 4, 3</span></span></span></span></p>"
        },
        {
          "id": 245064,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3, 2, 1, 8</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A throat swab was obtained from a patient with sore throat, and the specimen was stained as shown in the image. What is the most likely order of staining procedures performed in this Gram staining technique?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-101212.png\" style=\"height:199px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albert&#39;s Stain-I</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acid alcohol</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gram&#39;s iodine</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Safranin</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methylene blue</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crystal violet</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbol fuschin</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetone</span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q1278140",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B) 6, 3, 8, 4</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image and staining steps suggest that this is a <strong>Gram staining procedure</strong>, which is used to differentiate between <strong>Gram-positive</strong> and <strong>Gram-negative bacteria</strong>. The correct sequence for <strong>Gram staining</strong> involves:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crystal Violet (6)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This is the primary stain that stains all cells <strong>purple</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gram&#39;s Iodine (3)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This acts as a <strong>mordant</strong>, forming a complex with crystal violet to fix the stain in <strong>Gram-positive</strong> cells.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetone or Alcohol (8)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This is used as a <strong>decolorizing agent</strong>, which removes the primary stain from <strong>Gram-negative</strong> cells, leaving them colourless.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Safranin (4)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - This is the <strong>counterstain</strong> that imparts a pink/red color to <strong>Gram-negative</strong> bacteria, while <strong>Gram-positive</strong> bacteria retain the original purple color.</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Gram staining procedure</strong> is essential for differentiating bacteria into <strong>Gram-positive</strong> (purple) and <strong>Gram-negative</strong> (pink/red). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct order of steps is: <strong>crystal violet</strong>, <strong>Gram&#39;s iodine</strong>, <strong>acetone/alcohol</strong> as a decolorizer, and <strong>safranin</strong> as a counterstain. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245062,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61484,
      "choices": [
        {
          "id": 245213,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">External ballotment</span></span></p>"
        },
        {
          "id": 245214,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Placental sign</span></span></p>"
        },
        {
          "id": 245215,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hegar sign</span></span></p>"
        },
        {
          "id": 245216,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chadwick&#39;s sign</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 31-year-old woman visits a rural clinic with a history of missing her period for 2 weeks and suspects she might be pregnant. Her previous menstrual cycles have been regular. The clinic has run out of urine pregnancy tests. Which of the following physical signs would most likely be present if she is pregnant?</span></span></p>",
      "unique_key": "Q9711815",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Hegar sign</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hegar sign refers to the <strong>softening of the lower uterine segment</strong> that occurs around <strong>6-8 weeks</strong> of gestation and is a sign of early pregnancy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is detected during a pelvic exam when the examiner can feel a soft area between the cervix and the body of the uterus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This sign is one of the physical changes that can help in the diagnosis of early pregnancy when other tests are unavailable.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180545.jpg\" style=\"height:258px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. External ballotment:</span></strong><span style=\"font-size:14.0pt\"> External ballotment refers to the ability to feel the fetus move or rebound inside the uterus when tapping the abdomen. This sign is typically present later in pregnancy (around 16-20 weeks) and is not useful for early diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Placental sign:</span></strong><span style=\"font-size:14.0pt\"> The term &quot;placental sign&quot; is not a standard or recognized clinical sign for early pregnancy. While the placenta develops during pregnancy, it is not detectable by physical examination in the early weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Chadwick&#39;s sign:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Chadwick&#39;s sign is the <strong>bluish discoloration of the cervix, vagina, and vulva</strong> due to increased vascularity and is usually seen around <strong>6-8 weeks</strong> of pregnancy. While it is a sign of pregnancy, it is less specific than Hegar&#39;s sign for diagnosing pregnancy based on uterine changes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Hegar sign&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a physical sign of <strong>early pregnancy</strong> characterized by the <strong>softening of the lower uterine segment</strong>, usually detectable around <strong>6-8 weeks of gestation</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It can help in diagnosing pregnancy when other tests like urine hCG are not available.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245215,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61449,
      "choices": [
        {
          "id": 245073,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immune complex deposition</span></span></span></span></p>"
        },
        {
          "id": 245074,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IV hypersensitivity reaction</span></span></span></span></p>"
        },
        {
          "id": 245075,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fibrinoid deposition</span></span></span></span></p>"
        },
        {
          "id": 245076,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apoptosis of infected cells</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 47-year-old woman presents with a persistent cough, low-grade fever, and episodes of hemoptysis. A chest X-ray reveals a cavitary lesion in the right lung apex, and biopsy of the lesion demonstrates caseous necrosis. Which of the following best explains the underlying mechanism of her condition?<strong> </strong></span></span></p>",
      "unique_key": "Q1266314",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Type IV hypersensitivity reaction</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation with cough, fever, hemoptysis, and a cavitary lung lesion with caseous necrosis is characteristic of tuberculosis. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculosis is primarily driven by a type IV hypersensitivity reaction (delayed-type hypersensitivity). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This reaction is mediated by T cells, particularly CD4+ T cells, which recognize mycobacterial antigens presented by macrophages. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The activated T cells then release cytokines, leading to the activation of macrophages, which attempt to contain the infection but also contribute to tissue destruction and formation of granulomas with caseous necrosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Immune complex deposition</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is typically seen in conditions like systemic lupus erythematosus (SLE) or glomerulonephritis, where immune complexes deposit in tissues and cause inflammation. It is not the mechanism behind the granulomatous inflammation and caseous necrosis seen in tuberculosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fibrinoid deposition</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Fibrinoid necrosis is usually seen in immune-mediated vascular conditions, such as vasculitis or severe hypertension, where immune complexes and fibrin are deposited in vessel walls. It does not lead to caseous necrosis in cavitary lung lesions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Apoptosis of infected cells</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Apoptosis is a process of programmed cell death and does not result in the characteristic granulomas and caseous necrosis seen in tuberculosis. While infected macrophages may undergo apoptosis, this is not the primary mechanism leading to caseous necrosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculosis is characterized by caseous necrosis in affected tissues, driven by a type IV hypersensitivity reaction, where activated T cells stimulate macrophages, leading to granuloma formation and tissue damage.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245074,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61224,
      "choices": [
        {
          "id": 244177,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Measurement of urinary 5-HIAA levels</span></span></p>"
        },
        {
          "id": 244178,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initiate proton pump inhibitor therapy</span></span></p>"
        },
        {
          "id": 244179,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administer octreotide and schedule imaging of the pancreas</span></span></p>"
        },
        {
          "id": 244180,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perform an adrenal CT scan</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman presents with a 6-month history of profuse watery diarrhea, abdominal cramping, and unintentional weight loss. She reports up to 8 episodes of diarrhea daily, which do not improve with fasting. Physical examination reveals sign of mild dehydration and hyperactive bowel sounds. Laboratory studies show: sodium 130 mEq/L, potassium 2.5 mEq/L, and bicarbonate 18 mEq/L. Stool studies are negative for infection. Further investigation reveals a normal serum gastrin level and an elevated serum vasoactive intestinal peptide (VIP) level. Given these findings, what is the most appropriate initial step in the management of this patient&#39;s condition?<strong> </strong></span></span></p>",
      "unique_key": "Q3727315",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) Administer octreotide and schedule imaging of the pancreas</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation is consistent with a VIPoma, a rare neuroendocrine tumor of the pancreas that secretes vasoactive intestinal peptide (VIP). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The elevated serum VIP level and the presence of watery diarrhea, hypokalemia, and metabolic acidosis (Verner-Morrison syndrome or WDHA syndrome) confirm this diagnosis. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most appropriate initial step in management is to control symptoms using somatostatin analogs, such as octreotide, which can inhibit VIP secretion. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Simultaneously, imaging (CT or MRI) of the pancreas should be performed to localize the tumor and guide further treatment, including potential surgical resection.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Measurement of urinary 5-HIAA levels:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This test is used to diagnose carcinoid syndrome, which may cause diarrhea but is typically associated with symptoms like flushing and wheezing. Additionally, carcinoid syndrome does not usually present with hypokalemia and metabolic acidosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Initiate proton pump inhibitor therapy:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While proton pump inhibitors are effective in Zollinger-Ellison syndrome (gastrinoma), this patient has a normal gastrin level and elevated VIP, which points to VIPoma as the underlying condition. Proton pump inhibitors will not address the VIP-related symptoms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Perform an adrenal CT scan:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This would be appropriate if pheochromocytoma were suspected, which typically presents with episodic hypertension, palpitations, headaches, and diaphoresis, rather than persistent watery diarrhea and hypokalemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VIPoma is characterized by chronic watery diarrhea, hypokalemia, and metabolic acidosis. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initial management involves controlling symptoms with somatostatin analogs, such as octreotide, followed by imaging to localize the pancreatic tumor for potential resection.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244179,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61458,
      "choices": [
        {
          "id": 245109,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Corynebacterium minutissimum and Erythromycin</span></span></p>"
        },
        {
          "id": 245110,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mycobacterium marinum and Rifampin</span></span></p>"
        },
        {
          "id": 245111,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sporothrix schenckii and Itraconazole</span></span></p>"
        },
        {
          "id": 245112,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nocardia brasiliensis and Trimethoprim-sulfamethoxazole</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old diabetic patient presents with well-demarcated, reddish-brown patches in the groin region. A Wood&#39;s lamp examination reveals coral-red fluorescence. The culture on blood agar shows the colonies shown in the provided image. What is the most likely organism, and what is the drug of choice for treatment? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180107.jpg\" style=\"height:300px; width:300px\" /></p>",
      "unique_key": "Q6660690",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Corynebacterium minutissimum and Erythromycin</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Corynebacterium minutissimum&nbsp;</span></strong><span style=\"font-size:14.0pt\">is the causative agent of <strong>erythrasma</strong>, a <strong>superficial skin infection</strong> characterized by well-demarcated, reddish-brown patches often found in <strong>intertriginous areas</strong> (e.g., axillae, groin). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Under a <strong>Wood&#39;s lamp</strong>, erythrasma exhibits a <strong>coral-red fluorescence</strong> due to the presence of <strong>porphyrins</strong> produced by the organism. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>culture</strong> typically grows on <strong>blood agar</strong>, as shown in the image provided, with typical colony morphology for Corynebacterium species. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>drug of choice</strong> for treatment is <strong>Erythromycin</strong>, which is effective against Corynebacterium minutissimum.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Mycobacterium marinum and Rifampin</span></strong><span style=\"font-size:14.0pt\">: Mycobacterium marinum causes <strong>fish tank granuloma</strong> and is associated with <strong>exposure to aquatic environments</strong>. The presentation usually involves skin lesions after contact with contaminated water, and it does not present as well-demarcated, reddish-brown patches.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Sporothrix schenckii and Itraconazole:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Sporothrix schenckii causes <strong>sporotrichosis</strong>, which is characterized by <strong>nodular lymphangitis</strong> rather than localized patches. The typical treatment is <strong>Itraconazole</strong>, not erythromycin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Nocardia brasiliensis and Trimethoprim-sulfamethoxazole:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Nocardia brasiliensis causes <strong>cutaneous and pulmonary nocardiosis</strong>, often involving <strong>nodular skin lesions</strong> or <strong>abscesses</strong>. The treatment of choice is <strong>Trimethoprim-sulfamethoxazole</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective :</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Erythrasma</span></strong><span style=\"font-size:14.0pt\">, caused by <strong>Corynebacterium minutissimum</strong>, presents with <strong>well-demarcated reddish-brown patches</strong> and shows <strong>coral-red fluorescence</strong> under a <strong>Wood&#39;s lamp</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>drug of choice</strong> for treatment is <strong>Erythromycin</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245109,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61343,
      "choices": [
        {
          "id": 244653,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Matching</span></span></span></span></p>"
        },
        {
          "id": 244654,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Randomization</span></span></span></span></p>"
        },
        {
          "id": 244655,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stratified randomization</span></span></span></span></p>"
        },
        {
          "id": 244656,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multivariate analysis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is designing a clinical trial to assess the effectiveness of a new antihypertensive drug. He is concerned about confounding variables that could affect the outcome of the study. Which of the following methods is considered the most effective for minimizing confounding when assigning participants to treatment groups? </span></span></p>",
      "unique_key": "Q3946218",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Stratified randomization</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stratified randomization&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is considered the <strong>most effective method</strong> for controlling <strong>confounding</strong> in clinical trials. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It involves <strong>stratifying</strong> participants based on certain characteristics (e.g., age, gender, baseline disease severity) before <strong>randomizing</strong> them into treatment groups. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This ensures that each treatment group is balanced with respect to these key characteristics, thereby minimizing the impact of <strong>confounders</strong> on the study results.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Matching:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. <strong>Matching</strong> is a common and simple method to control confounding by pairing participants with similar characteristics. However, it is less effective than <strong>stratified randomization</strong> because it does not randomize participants after matching.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Randomization:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. <strong>Randomization</strong> is effective in reducing confounding by ensuring that each participant has an equal chance of being assigned to any treatment group. However, <strong>stratified randomization</strong> is better when specific known confounders need to be balanced between groups.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Multivariate analysis:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. <strong>Multivariate analysis</strong> (e.g., regression analysis) is used to statistically control for confounding after data collection, but it is not as effective as <strong>stratified randomization</strong> in the design phase of a study.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blinding is used to remove Bias.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Confounding can be removed by:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Matching <strong>(MC used /simplest)</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Randomisation <strong>(2nd Best Method)</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restriction</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stratification</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Statistical Modelling / Multivariate analysis (MVA)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stratified Randomization (Overall Best Method)</span></span></span></span></li>\r\n</ol>",
      "correct_choice_id": 244655,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61297,
      "choices": [
        {
          "id": 244469,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Middle meningeal artery</span></span></p>"
        },
        {
          "id": 244470,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bridging veins</span></span></p>"
        },
        {
          "id": 244471,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vertebral artery</span></span></p>"
        },
        {
          "id": 244472,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lenticulostriate artery</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man presents to the emergency department after a fall. He was found unconscious at home, and a neighbor mentioned he had hit his head against a table. Upon arrival, his Glasgow Coma Scale (GCS) is 8, indicating altered consciousness. A CT scan of the head reveals a crescent-shaped hemorrhage that crosses suture lines but does not cross the midline. An autopsy image is provided below. Which of the following vessels is most likely responsible for the bleeding seen in this patient&#39;s condition?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-163231.jpg\" style=\"height:271px; width:300px\" /></span></span></p>",
      "unique_key": "Q1457923",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Bridging veins</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The provided <strong>image</strong> and <strong>clinical scenario</strong> suggest a <strong>subdural hematoma</strong>, characterized by <strong>bleeding</strong> that results in a <strong>crescent-shaped</strong> collection on <strong>CT imaging</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Subdural hematomas are typically caused by the rupture of <strong>bridging veins</strong> that extend between the <strong>cortical surface</strong> of the brain and the <strong>dural sinuses</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These veins are vulnerable to tearing during <strong>trauma</strong> or <strong>rapid head movements</strong>, especially in the <strong>elderly</strong> due to <strong>brain atrophy</strong>, which increases the tension on these veins.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-163247.jpg\" style=\"height:283px; width:700px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Middle meningeal artery</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The <strong>middle meningeal artery</strong> is associated with <strong>epidural hematoma</strong>, which presents as a <strong>lens-shaped (biconvex) hemorrhage</strong> on imaging. It is commonly seen after trauma to the <strong>temporal bone</strong>, not in this patient&#39;s presentation of a <strong>crescent-shaped hemorrhage</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Vertebral artery</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Injury to the <strong>vertebral artery</strong> typically results in <strong>posterior circulation strokes</strong> or <strong>dissections</strong>, rather than a subdural hematoma. This presentation is inconsistent with the bleeding pattern described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Lenticulostriate artery</span></strong><span style=\"font-size:14.0pt\">: Incorrect. The <strong>lenticulostriate arteries</strong> are small perforating branches of the <strong>middle cerebral artery</strong> and are usually involved in <strong>deep intracerebral hemorrhages</strong>, particularly in patients with <strong>chronic hypertension</strong>. These do not cause the <strong>crescent-shaped hemorrhage</strong> seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Subdural hematomas&nbsp;</span></strong><span style=\"font-size:14.0pt\">occur due to the rupture of <strong>bridging veins</strong>, leading to a <strong>crescent-shaped hemorrhage</strong> that can cross <strong>suture lines</strong> but not the <strong>midline</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition is more common in <strong>elderly patients</strong> following <strong>trauma</strong> or <strong>falls</strong> due to increased susceptibility of the veins.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244470,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61246,
      "choices": [
        {
          "id": 244265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PTH falls &gt;20% within 10 minutes of removal of gland</span></span></span></p>"
        },
        {
          "id": 244266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PTH falls &gt;50% within 10 minutes of removal of gland</span></span></span></p>"
        },
        {
          "id": 244267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PTH falls &gt;10% within 10 minutes of removal of gland</span></span></span></p>"
        },
        {
          "id": 244268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PTH falls &gt;30% within 10 minutes of removal of gland</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old man with a history of primary hyperparathyroidism is scheduled for a focused parathyroidectomy due to a solitary parathyroid adenoma. During the procedure, intraoperative parathyroid hormone (PTH) levels are monitored. Ten minutes after removing the parathyroid gland, his PTH level drops significantly. Which of the following changes in PTH levels would indicate that the resection was adequate?</span></span></p>",
      "unique_key": "Q4036352",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) PTH falls &gt;50% within 10 minutes of removal of gland</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To confirm that an adequate parathyroid gland has been removed during surgery for primary hyperparathyroidism, the <strong>parathyroid hormone (PTH)</strong> level should decrease by more than <strong>50% within 10 minutes</strong> after the removal of the gland. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This method is based on the <strong>Miami criteria</strong>, which utilizes the short half-life of PTH (3-5 minutes). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A drop in PTH levels of more than 50% indicates that the hyperfunctioning parathyroid tissue has been successfully excised, and no other hyperactive parathyroid gland remains. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This rapid assay helps guide surgeons in real-time during the procedure, ensuring that further exploration is unnecessary if the criterion is met.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In <strong>primary hyperparathyroidism</strong>, a <strong>&gt;50% drop in PTH levels within 10 minutes</strong> following the removal of the hyperfunctioning gland is used to confirm adequate resection during parathyroidectomy, according to the <strong>Miami criteria</strong>.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244266,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61406,
      "choices": [
        {
          "id": 244901,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CAG</span></span></span></span></p>"
        },
        {
          "id": 244902,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CGG</span></span></span></span></p>"
        },
        {
          "id": 244903,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CTG</span></span></span></span></p>"
        },
        {
          "id": 244904,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GAA</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">32-year-old man presents with progressive muscle weakness and difficulty relaxing his grip after shaking hands. He also reports experiencing daytime sleepiness and episodes of palpitations. On examination, he has facial muscle wasting, a frontal balding pattern, and a delayed relaxation of the hand grip. His mother had similar symptoms. Genetic testing is performed and confirms the diagnosis. Which of the following trinucleotide repeats is most likely responsible for this patient&rsquo;s condition?</span></span></p>",
      "unique_key": "Q5973531",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) CTG</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms, including progressive muscle weakness, myotonia (difficulty relaxing muscles), facial muscle wasting, and a family history, are consistent with myotonic dystrophy. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myotonic dystrophy type 1 (DM1) is caused by an expansion of the CTG trinucleotide repeat in the <em>DMPK</em> gene on chromosome 19. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This trinucleotide repeat expansion leads to the abnormal expression of RNA-binding proteins, affecting multiple body systems.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. CAG</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: CAG trinucleotide repeats are associated with Huntington&#39;s disease and some spinocerebellar ataxias, not myotonic dystrophy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. CGG</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: CGG repeat expansion is linked to fragile X syndrome, which presents with intellectual disability, not myotonia or muscle wasting.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. GAA</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: GAA repeats are found in Friedreich&#39;s ataxia, a condition characterized by progressive neurological deterioration, not myotonic dystrophy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myotonic dystrophy type 1 (DM1) is caused by an expansion of the CTG trinucleotide repeat in the <em>DMPK</em> gene, leading to progressive muscle weakness, myotonia, and multi-systemic involvement.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244903,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61281,
      "choices": [
        {
          "id": 244405,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bradycardia</span></span></span></p>"
        },
        {
          "id": 244406,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tachycardia</span></span></span></p>"
        },
        {
          "id": 244407,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased urine output</span></span></span></p>"
        },
        {
          "id": 244408,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased mean arterial blood pressure (MAP)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old male with a history of diabetes mellitus is admitted to the ICU with septic shock. He is started on a norepinephrine infusion to maintain perfusion pressure. During therapy, which of the following is the most appropriate parameter to monitor to assess the effectiveness of norepinephrine therapy?</span></span></p>",
      "unique_key": "Q8998693",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Increased mean arterial blood pressure (MAP)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Norepinephrine is a first-line vasopressor used in the management of septic shock.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;It acts by stimulating <strong>&alpha;1 and &alpha;2 adrenergic receptors</strong>, leading to vasoconstriction and an increase in systemic vascular resistance (SVR).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;It also stimulates <strong>&beta;1 receptors</strong>, increasing cardiac contractility, which helps maintain cardiac output.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>primary goal</strong> of norepinephrine therapy in septic shock is to <strong>increase mean arterial pressure (MAP)</strong> to improve organ perfusion.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Monitoring MAP is crucial, as it provides a direct measure of the pressure required to ensure adequate blood flow to the vital organs.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;A target <strong>MAP of &ge;65 mm Hg</strong> is typically aimed for in septic shock management, indicating that the therapy is effective in maintaining sufficient perfusion.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Bradycardia</span></strong><span style=\"font-size:14.0pt\">: Norepinephrine may cause reflex bradycardia due to increased blood pressure, but monitoring heart rate alone does not directly assess the effectiveness of perfusion or organ function in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Tachycardia</span></strong><span style=\"font-size:14.0pt\">: While heart rate is an important vital sign, it is not the primary indicator of the effectiveness of norepinephrine in improving perfusion. Tachycardia could indicate stress or poor perfusion but is not a direct measure of the success of vasopressor therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Increased urine output</span></strong><span style=\"font-size:14.0pt\">: While increased urine output is a sign of improved kidney perfusion; it is not as direct or reliable a parameter as MAP for monitoring the overall effectiveness of norepinephrine in managing septic shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Norepinephrine&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a key vasopressor in the treatment of <strong>septic shock</strong>, used to increase <strong>mean arterial pressure (MAP)</strong> and improve organ perfusion.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">MAP&nbsp;</span></strong><span style=\"font-size:14.0pt\">is the most reliable parameter for monitoring the effectiveness of norepinephrine therapy in septic shock, with a target of <strong>&ge;65 mm Hg</strong> to ensure adequate perfusion.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244408,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61266,
      "choices": [
        {
          "id": 244345,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1,2,5</span></span></span></span></p>"
        },
        {
          "id": 244346,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1,3,5</span></span></span></span></p>"
        },
        {
          "id": 244347,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1,3,4,5</span></span></span></span></p>"
        },
        {
          "id": 244348,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1,2,3,4,5</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old male who underwent a kidney transplant six months ago is being treated with cyclosporine to prevent graft rejection. Which of the following are known complications of cyclosporine therapy?<strong> </strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertension </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulmonary fibrosis </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hirsutism </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nephrotoxicity </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia</span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q9402874",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 1,3,4,5 </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclosporine is an immunosuppressant used to prevent transplant rejection.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Its most common adverse effects include:</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:24px\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1. Hypertension</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cyclosporine causes vasoconstriction, leading to elevated blood pressure.</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:24px\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3. Hirsutism</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Unwanted facial and body hair growth is a frequent cosmetic side effect.</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:24px\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4. Nephrotoxicity</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cyclosporine can cause renal vasoconstriction, leading to a reduction in glomerular filtration rate and kidney damage.</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:24px\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5. Hyperkalemia</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cyclosporine can impair renal potassium excretion, resulting in elevated potassium levels.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Option:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2. Pulmonary fibrosis</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pulmonary fibrosis is not associated with cyclosporine but may be seen with other immunosuppressive agents, like methotrexate.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common side effects of cyclosporine include hypertension, nephrotoxicity, hirsutism, and hyperkalemia.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulmonary fibrosis is not a known side effect of cyclosporine. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244347,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61452,
      "choices": [
        {
          "id": 245085,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chondrosarcoma</span></span></span></span></p>"
        },
        {
          "id": 245086,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ewing sarcoma</span></span></span></span></p>"
        },
        {
          "id": 245087,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osteoclastoma</span></span></span></span></p>"
        },
        {
          "id": 245088,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Langerhans cell histiocytosis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15-year-old male presents with pain and swelling in the upper part of his right leg. Imaging reveals a periosteal reaction in the diaphysis of the proximal tibia. A biopsy of the lesion is performed, and the histopathological image is shown below. Immunohistochemical staining is positive for Synaptophysin and MIC-2. What is the most likely diagnosis?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-102156.png\" style=\"height:276px; width:300px\" /></p>",
      "unique_key": "Q6607427",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Ewing sarcoma</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The histological image provided shows characteristic features like small, round, blue cells, which are tightly packed with scant cytoplasm pattern and <strong>hyperchromatic Nuclei</strong> is suggestive of <strong>Ewing sarcoma.</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ewing sarcoma is a malignant small round blue cell tumor that typically affects the diaphysis of long bones, such as the tibia, in adolescents. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical presentation often includes localized pain and swelling, along with a characteristic &quot;onion-skin&quot; periosteal reaction on X-ray imaging. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnosis is supported by immunohistochemistry, which shows positivity for <strong>MIC-2 (CD99)</strong> and sometimes <strong>Synaptophysin,</strong> differentiating it from other small round cell tumors. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This makes Ewing sarcoma the most likely diagnosis in this case.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-102348.png\" style=\"height:253px; width:600px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Chondrosarcoma:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chondrosarcoma is more common in older adults and typically affects the metaphysis or diaphysis of long bones but rarely presents in adolescents. It is characterized by cartilage matrix production rather than small round blue cells. Immunohistochemistry for MIC-2 would not be positive in chondrosarcoma.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Osteoclastoma (Giant cell tumor of bone):&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition typically occurs in the epiphysis of long bones in young adults. It presents as a lytic lesion and is histologically characterized by multinucleated giant cells. The immunohistochemical profile differs from that of Ewing sarcoma, as it does not show MIC-2 positivity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Langerhans cell histiocytosis:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Langerhans cell histiocytosis can involve bone lesions, often seen in children, but it is associated with eosinophilic granuloma and Langerhans cells with coffee bean-shaped nuclei. Immunohistochemistry would show positivity for CD1a and S-100, not MIC-2.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ewing sarcoma is a small round blue cell tumor that commonly affects the diaphysis of long bones in adolescents. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by immunohistochemical positivity for MIC-2 (CD99) and may show Synaptophysin positivity, distinguishing it from other bone tumors.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245086,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61505,
      "choices": [
        {
          "id": 245297,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To increase glucose absorption through sodium-glucose cotransport</span></span></p>"
        },
        {
          "id": 245298,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To replenish lost potassium and sodium</span></span></p>"
        },
        {
          "id": 245299,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To correct metabolic acidosis</span></span></p>"
        },
        {
          "id": 245300,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To provide direct hydration to intestinal cells</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old boy presents to the clinic with a 2-day history of profuse watery diarrhea and signs of dehydration after a suspected case of cholera. The physician prescribes oral rehydration solution (ORS) that contains sodium chloride, potassium chloride, glucose, and sodium citrate. Which of the following is the primary purpose of sodium citrate in this ORS formulation? </span></span></p>",
      "unique_key": "Q5424890",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) To correct metabolic acidosis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium citrate&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in ORS serves as a <strong>base</strong> that helps <strong>correct metabolic acidosis</strong>, which commonly occurs in patients with severe diarrhea due to the <strong>loss of bicarbonate</strong> in the stools. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The citrate is metabolized in the liver into <strong>bicarbonate</strong>, helping to buffer the acid in the blood. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is especially important in conditions like <strong>cholera</strong>, where severe acidosis can develop due to the large losses of alkaline fluid in the form of diarrhea.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. To increase glucose absorption through sodium-glucose cotransport:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. While ORS does facilitate glucose absorption via the <strong>sodium-glucose cotransport mechanism</strong>, this function is primarily driven by <strong>glucose</strong> and <strong>sodium</strong>, not sodium citrate.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. To replenish lost potassium and sodium:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. <strong>Potassium chloride</strong> and <strong>sodium chloride</strong> in the ORS are responsible for replenishing lost electrolytes. Sodium citrate&rsquo;s role is focused on correcting acidosis rather than directly replacing electrolytes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. To provide direct hydration to intestinal cells:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. Sodium citrate indirectly aids hydration by improving the intestinal absorption of sodium and water, but its main function is to help <strong>correct acidosis</strong> through its conversion to bicarbonate.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium citrate&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in ORS is primarily used to <strong>correct metabolic acidosis</strong> resulting from the loss of bicarbonate during diarrhea. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is converted to <strong>bicarbonate</strong> in the liver, helping to buffer acids in the blood and maintain pH balance.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245299,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61436,
      "choices": [
        {
          "id": 245021,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-a, 2-b, 3-c, 4-d</span></span></span></span></p>"
        },
        {
          "id": 245022,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-a, 3-d, 4-b</span></span></span></span></p>"
        },
        {
          "id": 245023,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-b, 3-d, 4-a</span></span></span></span></p>"
        },
        {
          "id": 245024,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-a, 3-b, 4-d</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the options: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MC neoplasm of salivary gland</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MC malignant tumor of salivary gland</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor of salivary gland with perineural invasion</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor that shows hot spot in Tc-99 scan</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warthin&rsquo;s tumor</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mucoepidermoid carcinoma</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pleomorphic adenoma</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenoid cystic carcinoma</span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q9961037",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 1-c, 2-b, 3-d, 4-a</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-094917.png\" style=\"height:236px; width:1000px\" /></span></span></strong></span></span></p>",
      "correct_choice_id": 245023,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61240,
      "choices": [
        {
          "id": 244241,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hendra virus</span></span></span></span></p>"
        },
        {
          "id": 244242,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">West Nile virus</span></span></span></span></p>"
        },
        {
          "id": 244243,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ebola virus</span></span></span></span></p>"
        },
        {
          "id": 244244,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Yellow fever</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 38-year-old man from southern India presents with fever, headache, muscle weakness, and altered sensorium. He reports mosquito bites during his recent outdoor activities. Laboratory evaluation is initiated, and it is determined that a specific viral agent is the likely cause. Reverse transcription polymerase chain reaction (RT-PCR) is used as part of the diagnostic workup. Which of the following viruses is endemic to India and can be detected using this method?<strong> </strong></span></span></p>",
      "unique_key": "Q9315453",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>B) West Nile virus</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">West Nile Virus (WNV)&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a member of the <strong>flavivirus genus</strong> and belongs to the <strong>Japanese encephalitis antigenic complex</strong> of the family <strong>Flaviviridae</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an <strong>arbovirus</strong>, meaning it is transmitted by <strong>arthropods</strong>, specifically <strong>mosquitoes</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The virus is endemic to many regions, including <strong>India</strong>, where antibodies against WNV were first detected in <strong>Mumbai</strong> in 1952. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Since then, WNV activity has been reported in <strong>southern, central, and western India</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WNV primarily involves a transmission cycle between <strong>birds and mosquitoes</strong>; however, humans and other mammals (e.g., horses) can also become infected. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The virus can cause <strong>neurological disease</strong> in some individuals, ranging from mild febrile illness to severe <strong>encephalitis</strong> or <strong>meningitis</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis can be made by several methods, including <strong>RT-PCR</strong>, which helps detect viral RNA in blood or cerebrospinal fluid, especially during the acute phase of infection.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hendra virus</strong>: Hendra virus is an emerging zoonotic virus found primarily in <strong>Australia</strong>. It is not endemic to India, and its primary reservoir is the <strong>flying fox</strong> (fruit bat).</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ebola virus</strong>: Ebola virus is primarily found in <strong>Africa</strong> and is not endemic to India. It can cause <strong>hemorrhagic fever</strong> and has a high mortality rate.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Yellow fever</strong>: <strong>Yellow fever</strong> is a <strong>flavivirus</strong> that primarily affects regions of <strong>Africa and South America</strong>. It is not endemic to India, and vaccination is used for prevention in endemic regions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">West Nile Virus (WNV)&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is endemic to many parts of <strong>India</strong> and can cause <strong>neurological disease</strong> in humans. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is transmitted by mosquitoes in a cycle involving birds as the reservoir. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RT-PCR&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">can be used to diagnose WNV infection by detecting viral RNA during the acute phase. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244242,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61489,
      "choices": [
        {
          "id": 245233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-4, B-1, C-3, D-2</span></span></span></p>"
        },
        {
          "id": 245234,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-3, B-4, C-1, D-2</span></span></span></p>"
        },
        {
          "id": 245235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-3, B-1, C-2, D-4</span></span></span></p>"
        },
        {
          "id": 245236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A-4, B-3, C-1, D-2</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pediatric resident is reviewing neonatal reflexes with a medical student. They observe four different infants demonstrating various reflexes as shown in images labelled A, B, C, and D. The resident asks the student to match the reflexes to the images shown. Which of the following is the correct match of the neonatal reflexes to their corresponding images?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180641.jpg\" style=\"height:285px; width:400px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Asymmetrical tonic neck reflex</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Palmar Grasp Reflex</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Parachute reflex</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Moro&rsquo;s Reflex</span></span></span></li>\r\n</ol>",
      "unique_key": "Q7897131",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) A-4, B-3, C-1, D-2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/17/screenshot-2024-10-17-101034.jpg\" style=\"height:971px; width:700px\" /></p>",
      "correct_choice_id": 245236,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61491,
      "choices": [
        {
          "id": 245241,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NST and breathing movements</span></span></span></span></p>"
        },
        {
          "id": 245242,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NST and amniotic fluid index (AFI)</span></span></span></span></p>"
        },
        {
          "id": 245243,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NST and fetal tone</span></span></span></span></p>"
        },
        {
          "id": 245244,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NST and gross fetal movements</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old pregnant woman at 38 weeks of gestation is undergoing an evaluation of fetal well-being due to concerns about decreased fetal movements. The obstetrician decides to perform a modified biophysical profile. Which of the following components is included in a modified biophysical profile? </span></span></p>",
      "unique_key": "Q2247346",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>B) NST and amniotic fluid index (AFI)</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct answer is <strong>NST and amniotic fluid index (AFI)</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>modified biophysical profile (BPP)</strong> is a simplified version of the full BPP, which includes <strong>non-stress test (NST)</strong> and <strong>amniotic fluid index (AFI)</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The NST assesses fetal heart rate reactivity, while AFI provides an evaluation of the amniotic fluid volume, which is an indicator of chronic fetal well-being and placental function. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This combination gives a quick and effective assessment of fetal health.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. NST and breathing movements</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This option is incorrect because fetal breathing movements are a component of the full biophysical profile, not the modified version. The modified BPP focuses specifically on NST and AFI.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. NST and fetal tone</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is incorrect as fetal tone is part of the full BPP rather than the modified BPP. In the modified version, the emphasis is placed on assessing acute (NST) and chronic (AFI) markers of fetal health.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. NST and gross fetal movements</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is incorrect because gross fetal movements are also assessed in the full BPP. The modified BPP does not evaluate gross fetal movements but focuses on NST and AFI for a quicker assessment of fetal well-being.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>modified biophysical profile (BPP)</strong> includes <strong>non-stress test (NST)</strong> and <strong>amniotic fluid index (AFI)</strong>, providing a rapid assessment of fetal well-being by evaluating both acute and chronic markers of fetal health. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This version is often used when a quick but effective evaluation of fetal status is required.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245242,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61503,
      "choices": [
        {
          "id": 245289,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cross-sectional study</span></span></p>"
        },
        {
          "id": 245290,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cohort study</span></span></p>"
        },
        {
          "id": 245291,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nested case-control study</span></span></p>"
        },
        {
          "id": 245292,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Case-control study</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is studying the relationship between a new medication and the risk of developing a rare adverse cardiac event in a cohort of 10,000 patients. Initial data on exposure is collected. After 5 years of follow-up, 100 patients develop the cardiac event (cases). For each of these patients, the researcher selects 200 patients from the same cohort who did not develop the event during the follow-up period (controls) to compare their exposure to the medication. What type of study design is being used in this scenario? </span></span></p>",
      "unique_key": "Q7459213",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Nested case-control study</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A <strong>nested case-control study</strong> is a type of <strong>case-control study</strong> that is conducted within a <strong>pre-existing cohort</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In this study design, <strong>cases</strong> (patients who develop the outcome of interest, such as a rare cardiac event) are identified from the cohort, and a set of <strong>controls</strong> is selected from those who <strong>do not develop the outcome</strong> during the follow-up period. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The exposures of cases and controls are then compared to assess associations. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This approach combines the <strong>prospective data collection</strong> of a cohort study with the <strong>efficiency</strong> of a case-control study.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Cross-sectional study:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. A cross-sectional study assesses <strong>prevalence</strong> by looking at exposure and outcome at a single point in time, rather than following patients over time or selecting cases and controls.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Cohort study:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. A cohort study follows a group over time to observe the <strong>development of outcomes</strong> based on exposure status. While the nested case-control study uses a cohort, it specifically selects cases and controls for a more focused analysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Case-control study:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. A traditional case-control study selects cases and controls from the general population without necessarily having a pre-defined cohort, whereas a <strong>nested case-control study</strong> selects both from within an existing cohort.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A <strong>nested case-control study</strong> is conducted within a <strong>pre-existing cohort</strong>, allowing researchers to efficiently study <strong>rare outcomes</strong> by focusing on cases and a matched subset of controls, providing the advantages of both <strong>prospective</strong> and <strong>retrospective</strong> study designs.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245291,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61498,
      "choices": [
        {
          "id": 245269,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">60 mL/min</span></span></span></span></p>"
        },
        {
          "id": 245270,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">80 mL/min</span></span></span></span></p>"
        },
        {
          "id": 245271,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">160 mL/min</span></span></span></span></p>"
        },
        {
          "id": 245272,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">180 mL/min</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man undergoing evaluation for renal function had a test substance administered to measure his renal clearance. Laboratory results show a urine concentration of the substance as 120 mg/mL, a plasma concentration of 40 mg/mL, and a urinary flow rate of 20 mL/min. What is the renal clearance of this substance?<strong> </strong></span></span></p>",
      "unique_key": "Q7978009",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 60 mL/min</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal clearance of a substance is calculated using the formula:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-114839.png\" style=\"height:69px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine concentration</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> = 120 mg/mL</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasma concentration</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> = 40 mg/mL</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary flow rate</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> = 20 mL/min</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Substitute these values into the formula:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-114927.png\" style=\"height:142px; width:400px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So, the renal clearance of the substance is <strong>60 mL/min</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To determine renal clearance, use the formula</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-115031.png\" style=\"height:84px; width:700px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This formula helps assess kidney function by evaluating how effectively a substance is removed from the blood and excreted in the urine.</span></span></span></span></p>",
      "correct_choice_id": 245269,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61475,
      "choices": [
        {
          "id": 245177,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vincristine</span></span></span></p>"
        },
        {
          "id": 245178,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Carmustine</span></span></span></p>"
        },
        {
          "id": 245179,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Melphalan</span></span></span></p>"
        },
        {
          "id": 245180,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cyclophosphamide</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old patient with a history of non-Hodgkin&#39;s lymphoma is undergoing chemotherapy. The oncologist discusses different classes of chemotherapeutic agents, including those that are effective irrespective of the cell cycle phase (proliferation-independent). Which of the following drugs is not considered a proliferation-independent chemotherapeutic agent?</span></span></p>",
      "unique_key": "Q6152067",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Vincristine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Vincristine&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>vinca alkaloid</strong> that acts by binding to tubulin and inhibiting microtubule formation, effectively blocking cells in the <strong>M phase</strong> of the cell cycle.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;This means that its activity is dependent on the cells being in a specific phase of proliferation, making it <strong>proliferation-dependent</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Carmustine</span></strong><span style=\"font-size:14.0pt\">: <strong>Carmustine</strong> is an <strong>alkylating agent</strong> that works by forming cross-links in DNA, preventing replication and transcription. It is effective against both dividing and non-dividing cells, making it a <strong>proliferation-independent</strong> agent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Melphalan</span></strong><span style=\"font-size:14.0pt\">: <strong>Melphalan</strong> is another <strong>alkylating agent</strong> that is effective in damaging DNA, regardless of the cell cycle phase, thus it is considered <strong>proliferation-independent</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Cyclophosphamide</span></strong><span style=\"font-size:14.0pt\">: <strong>Cyclophosphamide</strong> is also an <strong>alkylating agent</strong>, working by cross-linking DNA strands, and can kill cells in both dividing and resting phases, making it <strong>proliferation-independent</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Vinca alkaloids&nbsp;</span></strong><span style=\"font-size:14.0pt\">like <strong>vincristine</strong> are <strong>proliferation-dependent</strong> agents, targeting cells in the <strong>M phase</strong> of the cell cycle.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Alkylating agents&nbsp;</span></strong><span style=\"font-size:14.0pt\">like <strong>carmustine</strong>, <strong>melphalan</strong>, and <strong>cyclophosphamide</strong> are <strong>proliferation-independent</strong> and can act on both dividing and non-dividing cells.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245177,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61251,
      "choices": [
        {
          "id": 244285,
          "text": "<p><span style=\"font-size:14.0pt;\">Hereditary spherocytosis</span></p>"
        },
        {
          "id": 244286,
          "text": "<p><span style=\"font-size:14.0pt;\">Sickle cell anemia</span></p>"
        },
        {
          "id": 244287,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucose-6-phosphate dehydrogenase (G6PD) deficiency</span></p>"
        },
        {
          "id": 244288,
          "text": "<p><span style=\"font-size:14.0pt;\">Thalassemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents with episodes of jaundice and anemia. Laboratory testing reveals increased reticulocyte count and elevated indirect bilirubin levels. A test is performed that shows increased red blood cell lysis when exposed to hypotonic solutions. Which of the following conditions is most likely associated with this finding?</span></p>",
      "unique_key": "Q5309173",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Hereditary spherocytosis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Hereditary spherocytosis&nbsp;</strong>is characterized by a defect in the red blood cell membrane proteins (such as spectrin and ankyrin), leading to <strong>spherocytes</strong> that are more prone to <strong>hemolysis</strong> in hypotonic solutions.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>osmotic fragility test</strong> measures the extent of red blood cell lysis when placed in varying concentrations of hypotonic saline.</span></li><li><span style=\"font-size:14.0pt;\">In hereditary spherocytosis, the <strong>increased fragility</strong> of red cells due to their shape results in <strong>increased hemolysis</strong> during the test, confirming the diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-164742.png\" alt=\"\" width=\"500\" height=\"214\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Sickle cell anemia</strong>: This condition is due to a mutation in the beta-globin gene, leading to the formation of sickle-shaped cells. These cells have altered deformability but do not show increased osmotic fragility as seen in hereditary spherocytosis. The diagnosis is typically made by hemoglobin electrophoresis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Glucose-6-phosphate dehydrogenase (G6PD) deficiency</strong>: This condition leads to hemolysis triggered by oxidative stress. The osmotic fragility test is not used for diagnosis; instead, a G6PD enzyme assay is the diagnostic test.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Thalassemia</strong>: This is a genetic disorder affecting hemoglobin synthesis, leading to microcytic anemia. Osmotic fragility is not the primary diagnostic test; hemoglobin electrophoresis is used for diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hereditary spherocytosis is caused by mutations in proteins like spectrin, ankyrin, band 3, or protein 4.2 that maintain the RBC cytoskeleton</span></li><li><span style=\"font-size:14.0pt;\">This causes spherically shaped RBCs that are less deformable and more prone to lysis, especially in hypotonic environments</span></li><li><span style=\"font-size:14.0pt;\">The osmotic fragility test is positive due to increased susceptibility to hemolysis in hypotonic saline</span></li><li><span style=\"font-size:14.0pt;\">The diagnosis is confirmed with help of EMA flowcytometry.</span></li></ul>",
      "correct_choice_id": 244285,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61403,
      "choices": [
        {
          "id": 244889,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammatory myopathy with skin involvement</span></span></span></span></p>"
        },
        {
          "id": 244890,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Central sensitization of pain pathways</span></span></span></span></p>"
        },
        {
          "id": 244891,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immune complex deposition in medium-sized arteries</span></span></span></span></p>"
        },
        {
          "id": 244892,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammatory disorder of the joints and periarticular structures</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old woman presents to the clinic with a 2-month history of bilateral shoulder and hip stiffness accompanied by pain that is most pronounced in the morning. She finds it increasingly difficult to perform daily activities, such as combing her hair and getting dressed. On physical examination, there is limited active range of motion in her shoulders and hips due to pain, but muscle strength testing reveals no true muscle weakness. Her laboratory tests show a markedly elevated erythrocyte sedimentation rate (ESR), while X-rays of the affected joints appear normal. Which pathophysiological process best explains this patient&rsquo;s symptoms?<strong> </strong></span></span></p>",
      "unique_key": "Q1460135",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D) Inflammatory disorder of the joints and periarticular structures</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation, characterized by bilateral shoulder and hip stiffness that is worse in the morning, limited movement due to pain, and an elevated ESR, is highly suggestive of <strong>polymyalgia rheumatica (PMR)</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PMR is an inflammatory disorder that primarily affects the joints and periarticular structures, such as bursae and tendons, leading to pain and stiffness, particularly in the shoulders and hips. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The absence of muscle weakness and the normal joint X-rays further support this diagnosis, distinguishing PMR from other inflammatory and musculoskeletal conditions.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Inflammatory myopathy with skin involvement</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This describes <strong>dermatomyositis</strong>, which presents with muscle weakness and characteristic skin changes such as a heliotrope rash. The absence of muscle weakness and normal X-ray findings make dermatomyositis unlikely in this case.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Central sensitization of pain pathways</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This mechanism is seen in <strong>fibromyalgia</strong>, which involves widespread musculoskeletal pain, fatigue, and tender points without objective inflammatory markers like an elevated ESR. Fibromyalgia typically does not present with significant morning stiffness localized to the shoulders and hips.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Immune complex deposition in medium-sized arteries</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This describes <strong>polyarteritis nodosa (PAN)</strong>, a vasculitis that affects medium-sized arteries and leads to systemic symptoms, including organ dysfunction. It does not present with the classic stiffness and pain in the shoulder and hip girdles seen in PMR.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polymyalgia rheumatica is characterized by proximal muscle stiffness and pain, particularly in the shoulders and hips, without true muscle weakness. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is associated with elevated inflammatory markers such as ESR, and the symptoms typically respond well to low-dose corticosteroids</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244892,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61399,
      "choices": [
        {
          "id": 244873,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonal anergy</span></span></span></span></p>"
        },
        {
          "id": 244874,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum sickness</span></span></span></span></p>"
        },
        {
          "id": 244875,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SOD1 mutation</span></span></span></span></p>"
        },
        {
          "id": 244876,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II hypersensitivity</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man presents with a 3-month history of progressive fatigue, generalized weakness, a sensation of heaviness in the head, difficulty smiling, and a drooping left eyelid. Neurological examination reveals ptosis that significantly improves following the administration of edrophonium. Additional workup shows no cranial nerve deficits, and his reflexes are normal. Which of the following is the most likely underlying mechanism of this patient&#39;s condition?<strong> </strong></span></span></p>",
      "unique_key": "Q6421151",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D) Type II hypersensitivity</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms and the improvement in ptosis with the administration of edrophonium strongly suggest <strong>myasthenia gravis (MG)</strong>. MG is an autoimmune disorder characterized by the production of autoantibodies against acetylcholine receptors (AChRs) at the neuromuscular junction. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These antibodies block, alter, or destroy the receptors, leading to muscle weakness and fatigue. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This autoimmune process is an example of a <strong>Type II hypersensitivity reaction</strong>, where antibodies are directed against cell surface antigens, leading to tissue-specific effects. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The use of edrophonium, an acetylcholinesterase inhibitor, temporarily increases the availability of acetylcholine at the neuromuscular junction, resulting in an improvement in muscle strength, confirming the diagnosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Clonal anergy:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clonal anergy refers to the inactivation of specific immune cells, usually T or B cells, preventing them from responding to antigens. This mechanism is associated with immune tolerance rather than the production of pathogenic autoantibodies seen in myasthenia gravis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Serum sickness:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum sickness is a Type III hypersensitivity reaction involving the formation of immune complexes, typically after exposure to foreign proteins or medications. It presents with systemic symptoms such as fever, rash, and joint pain, not focal neuromuscular weakness.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. SOD1 mutation:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutations in the superoxide dismutase 1 (SOD1) gene are associated with familial amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder characterized by progressive motor neuron loss. ALS does not exhibit improvement with edrophonium and does not primarily involve autoantibodies against the neuromuscular junction.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myasthenia gravis is an autoimmune neuromuscular disorder mediated by a Type II hypersensitivity reaction, where autoantibodies target acetylcholine receptors, resulting in muscle weakness that can temporarily improve with acetylcholinesterase inhibitors like edrophonium.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244876,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61473,
      "choices": [
        {
          "id": 245169,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is combination of cholinergic and anticholinergic drug</span></span></span></span></p>"
        },
        {
          "id": 245170,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This combination is approved for treatment of schizophrenia </span></span></span></span></p>"
        },
        {
          "id": 245171,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can cause urinary retention as an adverse effect</span></span></span></span></p>"
        },
        {
          "id": 245172,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an irrational combination</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A new combination therapy of xanomeline and trospium has recently been approved for the treatment of a psychiatric disorder. Which of the following statements about this combination is <span style=\"font-family:&quot;Calibri&quot;,sans-serif\">false</span>?<strong> </strong></span></span></p>",
      "unique_key": "Q3397028",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) It is an irrational combination</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is false. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The combination of xanomeline (a muscarinic agonist) and trospium (a muscarinic antagonist) is rational because it is designed to leverage the central beneficial effects of enhancing muscarinic activity in the brain (with xanomeline) while mitigating the peripheral muscarinic side effects (using trospium). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This strategic use of an anticholinergic to manage side effects while promoting the therapeutic effect of a cholinergic drug represents a thoughtful and effective approach to pharmacotherapy in schizophrenia.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It is a combination of cholinergic and anticholinergic drug:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is true. Xanomeline is a muscarinic cholinergic receptor agonist, and trospium is an anticholinergic drug. The rationale for this combination is that xanomeline targets muscarinic receptors to improve symptoms of schizophrenia, while trospium counteracts the peripheral cholinergic side effects of xanomeline, such as salivation and gastrointestinal distress.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. This combination is approved for treatment of schizophrenia:</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;This statement is true. The combination of xanomeline and trospium is designed to reduce the cognitive and behavioral symptoms of schizophrenia by enhancing cholinergic transmission in the brain while mitigating peripheral side effects through the anticholinergic action of trospium.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It can cause urinary retention as an adverse effect:</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;This statement is true. Trospium, as an anticholinergic agent, can lead to urinary retention among other potential anticholinergic effects like dry mouth and constipation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The combination of xanomeline and trospium is designed to optimize the benefits of muscarinic receptor stimulation while minimizing peripheral side effects, making it a rational choice for treating schizophrenia.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245172,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61299,
      "choices": [
        {
          "id": 244477,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin B12</span></span></p>"
        },
        {
          "id": 244478,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyridoxine</span></span></p>"
        },
        {
          "id": 244479,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin B3</span></span></p>"
        },
        {
          "id": 244480,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiamine (Vitamin B1)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male presents with symptoms of chronic fatigue, pallor, and difficulty concentrating. Laboratory tests reveal microcytic anemia, and a bone marrow biopsy shows ringed sideroblasts. The patient is diagnosed with sideroblastic anemia. Which of the following is the most appropriate treatment for this condition?<strong> </strong></span></span></p>",
      "unique_key": "Q5318818",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B) Pyridoxine</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sideroblastic anemia is a type of anemia where the bone marrow produces ringed sideroblasts rather than healthy red blood cells. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common cause of this condition is a deficiency in the enzyme ALA synthase, which requires vitamin B6 (pyridoxine) as a cofactor. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Supplementation with pyridoxine is particularly effective in cases of sideroblastic anemia that are due to congenital pyridoxine-responsive forms or acquired deficiencies caused by medications like isoniazid.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Vitamin B12:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin B12 is used to treat megaloblastic anemia, not sideroblastic anemia. B12 deficiency results in macrocytic red blood cells, which is different from the microcytic nature of sideroblastic anemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vitamin B3:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin B3 (niacin) is involved in energy metabolism but does not have a direct role in the treatment of sideroblastic anemia. It is not involved in the heme synthesis pathway that is impaired in sideroblastic anemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Thiamine (Vitamin B1):&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiamine is used in conditions like beriberi and Wernicke-Korsakoff syndrome. It does not play a direct role in heme synthesis, making it ineffective in the treatment of sideroblastic anemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sideroblastic anemia, characterized by the presence of ringed sideroblasts in the bone marrow, can be treated effectively with pyridoxine (vitamin B6) due to its role as a cofactor in heme synthesis. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244478,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61282,
      "choices": [
        {
          "id": 244409,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mucor</span></span></p>"
        },
        {
          "id": 244410,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspergillus</span></span></p>"
        },
        {
          "id": 244411,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Candida</span></span></p>"
        },
        {
          "id": 244412,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichosporon</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male with a history of poorly controlled diabetes mellitus was treated with high-dose corticosteroids for an episode of exacerbated asthma 4 weeks ago. He now presents with complaints of nasal congestion, bloody nasal discharge, and facial pain for the past 3 weeks. On examination, there is evidence of black eschar on the nasal mucosa. A nasal biopsy was obtained, and the histopathological image is shown. What is the most likely causative organism?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-170658.png\" style=\"height:212px; width:300px\" /></p>",
      "unique_key": "Q8234674",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>A) Mucor</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The histopathological image shows <strong>broad, non-septate hyphae</strong> with <strong>irregular, right-angle branching</strong>, which is indicative of an infection with <strong>Mucorales species</strong> (Mucormycosis). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mucormycosis typically presents in <strong>immunocompromised individuals</strong>, such as those with poorly controlled <strong>diabetes mellitus</strong> or those on <strong>corticosteroids</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients often present with <strong>sinus involvement</strong>, nasal discharge, <strong>facial pain</strong>, and <strong>blackening of skin</strong>, which is characteristic of the tissue necrosis caused by vascular invasion by Mucor.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Aspergillus</strong>: This fungus forms <strong>septate hyphae</strong> with <strong>acute-angle branching</strong> (approximately 45&deg;). It is commonly found in <strong>aspergillosis</strong>, particularly in patients with chronic lung disease or severe immunocompromise, but it does not produce the broad, non-septate hyphae seen here.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Candida</strong>: Candida is seen as <strong>budding yeast</strong> or <strong>pseudohyphae</strong>, typically in mucosal infections or systemic candidiasis, and does not show the broad hyphal features seen in this image.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Trichosporon</strong>: Trichosporon forms <strong>yeast-like cells</strong> and does not produce the broad, non-septate hyphae indicative of Mucor. It is seen in systemic infections in severely immunocompromised individuals.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mucormycosis&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">should be suspected in patients with <strong>diabetes mellitus</strong> or who are on <strong>corticosteroids</strong> presenting with <strong>sinus involvement</strong>, <strong>blackening of skin</strong>, and <strong>facial pain</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histopathology showing <strong>broad, non-septate hyphae</strong> with <strong>right-angle branching</strong> is characteristic of Mucorales infection. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early diagnosis and aggressive treatment are crucial due to its rapid, invasive nature.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244409,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61485,
      "choices": [
        {
          "id": 245217,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fetus is in breech presentation</span></span></p>"
        },
        {
          "id": 245218,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fetus is in cephalic presentation</span></span></p>"
        },
        {
          "id": 245219,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fetus is in oblique lie</span></span></p>"
        },
        {
          "id": 245220,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The fetus is in compound presentation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old primigravida at 32 weeks gestation is undergoing a routine check-up. On abdominal palpation, the provider identifies a hard, ballotable structure near the upper abdomen. Which of the following best describes the likely fetal position?</span></span></p>",
      "unique_key": "Q4147212",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) The fetus is in breech presentation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A <strong>ballotable hard structure</strong> felt during a fundal grip is typically the <strong>fetal head</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If this hard structure is felt at the <strong>upper abdomen</strong> (fundus), it suggests that the <strong>head is positioned upwards</strong> while the buttocks or legs are downwards, indicating a <strong>breech presentation</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. The fetus is in cephalic presentation:&nbsp;</span></strong><span style=\"font-size:14.0pt\">In a <strong>cephalic presentation</strong>, the <strong>fetal head</strong> is expected to be positioned downwards, near the <strong>pelvis</strong>. During fundal grip, a soft structure, which is the fetal <strong>buttocks</strong>, would be felt at the fundus instead of a hard, ballotable structure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. The fetus is in oblique lie:&nbsp;</span></strong><span style=\"font-size:14.0pt\">An <strong>oblique lie</strong> occurs when the fetus is positioned diagonally between the head-down and head-up positions. It would not typically result in a <strong>ballotable hard structure</strong> being felt directly at the fundus, as this position involves a more diagonal orientation of the fetus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. The fetus is in compound presentation:&nbsp;</span></strong><span style=\"font-size:14.0pt\">A <strong>compound presentation</strong> involves a situation where an extremity (such as a hand) is presenting alongside the main presenting part (head or breech). It does not explain the presence of a <strong>ballotable hard structure</strong> at the fundus and would not typically align with the findings of this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In obstetric examinations, a <strong>ballotable hard structure</strong> felt at the <strong>upper abdomen (fundus)</strong> during fundal grip indicates that the <strong>fetal head</strong> is positioned upwards, suggesting a <strong>breech presentation</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This assessment aids in determining the fetal presentation during antenatal care.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245217,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61330,
      "choices": [
        {
          "id": 244601,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">REM sleep</span></span></span></span></p>"
        },
        {
          "id": 244602,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage 1 Non-REM sleep</span></span></span></span></p>"
        },
        {
          "id": 244603,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage 2 Non-REM sleep</span></span></span></span></p>"
        },
        {
          "id": 244604,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stage 3 Non-REM sleep</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presents to the sleep clinic with complaints of feeling unrefreshed after sleep and experiencing frequent awakenings. A polysomnography study is ordered, and the results show prominent features of sleep spindles and K-complexes. These findings are characteristic of which stage of sleep?<strong> </strong></span></span></p>",
      "unique_key": "Q7268994",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Stage 2 Non-REM sleep</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sleep spindles and K-complexes are characteristic features seen during <strong>Stage 2 of Non-REM sleep</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sleep spindles are bursts of rapid, rhythmic brain wave activity, while K-complexes are sharp, high-amplitude waves followed by slower waves. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These features help in transitioning into deeper stages of sleep and play a role in memory consolidation.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-174743.png\" style=\"height:214px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. REM sleep:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is incorrect because REM sleep is characterized by rapid eye movements, low-amplitude mixed-frequency EEG activity, and muscle atonia, not by sleep spindles and K-complexes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Stage 1 Non-REM sleep:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is incorrect because Stage 1 Non-REM sleep is characterized by theta wave activity and is a lighter sleep stage. It lacks the distinctive sleep spindles and K-complexes seen in Stage 2.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Stage 3 Non-REM sleep:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is incorrect because Stage 3 Non-REM sleep, also known as deep sleep or slow-wave sleep, is marked by delta waves rather than sleep spindles and K-complexes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sleep spindles and K-complexes are key features of Stage 2 Non-REM sleep and play a role in sleep stability and memory consolidation.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 244603,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61280,
      "choices": [
        {
          "id": 244401,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspergillus fumigatus</span></span></span></span></p>"
        },
        {
          "id": 244402,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coccidioides immitis</span></span></span></span></p>"
        },
        {
          "id": 244403,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rhinosporidium seeberi</span></span></span></span></p>"
        },
        {
          "id": 244404,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blastomyces dermatitidis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents with a nasal polypoid mass that has been slowly growing for several months. He works as a farmer and frequently bathes in stagnant water bodies. A biopsy of the mass is taken and reveals structures as shown in the image. Which of the following organisms is most likely responsible for this patient&#39;s condition?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-170518.png\" style=\"height:231px; width:300px\" /></p>",
      "unique_key": "Q9215572",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C) Rhinosporidium seeberi</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rhinosporidium seeberi&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an aquatic pathogen known to cause <strong>rhinosporidiosis</strong>, which is characterized by <strong>polypoid masses</strong> in the nasal cavity and nasopharynx. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows <strong>large sporangia</strong> filled with endospores, which are classic histopathological findings for <strong>Rhinosporidium seeberi</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rhinosporidiosis is often acquired through <strong>exposure to stagnant water</strong>, and the organism cannot be cultured in standard laboratory media.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspergillus fumigatus</strong>: <strong>Aspergillus</strong> species cause <strong>aspergillosis</strong>, which can present with sinus involvement, particularly in immunocompromised individuals. However, the histopathology typically shows <strong>septate hyphae</strong>, which is not seen here.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Coccidioides immitis</strong>: <strong>Coccidioides</strong> causes <strong>coccidioidomycosis</strong> (Valley Fever), typically presenting with <strong>spherules</strong> containing endospores, but not in the form of polypoid nasal masses.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Blastomyces dermatitidis</strong>: <strong>Blastomyces</strong> causes <strong>blastomycosis</strong>, often presenting with pulmonary and skin involvement. Histologically, it appears as <strong>broad-based budding yeast</strong> rather than large sporangia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rhinosporidium seeberi&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is associated with <strong>rhinosporidiosis</strong>, characterized by <strong>polypoid masses</strong> primarily in the nasal cavity. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is histologically recognized by the presence of large <strong>sporangia filled with endospores</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is typically acquired through <strong>exposure to stagnant water</strong>, and the diagnosis is confirmed by biopsy, as it cannot be cultured on standard media.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244403,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61476,
      "choices": [
        {
          "id": 245181,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serotonin syndrome</span></span></p>"
        },
        {
          "id": 245182,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuroleptic malignant syndrome</span></span></p>"
        },
        {
          "id": 245183,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Delirium</span></span></p>"
        },
        {
          "id": 245184,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anticholinergic toxicity</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man with major depressive disorder is started on paroxetine. After 5 days, he develops confusion, myoclonus, and hyperhidrosis. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q9729711",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Serotonin syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Serotonin syndrome</span></strong><span style=\"font-size:14.0pt\"> is a potentially life-threatening condition that can occur when there is an excess of serotonin in the central nervous system, often due to the use of medications like SSRIs (e.g., paroxetine). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Symptoms include mental status changes (confusion), neuromuscular abnormalities (e.g., myoclonus), and autonomic hyperactivity (e.g., hyperhidrosis, increased heart rate).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Neuroleptic malignant syndrome:</span></strong><span style=\"font-size:14.0pt\"> This condition is associated with antipsychotic medications and presents with hyperthermia, &quot;lead-pipe&quot; rigidity, altered mental status, and autonomic dysregulation. It does not typically present with myoclonus and is more often associated with dopamine blockade rather than serotonin excess.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Delirium:</span></strong><span style=\"font-size:14.0pt\"> Delirium involves acute confusion and cognitive impairment but does not typically present with myoclonus or autonomic hyperactivity like hyperhidrosis. It is a broader term for a state of acute confusion that can be caused by many factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Anticholinergic toxicity:</span></strong><span style=\"font-size:14.0pt\"> Anticholinergic toxicity presents with symptoms such as dry skin, dry mouth, urinary retention, and dilated pupils, as well as altered mental status. It does not typically cause myoclonus or hyperhidrosis but rather symptoms like &quot;dry as a bone&quot; and &quot;blind as a bat.&quot;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serotonin syndrome presents with confusion, myoclonus, and autonomic symptoms like hyperhidrosis, often triggered by serotonergic medications such as SSRIs.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180516.jpg\" style=\"height:466px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Management includes discontinuation of serotonergic agents (most crucial), supportive care, and cyproheptadine.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245181,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61310,
      "choices": [
        {
          "id": 244521,
          "text": "<p><span style=\"font-size:18px;\">Antiphospholipid antibody (APLA) syndrome</span></p>"
        },
        {
          "id": 244522,
          "text": "<p><span style=\"font-size:18px;\">Chromosomal anomalies in the fetus</span></p>"
        },
        {
          "id": 244523,
          "text": "<p><span style=\"font-size:18px;\">Uterine didelphys</span></p>"
        },
        {
          "id": 244524,
          "text": "<p><span style=\"font-size:18px;\">Cervical insufficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 32-year-old woman presents to the clinic with a history of multiple pregnancy losses occurring during the second trimester. After a detailed evaluation, the physician considers various potential causes for these recurrent mid-trimester losses. Which of the following is least likely to be a cause in this patient?</span></p>",
      "unique_key": "Q2189236",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Chromosomal anomalies in the fetus</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Fetal chromosomal anomalies&nbsp;</strong>are more commonly associated with <strong>first-trimester</strong> pregnancy losses rather than <strong>mid-trimester</strong> losses.</span></li><li><span style=\"font-size:18px;\">While these anomalies can cause spontaneous abortions, they are typically a cause of early pregnancy failure rather than recurrent losses in the second trimester.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Antiphospholipid antibody (APLA) syndrome:&nbsp;</strong>APLA syndrome is a known cause of recurrent pregnancy loss, including losses in the second trimester. It is associated with thrombosis and placental insufficiency, leading to pregnancy complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Uterine didelphys:&nbsp;</strong>A structural abnormality like uterine didelphys can lead to recurrent pregnancy loss, especially during the second trimester, due to inadequate space or support for the growing fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Cervical insufficiency:&nbsp;</strong>Cervical insufficiency is a common cause of mid-trimester pregnancy loss. It involves a weakened cervix that opens prematurely, leading to the loss of the pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Chromosomal anomalies are more commonly associated with early pregnancy losses rather than mid-trimester losses, making them less likely to be the cause of recurrent second-trimester losses in comparison to other conditions like APLA syndrome or uterine anomalies.</span></li></ul>",
      "correct_choice_id": 244522,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61242,
      "choices": [
        {
          "id": 244249,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Declaration of Tokyo</span></span></p>"
        },
        {
          "id": 244250,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Declaration of Helsinki</span></span></p>"
        },
        {
          "id": 244251,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Declaration of Oslo</span></span></p>"
        },
        {
          "id": 244252,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Declaration of Geneva</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A newly joined medical officer is attending an ethics seminar focused on the responsibilities of medical professionals in adhering to international guidelines and declarations. A discussion arises about the ethical obligations of doctors to refuse participation in acts of torture and other cruel, inhuman, or degrading treatment. The medical officer recalls a specific declaration that explicitly prohibits doctors from participating in torture. Which of the following declarations includes these guidelines?<strong> </strong></span></span></p>",
      "unique_key": "Q1011893",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A) Declaration of Tokyo</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Declaration of Tokyo, established by the World Medical Association in 1975, specifically addresses the role of physicians concerning torture and other cruel, inhuman, or degrading treatment or punishment. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It explicitly states that doctors should not be involved in these practices and must not provide any assistance or knowledge to facilitate torture or other forms of ill treatment.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Declaration of Helsinki</strong>: This declaration focuses primarily on ethical principles for medical research involving human subjects, emphasizing the safety, well-being, and informed consent of participants.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Declaration of Oslo</strong>: This declaration is less commonly referenced and primarily focuses on therapeutic abortion and other health care ethics, not specifically on torture.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Declaration of Geneva</strong>: While this declaration includes a pledge for doctors to maintain the utmost respect for human life, it is more of a modern-day Hippocratic Oath and does not specifically address participation in torture.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Declaration of Tokyo is a pivotal document that outlines the ethical duty of physicians to abstain from participating in, or facilitating, torture and other inhumane treatments. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is essential for medical professionals to be aware of such guidelines to uphold the integrity and ethical standards of the medical profession, especially in settings where human rights are at risk.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244249,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61274,
      "choices": [
        {
          "id": 244377,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-c, 2-b, 3-a, 4-d</span></span></span></p>"
        },
        {
          "id": 244378,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-c, 2-a, 3-d, 4-b</span></span></span></p>"
        },
        {
          "id": 244379,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-c, 2-a, 3-b, 4-d</span></span></span></p>"
        },
        {
          "id": 244380,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-d, 2-c, 3-b, 4-a</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the eczemas in column A with the characteristic features given in column B .</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162913.jpg\" style=\"height:263px; width:700px\" /></span></span></p>",
      "unique_key": "Q8494800",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) 1-c, 2-a, 3-d, 4-b</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">1. Hair Dye Dermatitis &rarr; c. Paraphenylenediamine (PPD):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Hair dye dermatitis is commonly caused by <strong>Paraphenylenediamine (PPD)</strong>, a chemical found in many hair dyes. PPD is a well-known allergen and can cause allergic contact dermatitis, leading to redness, itching, and swelling in areas exposed to the dye, especially around the scalp and neck.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">2. Atopic Dermatitis &rarr; a. Subcapsular Cataract:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Atopic dermatitis is a chronic inflammatory skin condition that often presents in early childhood. A significant feature of severe or long-standing atopic dermatitis is the increased risk of developing <strong>subcapsular cataracts</strong> in adulthood, particularly in patients who have been treated with long-term corticosteroids.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">3. Irritant Contact Dermatitis &rarr; d. Sensitization Phase Absent:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Unlike allergic contact dermatitis, <strong>irritant contact dermatitis</strong> does not involve an immune-mediated sensitization phase. It results from direct damage to the skin by irritants such as chemicals, soaps, or detergents. The inflammation is localized to the site of contact with the irritant.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>4. Bindi Dermatitis &rarr; b. Patch Test:</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Bindi dermatitis</strong> occurs from prolonged exposure to adhesives or dyes in decorative bindis. A <strong>patch test</strong> is used to identify the specific allergen causing the contact dermatitis in such cases, helping to pinpoint sensitivities to substances present in the bindi.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162936.jpg\" style=\"height:265px; width:700px\" /></span></strong></span></span></p>",
      "correct_choice_id": 244378,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61230,
      "choices": [
        {
          "id": 244201,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary closure of the wound</span></span></span></span></p>"
        },
        {
          "id": 244202,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Application of a skin graft</span></span></span></span></p>"
        },
        {
          "id": 244203,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate debridement and tissue reconstruction</span></span></span></span></p>"
        },
        {
          "id": 244204,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antibiotics and delayed wound closure</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old man is brought to the emergency department after a motorcycle accident. On examination, his right leg shows a large, avulsed area where the skin and subcutaneous tissue have been torn off, exposing muscle and tendons. There is extensive soft tissue damage with compromised blood supply to the avulsed tissue. What is the most appropriate next step in management? </span></span></p>",
      "unique_key": "Q1430097",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Immediate debridement and tissue reconstruction</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>degloving injury</strong> is a traumatic injury in which the skin and subcutaneous tissue are separated from the underlying fascia, muscles, and tendons, often resulting in extensive soft tissue damage and compromised blood supply. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This type of injury is common in high-energy trauma, such as motorcycle accidents, and requires <strong>immediate debridement</strong> to remove non-viable tissue, reduce infection risk, and promote healing.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Once debridement is done, further steps like <strong>tissue reconstruction</strong> can be planned, which may involve flap reconstruction or skin grafting depending on the extent of the injury and tissue loss. Delaying treatment can lead to infection, necrosis, and a poor functional outcome.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Primary closure of the wound</strong>: Primary closure is not appropriate for a degloving injury because the tissue is avulsed and often non-viable. Closing such a wound without debridement would trap necrotic tissue and increase the risk of infection.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Application of a skin graft</strong>: Skin grafts may be needed in the future, but grafting is not the initial step in the management of a degloving injury. First, debridement and assessment of tissue viability must occur.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Antibiotics and delayed wound closure</strong>: While antibiotics may be indicated to prevent infection, delayed wound closure alone is not sufficient. The priority in a degloving injury is to promptly debride non-viable tissue and plan for reconstruction, either with flaps or skin grafts, depending on the extent of the injury.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a <strong>degloving injury</strong>, <strong>immediate debridement</strong> of non-viable tissue is crucial to prevent infection and promote healing. Tissue reconstruction with flaps or skin grafts follows debridement, depending on the extent of the injury.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244203,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61439,
      "choices": [
        {
          "id": 245033,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lateralization of vocal cord</span></span></span></span></p>"
        },
        {
          "id": 245034,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tensioning of vocal cord</span></span></span></span></p>"
        },
        {
          "id": 245035,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medialization of vocal cord</span></span></span></span></p>"
        },
        {
          "id": 245036,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Relaxation of vocal cord</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old professional singer presents with a low-pitched voice and vocal fatigue. She is evaluated for a surgical intervention to improve her vocal quality. After consultation, a phonosurgical technique is recommended. According to Isshiki&rsquo;s classification, which type of thyroplasty is most appropriate for this patient?<strong> </strong></span></span></p>",
      "unique_key": "Q3875031",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B) Tensioning of vocal cord</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tensioning of vocal cord (Type IV)</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></strong> </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This involves increasing the tension of the vocal cords and is typically used to&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">raise the pitch&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of the voice by elongating the cords. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the procedure needed in this patient.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Lateralization of vocal cord (Type II)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This procedure involves moving the vocal cord laterally and is typically used to </span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">widen the airway&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in cases of&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">bilateral vocal cord paralysis</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. It is not used for altering pitch or vocal fatigue.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Medializ</span></span></strong></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ation of vocal cord (Type I)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This procedure is used to&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">bring the vocal cord medially&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">to improve&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">glottic closure&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in cases of&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">unilateral vocal cord paralysis&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">or weakness, not for relaxation or pitch adjustment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Relaxation of vocal cord (Type III):</strong></span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type III thyroplasty&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">involves the&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">relaxation or shortening of the vocal cord</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. It is used for patients who have a high-pitched voice and need their vocal cords shortened to lower the pitch.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type IV thyroplasty</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, as described by Isshiki, involves&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">lengthening of the vocal cord&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and is used to modify the pitch and tone of the voice, particularly in patients with low-pitched voice. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognizing the indications for different types of thyroplasty is essential for appropriate surgical management of voice disorders.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245034,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61497,
      "choices": [
        {
          "id": 245265,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By stimulating osteoblastic activity</span></span></p>"
        },
        {
          "id": 245266,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By promoting calcium absorption in the intestines</span></span></p>"
        },
        {
          "id": 245267,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By increasing both osteoclastic activity and reducing renal calcium excretion</span></span></p>"
        },
        {
          "id": 245268,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By enhancing phosphate absorption in the intestine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old patient presents with symptoms of hyperparathyroidism. Laboratory analysis shows elevated levels of parathyroid hormone (PTH). The accompanying graph shows changes in plasma calcium and phosphate levels after administration of PTH. Which of the following mechanisms explains how PTH increases plasma calcium levels?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180842.jpg\" style=\"height:226px; width:400px\" /></span></span></p>",
      "unique_key": "Q3516066",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) By increasing both osteoclastic activity and reducing renal calcium excretion</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Parathyroid hormone (PTH) increases blood calcium levels through two primary mechanisms:</span></span></span>\r\n\r\n\t<ol>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Increasing osteoclastic activity</span></strong><span style=\"font-size:14.0pt\">: PTH stimulates osteoclasts indirectly by acting on osteoblasts, which in turn produce signals that promote osteoclast activity. Osteoclasts break down bone, releasing calcium into the bloodstream.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Decreasing renal calcium excretion</span></strong><span style=\"font-size:14.0pt\">: PTH acts on the kidneys to increase calcium reabsorption in the distal tubules, thus reducing the amount of calcium excreted in the urine.</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Together, these actions lead to an increase in plasma calcium levels, as shown in the graph.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. By stimulating osteoblastic activity</span></strong><span style=\"font-size:14.0pt\">: Osteoblasts are involved in bone formation and would decrease plasma calcium by promoting its deposition into bone. PTH initially targets osteoblasts to indirectly stimulate osteoclasts, but its primary effect on blood calcium is through osteoclast-mediated bone resorption.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. By promoting calcium absorption in the intestines</span></strong><span style=\"font-size:14.0pt\">: While PTH indirectly promotes intestinal calcium absorption through its role in stimulating vitamin D activation, this mechanism is not the primary way that PTH raises serum calcium acutely. Its more immediate effects are through bone resorption and renal calcium retention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. By enhancing phosphate absorption in the intestine</span></strong><span style=\"font-size:14.0pt\">: PTH actually decreases phosphate reabsorption in the kidneys, leading to increased phosphate excretion. This is the opposite of what would be expected if PTH enhanced phosphate absorption. Reducing serum phosphate indirectly helps increase calcium levels by reducing calcium-phosphate complex formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Parathyroid hormone (PTH) increases serum calcium levels primarily by stimulating osteoclasts to resorb bone and reducing renal calcium excretion, leading to increased blood calcium levels.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245267,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61504,
      "choices": [
        {
          "id": 245293,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ANOVA</span></span></p>"
        },
        {
          "id": 245294,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bland-Altman analysis</span></span></p>"
        },
        {
          "id": 245295,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chi-square test</span></span></p>"
        },
        {
          "id": 245296,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cox proportional hazards test</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A clinical researcher is analyzing the survival outcomes of two different treatment groups using Kaplan-Meier survival curves. To determine if there is a significant difference between the survival distributions of the groups, which of the following statistical tests is most appropriate?</span></span></p>",
      "unique_key": "Q5648551",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Cox proportional hazards test</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>Cox proportional hazards test</strong> (also known as the <strong>Cox regression model</strong>) is used for comparing <strong>Kaplan-Meier survival curves</strong> when analyzing time-to-event data, such as comparing survival between two or more groups. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This test assesses the effect of various covariates on the survival time and can account for <strong>censoring</strong> (patients lost to follow-up). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is particularly useful when researchers need to adjust for other variables that could affect survival time.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. ANOVA:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. ANOVA (Analysis of Variance) is used for comparing the means of more than two groups, typically for continuous outcomes. It is not suitable for comparing survival distributions or time-to-event data.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Bland-Altman analysis:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. Bland-Altman analysis is used to assess <strong>agreement</strong> between two different measurement methods for continuous data. It is not designed for survival analysis or comparing survival curves.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Chi-square test:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. While the <strong>Chi-square test</strong> can be used to compare categorical variables and frequencies, it is not specifically used to compare survival curves. For comparing Kaplan-Meier curves, tests like the <strong>log-rank test</strong> or <strong>Cox proportional hazards test</strong> are more appropriate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To compare <strong>Kaplan-Meier survival curves</strong>, the <strong>Cox proportional hazards test</strong> is used when accounting for covariates and adjusting for potential confounders. The <strong>log-rank test</strong> can also be used when comparing unadjusted survival curves between groups.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245296,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61287,
      "choices": [
        {
          "id": 244429,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are not considered core features of the disorder</span></span></p>"
        },
        {
          "id": 244430,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They typically respond well to antipsychotic medication</span></span></p>"
        },
        {
          "id": 244431,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They can include deficits in attention and working memory</span></span></p>"
        },
        {
          "id": 244432,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They only develop in the late stages of the illness</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statement about cognitive symptoms in schizophrenia is true?</span></span></p>",
      "unique_key": "Q5190336",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) They can include deficits in attention and working memory</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cognitive symptoms in schizophrenia often include difficulties with </span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Attention</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Working memory</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Executive functioning. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These impairments are considered core features of schizophrenia and significantly impact daily functioning.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. They are not considered core features of the disorder : False,</span></strong><span style=\"font-size:14.0pt\">&nbsp;Cognitive symptoms are indeed considered core features of schizophrenia. They can significantly impair a person&rsquo;s ability to function and are present throughout the course of the illness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. They typically respond well to antipsychotic medication : False,</span></strong><span style=\"font-size:14.0pt\">&nbsp;Cognitive symptoms are generally less responsive to antipsychotic medication compared to positive symptoms like hallucinations and delusions. Cognitive remediation therapy is often used to target these symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. They only develop in the late stages of the illness : False,&nbsp;</span></strong><span style=\"font-size:14.0pt\">Cognitive deficits in schizophrenia often appear early, even before the onset of overt psychotic symptoms, and may persist throughout the course of the disorder.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><u><span style=\"font-size:14.0pt\">Cognitive symptoms in schizophrenia:</span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They may be subtle, particularly early in the disease, but are very impairing and account for much of the disability associated with this disorder.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They include impairments of:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Attention</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Working memory</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Executive functioning</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Symptom Profile of Schizophrenia:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-163029.jpg\" style=\"height:216px; width:700px\" /></span></strong></span></span></p>",
      "correct_choice_id": 244431,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61488,
      "choices": [
        {
          "id": 245229,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adduction</span></span></p>"
        },
        {
          "id": 245230,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flexion</span></span></p>"
        },
        {
          "id": 245231,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abduction</span></span></p>"
        },
        {
          "id": 245232,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Extension</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presents with difficulty in moving her leg outward after slipping on a wet floor. Physical examination reveals tenderness over the lateral aspect of her upper thigh. Imaging indicates a possible injury to the structure attached to the marked area in the image. Which of the following actions is primarily affected due to injury to the muscle attached at the marked site?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180606.jpg\" style=\"height:432px; width:300px\" /></span></span></p>",
      "unique_key": "Q4183645",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Abduction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The marked area in the image is the <strong>greater trochanter</strong> of the <strong>femur</strong>, which serves as the attachment site for muscles such as the <strong>gluteus medius</strong> and <strong>gluteus minimus</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These muscles are critical for the <strong>abduction</strong> of the thigh at the hip joint. They help to <strong>move the leg laterally</strong> and <strong>stabilize the pelvis</strong> during activities like walking.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180624.jpg\" style=\"height:526px; width:900px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Adduction</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Adduction of the thigh involves muscles like the <strong>adductor longus</strong>, <strong>adductor magnus</strong>, and <strong>gracilis</strong>, which attach to the medial side of the thigh and not to the <strong>greater trochanter</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Flexion</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Thigh flexion is primarily performed by muscles such as the <strong>iliopsoas</strong> and <strong>rectus femoris</strong>, not the <strong>gluteus medius</strong> or <strong>gluteus minimus</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Extension</span></strong><span style=\"font-size:14.0pt\">: Incorrect. Thigh extension involves muscles like the <strong>gluteus maximus</strong> and <strong>hamstrings</strong>, which are not attached to the <strong>greater trochanter</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>gluteus medius</strong> and <strong>gluteus minimus</strong> muscles, which attach to the <strong>greater trochanter</strong> of the femur, are responsible for <strong>abduction of the thigh</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These muscles also play a crucial role in <strong>stabilizing the pelvis</strong> during ambulation.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245231,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61481,
      "choices": [
        {
          "id": 245201,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian failure</span></span></p>"
        },
        {
          "id": 245202,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometrial scarring</span></span></p>"
        },
        {
          "id": 245203,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pituitary adenoma</span></span></p>"
        },
        {
          "id": 245204,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine synechiae</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old woman presents with secondary amenorrhea following a spontaneous abortion six months ago. Her current laboratory results show an FSH level of 6 mIU/mL. Which of the following is the most likely cause of her amenorrhea?</span></span></p>",
      "unique_key": "Q1443400",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) Uterine synechiae</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s presentation of secondary amenorrhea after a spontaneous abortion is highly suggestive of <strong>Asherman syndrome</strong>, which is characterized by the formation of <strong>intrauterine adhesions (synechiae)</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These adhesions are often a result of trauma to the uterine lining, typically after a procedure such as dilation and curettage (D&amp;C) following a miscarriage. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The normal FSH level indicates that the hypothalamic-pituitary-ovarian axis is functioning normally, making uterine factors like synechiae the likely cause of amenorrhea.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Ovarian failure:</span></strong><span style=\"font-size:14.0pt\"> Ovarian failure usually results in elevated FSH levels due to the loss of negative feedback from the ovaries to the hypothalamus and pituitary gland. The normal FSH level in this patient suggests that her ovaries are still functional, making ovarian failure less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Endometrial scarring:</span></strong><span style=\"font-size:14.0pt\"> While endometrial scarring is related to the underlying cause (Asherman syndrome), &quot;uterine synechiae&quot; is a more specific term for the intrauterine adhesions that result in this condition. Therefore, this option is not the best answer when compared to &quot;uterine synechiae.&quot;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Pituitary adenoma:</span></strong><span style=\"font-size:14.0pt\"> A pituitary adenoma, such as a prolactinoma, typically presents with elevated prolactin levels and possibly suppressed FSH levels. In this case, the FSH level is normal, making a pituitary cause less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Asherman syndrome&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a cause of <strong>secondary amenorrhea</strong> following uterine trauma, such as dilation and curettage (D&amp;C). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is characterized by <strong>intrauterine adhesions (synechiae)</strong> that prevent normal endometrial function. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Normal FSH levels in the presence of amenorrhea and a history of uterine trauma should prompt evaluation for this condition.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245204,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61450,
      "choices": [
        {
          "id": 245077,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lytic bone lesion with well-defined margins</span></span></span></p>"
        },
        {
          "id": 245078,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cortical thickening with periosteal reaction</span></span></span></p>"
        },
        {
          "id": 245079,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Onion skin appearance of the cortex</span></span></span></p>"
        },
        {
          "id": 245080,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sclerotic bone lesion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following describes the typical radiological appearance of osteosarcoma?</span></span></p>",
      "unique_key": "Q9823052",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) Cortical thickening with periosteal reaction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This option accurately describes the typical radiological appearance of osteosarcoma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The tumour often causes thickening of the cortex and can elicit a periosteal reaction, leading to a layered or &quot;sunburst&quot; appearance due to new bone formation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is a hallmark finding in osteosarcoma.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Lytic bone lesion with well-defined margins:&nbsp;</span></strong><span style=\"font-size:14.0pt\">This description is more characteristic of certain benign bone lesions or metastatic lesions. Osteosarcoma typically presents as a destructive lesion that can be lytic but often has poorly defined margins rather than well-defined ones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Onion skin appearance of the cortex:&nbsp;</span></strong><span style=\"font-size:14.0pt\">This description is indicative of an aggressive periosteal reaction seen in certain conditions, such as Ewing&rsquo;s sarcoma or some types of chronic osteomyelitis. It refers to concentric layers of new bone formation and is not characteristic of osteosarcoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Sclerotic bone lesion:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Sclerotic lesions are typically seen in conditions such as osteoblastic metastases or certain benign lesions like osteomas. Osteosarcoma usually presents as a mixed pattern of lytic and sclerotic features, but it is more commonly known for its aggressive, lytic nature rather than being purely sclerotic.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Osteosarcoma typically presents with cortical thickening and a periosteal reaction which reflects its aggressive nature and impact on the surrounding bone.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245078,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61250,
      "choices": [
        {
          "id": 244281,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 1</span></span></span></span></p>"
        },
        {
          "id": 244282,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 2</span></span></span></span></p>"
        },
        {
          "id": 244283,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 3b</span></span></span></span></p>"
        },
        {
          "id": 244284,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 4</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A newborn is diagnosed with jejunoileal atresia and an abdominal X-ray reveals a triple bubble sign. Intra-operative findings are as shown. What type of jejunoileal atresia does this describe? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-164153.png\" style=\"height:283px; width:300px\" /></span></span></p>",
      "unique_key": "Q4579380",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Type 3b</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 3b jejunoileal atresia&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by the &quot;apple peel&quot; or &quot;Christmas tree&quot; deformity, where there is a large mesenteric gap, and the remaining small intestine is twisted around a single blood vessel. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition results in a loss of a portion of the mesentery, causing the characteristic appearance on imaging. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The triple bubble sign is also seen in proximal jejunoileal atresia.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type 1</strong>: This involves a mucosal web or diaphragm causing the atresia. It does not present with an apple peel deformity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Type 2</strong>: In this type, the atretic ends of the bowel are connected by a fibrous cord with intact mesentery, but there is no mesenteric gap or apple peel deformity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type 4</strong>: This type involves multiple atresias, with the bowel appearing like a string of sausages, but it does not present with the apple peel deformity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type 3b jejunoileal atresia&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">presents with an &quot;apple peel&quot; deformity and involves a large mesenteric gap, often requiring surgical intervention to address the anatomical abnormality.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-164521.png\" style=\"height:446px; width:1000px\" /></span></span></span></span></p>",
      "correct_choice_id": 244283,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61247,
      "choices": [
        {
          "id": 244269,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum immunoglobulin electrophoresis</span></span></span></span></p>"
        },
        {
          "id": 244270,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B cell tyrosine kinase activity detection</span></span></span></span></p>"
        },
        {
          "id": 244271,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T-cell receptor gene rearrangement studies</span></span></span></span></p>"
        },
        {
          "id": 244272,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neutrophil oxidative burst assay</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 5-year-old boy presents with a history of recurrent bacterial infections, including pneumonia and otitis media. Laboratory evaluation reveals significantly reduced levels of all immunoglobulins (IgG, IgA, and IgM). Which of the following tests would most likely confirm the diagnosis?<strong> </strong></span></span></p>",
      "unique_key": "Q6293438",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) B cell tyrosine kinase activity detection</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this case, a <strong>5-year-old boy</strong> with <strong>recurrent bacterial infections</strong> (e.g., pneumonia, otitis media) and <strong>low immunoglobulin levels</strong> (IgG, IgA, IgM) suggests <strong>X-linked agammaglobulinemia (Bruton&#39;s disease)</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is due to mutations in the <strong>BTK gene</strong>, which is essential for <strong>B cell development</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnosis is confirmed through <strong>B cell tyrosine kinase (BTK) activity detection</strong>, which directly identifies defects in BTK function. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This defect impairs B cell maturation, leading to a significant deficiency in immunoglobulins, making it the most definitive test for this condition.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Serum immunoglobulin electrophoresis:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It measures levels of different immunoglobulins but cannot specifically identify a defect in BTK. While immunoglobulin levels would be low in this condition, this test alone is not confirmatory for Bruton&#39;s disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. T-cell receptor gene rearrangement studies:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These are used to evaluate T-cell abnormalities or clonality but do not provide information regarding B cell function or BTK mutations, making it irrelevant for diagnosing Bruton&#39;s disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Neutrophil oxidative burst assay:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It assesses the function of neutrophils in conditions like chronic granulomatous disease (CGD). It does not help in diagnosing a B cell maturation defect such as Bruton&#39;s disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In X-linked agammaglobulinemia (Bruton&#39;s disease), detection of B cell tyrosine kinase (BTK) activity is essential for confirming the diagnosis, as BTK mutations prevent B cell maturation and result in low immunoglobulin levels and recurrent bacterial infections.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244270,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61413,
      "choices": [
        {
          "id": 244929,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obesity</span></span></span></span></p>"
        },
        {
          "id": 244930,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Active infection</span></span></span></span></p>"
        },
        {
          "id": 244931,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous knee surgery</span></span></span></span></p>"
        },
        {
          "id": 244932,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Moderate renal impairment</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with severe osteoarthritis, which of the following is considered a contraindication for arthroplasty?</span></span><strong> </strong></p>",
      "unique_key": "Q6891177",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B) Active infection</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Active infection is indeed a contraindication for arthroplasty. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Performing surgery on a joint with an active infection can lead to further complications, including the spread of infection, poor healing, and implant failure. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is crucial to treat any infections prior to considering joint replacement surgery.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Obesity</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Obesity is not an absolute contraindication for arthroplasty but rather a relative contraindication. While obesity increases the risk of complications such as infection, wound healing issues, and implant failure, many surgeons will still proceed with the surgery if the benefits outweigh the risks. Weight loss prior to surgery may be encouraged to improve outcomes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Previous knee surgery</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> </strong>Previous knee surgery is not necessarily a contraindication for arthroplasty. Many patients who have undergone prior surgeries, such as arthroscopy or ligament repair, can still be candidates for joint replacement. The decision depends on the condition of the joint and the specific surgical history. However, previous surgeries may complicate the procedure or affect the recovery process.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Moderate renal impairment</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> </strong>Moderate renal impairment is generally not an absolute contraindication for arthroplasty. While it may increase the risk of perioperative complications, many patients with moderate renal impairment can still safely undergo surgery with appropriate management and monitoring. The surgical team will typically assess the patient&#39;s overall health and kidney function prior to proceeding.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Active infection<strong> </strong>is the primary contraindication due to the high risk of complications if surgery is performed in the presence of infection.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244930,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61502,
      "choices": [
        {
          "id": 245285,
          "text": "<p><span dir=\"ltr\" lang=\"ES\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-E, 2-A, 3-B, 4-C, 5-D</span></span></p>"
        },
        {
          "id": 245286,
          "text": "<p><span dir=\"ltr\" lang=\"ES\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-C, 2-D, 3-A, 4-E, 5-B</span></span></p>"
        },
        {
          "id": 245287,
          "text": "<p><span dir=\"ltr\" lang=\"ES\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-B, 2-E, 3-C, 4-D, 5-A</span></span></p>"
        },
        {
          "id": 245288,
          "text": "<p><span dir=\"ltr\" lang=\"ES\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-A, 2-B, 3-D, 4-C, 5-E</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following reporting guidelines with their corresponding area of application: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-131945.png\" style=\"height:182px; width:800px\" /></span></span></p>",
      "unique_key": "Q4531448",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1-E, 2-A, 3-B, 4-C, 5-D</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AGREE (Appraisal of Guidelines for Research and Evaluation)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>E. </strong>This tool is used to assess the <strong>quality of clinical practice guidelines (CPGs)</strong>. It helps to ensure that guidelines are rigorously developed, transparent, and applicable to clinical practice.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">COREQ (Consolidated Criteria for Reporting Qualitative Research)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>A. </strong>COREQ is a <strong>32-item checklist</strong> designed specifically for <strong>reporting qualitative research</strong>, focusing on studies that use <strong>interviews and focus groups</strong>. It ensures that qualitative studies are reported with sufficient detail and rigor.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ARRIVE (Animal Research&nbsp;Reporting of In Vivo Experiments)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>B. </strong>These guidelines provide a <strong>checklist for reporting animal research</strong>. The goal of the ARRIVE guidelines is to improve the <strong>transparency and reproducibility</strong> of studies involving animal experiments.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SQUIRE (Standards for Quality Improvement Reporting Excellence)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>C.</strong> SQUIRE guidelines provide a <strong>framework for reporting on quality improvement (QI) studies</strong>. They ensure that QI research is reported systematically, covering aspects like study design, context, and outcomes to improve healthcare delivery.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CHEERS (Consolidated Health Economic Evaluation Reporting Standards)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> D.</strong> CHEERS is a <strong>guidance document</strong> that provides a checklist for <strong>reporting health economic evaluations</strong>. It aims to ensure that economic studies in healthcare are reported with a <strong>minimum level of quality</strong>, focusing on cost-effectiveness, cost-utility, and cost-benefit analyses.</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-120455.png\" style=\"height:626px; width:1000px\" /></span></span></strong></span></span></p>",
      "correct_choice_id": 245285,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61471,
      "choices": [
        {
          "id": 245161,
          "text": "<p><span style=\"font-size:14.0pt;\">Pioglitazone</span></p>"
        },
        {
          "id": 245162,
          "text": "<p><span style=\"font-size:14.0pt;\">Telmisartan</span></p>"
        },
        {
          "id": 245163,
          "text": "<p><span style=\"font-size:14.0pt;\">Saroglitazar</span></p>"
        },
        {
          "id": 245164,
          "text": "<p><span style=\"font-size:14.0pt;\">Elafibranor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old patient with non-alcoholic steatohepatitis (NASH) is being considered for treatment with a drug that acts as a dual agonist of both PPAR alpha and PPAR delta receptors. Which of the following medications is follow this mechanism of action?</span></p>",
      "unique_key": "Q9277909",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Elafibranor</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Elafibranor is a dual PPAR alpha and delta agonist.</span></li><li><span style=\"font-size:14.0pt;\">It has been recently approved by FDA for treatment of primary biliary cholangitis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pioglitazone:&nbsp; </strong>Pioglitazone is a thiazolidinedione class of drug and primarily acts as a PPAR gamma agonist. It is commonly used in the treatment of type 2 diabetes for its insulin-sensitizing effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Telmisartan:</strong>&nbsp; Telmisartan is an angiotensin receptor blocker (ARB) used primarily for the treatment of hypertension. It also has some PPAR gamma modulatory activity, but it is not a dual PPAR gamma and delta agonist.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Saroglitazar:</strong>&nbsp; Saroglitazar is a medication mainly used to treat dyslipidemia in diabetic patients. It acts as a dual PPAR alpha/gamma agonist, but it does not have significant action on PPAR delta.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Elafibranor acts as a dual agonist of PPAR alpha and PPAR delta receptors, making it suitable for conditions like non-alcoholic steatohepatitis (NASH) where modulation of lipid metabolism and inflammation is beneficial.</span></li></ul>",
      "correct_choice_id": 245164,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61239,
      "choices": [
        {
          "id": 244237,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytomegalovirus (CMV)</span></span></p>"
        },
        {
          "id": 244238,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epstein-Barr virus (EBV)</span></span></p>"
        },
        {
          "id": 244239,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parvovirus B19</span></span></p>"
        },
        {
          "id": 244240,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Human Papillomavirus (HPV)</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old pregnant woman, who is in her second trimester, presents with complaints of decreased fetal movement for the past few days. A fetal ultrasound reveals <span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hydrops fetalis</span> with evidence of <span style=\"font-family:&quot;Calibri&quot;,sans-serif\">fetal anemia</span>. Laboratory investigations reveal a history of exposure to a daycare center, where there were cases of a viral exanthem among children. Which of the following organisms is most likely responsible for the <span style=\"font-family:&quot;Calibri&quot;,sans-serif\">non-immune hydrops fetalis</span> seen in this fetus? </span></span></p>",
      "unique_key": "Q6809771",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Parvovirus B19</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Parvovirus B19&nbsp;</span></strong><span style=\"font-size:14.0pt\">has a special affinity for <strong>erythroid progenitor cells</strong> found in <strong>adult bone marrow</strong> and the <strong>fetal liver</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When a pregnant woman is infected with <strong>Parvovirus B19</strong>, the virus can cross the placenta and infect the fetus. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This infection disrupts red blood cell production, leading to <strong>severe anemia</strong> in the fetus, which can result in <strong>non-immune hydrops fetalis</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydrops fetalis manifests as excessive fluid accumulation in fetal compartments, often leading to fetal demise. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The greatest risk to the fetus occurs during the <strong>second trimester</strong>, when rapid erythropoiesis is critical for fetal growth.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Cytomegalovirus (CMV)</strong>: CMV can cause <strong>congenital infection</strong> with neurological impairment and growth restriction but is not typically associated with <strong>non-immune hydrops fetalis</strong> due to severe anemia.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Epstein-Barr virus (EBV)</strong>: EBV primarily causes <strong>infectious mononucleosis</strong> and is not a common cause of congenital infection or hydrops fetalis.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Human Papillomavirus (HPV)</strong>: HPV is known to cause <strong>genital warts</strong> and <strong>cervical dysplasia</strong>, but it is not associated with fetal infections or hydrops fetalis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Parvovirus B19&nbsp;</span></strong><span style=\"font-size:14.0pt\">can cross the placenta and infect the fetus, leading to <strong>non-immune hydrops fetalis</strong> due to <strong>severe fetal anemia</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The virus has a particular tropism for erythroid progenitor cells and poses the greatest risk during the <strong>second trimester&nbsp;</strong>of pregnancy, making early diagnosis and monitoring essential for at-risk pregnancies.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244239,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61275,
      "choices": [
        {
          "id": 244381,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FSH &gt; LH</span></span></span></span></p>"
        },
        {
          "id": 244382,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LH &gt; FSH</span></span></span></span></p>"
        },
        {
          "id": 244383,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both FSH and LH decreased</span></span></span></span></p>"
        },
        {
          "id": 244384,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both FSH and LH elevated</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old woman presents with irregular menstrual cycles and signs of hirsutism, including excessive facial hair growth. An ultrasound reveals enlarged ovaries with multiple small cysts. Which of the following hormonal findings is most consistent with her condition? </span></span></p>",
      "unique_key": "Q1311963",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B) LH &gt; FSH</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The characteristic hormonal finding in Polycystic Ovary Syndrome (PCOS) is <strong>increased LH to FSH ratio</strong>, often seen as LH &gt; FSH. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In PCOS, the pulsatile release of GnRH is altered, leading to an increased secretion of luteinizing hormone (LH) relative to follicle-stimulating hormone (FSH). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This hormonal imbalance contributes to anovulation and the clinical manifestations of PCOS, such as irregular menses and hyperandrogenism.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. FSH &gt; LH</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is not consistent with PCOS. In PCOS, LH levels are typically elevated relative to FSH, not the other way around.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Both FSH and LH decreased</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This finding is not characteristic of PCOS. Decreased levels of both hormones may be seen in hypogonadotropic hypogonadism but not in PCOS.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Both FSH and LH elevated:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While LH levels can be elevated, FSH levels do not increase proportionally in PCOS. The ratio is skewed towards higher LH levels compared to FSH.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic Ovary Syndrome (PCOS) is typically associated with an increased LH to FSH ratio, reflecting altered GnRH secretion patterns, which contribute to the clinical and endocrine features of the condition. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244382,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61222,
      "choices": [
        {
          "id": 244169,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatitis serologic panel</span></span></p>"
        },
        {
          "id": 244170,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum ferritin and transferrin saturation</span></span></p>"
        },
        {
          "id": 244171,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doppler ultrasound of the hepatic veins</span></span></p>"
        },
        {
          "id": 244172,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Echocardiography</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man presents with right upper quadrant abdominal pain and shortness of breath. His medical history includes hypertension and type 2 diabetes mellitus. On examination, he has jaundice, a distended abdomen with a positive fluid wave, and tender hepatomegaly. A grade 2/6 systolic ejection murmur is auscultated along the right upper sternal border. Laboratory studies reveal a hemoglobin level of 19 g/dL, AST of 450 U/L, ALT of 350 U/L, and total bilirubin of 2.1 mg/dL. Abdominal ultrasound shows a congested liver with dilated hepatic veins. Given these findings, what is the most appropriate diagnostic test to confirm the underlying cause of this patient&#39;s condition?</span></span></p>",
      "unique_key": "Q3296829",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) Doppler ultrasound of the hepatic veins</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient&#39;s symptoms, physical examination findings, and lab results are consistent with hepatic vein obstruction, also known as Budd-Chiari syndrome. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presentation of right upper quadrant pain, tender hepatomegaly, jaundice, and ascites (distended abdomen) points toward liver congestion. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The elevated hemoglobin suggests polycythemia, which is associated with hypercoagulable states that can lead to hepatic vein thrombosis. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doppler ultrasound of the hepatic veins is the most appropriate next step, as it can assess blood flow and identify any obstruction in the hepatic veins, confirming the diagnosis of Budd-Chiari syndrome.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hepatitis serologic panel:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While viral hepatitis can cause liver enzyme elevations and jaundice, it typically does not present with ascites or tender hepatomegaly in the context of acute right upper quadrant pain. Additionally, a congested liver and polycythemia are not characteristic findings of a viral infection.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Serum ferritin and transferrin saturation:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased iron absorption, as seen in hemochromatosis, can lead to liver dysfunction. However, hemochromatosis usually presents with chronic liver disease signs, such as cirrhosis, diabetes, and skin pigmentation (&quot;bronze diabetes&quot;). The acute presentation here, along with congested hepatic veins on imaging, is more consistent with hepatic vein obstruction.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Echocardiography:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While cardiac conditions, such as constrictive pericarditis, can lead to liver congestion, the presentation here, including the ultrasound findings of hepatic vein dilation, is more suggestive of a primary hepatic vein obstruction. Doppler ultrasound is more specific in confirming this diagnosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic vein obstruction (Budd-Chiari syndrome) presents with symptoms of liver congestion, including right upper quadrant pain, hepatomegaly, jaundice, and ascites. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doppler ultrasound is the key diagnostic test to confirm hepatic vein thrombosis, which can guide further management.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244171,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61264,
      "choices": [
        {
          "id": 244337,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flunitrazepam</span></span></span></span></p>"
        },
        {
          "id": 244338,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diazepam</span></span></span></span></p>"
        },
        {
          "id": 244339,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxazepam</span></span></span></span></p>"
        },
        {
          "id": 244340,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nitrazepam</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old female with a history of generalized anxiety disorder is being considered for a benzodiazepine to help manage her symptoms. She has underlying liver cirrhosis, which may impact the metabolism of medications. Which of the following benzodiazepines is the most appropriate choice given that it is primarily metabolized through conjugation and is less dependent on hepatic function?<strong> </strong></span></span></p>",
      "unique_key": "Q2785666",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Oxazepam</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxazepam is a benzodiazepine that undergoes phase II metabolism (glucuronidation), which is less affected by hepatic function compared to phase I metabolism.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This makes it a preferred choice in patients with liver impairment, such as those with cirrhosis, since it does not rely on the liver&#39;s cytochrome P450 enzymes for metabolism.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Flunitrazepam</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This drug is primarily metabolized by the liver through the cytochrome P450 enzyme system (phase I metabolism). It is not an ideal choice for patients with liver dysfunction as its metabolism could be impaired.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Diazepam</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Diazepam is extensively metabolized in the liver through phase I reactions, producing active metabolites. Due to its dependency on hepatic metabolism, it is not suitable for patients with significant liver impairment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Nitrazepam</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nitrazepam also undergoes hepatic metabolism and is processed by cytochrome P450 enzymes. Thus, its clearance would be significantly affected in individuals with liver dysfunction.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxazepam, Lorazepam, and Temazepam are benzodiazepines that undergo phase II metabolism (glucuronidation), making them safer choices in patients with liver impairment.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benzodiazepines that undergo phase I metabolism (e.g., Diazepam, Nitrazepam) should be avoided or used cautiously in patients with liver disease.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244339,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61482,
      "choices": [
        {
          "id": 245205,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thymoma</span></span></span></span></p>"
        },
        {
          "id": 245206,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neurogenic tumor</span></span></span></span></p>"
        },
        {
          "id": 245207,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Teratoma</span></span></span></span></p>"
        },
        {
          "id": 245208,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchogenic cyst</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male presents with chest discomfort and shortness of breath. A CT scan of the chest reveals a mediastinal mass, as shown in the image. The Hounsfield Unit (HU) measurement of the mass is -70 HU. Which of the following is the most likely diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-111231.png\" style=\"height:247px; width:300px\" /></span></span></p>",
      "unique_key": "Q7518299",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C) Teratoma</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The provided CT image shows a mediastinal mass consistent with a <strong>teratoma</strong>, typically located in the <strong>anterior mediastinum</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Hounsfield Unit (HU) measurement</strong> of <strong>-70</strong> indicates <strong>fat content</strong>, a key feature of teratomas. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These tumors often appear <strong>heterogeneous</strong> due to their mix of tissue types, including <strong>hair, fat, calcifications, and soft tissue</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of <strong>fat</strong> is a distinguishing characteristic, helping to differentiate teratomas from other mediastinal masses like <strong>thymomas</strong> or <strong>lymphomas</strong>, which generally lack fatty components.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-111442.png\" style=\"height:275px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Thymoma</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Thymomas are also anterior mediastinal masses, but they typically appear as soft tissue density on imaging. They do not contain fat, which would not produce a -70 HU measurement.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Neurogenic tumor</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> </strong>Neurogenic tumors are more commonly located in the posterior mediastinum rather than the anterior. They also do not usually present with fat content, making this diagnosis less likely.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Bronchogenic cyst</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: These are generally fluid-filled cystic structures found in the mediastinum, but they do not contain fat. Their HU values would typically be closer to water density, around zero, rather than negative.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Teratomas&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are often identified in the anterior mediastinum and can be distinguished from other mediastinal masses by their mixed composition, including fat, which is evident on imaging as a low Hounsfield Unit (HU) measurement (negative HU values indicate fat density). </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245207,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61220,
      "choices": [
        {
          "id": 244161,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anterior superior frontal lobe</span></span></span></span></p>"
        },
        {
          "id": 244162,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arcuate fasciculus</span></span></span></span></p>"
        },
        {
          "id": 244163,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diffuse territory of the left middle cerebral artery</span></span></span></span></p>"
        },
        {
          "id": 244164,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Posterior inferior frontal gyrus</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old man presents for a follow-up visit one month after experiencing a stroke. He has regained partial motor function on the right side of his body. However, his speech remains fragmented, slow, and effortful, and he appears frustrated by the difficulty in expressing his thoughts. He can follow verbal commands but struggles to name objects correctly or repeat phrases. The lesion responsible for this patient&#39;s symptoms is most likely located in which of the following regions?<strong> </strong></span></span></p>",
      "unique_key": "Q9178933",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Posterior inferior frontal gyrus</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms are characteristic of Broca&#39;s aphasia, which results from a lesion in the posterior inferior frontal gyrus, also known as Broca&#39;s area. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This region of the dominant (usually left) hemisphere is crucial for speech production. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In Broca&#39;s aphasia, patients exhibit non-fluent, fragmented, and effortful speech but have relatively preserved comprehension. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They often struggle with naming objects and repeating phrases.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Anterior superior frontal lobe</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lesions in this area are not typically associated with language deficits; they may be more related to executive function, motivation, and behavior.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Arcuate fasciculus</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Damage to the arcuate fasciculus can result in conduction aphasia, which is characterized by relatively fluent speech and good comprehension but significant difficulty with repetition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Diffuse territory of the left middle cerebral artery</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While a large MCA stroke can cause both language and motor deficits, it would result in more widespread symptoms, including global aphasia if the entire territory is affected, rather than the specific pattern seen in Broca&#39;s aphasia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Broca&#39;s aphasia is caused by a lesion in the posterior inferior frontal gyrus of the dominant hemisphere and is characterized by non-fluent, effortful speech with relatively preserved comprehension.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244164,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61331,
      "choices": [
        {
          "id": 244605,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perceived control</span></span></p>"
        },
        {
          "id": 244606,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Behavioral modification</span></span></p>"
        },
        {
          "id": 244607,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Health motivation</span></span></p>"
        },
        {
          "id": 244608,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Self-efficacy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A public health researcher is studying factors that influence individuals&#39; decisions to get vaccinated during a flu season. She uses the Health Belief Model (HBM) to assess how beliefs and attitudes impact health behaviors. According to the HBM, an individual&rsquo;s readiness and willingness to engage in health-promoting behavior is influenced by various modifying factors like demographic and psychological characteristics. Which of the following best represents Box C in the provided diagram, which signifies this concept?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-174731.jpg\" style=\"height:226px; width:500px\" /></span></span></p>",
      "unique_key": "Q9915306",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Health motivation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Box C&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in the Health Belief Model (HBM) represents <strong>health motivation</strong>, which refers to an individual&#39;s readiness and willingness to take action towards health-promoting behaviors. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It serves as a central factor that influences how individuals perceive their susceptibility to and severity of health conditions, as well as the perceived benefits and barriers to taking action. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Health motivation is essential in determining whether an individual moves from awareness to taking action, such as getting vaccinated or adopting other preventive health measures.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-174829.jpg\" style=\"height:406px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Perceived control:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. Perceived control relates more to an individual&rsquo;s belief in their ability to influence events or outcomes, but it does not specifically represent the readiness to take action in the HBM framework.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Behavioral modification:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. Behavioral modification refers to changes in behavior that result from conditioning or other methods. It is not a part of the HBM model directly.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Self-efficacy:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. Self-efficacy is a belief in one&rsquo;s ability to perform a specific task or behavior successfully. While it influences actions, it is not what Box C represents in the diagram of the HBM.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Health Belief Model</strong> outlines that an individual&rsquo;s <strong>health motivation</strong> influences their likelihood of engaging in health-promoting behavior. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Health motivation is shaped by perceived susceptibility, severity, benefits, barriers, and cues to action.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244607,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61417,
      "choices": [
        {
          "id": 244945,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Observation for 4 hours </span></span></span></span></p>"
        },
        {
          "id": 244946,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plain CT imaging within 24 hours</span></span></span></span></p>"
        },
        {
          "id": 244947,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate plain CT imaging within 1 hour</span></span></span></span></p>"
        },
        {
          "id": 244948,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contrast CT brain within 10 minutes</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old man is brought to the emergency department after a motor vehicle accident. On arrival, his Glasgow Coma Score (GCS) is 13. He has had two episodes of vomiting since the accident and a post-traumatic seizure. He has no focal neurological deficits, but there is suspicion of a basal skull fracture. Which of the following is the most appropriate next step? </span></span></p>",
      "unique_key": "Q3631326",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Immediate plain CT imaging within 1 hour</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">According to the indications for&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT imaging within 1 hour</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, the patient meets multiple criteria for urgent imaging:</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle; margin-left:40px\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GCS &lt;15&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(specifically 13 here) on initial assessment.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More than one episode of vomiting</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-traumatic seizure</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Suspected basal skull fracture</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These factors place the patient at high risk for intracranial injury, and immediate&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT imaging&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is necessary to evaluate for potential brain injury and guide further management.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Observation for 4 hours</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is inappropriate given the presence of multiple risk factors for significant intracranial injury, including a post-traumatic seizure and GCS &lt;15.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Plain CT imaging within 24 hours</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This would be too delayed for a patient with multiple high-risk factors and could result in missing early detection of a significant brain injury.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Contrast CT brain within 10 minutes: In setting of trauma, plain CT brain is done.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">head trauma&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">who present with&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GCS &lt;15</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">,&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">multiple episodes of vomiting</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">,&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">post-traumatic seizures</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, or&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">suspected skull fractures&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">should undergo&nbsp;</span></span><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CT imaging within 1 hour&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">to assess for intracranial injury and ensure timely management.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244947,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61337,
      "choices": [
        {
          "id": 244629,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased heart rate and blood pressure</span></span></p>"
        },
        {
          "id": 244630,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased parasympathetic outflow</span></span></p>"
        },
        {
          "id": 244631,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased baroreceptor sensitivity</span></span></p>"
        },
        {
          "id": 244632,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased activity of the vasomotor center</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old male undergoes surgery for carotid artery stenosis. During the procedure, the surgeon accidentally clamps the carotid artery just below the level of the carotid sinus. Which of the following physiological responses is most likely to occur due to this clamping?<strong> </strong></span></span></p>",
      "unique_key": "Q9037004",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Increased activity of the vasomotor center</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clamping of the carotid artery below the carotid sinus reduces the blood flow and pressure detected by the baroreceptors located in the carotid sinus. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The baroreceptors, sensing a drop in pressure, decrease their firing rate. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This decrease in baroreceptor activity is interpreted by the vasomotor center in the brainstem as low blood pressure, leading to an increase in sympathetic outflow. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As a result, the vasomotor center increases its activity, which leads to vasoconstriction, increased heart rate, and elevated blood pressure in an attempt to restore perfusion.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreased heart rate and blood pressure</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is incorrect because a decrease in baroreceptor signaling due to reduced pressure in the carotid sinus would result in an increase in sympathetic nervous system activity, leading to increased heart rate and blood pressure, not a decrease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Increased parasympathetic outflow</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is incorrect because the drop in baroreceptor signaling would lead to a decrease in parasympathetic activity and a compensatory increase in sympathetic activity to maintain blood pressure.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Decreased baroreceptor sensitivity</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is incorrect because the sensitivity of the baroreceptors themselves is not altered in this scenario. Rather, it is the reduced pressure sensed by them that results in decreased firing and subsequent physiological responses.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clamping the carotid artery below the carotid sinus reduces pressure sensed by baroreceptors, leading to decreased afferent signaling, increased vasomotor center activity, and increased sympathetic response, resulting in elevated heart rate and blood pressure.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244632,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61235,
      "choices": [
        {
          "id": 244221,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Typical optic neuritis</span></span></span></p>"
        },
        {
          "id": 244222,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute Papilledema</span></span></span></p>"
        },
        {
          "id": 244223,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Toxic optic neuropathy</span></span></span></p>"
        },
        {
          "id": 244224,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Leber&#39;s hereditary optic neuropathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old male presents with painless blurring of vision in his left eye that started 2 months ago. Recently, he has also developed similar blurring in his right eye. On examination, there is hyperemia of the optic disc with mild edema, and circumpapillary telangiectasia is noted. The pupillary response remains intact, and perimetry reveals a centrocecal scotoma. Which of the following is the most likely diagnosis?<strong> </strong></span></span></p>",
      "unique_key": "Q5832912",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.</span></strong><span style=\"font-size:14.0pt\"> <strong>D) Leber&#39;s hereditary optic neuropathy</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Leber&#39;s hereditary optic neuropathy (LHON)</span></strong><span style=\"font-size:14.0pt\"> is an inherited mitochondrial condition that generally presents in young males as painless, progressive vision loss, typically beginning in one eye and soon affecting the other. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Key features include optic disc hyperemia, edema, circumpapillary telangiectasia, and a centrocecal scotoma on perimetry, while pupillary responses remain intact. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This pattern is highly consistent with LHON.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Typical optic neuritis</strong>: Usually associated with painful vision loss and often an abnormal pupillary response (relative afferent pupillary defect, RAPD), which is inconsistent with this presentation.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Acute Papilledema</strong>: Characterized by bilateral optic disc swelling due to raised intracranial pressure, but it generally does not present with sequential monocular vision loss or centrocecal scotoma.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Toxic optic neuropathy</strong>: Presents with bilateral, symmetric visual loss, typically associated with toxic exposure. However, this patient shows sequential vision loss in both eyes, which is more characteristic of LHON.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Leber&#39;s hereditary optic neuropathy (LHON)</span></strong><span style=\"font-size:14.0pt\"> is characterized by painless, sequential vision loss, typically beginning in young males. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244224,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61339,
      "choices": [
        {
          "id": 244637,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamivudine + Zidovudine + Lopinavir</span></span></span></span></p>"
        },
        {
          "id": 244638,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamivudine + Zidovudine + Dolutegravir</span></span></span></span></p>"
        },
        {
          "id": 244639,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamivudine + Tenofovir + Dolutegravir</span></span></span></span></p>"
        },
        {
          "id": 244640,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tenofovir + Emtricitabine + Efavirenz</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 14-year-old adolescent boy presents to the emergency department after a needlestick injury. He weighs 35 kg and reports that the injury occurred 36 hours ago while helping in a community health camp. The physician decides to initiate Post Exposure Prophylaxis (PEP) for HIV. According to the current guidelines, which of the following regimens is most appropriate for this patient?</span></span></p>",
      "unique_key": "Q1162161",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Lamivudine + Tenofovir + Dolutegravir</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For <strong>adolescents over 10 years</strong> of age and <strong>weighing more than 30 kg</strong>, the recommended <strong>PEP regimen for HIV</strong> is <strong>Lamivudine (300 mg) + Tenofovir (300 mg) + Dolutegravir (50 mg)</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The prophylaxis should be initiated as soon as possible, preferably within <strong>24 hours</strong>, but it can be started up to <strong>72 hours</strong> after exposure. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>duration</strong> of the prophylaxis is <strong>28 days</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post Exposure Prophylaxis HIV</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preferably within 24 hours. Maximum within 72 hours.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Duration of prophylaxis is 28 days</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-180248.png\" style=\"height:493px; width:1000px\" /></span></span></span></span></p>",
      "correct_choice_id": 244639,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61279,
      "choices": [
        {
          "id": 244397,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">High dose salicylates</span></span></span></p>"
        },
        {
          "id": 244398,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phenytoin</span></span></span></p>"
        },
        {
          "id": 244399,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ethanol</span></span></span></p>"
        },
        {
          "id": 244400,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Methotrexate</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old patient is brought to the emergency department with symptoms of intoxication after consuming a large quantity of an unknown substance. His metabolic panel reveals a significantly elevated blood level of the substance, and further tests indicate that its elimination follows zero-order kinetics at this high concentration. Which of the following drugs is least likely to exhibit zero-order kinetics at high doses?</span></span></p>",
      "unique_key": "Q6102530",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Methotrexate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Zero-order kinetics describes the elimination process where a constant amount of the drug is metabolized per unit of time, regardless of its concentration. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This occurs when the metabolizing enzymes become saturated.</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">High dose salicylates</span></strong><span style=\"font-size:14.0pt\"> (e.g., aspirin) can show zero-order kinetics when taken in excessive amounts, as the liver&#39;s ability to metabolize them becomes saturated.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Phenytoin</span></strong><span style=\"font-size:14.0pt\"> exhibits zero-order kinetics at higher levels due to saturation of its hepatic enzymes.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ethanol&nbsp;</span></strong><span style=\"font-size:14.0pt\">is commonly known to exhibit zero-order kinetics, as alcohol dehydrogenase becomes saturated even at relatively low concentrations.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Methotrexate,</span></strong><span style=\"font-size:14.0pt\"> on the other hand, typically follows first-order kinetics, where the elimination rate is proportional to its concentration, except in cases of renal impairment or toxicity. Thus, it is the least likely to follow zero-order kinetics at higher doses compared to the other options.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. High dose salicylates</span></strong><span style=\"font-size:14.0pt\">: Salicylates can exhibit zero-order kinetics when taken in toxic doses due to saturation of metabolic pathways.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Phenytoin</span></strong><span style=\"font-size:14.0pt\">: Phenytoin&#39;s metabolism can become saturated, leading to zero-order elimination at therapeutic and toxic levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Ethanol</span></strong><span style=\"font-size:14.0pt\">: Ethanol follows zero-order kinetics due to the early saturation of alcohol dehydrogenase, leading to a fixed rate of elimination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Zero-order kinetics&nbsp;</span></strong><span style=\"font-size:14.0pt\">is characterized by a constant rate of drug elimination, seen when metabolizing enzymes are saturated, as in <strong>phenytoin</strong>, <strong>high-dose salicylates</strong>, and <strong>ethanol</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Methotrexate&nbsp;</span></strong><span style=\"font-size:14.0pt\">usually follows <strong>first-order kinetics</strong>, where the rate of elimination is proportional to drug concentration, making it less likely to exhibit zero-order kinetics.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244400,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61335,
      "choices": [
        {
          "id": 244621,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alveolar collapse</span></span></p>"
        },
        {
          "id": 244622,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apnea due to reduced stimulation of peripheral chemoreceptors</span></span></p>"
        },
        {
          "id": 244623,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypercapnic coma</span></span></p>"
        },
        {
          "id": 244624,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DPG levels alteration</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man with chronic obstructive pulmonary disease (COPD) presents to the emergency department with severe shortness of breath. His oxygen saturation is low, and the medical team considers administering 100% oxygen. Which of the following best explains why administering pure oxygen to a patient with chronic hypoxia may be dangerous? </span></span></p>",
      "unique_key": "Q8866618",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Apnea due to reduced stimulation of peripheral chemoreceptors</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with chronic respiratory conditions like COPD, the body adapts to persistently low oxygen levels, and peripheral chemoreceptors become the primary drive for respiration.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These chemoreceptors respond to low oxygen levels (hypoxia) to stimulate breathing. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When pure oxygen is administered to these patients, it raises blood oxygen levels, leading to a reduction in the hypoxic drive, which can cause a dangerous decrease in respiratory rate or even apnea.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alveolar collapse:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alveolar collapse, also known as atelectasis, is not a direct consequence of administering pure oxygen in this scenario. While high concentrations of oxygen can promote nitrogen washout and potentially lead to atelectasis over time, this is not the primary danger in cases of hypoxic drive suppression.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hypercapnic coma:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While the administration of high levels of oxygen can lead to an increase in carbon dioxide retention (hypercapnia) in patients with COPD, the immediate risk is more related to a decrease in the respiratory drive caused by the lack of hypoxic stimulation. Hypercapnic coma would be a result of prolonged hypoventilation but is not the initial direct consequence.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. DPG levels alteration:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2,3-DPG (diphosphoglycerate) levels help regulate oxygen release from hemoglobin. However, administering oxygen does not directly cause a significant or immediate change in DPG levels that would lead to dangerous outcomes in this scenario.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with chronic hypoxia, such as those with COPD, the respiratory drive may rely on low oxygen levels.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administering pure oxygen can suppress this hypoxic drive, leading to a risk of hypoventilation or apnea.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244622,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61456,
      "choices": [
        {
          "id": 245101,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-c, 3-b, 4-a</span></span></p>"
        },
        {
          "id": 245102,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-c, 3-d, 4-a</span></span></p>"
        },
        {
          "id": 245103,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-d, 3-b, 4-a</span></span></p>"
        },
        {
          "id": 245104,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-c, 3-a, 4-d</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following </span></span>:</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180045.jpg\" style=\"height:199px; width:700px\" /></p>",
      "unique_key": "Q1604874",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) 1-b, 2-c, 3-d, 4-a</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The correct matches for the signs and their associated diseases are <strong>1-b, 2-c, 3-d, 4-a</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Alport&#39;s syndrome - b. Glomerulonephritis and SNHL</span></strong><span style=\"font-size:14.0pt\">:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Alport&#39;s syndrome&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a genetic disorder characterized by <strong>progressive kidney disease (glomerulonephritis)</strong> and <strong>sensorineural hearing loss (SNHL)</strong>. It results from mutations affecting the <strong>collagen IV</strong> network, which is essential for the structural integrity of the basement membranes in the kidneys, cochlea, and eyes.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Norrie&#39;s syndrome - c. Optic atrophy and SNHL</span></strong><span style=\"font-size:14.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Norrie&#39;s syndrome&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a rare X-linked disorder that leads to <strong>optic atrophy</strong>, resulting in blindness from a very young age, and is often accompanied by <strong>sensorineural hearing loss (SNHL)</strong>. It is caused by mutations in the <strong>NDP gene</strong>, affecting retinal and cochlear development.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Pendred syndrome - d. Thyroid abnormality and vestibular aqueduct syndrome</span></strong><span style=\"font-size:14.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Pendred syndrome&nbsp;</span></strong><span style=\"font-size:14.0pt\">is associated with <strong>thyroid abnormalities</strong>, such as <strong>goiter</strong> and <strong>hypothyroidism</strong>, and is also linked to <strong>enlarged vestibular aqueduct syndrome</strong>, which can result in <strong>hearing loss</strong>. It is due to mutations in the <strong>SLC26A4 (Pendrin)</strong> gene, impacting inner ear function and thyroid development.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Jervell and Lange-Nielsen syndrome - a. Long QT syndrome and hearing loss</span></strong><span style=\"font-size:14.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Jervell and Lange-Nielsen syndrome&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a <strong>congenital long QT syndrome</strong> associated with <strong>profound sensorineural hearing loss</strong>. It is a rare autosomal recessive condition caused by mutations in <strong>KCNQ1 or KCNE1 genes</strong>, which affect potassium ion channels in both the heart and cochlea, leading to <strong>arrhythmias</strong> and <strong>hearing loss</strong>.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Alport&#39;s syndrome&nbsp;</span></strong><span style=\"font-size:14.0pt\">presents with <strong>glomerulonephritis</strong> and <strong>SNHL</strong> due to collagen IV defects.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Norrie&#39;s syndrome&nbsp;</span></strong><span style=\"font-size:14.0pt\">involves <strong>optic atrophy</strong> and <strong>SNHL</strong> due to mutations affecting retinal and cochlear development.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Pendred syndrome&nbsp;</span></strong><span style=\"font-size:14.0pt\">is associated with <strong>thyroid issues</strong> and <strong>enlarged vestibular aqueduct syndrome</strong>, leading to hearing loss.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Jervell and Lange-Nielsen syndrome&nbsp;</span></strong><span style=\"font-size:14.0pt\">combines <strong>long QT syndrome</strong> with <strong>SNHL</strong>, linked to potassium channel gene mutations.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245102,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61277,
      "choices": [
        {
          "id": 244389,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">30 days</span></span></span></span></p>"
        },
        {
          "id": 244390,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5 days</span></span></span></span></p>"
        },
        {
          "id": 244391,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">21 days</span></span></span></span></p>"
        },
        {
          "id": 244392,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">15 days</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old woman, 3 days postpartum after a normal vaginal delivery, is concerned about the duration of her blood-stained vaginal discharge. Which of the following is the most likely duration of her discharge? </span></span></p>",
      "unique_key": "Q1338265",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B) 5 days</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lochia is the vaginal discharge that occurs after childbirth as the uterus sheds its lining and heals. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It typically starts as <strong>lochia rubra</strong>, which is blood-tinged and lasts for about <strong>5 days</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After this period, the discharge becomes lighter in color <strong>(lochia serosa)</strong> and eventually turns yellowish-white <strong>(lochia alba). </strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The total duration of lochia can last up to 4-6 weeks, but the blood-stained discharge specifically (lochia rubra) lasts around 5 days.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 30 days:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the total possible duration of lochia (including serosa and alba stages) but not the duration of blood-stained lochia rubra.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 21 days:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While lochia discharge can last up to 3 weeks or more, lochia rubra (the blood-stained phase) does not persist for this long.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 15 days:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The blood-stained lochia rubra is typically replaced by lochia serosa well before 15 days postpartum, making this answer incorrect.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After delivery, <strong>lochia rubra</strong>, the initial blood-stained vaginal discharge, typically lasts about <strong>5 days</strong> before transitioning into lighter-colored lochia. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244390,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61234,
      "choices": [
        {
          "id": 244217,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thoracodorsal nerve</span></span></span></p>"
        },
        {
          "id": 244218,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Long thoracic nerve</span></span></span></p>"
        },
        {
          "id": 244219,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spinal accessory nerve</span></span></span></p>"
        },
        {
          "id": 244220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dorsal scapular nerve</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman undergoes a modified radical mastectomy (MRM) for breast cancer. During the surgery, the surgeon identifies and carefully preserves the nerve marked in the image. Which nerve is being identified in the image? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162630.png\" style=\"height:207px; width:300px\" /></p>",
      "unique_key": "Q1912307",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Long thoracic nerve</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This nerve innervates the serratus anterior muscle and is important for scapular protraction and stabilization. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Damage to the long thoracic nerve can result in a &quot;winged scapula.&quot;</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Thoracodorsal nerve</span></strong><span style=\"font-size:14.0pt\">: The thoracodorsal nerve, also known as the nerve to latissimus dorsi, is responsible for innervating the latissimus dorsi muscle. This muscle plays a key role in shoulder adduction, extension, and internal rotation. The thoracodorsal nerve arises from the posterior cord of the brachial plexus and runs along the axillary region, which is commonly encountered and preserved during surgeries such as a modified radical mastectomy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Spinal accessory nerve:</span></strong><span style=\"font-size:14.0pt\"> This nerve innervates the trapezius and sternocleidomastoid muscles. It is often involved in shoulder elevation and neck movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Dorsal scapular nerve</span></strong><span style=\"font-size:14.0pt\">: This nerve innervates the rhomboid muscles and the levator scapulae, which are involved in the retraction and elevation of the scapula.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/whatsapp-image-2024-10-16-at-113725-am.jpeg\" style=\"height:383px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Long thoracic nerve innervates the serratus anterior muscle and is important for scapular protraction and stabilization. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Damage to the long thoracic nerve can result in a &quot;winged scapula.&quot;</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244218,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61265,
      "choices": [
        {
          "id": 244341,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Granular promyelocyte </span></span></p>"
        },
        {
          "id": 244342,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abnormal promyelocyte</span></span></p>"
        },
        {
          "id": 244343,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Faggot cell</span></span></p>"
        },
        {
          "id": 244344,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysplastic myelocyte</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old male is diagnosed with acute myeloid leukemia (AML). A peripheral blood smear is obtained, and the image is shown below. Which of the following describes the characteristic cell seen in the smear?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162637.jpg\" style=\"height:264px; width:400px\" /></span></span></p>",
      "unique_key": "Q1987954",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Faggot cell</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Faggot cells&nbsp;</span></strong><span style=\"font-size:14.0pt\">are seen in <strong>acute promyelocytic leukemia (APL)</strong>, a subtype of AML (M3). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are characterized by the presence of numerous <strong>Auer rods</strong> within the cytoplasm, often arranged in bundles, which gives them a unique appearance. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These cells indicate a high risk of disseminated intravascular coagulation (DIC) in APL, necessitating urgent treatment.</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162649.jpg\" style=\"height:201px; width:400px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Granular promyelocyte:</strong> Granular promyelocytes are seen in the progression of AML, but they do not specifically refer to cells containing numerous Auer rods like the faggot cell shown in the image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Abnormal promyelocyte</span></strong><span style=\"font-size:14.0pt\">: While APL involves abnormal promyelocytes, the image specifically shows a <strong>faggot cell</strong>, which has an abundance of Auer rods.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Dysplastic myelocyte</span></strong><span style=\"font-size:14.0pt\">: This term refers to abnormal maturation seen in myelodysplastic syndromes, not to the APL-specific cells seen here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Faggot cells&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are characteristic of <strong>acute promyelocytic leukemia (APL)</strong> and contain numerous <strong>Auer rods</strong>. </span></span></li>\r\n</ul>",
      "correct_choice_id": 244343,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33321,
      "choices": [
        {
          "id": 133130,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypothyroidism</span></p>"
        },
        {
          "id": 133131,
          "text": "<p><span style=\"font-size:12.0pt;\">Hearing loss</span></p>"
        },
        {
          "id": 133132,
          "text": "<p><span style=\"font-size:12.0pt;\">Short stature</span></p>"
        },
        {
          "id": 133133,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudal regression syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not seen in Downs syndrome?&nbsp; (</span>INICET Nov 2023)</p>",
      "unique_key": "Q8633052",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;Caudal regression syndrome</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Caudal regression syndrome is not typically associated with Down syndrome. Caudal regression syndrome is a congenital disorder characterized by abnormal development of the lower spine (caudal region). It is a separate condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Hypothyroidism: </strong>Hypothyroidism is a known association with Down syndrome.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Hearing loss: </strong>Hearing loss is commonly observed in individuals with Down syndrome. Ear infections and structural abnormalities may contribute to this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Short stature: </strong>Short stature is a characteristic feature of Down syndrome. Individuals with Down syndrome often have a shorter stature compared to the general population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Recognize the common clinical features and associated conditions of Down syndrome. Understand that hypothyroidism, hearing loss, and short stature are commonly observed in individuals with Down syndrome. Be aware of the distinct features of other congenital conditions, such as caudal regression syndrome, that are not typically associated with Down syndrome.</span></p>",
      "correct_choice_id": 133133,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61492,
      "choices": [
        {
          "id": 245245,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">A-iii, B-iv, C-ii, D-i</span></span></span></p>"
        },
        {
          "id": 245246,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">A-iv, B-iii, C-i, D-ii</span></span></span></p>"
        },
        {
          "id": 245247,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">A-iii, B-iv, C-i, D-ii</span></span></span></p>"
        },
        {
          "id": 245248,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">A-iv, B-iii, C-ii, D-i</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following congenital malformations with their radiological findings:<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180819.jpg\" style=\"height:227px; width:700px\" /></p>",
      "unique_key": "Q3247133",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) A-iii, B-iv, C-i, D-ii</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Sigmoid volvulus and Coffee bean sign (A-iii):</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The coffee bean sign is indicative of sigmoid volvulus. It appears as a large, dilated loop of bowel that resembles a coffee bean on an abdominal X-ray due to the twisting of the sigmoid colon.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Achalasia cardia and Bird beak sign (B-iv):</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The bird beak sign is seen in achalasia cardia, where the lower esophageal sphincter is narrowed, creating a tapering appearance that resembles a bird&#39;s beak.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Duodenal atresia and Double bubble sign (C-i):</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The double bubble sign is a classic finding of duodenal atresia, where there is distension of the stomach and the first part of the duodenum with a characteristic appearance on abdominal X-ray.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Jejunal and ileal atresia and Multiple air fluid levels (D-ii):</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Multiple air-fluid levels on an erect abdominal X-ray are suggestive of jejunal and ileal atresia, indicating a bowel obstruction.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The radiological signs associated with specific congenital malformations are-&nbsp; double bubble sign in duodenal atresia, bird beak sign in achalasia cardia, coffee bean sign in sigmoid volvulus, and multiple air-fluid levels in jejunal and ileal atresia.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245247,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61506,
      "choices": [
        {
          "id": 245301,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thick smear</span></span></p>"
        },
        {
          "id": 245302,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thin smear with Acridine orange stain</span></span></p>"
        },
        {
          "id": 245303,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quantitative buffy coat</span></span></p>"
        },
        {
          "id": 245304,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thin smear with Giemsa stain</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman presents to the emergency department with a 5-day history of high-grade fever, chills, and headache after returning from a trip to Sub-Saharan Africa. Physical examination reveals a temperature of 39.5&deg;C (103.1&deg;F) and mild splenomegaly. Malaria is suspected, and the physician orders test to confirm the presence and species of Plasmodium. Which of the following tests is most accurate for the rapid identification of the specific malaria species in this patient?</span></span></p>",
      "unique_key": "Q1497829",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Thin smear with Acridine orange stain</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>thin smear with Acridine orange stain</strong> is highly sensitive for detecting malaria and is particularly effective for the <strong>rapid identification of the specific <em>Plasmodium</em> species</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Acridine orange stain allows the parasites to fluoresce under a microscope, producing results within <strong>3 to 10 minutes</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This rapid turnaround makes it valuable in clinical situations where prompt identification is critical, such as in febrile patients returning from malaria-endemic areas.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Thick smear:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. A thick smear is very sensitive for <strong>detecting the presence of malaria parasites</strong>, as it allows for the examination of a larger volume of blood. However, it is less effective in determining the species, as it does not preserve the morphology of the parasites well.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Quantitative buffy coat:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. This method concentrates the parasites using centrifugation and fluorescence microscopy. While it can detect malaria more rapidly than traditional microscopy, it is less effective than the thin smear with Acridine orange stain in terms of <strong>species identification</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Thin smear with Giemsa stain:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. The <strong>thin smear with Giemsa stain</strong> is considered the <strong>gold standard</strong> for identifying <em>Plasmodium</em> species because it allows for detailed observation of parasite morphology. However, it takes about <strong>45 minutes</strong> for results, making it less suitable for situations requiring a rapid diagnosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>thin smear with Acridine orange stain</strong> is a highly sensitive and rapid method for identifying specific <em>Plasmodium</em> species, providing faster results compared to the traditional <strong>thin smear with Giemsa stain</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For general detection of malaria, a <strong>thick smear</strong> is preferred due to its sensitivity.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For identifying malaria species, <strong>thin smear with Acridine orange stain</strong> is the preferred method due to its higher sensitivity and faster processing time.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-121955.png\" style=\"height:184px; width:700px\" /></span></span></span></span></p>",
      "correct_choice_id": 245302,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61248,
      "choices": [
        {
          "id": 244273,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Stage 1</span></span></span></p>"
        },
        {
          "id": 244274,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Stage 2</span></span></span></p>"
        },
        {
          "id": 244275,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Stage 3</span></span></span></p>"
        },
        {
          "id": 244276,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Stage 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 78-year-old bedridden woman presents with a pressure ulcer over her sacral area. On examination, the ulcer extends through the full thickness of the skin, exposing subcutaneous fat, but there is no visible bone, muscle, or tendon. Which of the following best describes the stage of this pressure ulcer?</span></span></p>",
      "unique_key": "Q5021270",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Stage 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Stage 3 pressure ulcers</span></strong><span style=\"font-size:14.0pt\"> involve full-thickness skin loss, where the damage extends into the subcutaneous tissue but does not expose muscle, tendon, or bone. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The ulcer may appear as a deep crater, with or without undermining of adjacent tissue. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Subcutaneous fat may be visible, but the deeper structures remain covered.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Stage 1</span></strong><span style=\"font-size:14.0pt\">: Stage 1 pressure ulcers present as <strong>intact skin</strong> with non-blanchable erythema. There is no open wound or loss of skin layers, making this option incorrect for an ulcer with full-thickness loss.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Stage 2</span></strong><span style=\"font-size:14.0pt\">: Stage 2 pressure ulcers involve <strong>partial-thickness skin loss</strong> affecting the epidermis, dermis, or both. They may present as a shallow open ulcer with a red-pink wound bed or as an intact or ruptured blister. They do not reach the subcutaneous fat layer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Stage 4</span></strong><span style=\"font-size:14.0pt\">: Stage 4 pressure ulcers are the most severe, involving <strong>full-thickness tissue loss</strong> with <strong>exposed bone, tendon, or muscle</strong>. There may be slough or eschar present on some parts of the wound bed, along with possible undermining and tunneling. This description does not match the case of subcutaneous exposure without deeper structure involvement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Stage 3 pressure ulcers&nbsp;</span></strong><span style=\"font-size:14.0pt\">are characterized by <strong>full-thickness skin loss</strong> extending into the subcutaneous tissue, but without exposure of deeper structures like bone, muscle, or tendons. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the stages of pressure ulcers is essential for appropriate treatment and management.</span></span></li>\r\n</ul>",
      "correct_choice_id": 244275,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61333,
      "choices": [
        {
          "id": 244613,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increasing the number of patients in the study</span></span></p>"
        },
        {
          "id": 244614,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reducing the number of patients in the study</span></span></p>"
        },
        {
          "id": 244615,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raising the confidence level from 95% to 99%</span></span></p>"
        },
        {
          "id": 244616,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Observing higher variability in HbA1c levels between patients</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A clinical trial investigator is analyzing data from a study comparing two treatments for type 2 diabetes. She aims to estimate the difference in mean HbA1c levels between the groups and is working on constructing a 95% confidence interval for the mean difference. The investigator wants to ensure that the confidence interval remains narrow to improve the precision of her estimate. She considers adjusting various aspects of her study. Which of the following changes will not result in a wider confidence interval?</span></span></p>",
      "unique_key": "Q6336903",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Increasing the number of patients in the study</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increasing the number of patients&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(sample size) in a study decreases the standard error of the estimate, leading to a <strong>narrower confidence interval</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This occurs because a larger sample size provides a more accurate estimate of the population parameter, reducing the range of uncertainty around the mean difference in HbA1c levels.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Reducing the number of patients in the study:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. <strong>Reducing the sample size</strong> increases, the standard error, leading to a <strong>wider confidence interval</strong> because fewer data points result in greater uncertainty in the estimate.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Raising the confidence level from 95% to 99%:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. <strong>Increasing the confidence level</strong> requires a broader range to ensure the true population parameter is captured within the interval, thus <strong>widening</strong> the confidence interval.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Observing higher variability in HbA1c levels between patients:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect. <strong>Higher variability</strong> increases the standard error, which results in a <strong>wider confidence interval</strong> as it reflects greater uncertainty in the difference between groups.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increasing the sample size&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">results in a <strong>narrower confidence interval</strong> due to reduced standard error. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In contrast, <strong>decreasing sample size</strong>, <strong>increasing the confidence level</strong>, or <strong>higher variability</strong> lead to <strong>wider confidence intervals</strong> due to increased uncertainty.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244613,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61283,
      "choices": [
        {
          "id": 244413,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Start tafenoquine and monitor for signs of anemia.</span></span></span></p>"
        },
        {
          "id": 244414,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Obtain G6PD testing before starting tafenoquine.</span></span></span></p>"
        },
        {
          "id": 244415,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Administer tafenoquine only at a lower dose to minimize risk.</span></span></span></p>"
        },
        {
          "id": 244416,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Start tafenoquine and prescribe iron supplements to prevent anemia.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old male is being considered for prophylactic treatment with tafenoquine before a trip to a malaria-endemic region. Which of the following is the most appropriate next step before initiating tafenoquine?<strong> </strong></span></span></p>",
      "unique_key": "Q6704641",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Obtain G6PD testing before starting tafenoquine.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Tafenoquine&nbsp;</span></strong><span style=\"font-size:14.0pt\">is an antimalarial medication that can cause <strong>severe hemolytic anemia</strong> in individuals with <strong>G6PD deficiency</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This occurs because G6PD-deficient individuals lack the necessary enzyme to protect red blood cells from oxidative damage, leading to hemolysis when exposed to certain drugs. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Because of this risk, tafenoquine is <strong>contraindicated</strong> in patients with <strong>G6PD deficiency</strong> or <strong>unknown G6PD status</strong>. Therefore, it is essential to perform G6PD testing before initiating tafenoquine to ensure it is safe for use in the patient.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Start tafenoquine and monitor for signs of anemia</span></strong><span style=\"font-size:14.0pt\">: This approach is not safe. Administering tafenoquine without confirming the patient&rsquo;s G6PD status can lead to severe hemolytic anemia, which may occur rapidly and be life-threatening.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Administer tafenoquine only at a lower dose to minimize risk</span></strong><span style=\"font-size:14.0pt\">: Reducing the dose does not eliminate the risk of hemolytic anemia in G6PD-deficient individuals, so this approach is not appropriate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Start tafenoquine and prescribe iron supplements to prevent anemia</span></strong><span style=\"font-size:14.0pt\">: Iron supplements do not prevent hemolysis caused by tafenoquine in G6PD-deficient patients, making this option ineffective and unsafe.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Tafenoquine&nbsp;</span></strong><span style=\"font-size:14.0pt\">can cause <strong>severe hemolytic anemia</strong> in patients with <strong>G6PD deficiency</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is <strong>contraindicated</strong> in individuals with G6PD deficiency or <strong>unknown G6PD status</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">G6PD testing</span></strong><span style=\"font-size:14.0pt\"> must be performed before prescribing tafenoquine to ensure patient safety.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244414,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61341,
      "choices": [
        {
          "id": 244645,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pie chart and Scatter plot</span></span></span></span></p>"
        },
        {
          "id": 244646,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bar chart and Line graph</span></span></span></span></p>"
        },
        {
          "id": 244647,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dot plot and Histogram</span></span></span></span></p>"
        },
        {
          "id": 244648,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Line chart and Box plot</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A hematologist is evaluating a 45-year-old man with unexplained anemia and frequent episodes of hemolysis. To investigate further, the physician orders flow cytometry to assess surface markers on red blood cells, focusing on markers like CD55 and CD59. The results from the flow cytometry are plotted to visualize the differences in marker expression between normal and abnormal cell populations. Which of the following is the most appropriate method for visualizing this flow cytometry data?</span></span></p>",
      "unique_key": "Q9719055",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Dot plot and Histogram</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flow cytometry is a technique used to analyze the expression of <strong>surface markers</strong> on cells. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For visualizing the distribution of these markers, <strong>dot plots</strong> are commonly used to show the relationship between two fluorescence parameters, allowing identification of distinct cell populations. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Histograms</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are used to display the intensity of a single parameter, such as the expression level of a specific <strong>CD marker</strong> like <strong>CD55</strong> or <strong>CD59</strong>. Together, these methods provide a detailed representation of the <strong>heterogeneity</strong> of cell populations in terms of marker expression.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-180417.png\" style=\"height:1007px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Pie chart and Scatter plot:</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pie charts</strong> are not used for visualizing flow cytometry data. While <strong>scatter plots</strong> might show relationships, they lack the detail and specificity provided by <strong>dot plots</strong> and <strong>histograms</strong> in flow cytometry.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Bar chart and Line graph:</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bar charts</strong> and <strong>line graphs</strong> are not used to display cell population distributions or marker expression levels in flow cytometry. They are more suited for statistical comparisons rather than cellular analysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Line chart and Box plot:</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Line charts</strong> and <strong>box plots</strong> do not provide the detailed analysis required for flow cytometry data, particularly for visualizing fluorescence intensity or identifying specific populations of cells.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In flow cytometry, <strong>dot plots&nbsp;</strong>and <strong>histograms&nbsp;</strong>are essential tools for analyzing cell populations based on their <strong>fluorescence characteristics</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dot plots help differentiate between distinct cell groups, while histograms provide insight into the <strong>intensity of marker expression</strong> on individual cell populations.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244647,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61295,
      "choices": [
        {
          "id": 244461,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral retinoids are the drug of choice for nodulocystic acne</span></span></span></span></p>"
        },
        {
          "id": 244462,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topical retinoids can be used in Grade 1 acne vulgaris</span></span></span></span></p>"
        },
        {
          "id": 244463,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acne vulgaris is a disease of the pilosebaceous unit</span></span></span></span></p>"
        },
        {
          "id": 244464,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by monomorphic skin lesions</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements regarding acne vulgaris is incorrect? </span></span></p>",
      "unique_key": "Q5976829",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>D) It is characterized by monomorphic skin lesions</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acne vulgaris is <strong>not</strong> characterized by <strong>monomorphic skin lesions</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acne lesions are <strong>polymorphic</strong>, which means they consist of various types, such as open and closed comedones, inflammatory papules, pustules, nodules, and cysts. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monomorphic skin lesions are typically seen in other conditions like drug eruptions (e.g., drug-induced acne), not in classical acne vulgaris.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-171613.png\" style=\"height:234px; width:400px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Oral retinoids are the drug of choice for nodulocystic acne:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>correct</strong>. <strong>Oral isotretinoin</strong> is the most effective treatment for <strong>nodulocystic acne</strong>, a severe form of acne vulgaris. It works by reducing sebaceous gland activity, normalizing follicular keratinization, and has anti-inflammatory effects. Due to its effectiveness in resistant or severe cases, it is considered the drug of choice for nodulocystic acne.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Topical retinoids can be used in Grade 1 acne vulgaris:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>correct</strong>. <strong>Topical retinoids</strong> are often used as first-line therapy in <strong>Grade 1 (mild)</strong> acne vulgaris, which primarily includes comedones (non-inflammatory lesions). Retinoids help normalize keratinocyte desquamation, preventing the formation of new comedones, and are effective in both inflammatory and non-inflammatory acne.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Acne vulgaris is a disease of the pilosebaceous unit:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>correct</strong>. Acne vulgaris is a disorder of the <strong>pilosebaceous unit</strong>, which consists of the hair follicle, sebaceous gland, and its associated duct. Factors such as excess sebum production, follicular hyperkeratinization, and Propionibacterium acnes colonization contribute to the pathogenesis of acne vulgaris.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acne vulgaris presents with <strong>polymorphic skin lesions</strong>, not monomorphic ones, and involves a disorder of the pilosebaceous unit. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral retinoids&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are the treatment of choice for severe nodulocystic acne, and <strong>topical retinoids</strong> are effective for milder forms of acne, including Grade 1.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244464,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61463,
      "choices": [
        {
          "id": 245129,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichorrhexis invaginata</span></span></span></span></p>"
        },
        {
          "id": 245130,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monilethrix</span></span></span></span></p>"
        },
        {
          "id": 245131,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichothiodystrophy</span></span></span></span></p>"
        },
        {
          "id": 245132,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichorrhexis nodosa</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old girl presents to the clinic with concerns about brittle hair that easily breaks. Her parents report that her hair has been fragile since infancy, and they have noticed irregularly spaced thinning and beading along the length of her hair strands. A microscopy image of her hair is shown below. What is the most likely diagnosis for this hair condition?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-104438.png\" style=\"height:217px; width:300px\" /></span></span></p>",
      "unique_key": "Q8343893",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C)</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Trichothiodystrophy</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image provided shows alternating light and dark bands along the hair shaft, which is characteristic of <strong>Trichothiodystrophy</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This rare genetic disorder affects multiple systems, including the hair, skin, and nails. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The hallmark feature is sulfur-deficient brittle hair that fractures easily, leading to alternating dark and light bands on the hair shaft, giving it a &quot;tiger tail&quot; pattern under polarized light microscopy. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The condition is caused by a defect in DNA repair mechanisms and is associated with features like intellectual disability, photosensitivity, and ichthyosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Trichorrhexis invaginata</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Also known as &quot;bamboo hair,&quot; this condition is associated with <strong>Netherton syndrome</strong>. It shows a &quot;ball and socket&quot; appearance where the distal hair invaginates into the proximal portion. This pattern differs from the alternating light and dark bands seen in Trichothiodystrophy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Monilethrix</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This hereditary condition presents with a beaded appearance of the hair shaft, where constrictions are regularly spaced along the hair strand. The appearance is more uniform, unlike the &quot;tiger tail&quot; pattern seen in Trichothiodystrophy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Trichorrhexis nodosa</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This condition is characterized by the formation of nodules along the hair shaft, where the hair breaks easily at weak points, giving it a frayed, &quot;broomstick&quot; appearance. It typically results from physical or chemical trauma and does not show the banding pattern of Trichothiodystrophy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichothiodystrophy&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a genetic condition characterized by sulfur-deficient hair, leading to a &quot;tiger tail&quot; banding pattern under polarized light. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is important to recognize this distinctive feature, along with its association with DNA repair defects, for accurate diagnosis.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245131,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61395,
      "choices": [
        {
          "id": 244857,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bag &amp; Mask ventilation </span></span></span></span></p>"
        },
        {
          "id": 244858,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intermittent Positive Pressure Ventilation (IPPV)</span></span></span></span></p>"
        },
        {
          "id": 244859,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Intubation</span></span></span></span></p>"
        },
        {
          "id": 244860,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of these&nbsp;</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is contraindicated in a neonate with a scaphoid abdomen? </span></span></p>",
      "unique_key": "Q5973370",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Bag &amp; Mask ventilation </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a neonate presenting with a scaphoid abdomen, certain respiratory interventions need to be carefully considered due to the high risk of underlying conditions like congenital diaphragmatic hernia (CDH). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bag &amp; Mask ventilation is contraindicated in neonates with a scaphoid abdomen suspected of having CDH. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The use of positive pressure from bag and mask ventilation can exacerbate the displacement of abdominal contents into the thoracic cavity through the diaphragmatic defect, potentially worsening respiratory distress and leading to further compromise of pulmonary function. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This method of ventilation can increase the risk of pneumothorax, gastric distention, and further reduce lung volume, which is already compromised in CDH.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. IPPV (Intermittent Positive Pressure Ventilation)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: IPPV is used via a mechanical ventilator after intubation and can provide controlled and safe respiratory support. It is also appropriate in these scenarios to ensure that airway pressure is managed carefully to avoid exacerbating the hernia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Intubation</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is the preferred method for securing the airway in a neonate with a scaphoid abdomen when CDH is suspected. Intubation allows for controlled ventilation settings, minimizes gastric distension, and helps manage the baby&rsquo;s respiratory status more effectively.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The critical point in managing a neonate with a scaphoid abdomen, particularly when a condition like CDH is suspected, involves avoiding exacerbation of the hernia through inappropriate respiratory support techniques. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opting for intubation and controlled mechanical ventilation instead of bag &amp; mask ventilation is crucial to prevent further complications and stabilize the infant&#39;s condition. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Properly securing the airway and ensuring adequate ventilation without increasing the risk of further pulmonary or gastrointestinal injury is essential in the initial management of these patients.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244857,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61461,
      "choices": [
        {
          "id": 245121,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arsenic</span></span></p>"
        },
        {
          "id": 245122,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antimony</span></span></p>"
        },
        {
          "id": 245123,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Barium</span></span></p>"
        },
        {
          "id": 245124,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cadmium</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 48-year-old farmer from a rural village presents to the clinic with a long-standing history of foot discoloration and painful lesions, as shown in the image. The community has a history of using well water for all household purposes. Suspecting a link to environmental toxin exposure through contaminated water, the medical officer considers several metals known to cause systemic toxicity. Which metal is most likely responsible for the symptoms exhibited in this patient?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180155.jpg\" style=\"height:439px; width:400px\" /></span></span></p>",
      "unique_key": "Q2936536",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Arsenic</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Arsenic exposure is the known cause of Blackfoot disease, particularly in geographic regions where well water contains high levels of this metal. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chronic exposure to arsenic in drinking water can lead to this severe peripheral vascular disease, which is characterized by symptoms as seen in the patient&mdash;blackening, ulceration, and progressive gangrene of the extremities.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Antimony</strong>: Generally associated with respiratory irritation and skin problems, not peripheral vascular diseases like Blackfoot disease.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Barium</strong>: Exposure can lead to gastrointestinal and muscle issues but is not associated with diseases like Blackfoot disease.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">.&nbsp;<strong>Cadmium</strong>: Known to cause kidney damage and bone disorders like itai-itai disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180211.jpg\" style=\"height:389px; width:700px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Image &ndash; Cadmium Poisoning (Itai-itai disease)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chronic arsenic exposure through contaminated drinking water can lead to Blackfoot disease, a serious condition marked by severe vascular damage and skin necrosis in the extremities. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early identification of environmental exposure and mitigation strategies are crucial for preventing and managing this toxic effect.</span></span></li>\r\n</ul>",
      "correct_choice_id": 245121,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61499,
      "choices": [
        {
          "id": 245273,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\">Bacillus anthracis (Anthrax)</span></span></span></p>"
        },
        {
          "id": 245274,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\">Yersinia pestis (Plague)</span></span></span></p>"
        },
        {
          "id": 245275,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\">Brucella spp. </span><span style=\"font-size:14.0pt\">(Brucellosis)</span></span></span></p>"
        },
        {
          "id": 245276,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Variola major (Smallpox)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following agents is most likely classified as a Category B bioterrorism agent?</span></span></p>",
      "unique_key": "Q3357945",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Brucella spp. (Brucellosis)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Category B&nbsp;</span></strong><span style=\"font-size:14.0pt\">bioterrorism agents are characterized by their <strong>moderate ease of dissemination</strong>, ability to cause <strong>moderate morbidity with low mortality</strong>, and the need for <strong>enhanced diagnostic and surveillance capabilities</strong> by the CDC. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Brucella spp.</span></strong><span style=\"font-size:14.0pt\">, the causative agent of <strong>Brucellosis</strong>, fits this profile as it can be spread through <strong>aerosols or contaminated animal products</strong> and may present with non-specific flu-like symptoms, making it challenging to diagnose without specialized testing. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Other examples of <strong>Category B</strong> agents include <strong>Salmonella spp., Q fever (Coxiella burnetii)</strong>, and <strong>Ricin toxin</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Bacillus anthracis (Anthrax):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. <strong>Anthrax</strong> is a <strong>Category A</strong> bioterrorism agent, not Category B. Category A agents are more dangerous due to their high mortality rates, ease of dissemination, and the potential for mass casualties.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\">Option B. Yersinia pestis (Plague):</span></strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\"> Incorrect. </span><strong><span style=\"font-size:14.0pt\">Yersinia pestis</span></strong><span style=\"font-size:14.0pt\">, the causative agent of <strong>plague</strong>, is classified as a <strong>Category A</strong> bioterrorism agent due to its potential for causing high mortality and its ease of spread.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Variola major (Smallpox):&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect. <strong>Smallpox</strong> is also a <strong>Category A</strong> agent, due to its high mortality rate, ease of transmission, and potential for severe impact on public health.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/cdc-category_page_1.jpg\" style=\"height:1342px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 245275,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61483,
      "choices": [
        {
          "id": 245209,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salpingostomy</span></span></span></span></p>"
        },
        {
          "id": 245210,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian cystectomy</span></span></span></span></p>"
        },
        {
          "id": 245211,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salpingectomy</span></span></span></span></p>"
        },
        {
          "id": 245212,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oophorectomy</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman is undergoing surgery for an ectopic pregnancy located in the right fallopian tube. The surgeon begins by incising the mesosalpinx, as shown in the image below. Which of the following surgical procedures involves this step? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-111912.png\" style=\"height:219px; width:300px\" /></span></span></p>",
      "unique_key": "Q4248750",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C) Salpingectomy</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>salpingectomy</strong> is the surgical removal of a fallopian tube. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incision of the <strong>mesosalpinx</strong> is a critical step during this procedure to separate the tube from its supporting structures, allowing for its complete removal. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This technique is often performed for conditions like ectopic pregnancy or tubal pathology.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Salpingostomy</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A <strong>salpingostomy</strong> involves making an incision into the fallopian tube to remove an ectopic pregnancy or to clear a blockage. It does not require the complete removal of the tube, and the mesosalpinx is generally not dissected in the same manner as in a salpingectomy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Ovarian cystectomy</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: An <strong>ovarian cystectomy</strong> involves the removal of a cyst from the ovary, leaving the ovarian tissue intact. This procedure focuses on the ovary rather than the fallopian tube, and the <strong>mesosalpinx</strong> is not typically incised as a part of this operation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Oophorectomy:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An&nbsp;<strong>oophorectomy&nbsp;</strong>involves the removal of an entire ovary. While this procedure may sometimes involve manipulation of nearby structures, it is primarily focused on removing the ovarian tissue and not the fallopian tube, so the <strong>mesosalpinx</strong> is not the focus of dissection.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a <strong>salpingectomy</strong>, the <strong>mesosalpinx</strong> is incised to facilitate the removal of the fallopian tube. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This procedure is commonly indicated in cases of ectopic pregnancy, particularly when the tube is significantly damaged or ruptured.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245211,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33324,
      "choices": [
        {
          "id": 133142,
          "text": "<p><span style=\"font-size:12.0pt;\">Bacterial meningitis</span></p>"
        },
        {
          "id": 133143,
          "text": "<p><span style=\"font-size:12.0pt;\">Viral meningitis</span></p>"
        },
        {
          "id": 133144,
          "text": "<p><span style=\"font-size:12.0pt;\">Tubercular meningitis</span></p>"
        },
        {
          "id": 133145,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old child presents with altered sensorium, persistent headache, and photophobia for the past 5 days. On examination, he has signs of meningeal irritation. Cerebrospinal fluid (CSF) analysis reveals:what is your diagnosis?</span><br><span style=\"font-size:12.0pt;\">Protein: 93 mg/dL</span></p><p><br><span style=\"font-size:12.0pt;\">Glucose: 20 mg/dL (serum glucose = 90 mg/dL)</span></p><p><br><span style=\"font-size:12.0pt;\">Cell count: Predominantly lymphocytic pleocytosis (INICET Nov 2023)</span><br>&nbsp;</p>",
      "unique_key": "Q8337325",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Tubercular meningitis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Tubercular meningitis is often associated with CSF findings of elevated protein, decreased glucose, and lymphocytic pleocytosis. These findings are consistent with the given CSF results.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Bacterial meningitis: </strong>The CSF findings of elevated protein, decreased glucose, and an increased number of neutrophil predominance (not lymphocytes) are suggestive of meningitis. However, bacterial meningitis is more commonly associated with a significantly higher white blood cell count (pleocytosis) in the CSF. The given CSF results are not typical for bacterial meningitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Viral meningitis: </strong>This is a potential consideration. Viral meningitis can present with elevated protein, normal or mildly reduced glucose, and an increased number of lymphocytes in the CSF. It is a common cause of aseptic (non-bacterial) meningitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span><span style=\"font-size:11pt;\">&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-07-10%20175946.png\" width=\"1142\" height=\"649\"></p>",
      "correct_choice_id": 133144,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61440,
      "choices": [
        {
          "id": 245037,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenovirus</span></span></p>"
        },
        {
          "id": 245038,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rhinovirus</span></span></p>"
        },
        {
          "id": 245039,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Influenza virus</span></span></p>"
        },
        {
          "id": 245040,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rotavirus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old child presents with symptoms of <span style=\"font-family:&quot;Calibri&quot;,sans-serif\">fever, sore throat, and conjunctivitis</span> for the past three days. A <span style=\"font-family:&quot;Calibri&quot;,sans-serif\">throat swab</span> was obtained, and a viral culture was performed, showing the <span style=\"font-family:&quot;Calibri&quot;,sans-serif\">electron microscopic appearance</span> of viral particles as shown in the image. Which of the following viruses is most likely responsible for this patient&#39;s symptoms? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-100125.png\" style=\"height:215px; width:300px\" /></span></span></p>",
      "unique_key": "Q7387793",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A) Adenovirus</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>image</strong> shows <strong>non-enveloped, icosahedral</strong> viral particles with a <strong>double-stranded DNA</strong> structure typical of <strong>Adenovirus</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenoviruses are responsible for a range of clinical syndromes, including <strong>pharyngoconjunctival fever</strong>, which presents as a combination of <strong>fever, sore throat, and conjunctivitis</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are especially common in young children and are spread through <strong>respiratory droplets, fecal-oral routes, or contaminated surfaces</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-100208.png\" style=\"height:258px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Rhinovirus</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Rhinoviruses are a major cause of the <strong>common cold</strong>, but they typically do not cause conjunctivitis. They are <strong>non-enveloped</strong> viruses but appear smaller and do not match the structure seen in the image.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Influenza virus</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Influenza viruses are <strong>enveloped RNA viruses</strong> and typically present with <strong>fever, body aches, and respiratory symptoms</strong>. They do not cause the type of conjunctivitis seen in this patient and have a different morphology.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Rotavirus</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Rotaviruses are responsible for <strong>gastroenteritis</strong>, primarily causing <strong>vomiting and diarrhea</strong> in young children. They are <strong>non-enveloped RNA viruses</strong>, but they do not match the image or cause pharyngoconjunctival fever.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenovirus&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>non-enveloped, double-stranded DNA virus</strong> that can cause <strong>respiratory infections</strong>, <strong>conjunctivitis</strong>, <strong>gastroenteritis</strong>, and <strong>pharyngoconjunctival fever</strong>. It is characterized by its <strong>icosahedral structure</strong>, which is seen in electron microscopy. The combination of <strong>fever, sore throat, and conjunctivitis</strong> is a key clinical presentation.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245037,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61304,
      "choices": [
        {
          "id": 244497,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in K+ concentration</span></span></span></span></p>"
        },
        {
          "id": 244498,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease in afterload</span></span></span></span></p>"
        },
        {
          "id": 244499,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proteinuria</span></span></span></span></p>"
        },
        {
          "id": 244500,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood dyscrasia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Captopril is an ACE inhibitor used in the management of hypertension and heart failure. Which of the following effects is not typically associated with the use of captopril?<strong> </strong></span></span></p>",
      "unique_key": "Q3016737",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A) Decrease in K+ concentration</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Captopril, like other ACE inhibitors, inhibits the conversion of angiotensin I to angiotensin II, leading to vasodilation and a decrease in afterload, making it effective for the treatment of hypertension and heart failure.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;It can also lead to side effects such as proteinuria and blood dyscrasias in rare cases. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, ACE inhibitors are known to cause an <em>increase</em> in serum potassium concentration, not a decrease, due to reduced aldosterone production. Thus, decreased potassium concentration is not an expected effect of captopril.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decrease in afterload</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: ACE inhibitors, including captopril, reduce afterload by inhibiting angiotensin II formation, leading to vasodilation. This makes them effective in treating hypertension and improving cardiac output in heart failure.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Proteinuria</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Proteinuria can be a side effect of captopril, although it is relatively uncommon. Monitoring renal function and protein levels is recommended in patients receiving ACE inhibitors.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Blood dyscrasia</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Rarely, captopril can lead to blood dyscrasias, including neutropenia or thrombocytopenia, especially in patients with predisposing conditions such as renal impairment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Captopril, an ACE inhibitor, typically causes hyperkalemia, reduced afterload, and may cause proteinuria or blood dyscrasias. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is important to monitor potassium levels and blood counts in patients taking captopril.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244497,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61324,
      "choices": [
        {
          "id": 244577,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Selective estrogen receptor modulator</span></span></span></span></p>"
        },
        {
          "id": 244578,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tibolone</span></span></span></span></p>"
        },
        {
          "id": 244579,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adding progesterone to estrogen</span></span></span></span></p>"
        },
        {
          "id": 244580,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phytoestrogens</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 63-year-old postmenopausal woman is receiving hormone replacement therapy (HRT) for menopausal symptoms. She is concerned about her risk of endometrial cancer. Which of the following measures would most effectively reduce her risk of endometrial cancer while on HRT? </span></span></p>",
      "unique_key": "Q3596732",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C) Adding progesterone to estrogen</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In postmenopausal women on <strong>hormone replacement therapy (HRT)</strong>, adding <strong>progesterone to estrogen</strong> therapy significantly reduces the risk of endometrial cancer. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Estrogen alone can stimulate the endometrial lining, leading to hyperplasia and an increased risk of endometrial cancer. Progesterone counteracts this effect by thinning the endometrial lining, making the combined therapy safer.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Selective estrogen receptor modulator</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Selective estrogen receptor modulators (SERMs) like <strong>raloxifene</strong> are more commonly used to prevent osteoporosis rather than reduce endometrial cancer risk. While they have estrogenic effects on bone, they do not effectively counteract estrogen&#39;s proliferative effects on the endometrium.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Tibolone:</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tibolone</strong> is a synthetic steroid with mixed estrogenic, progestogenic, and androgenic properties. Although it can relieve menopausal symptoms, it does not specifically address the risk of endometrial hyperplasia or cancer in the same way that adding a progestin to estrogen therapy does.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Phytoestrogens:</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phytoestrogens</strong> are plant-derived compounds with estrogen-like activity. While they may have a mild effect on menopausal symptoms, they do not provide adequate protection against the proliferative effects of exogenous estrogen on the endometrium.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adding progesterone to estrogen therapy&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in postmenopausal women reduces the risk of <strong>endometrial cancer</strong> by counteracting the proliferative effects of estrogen on the endometrial lining. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an essential consideration for safer long-term HRT use.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244579,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61219,
      "choices": [
        {
          "id": 244157,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle biopsy for polymyositis</span></span></span></span></p>"
        },
        {
          "id": 244158,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chest CT scan to evaluate for thymoma</span></span></span></span></p>"
        },
        {
          "id": 244159,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">24-hour urinary free cortisol level to assess for Cushing disease</span></span></span></span></p>"
        },
        {
          "id": 244160,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRI of the brain and spinal cord for multiple sclerosis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">60-year-old man presents with progressive facial muscle weakness, difficulty chewing, and double vision. On examination, when asked to look upward toward the ceiling, he develops bilateral ptosis and diplopia. Laboratory tests reveal a serum creatine kinase of 65 U/L (within normal limits). Nerve conduction studies show a decremental response with repetitive stimulation. Given his clinical presentation and investigation findings, further work-up should include which of the following to confirm the most likely associated condition?<strong> </strong></span></span></p>",
      "unique_key": "Q3024090",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B) Chest CT scan to evaluate for thymoma</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms of progressive facial muscle weakness, difficulty chewing, and diplopia that worsens with sustained upward gaze are classic for myasthenia gravis (MG). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The normal serum creatine kinase level further supports this diagnosis, as inflammatory myopathies like polymyositis would typically present with elevated creatine kinase levels. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The decremental response on nerve conduction studies is also characteristic of MG, a condition often associated with thymoma. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thymomas can be identified through imaging such as a chest CT scan, which is a key step in the work-up for patients with suspected MG.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Muscle biopsy for polymyositis:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polymyositis usually presents with proximal muscle weakness rather than isolated facial muscle weakness, and it is typically associated with an elevated serum creatine kinase level. A muscle biopsy is unnecessary when clinical features and nerve conduction studies point towards MG.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 24-hour urinary free cortisol level to assess for Cushing disease:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing disease can present with muscle weakness, but it is typically associated with other symptoms such as central obesity, striae, and hypertension. Additionally, Cushing disease does not commonly present with fatigable muscle weakness or diplopia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. MRI of the brain and spinal cord for multiple sclerosis:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While multiple sclerosis can present with vision changes and muscle weakness, it more commonly presents with other neurological symptoms such as sensory disturbances, spasticity, and autonomic dysfunction. MRI findings characteristic of MS include demyelinating plaques, which are not necessary to pursue in this case given the findings consistent with MG.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myasthenia gravis presents with fatigable muscle weakness, often involving the eyes and facial muscles. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A key part of the diagnostic work-up in suspected cases is imaging to check for thymoma, as this condition can be associated with MG and may alter management.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244158,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61286,
      "choices": [
        {
          "id": 244425,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hodgkin lymphoma</span></span></p>"
        },
        {
          "id": 244426,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplastic large cell lymphoma (ALCL)</span></span></p>"
        },
        {
          "id": 244427,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diffuse large B-cell lymphoma (DLBCL)</span></span></p>"
        },
        {
          "id": 244428,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burkitt lymphoma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male presents with generalized lymphadenopathy and significant weight loss over the past 3 months. A biopsy of a lymph node is performed, and the histological image is given below. Immunohistochemical staining is positive for CD30. What is the most likely diagnosis?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-170951.png\" style=\"height:237px; width:300px\" /></p>",
      "unique_key": "Q8806213",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Anaplastic large cell lymphoma (ALCL)</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplastic large cell lymphoma (ALCL) is a type of T-cell lymphoma that often presents with systemic symptoms such as weight loss, fever, and generalized lymphadenopathy. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by large, atypical cells, often with horseshoe-shaped nuclei, known as <strong>&quot;Hallmark cells,&quot;</strong> which can be seen in the provided image. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immunohistochemical staining for CD30 is a key diagnostic feature of ALCL. The presence of these features supports the diagnosis of ALCL.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hodgkin lymphoma</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hodgkin lymphoma is characterized by Reed-Sternberg cells, which are large, atypical cells with a characteristic &quot;owl-eye&quot; appearance. This differs from the hallmark cells seen in ALCL.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Diffuse large B-cell lymphoma (DLBCL)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DLBCL is a B-cell lymphoma that is usually negative for CD30 staining and does not exhibit the hallmark cells seen in ALCL. DLBCL presents with sheets of large B-cells rather than the pleomorphic cells typical of ALCL.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Burkitt lymphoma</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Burkitt lymphoma is known for its &quot;starry sky&quot; appearance due to high mitotic activity and apoptotic cell debris. It typically involves the jaw or abdomen in endemic cases and is associated with EBV infection. It does not show CD30 positivity or the hallmark cells characteristic of ALCL.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplastic large cell lymphoma (ALCL) is a T-cell lymphoma that is positive for CD30 and characterized by large, pleomorphic cells with horseshoe-shaped nuclei (Hallmark cells). </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244426,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61307,
      "choices": [
        {
          "id": 244509,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Galantamine</span></span></span></span></p>"
        },
        {
          "id": 244510,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Donepezil</span></span></span></span></p>"
        },
        {
          "id": 244511,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tacrine</span></span></span></span></p>"
        },
        {
          "id": 244512,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Memantine</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old woman with Alzheimer&#39;s disease is being managed with multiple medications to improve cognitive function. Which of the following agents is not classified as a cholinergic agent?</span></span></p>",
      "unique_key": "Q1035118",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D) Memantine</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Memantine is an NMDA receptor antagonist used in the treatment of Alzheimer&#39;s disease.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It works by modulating the activity of glutamate, which is involved in learning and memory. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unlike the other agents listed, memantine does not enhance cholinergic transmission and is not considered a cholinergic agent.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Galantamine</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Galantamine is a cholinesterase inhibitor that enhances cholinergic neurotransmission by inhibiting the breakdown of acetylcholine. It is used in the management of Alzheimer&#39;s disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Donepezil</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Donepezil is also a cholinesterase inhibitor that prevents the breakdown of acetylcholine, thereby enhancing cholinergic neurotransmission in the brain. It is commonly used to treat symptoms of Alzheimer&#39;s disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Tacrine</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Tacrine is an older cholinesterase inhibitor that was used for Alzheimer&#39;s disease, but it is no longer commonly prescribed due to its hepatotoxicity. Like the others, it increases cholinergic activity by inhibiting acetylcholinesterase.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Memantine is not a cholinergic agent; it is an NMDA receptor antagonist used in Alzheimer&#39;s disease.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholinergic agents such as galantamine, donepezil, and tacrine enhance cholinergic neurotransmission by inhibiting acetylcholinesterase.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244512,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61470,
      "choices": [
        {
          "id": 245157,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Its Cmax is 20 &mu;g/dl.</span></span></span></p>"
        },
        {
          "id": 245158,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">AUC from the above graph reflects the rate of absorption.</span></span></span></p>"
        },
        {
          "id": 245159,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tmax for drug X is 7 hours.</span></span></span></p>"
        },
        {
          "id": 245160,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Instead of 100 mg, drug X should be given in divided doses.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A new drug X is administered orally in a dose of 100 mg to a healthy volunteer, and its plasma concentration is measured hourly. The graph below shows the relationship between plasma concentration (in &mu;g/dl) and time (in hours). Which of the following statements about drug X is true?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180306.jpg\" style=\"height:333px; width:500px\" /></span></span></p>",
      "unique_key": "Q7631424",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Instead of 100 mg, drug X should be given in divided doses.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D&nbsp;</span></strong><span style=\"font-size:14.0pt\">is correct because the graph indicates that the peak plasma concentration (Cmax) of drug X slightly exceeds the <strong>minimum toxic concentration</strong> after a single dose.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;This suggests that giving the drug as a single dose may increase the risk of toxicity.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;By administering the drug in <strong>divided doses</strong>, one can maintain therapeutic levels while reducing the peak concentration, thus avoiding the toxic range.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Its Cmax is 20 &mu;g/dl</span></strong><span style=\"font-size:14.0pt\">: This is incorrect. The Cmax (peak plasma concentration) observed on the graph is above 25 &mu;g/dl, which is higher than 20 &mu;g/dl.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. AUC from the above graph reflects the rate of absorption</span></strong><span style=\"font-size:14.0pt\">: This is incorrect. The <strong>Area Under the Curve (AUC)</strong> represents the <strong>total exposure</strong> of the body to the drug over time, not specifically the rate of absorption. The <strong>rate of absorption</strong> is better reflected by the <strong>Tmax</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Tmax for drug X is 7 hours.</span></strong><span style=\"font-size:14.0pt\">: This is incorrect. The <strong>Tmax</strong> is the time at which <strong>Cmax</strong> occurs, which is around <strong>4 hours</strong> on the graph, not 7 hours.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Cmax&nbsp;</span></strong><span style=\"font-size:14.0pt\">is the peak plasma concentration of a drug, and <strong>Tmax</strong> is the time at which this peak occurs.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">AUC&nbsp;</span></strong><span style=\"font-size:14.0pt\">(Area Under the Curve) measures <strong>total drug exposure</strong> in the body over time.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When a drug&#39;s single dose reaches concentrations near the <strong>minimum toxic concentration</strong>, <strong>dividing the dose</strong> can help maintain therapeutic levels while reducing the risk of toxicity.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245160,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61231,
      "choices": [
        {
          "id": 244205,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased uterine smooth muscle contractions</span></span></span></span></p>"
        },
        {
          "id": 244206,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased gastrointestinal peristalsis</span></span></span></span></p>"
        },
        {
          "id": 244207,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bladder detrusor contraction</span></span></span></span></p>"
        },
        {
          "id": 244208,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peripheral vasodilation</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">35-year-old woman with a history of asthma presents to the emergency department with an acute asthma exacerbation. She is administered a nebulized medication that leads to significant improvement in her symptoms. Shortly after administration, the patient reports experiencing transient tremors and mild flushing of the skin. Considering the side effect profile of the administered medication and its pharmacologic class, which of the following additional effects is most likely to be observed in this patient if the medication were administered chronically?<strong> </strong></span></span></p>",
      "unique_key": "Q8231743",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D) Peripheral vasodilation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The medication used for acute relief of bronchospasm in asthma patients is most likely a beta-2 adrenergic agonist, such as albuterol. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-2 agonists cause bronchodilation by relaxing the smooth muscles of the airways. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The transient tremors reported by the patient are a common side effect due to beta-2 receptor stimulation in skeletal muscles. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additionally, beta-2 agonists cause vasodilation of the peripheral blood vessels by relaxing vascular smooth muscle. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With chronic administration, this can lead to persistent peripheral vasodilation, potentially manifesting as mild flushing or a decrease in blood pressure.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreased uterine smooth muscle contractions</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This effect is more relevant in pregnant individuals, as beta-2 agonists can relax uterine smooth muscle. However, in a non-pregnant adult female, this effect is not applicable.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Increased gastrointestinal peristalsis</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Beta-2 agonists generally result in relaxation of smooth muscles, including the gastrointestinal tract, leading to decreased peristalsis rather than an increase.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Bladder detrusor contraction</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Beta-2 agonists typically relax the bladder detrusor muscle, potentially leading to urinary retention rather than contraction.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-2 adrenergic agonists are known for their smooth muscle relaxation properties, which extend beyond the airways to include effects such as peripheral vasodilation. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This side effect profile is important to consider in patients receiving chronic beta-2 agonist therapy.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244208,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61453,
      "choices": [
        {
          "id": 245089,
          "text": "<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-175803.jpg\" style=\"height:171px; width:300px\" /></p>"
        },
        {
          "id": 245090,
          "text": "<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-175828.jpg\" style=\"height:154px; width:300px\" /></p>"
        },
        {
          "id": 245091,
          "text": "<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-175859.jpg\" style=\"height:158px; width:300px\" /></p>"
        },
        {
          "id": 245092,
          "text": "<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-175918.jpg\" style=\"height:178px; width:300px\" /></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these surgical positions will help in reducing intracranial pressure during neurosurgery?</span></span></p>",
      "unique_key": "Q2606811",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B&nbsp;</span></strong><span style=\"font-size:14.0pt\">depicts the <strong>reverse Trendelenburg position</strong>, where the patient&#39;s head is elevated above the level of the heart, and the body is angled downward. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This position is effective in <strong>reducing intracranial pressure (ICP)</strong> during neurosurgical procedures. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevating the head helps to facilitate venous drainage from the brain by promoting blood flow out of the cranial cavity and reducing cerebral blood volume. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This, in turn, decreases intracranial pressure, which is crucial during neurosurgical interventions to prevent complications from increased pressure on the brain.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A</span></strong><span style=\"font-size:14.0pt\">: This is the <strong>Trendelenburg position</strong>, where the patient&rsquo;s body is tilted so that the head is lower than the feet. This position is not suitable for reducing intracranial pressure, as it can actually <strong>increase intracranial pressure</strong> by impeding venous outflow from the brain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C</span></strong><span style=\"font-size:14.0pt\">: This position appears to be the <strong>lithotomy position</strong>, often used for urological or gynecological procedures. It is not related to the management of intracranial pressure and does not aid in reducing ICP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">: This position is the <strong>prone position</strong>, which involves the patient lying on their stomach. It is used for certain spinal surgeries and posterior fossa neurosurgery but does not specifically help in reducing intracranial pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>reverse Trendelenburg position</strong> is useful in <strong>reducing intracranial pressure</strong> during neurosurgical procedures by improving venous outflow from the brain, thus decreasing cerebral blood volume and pressure.</span></span></li>\r\n</ul>",
      "correct_choice_id": 245090,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61325,
      "choices": [
        {
          "id": 244581,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Superior cerebellar artery</span></span></span></span></p>"
        },
        {
          "id": 244582,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Middle cerebral artery</span></span></span></span></p>"
        },
        {
          "id": 244583,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Internal carotid artery</span></span></span></span></p>"
        },
        {
          "id": 244584,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Posterior cerebral artery</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old man presents to the emergency department with sudden onset of dizziness, unsteady gait, and difficulty coordinating movements. On examination, he shows ataxia, dysmetria, and nystagmus. Thrombosis of which of the following arteries is most likely responsible for this patient&#39;s symptoms? </span></span></p>",
      "unique_key": "Q7433245",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Superior cerebellar artery</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>superior cerebellar artery (SCA)</strong> supplies blood to the <strong>upper portion of the cerebellum</strong> and the <strong>superior cerebellar peduncles</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>thrombosis</strong> or <strong>occlusion</strong> of the <strong>SCA</strong> can lead to <strong>cerebellar infarction</strong>, resulting in <strong>ataxia</strong>, <strong>dysmetria</strong>, and <strong>coordination difficulties</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptoms are typically localized to the <strong>cerebellum</strong>, leading to <strong>ipsilateral ataxia</strong> and issues with <strong>balance and coordination</strong>, as observed in this patient. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>SCA</strong> is thus the primary vessel implicated when symptoms are consistent with <strong>cerebellar dysfunction</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-174215.png\" style=\"height:246px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Middle cerebral artery (MCA)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. The <strong>MCA</strong> supplies large portions of the <strong>lateral cerebral cortex</strong>, affecting <strong>motor and sensory areas</strong>. <strong>Thrombosis</strong> of the <strong>MCA</strong> typically results in <strong>contralateral hemiparesis</strong>, <strong>aphasia</strong> (if dominant hemisphere is involved), and <strong>sensory deficits</strong>, but not primarily <strong>ataxia</strong> or <strong>coordination issues</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Internal carotid artery (ICA)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. The <strong>ICA</strong> is a major artery that supplies the <strong>anterior circulation</strong> of the brain, including the <strong>MCA</strong> and <strong>anterior cerebral artery</strong> (ACA). Occlusion of the <strong>ICA</strong> may cause <strong>widespread cerebral ischemia</strong>, but it is not specific to the <strong>cerebellum</strong>, and thus would not directly cause <strong>ataxia</strong> or <strong>coordination difficulties</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Posterior cerebral artery (PCA)</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Incorrect. The <strong>PCA</strong> supplies the <strong>occipital lobe</strong> and portions of the <strong>temporal lobe</strong>, leading to symptoms like <strong>contralateral homonymous hemianopia</strong> when occluded. It does not directly supply the <strong>cerebellum</strong>, and therefore <strong>PCA thrombosis</strong> is not primarily associated with <strong>ataxia</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombosis of the <strong>superior cerebellar artery (SCA)</strong> can result in <strong>cerebellar infarction</strong>, leading to symptoms such as <strong>ataxia</strong>, <strong>incoordination</strong>, and <strong>dysmetria</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 244581,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61259,
      "choices": [
        {
          "id": 244317,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arachidonic acid</span></span></span></span></p>"
        },
        {
          "id": 244318,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platelet aggregation</span></span></span></span></p>"
        },
        {
          "id": 244319,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholesterol-derived compounds</span></span></span></span></p>"
        },
        {
          "id": 244320,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysine</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the primary precursor for the formation of eicosanoids?<strong> </strong></span></span></p>",
      "unique_key": "Q4623431",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A) Arachidonic acid</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arachidonic acid is the key precursor for the synthesis of eicosanoids, including prostaglandins, thromboxanes, and leukotrienes. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These molecules play crucial roles in inflammation, fever, and the regulation of blood flow. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arachidonic acid is released from the cell membrane phospholipids by the action of phospholipase A2 during cell injury or inflammation and is then converted into various eicosanoids through cyclooxygenase (COX) or lipoxygenase pathways.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Platelet aggregation:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platelet aggregation refers to the clumping of platelets, a process involved in blood clotting, not the formation of eicosanoids. However, some eicosanoids like thromboxane A2 do influence platelet aggregation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Cholesterol-derived compounds:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eicosanoids are not synthesized from cholesterol. Cholesterol serves as a precursor for steroid hormones and bile acids, which are structurally different from eicosanoids.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Lysine:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysine is an amino acid involved in protein synthesis and is not a precursor for eicosanoid synthesis. It plays no direct role in the formation of lipid-derived signaling molecules like eicosanoids.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eicosanoids are lipid-derived signalling molecules formed from arachidonic acid through enzymatic pathways such as cyclooxygenase and lipoxygenase. They are important in mediating inflammatory responses, vasodilation, and platelet aggregation. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244317,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61270,
      "choices": [
        {
          "id": 244361,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polymerization of host actin filaments</span></span></span></span></p>"
        },
        {
          "id": 244362,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Using flagella for motility</span></span></span></span></p>"
        },
        {
          "id": 244363,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secretion of collagenase to penetrate cell membranes</span></span></span></span></p>"
        },
        {
          "id": 244364,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Producing toxins to lyse host cell junctions</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old woman presents with fever, malaise, and myalgia after consuming unpasteurized cheese. Blood culture findings is shown in the image. What mechanism does this organism use to move transcellularly and infect adjacent cells?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-165948.png\" style=\"height:402px; width:400px\" /></span></span></p>",
      "unique_key": "Q6814820",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>A) Polymerization of host actin filaments</strong></span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Listeria monocytogenes&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an intracellular pathogen that uses <strong>host cell actin filaments</strong> to propel itself within and between cells. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After entering a host cell, Listeria produces <strong>ActA</strong>, a protein that induces <strong>actin polymerization</strong>, resulting in &quot;comet tails&quot; that propel the bacterium through the cytoplasm. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This process helps Listeria to move from one cell to another, enabling efficient dissemination and evasion of immune responses by avoiding extracellular exposure.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Using flagella for motility</strong>: Listeria does possess <strong>flagella</strong>, but these are not used for intracellular movement. The flagella are used for motility in the external environment.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C</strong>. <strong>Secretion of collagenase to penetrate cell membranes</strong>: <strong>Collagenase</strong> is not involved in Listeria&#39;s mechanism of intracellular motility. Collagenase is more typically used by some bacteria to degrade connective tissue during invasion.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option D</strong>. <strong>Producing toxins to lyse host cell junctions</strong>: Listeria does not rely on toxins to lyse host cell junctions for movement. It primarily uses <strong>actin polymerization</strong> to move transcellularly without leaving the intracellular environment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Listeria monocytogenes&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">utilizes <strong>host actin polymerization</strong> to move within cells, forming &quot;comet tails&quot; that propel it and allow transcellular spread. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This actin-based motility helps Listeria evade immune detection and enhances its ability to disseminate efficiently between host cells. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244361,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61294,
      "choices": [
        {
          "id": 244457,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt;95 mg/dL</span></span></p>"
        },
        {
          "id": 244458,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt;89 mg/dL</span></span></p>"
        },
        {
          "id": 244459,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt;106 mg/dL</span></span></p>"
        },
        {
          "id": 244460,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt;92 mg/dL</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman at 24 weeks gestation undergoes a routine glucose tolerance test. Her fasting blood glucose level is measured. According to the International Association of the Diabetes and Pregnancy Study Groups (IADPSG), what is the fasting blood glucose threshold for diagnosing gestational diabetes mellitus (GDM)?</span></span></p>",
      "unique_key": "Q2394997",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) &gt;92 mg/dL</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The IADPSG guidelines specify that a fasting blood glucose level of greater than <strong>92 mg/dL</strong> is one of the criteria for diagnosing gestational diabetes mellitus (GDM). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The diagnosis of GDM can be made if any one of the following criteria is met during a 75-gram oral glucose tolerance test (OGTT): fasting glucose &gt;92 mg/dL, 1-hour glucose &gt;180 mg/dL, or 2-hour glucose &gt;153 mg/dL. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These thresholds are aimed at identifying levels of glucose intolerance that may increase the risk of adverse pregnancy outcomes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>IADPSG criteria</strong> for diagnosing gestational diabetes mellitus (GDM) include a <strong>fasting blood glucose level &gt;92 mg/dL</strong> as one of the thresholds during a 75-gram OGTT.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244460,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61263,
      "choices": [
        {
          "id": 244333,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goldmann, Zeiss</span></span></span></span></p>"
        },
        {
          "id": 244334,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Richardson, Koeppe</span></span></span></span></p>"
        },
        {
          "id": 244335,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Koeppe, Zeiss</span></span></span></span></p>"
        },
        {
          "id": 244336,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Richardson, Goldmann</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 63-year-old female is undergoing an ophthalmic examination to evaluate her anterior chamber angle due to increased intraocular pressure. The ophthalmologist decides to use an indirect gonioscope to visualize the angle structures. Which of the following gonioscopic lenses are suitable for indirect visualization of the angle? </span></span></p>",
      "unique_key": "Q1206454",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>A) Goldmann, Zeiss</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Goldmann</strong> and <strong>Zeiss</strong> lenses are <strong>indirect gonioscopes</strong>, meaning they use mirrors to reflect the image of the anterior chamber angle to the viewer. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indirect gonioscopes are often used to assess the angle configuration in cases like glaucoma to determine if it is open or closed.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-165438.png\" style=\"height:303px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Richardson, Koeppe</strong>: Both the <strong>Richardson</strong> and <strong>Koeppe</strong> lenses are <strong>direct gonioscopes</strong>, which means they provide direct visualization without mirrors.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Koeppe, Zeiss</strong>: The <strong>Koeppe</strong> lens is a <strong>direct gonioscope</strong>, whereas the <strong>Zeiss</strong> is an <strong>indirect gonioscope</strong>, making this combination incorrect.</span></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Richardson, Goldmann</strong>: The <strong>Richardson</strong> lens is a <strong>direct gonioscope</strong>, while the <strong>Goldmann</strong> lens is an <strong>indirect</strong> one, thus making this combination incorrect.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indirect gonioscopes</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, such as the <strong>Goldmann and Zeiss</strong> lenses, use mirrors to visualize the anterior chamber angle. This is in contrast to <strong>direct gonioscopes</strong> like <strong>Richardson</strong> and <strong>Koeppe</strong>, which do not require mirrors. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244333,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61298,
      "choices": [
        {
          "id": 244473,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced scavenging of RBCs by macrophages</span></span></p>"
        },
        {
          "id": 244474,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased production of NADH in red blood cells</span></span></p>"
        },
        {
          "id": 244475,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Impaired generation of reduced glutathione</span></span></p>"
        },
        {
          "id": 244476,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased membrane lipid peroxidation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male presents to the emergency department with symptoms of fatigue, jaundice, and dark-colored urine after taking a course of antibiotics for a respiratory infection. A blood smear reveals the presence of Heinz bodies and bite cells, and further investigation indicates oxidative stress damage to red blood cells. Which of the following mechanisms is most likely impaired in this patient&#39;s condition?<strong> </strong></span></span></p>",
      "unique_key": "Q7031472",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C) Impaired generation of reduced glutathione</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6PD (glucose-6-phosphate dehydrogenase) deficiency is characterized by a decreased ability to generate NADPH, which is crucial for maintaining the levels of reduced glutathione (GSH) in red blood cells (RBCs). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced glutathione plays a key role in detoxifying reactive oxygen species (ROS) and preventing oxidative damage to RBCs. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Without adequate levels of reduced glutathione, RBCs become more susceptible to oxidative stress, leading to hemolysis, especially after exposure to certain drugs, infections, or fava beans.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Reduced scavenging of RBCs by macrophages:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In G6PD deficiency, there is an increased, not decreased, scavenging of damaged RBCs by macrophages. Oxidative damage leads to hemoglobin denaturation, forming Heinz bodies, which are then removed by splenic macrophages.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decreased production of NADH in red blood cells:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6PD is involved in the pentose phosphate pathway and generates NADPH, not NADH. NADPH is essential for maintaining the oxidative balance in RBCs by regenerating reduced glutathione. Thus, this option is incorrect.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Decreased membrane lipid peroxidation:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6PD deficiency leads to <em>increased</em> membrane lipid peroxidation due to reduced levels of NADPH and glutathione. The resulting oxidative damage makes RBCs more fragile, leading to hemolysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6PD deficiency impairs the production of NADPH, which in turn leads to reduced levels of glutathione, making red blood cells more vulnerable to oxidative damage. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This vulnerability can trigger hemolysis, particularly after exposure to oxidative stressors such as certain medications or infections.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244475,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61301,
      "choices": [
        {
          "id": 244485,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamotrigine</span></span></span></span></p>"
        },
        {
          "id": 244486,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbamazepine</span></span></span></span></p>"
        },
        {
          "id": 244487,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproate</span></span></span></span></p>"
        },
        {
          "id": 244488,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topiramate</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man with bipolar disorder presents to the clinic with complaints of increasing fatigue, confusion, and nausea over the past few weeks. He has been taking a mood-stabilizing medication for the last 5 months. On examination, mild jaundice is noted. Laboratory tests reveal elevated liver transaminases and increased serum ammonia levels. Which of the following medications is most likely responsible for these findings?</span></span></p>",
      "unique_key": "Q8918369",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Valproate</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproate is a commonly used anticonvulsant and mood stabilizer for conditions like bipolar disorder and seizure disorders. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One of its adverse effects is hepatotoxicity, which can present with elevated liver enzymes and jaundice.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Valproate also disrupts the urea cycle, leading to hyperammonemia. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperammonemia often results in symptoms like fatigue, altered mental status, and nausea. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The risk of these adverse effects is particularly significant in patients during the initial months of therapy or those on multiple antiepileptic drugs.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Lamotrigine</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lamotrigine is also a mood stabilizer and anticonvulsant but is not typically associated with liver dysfunction or hyperammonemia. Its main side effects include rash and, in rare cases, Stevens-Johnson syndrome.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Carbamazepine</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Carbamazepine can cause liver enzyme elevation but is less commonly associated with significant liver dysfunction or hyperammonemia. Common adverse effects include hyponatremia, bone marrow suppression, and rash.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Topiramate</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Topiramate is an anticonvulsant and mood stabilizer that can cause side effects such as weight loss, cognitive dysfunction, and nephrolithiasis. It is not commonly linked with liver dysfunction or hyperammonemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproate can cause hepatotoxicity and hyperammonemia, particularly during the early stages of treatment. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is essential to monitor liver function tests and serum ammonia in patients taking valproate, especially if symptoms such as fatigue or jaundice develop.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244487,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61442,
      "choices": [
        {
          "id": 245045,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vincristine, prednisone, and asparaginase therapy</span></span></p>"
        },
        {
          "id": 245046,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytarabine and daunorubicin therapy</span></span></p>"
        },
        {
          "id": 245047,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allogeneic stem cell transplantation</span></span></p>"
        },
        {
          "id": 245048,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imatinib therapy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old man presents with a 3-month history of fatigue, excessive sweating, unintentional weight loss, and occasional gingival bleeding. He has a past medical history of radiation therapy. On physical examination, there is notable splenomegaly. Laboratory tests reveal: hemoglobin 9 g/dL, mean corpuscular volume (MCV) 86 fL, white blood cell count (WBC) of 110,000/mm&sup3; with a differential showing 24% segmented neutrophils, 1% blasts, 11% lymphocytes, and a platelet count of 650,000/mm&sup3;. Molecular testing identifies the presence of the BCR-ABL1 fusion gene. Which of the following is the most appropriate next step in the management of this patient?</span></span></p>",
      "unique_key": "Q6347484",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D) Imatinib therapy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient&rsquo;s presentation and laboratory findings are characteristic of <strong>chronic myeloid leukemia (CML)</strong>, particularly the chronic phase. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of leukocytosis with a marked increase in the WBC count, thrombocytosis, and splenomegaly, along with molecular confirmation of the BCR-ABL1 fusion gene, confirms the diagnosis. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The first-line treatment for CML is a tyrosine kinase inhibitor (TKI), such as <strong>imatinib</strong>, which specifically targets the BCR-ABL1 oncoprotein. Imatinib therapy effectively reduces disease progression, controls symptoms, and improves survival in patients with CML.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Vincristine, prednisone, and asparaginase therapy:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This regimen is used in the treatment of <strong>acute lymphoblastic leukemia (ALL)</strong>, not CML. The patient&#39;s presentation, particularly the identification of the BCR-ABL1 gene, points towards CML rather than ALL.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cytarabine and daunorubicin therapy:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a standard induction chemotherapy regimen for <strong>acute myeloid leukemia (AML)</strong>. However, the patient&#39;s low percentage of blasts (1%) and molecular findings are more consistent with CML in the chronic phase rather than AML.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Allogeneic stem cell transplantation:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While allogeneic stem cell transplantation may be considered in advanced or refractory cases of CML or if the patient has failed TKI therapy, it is not the first-line treatment for CML in the chronic phase, particularly when TKIs like imatinib are available.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of the BCR-ABL1 fusion gene in a patient with leukocytosis, thrombocytosis, and splenomegaly is diagnostic of chronic myeloid leukemia (CML). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Imatinib, a tyrosine kinase inhibitor, is the first-line treatment that specifically targets the abnormal protein produced by the BCR-ABL1 fusion gene, providing effective disease control.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245048,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61293,
      "choices": [
        {
          "id": 244453,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical dilatation &gt; 2 cm</span></span></p>"
        },
        {
          "id": 244454,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervix being posterior in position</span></span></p>"
        },
        {
          "id": 244455,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical effacement &gt; 80%</span></span></p>"
        },
        {
          "id": 244456,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4 contractions in 20 minutes with cervical changes</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a criterion for diagnosing preterm labor?</span></span></p>",
      "unique_key": "Q9345349",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) Cervix being posterior in position</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Preterm labor is defined as labor occurring before 37 weeks of gestation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Key diagnostic criteria for preterm labor include regular uterine contractions accompanied by cervical changes such as effacement (thinning) and dilation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A posterior cervix is not a criterion for diagnosing preterm labor and does not contribute to the assessment of labor progression. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cervical position is more relevant in assessing labor progress, but not in diagnosing preterm labor specifically.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Cervical dilatation &gt; 2 cm:</span></strong><span style=\"font-size:14.0pt\"> This is a significant finding that suggests cervical changes consistent with labor. Cervical dilation of more than 2 cm, especially in the presence of contractions, is a hallmark of preterm labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Cervical effacement &gt; 80%:</span></strong><span style=\"font-size:14.0pt\"> Cervical effacement (thinning of the cervix) is a key component in the diagnosis of labor. An effacement greater than 80% indicates that the cervix is significantly thinning, which, combined with contractions, supports a diagnosis of preterm labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. 4 contractions in 20 minutes with cervical changes:</span></strong><span style=\"font-size:14.0pt\"> Regular uterine contractions, especially when they are associated with cervical changes (dilation or effacement), are diagnostic of preterm labor. This frequency of contractions with cervical change is a recognized criterion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Preterm labor is diagnosed based on <strong>regular uterine contractions</strong> accompanied by <strong>cervical changes</strong> such as dilation or effacement occurring before 37 weeks gestation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cervical position (posterior or anterior) is not a diagnostic criterion for preterm labor.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244454,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61254,
      "choices": [
        {
          "id": 244297,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spotted fever</span></span></p>"
        },
        {
          "id": 244298,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scrub typhus</span></span></p>"
        },
        {
          "id": 244299,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epidemic typhus</span></span></p>"
        },
        {
          "id": 244300,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents to the hospital with high-grade fever, severe headache, and a maculopapular rash involving the trunk and extremities, including the palms and soles. He reports a recent history of outdoor activities, including hiking in a wooded area. Laboratory testing is initiated, including a Weil-Felix test. Which of the following is most likely to show positive results with both OX19 and OX2 antigens on the Weil-Felix test?</span></span></p>",
      "unique_key": "Q3773138",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Spotted fever</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>Weil-Felix test</strong> is a serologic test that uses certain strains of <strong>Proteus bacteria</strong> (OX2, OX19, and OXK) as antigens to detect antibodies against <strong>rickettsial infections</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A <strong>positive reaction</strong> with both <strong>OX19 and OX2 antigens</strong> is indicative of the <strong>spotted fever group</strong>, such as <strong>Rocky Mountain spotted fever</strong> or <strong>Indian tick typhus</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The <strong>spotted fever group of rickettsiae</strong>, which includes <strong>Rickettsia rickettsii</strong> (causative agent of Rocky Mountain spotted fever), cross-reacts with both OX19 and OX2 antigens on the Weil-Felix test, giving a positive result.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Scrub typhus</strong>: Scrub typhus is caused by <strong>Orientia tsutsugamushi</strong> and shows a positive reaction only with <strong>OXK antigen</strong> on the Weil-Felix test. It does not react with <strong>OX19 or OX2</strong>, distinguishing it from the spotted fever group.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Epidemic typhus</strong>: Epidemic typhus is caused by <strong>Rickettsia prowazekii</strong> and only gives a <strong>positive reaction with OX19 antigen</strong>. It does not show a positive result with <strong>OX2</strong>, unlike the spotted fever group.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Weil-Felix Results:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Epidemic and endemic typhus</span></strong><span style=\"font-size:14.0pt\">: Positive with <strong>OX19 antibody</strong> (&uarr; OX 19 Ab)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Tickborne spotted fever</span></strong><span style=\"font-size:14.0pt\">: Positive with both <strong>OX19 and OX2 antibodies</strong> (&uarr; OX 19 and OX 2 Ab)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Scrub typhus</span></strong><span style=\"font-size:14.0pt\">: Positive with <strong>OXK antibody</strong> (&uarr; OX K Ab)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Negative in</span></strong><span style=\"font-size:14.0pt\">:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Rickettsial pox</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Q fever</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ehrlichiosis</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Bartonellosis</span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 244297,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61490,
      "choices": [
        {
          "id": 245237,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bleeding disorder</span></span></span></span></p>"
        },
        {
          "id": 245238,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis</span></span></span></span></p>"
        },
        {
          "id": 245239,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anovulation</span></span></span></span></p>"
        },
        {
          "id": 245240,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine malignancy</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 14-year-old girl presents with heavy and irregular menstrual bleeding since menarche, which began a year ago. She reports periods lasting over 10 days with variable intervals between cycles. Physical examination is unremarkable. Which of the following is the most likely cause of her symptoms? </span></span></p>",
      "unique_key": "Q9521291",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C) Anovulation</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Puberty menorrhagia&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">often occurs due to <strong>anovulation</strong>, especially in the first few years following menarche. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During this time, the hypothalamic-pituitary-ovarian axis is immature, leading to irregular cycles without ovulation. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anovulation results in unopposed estrogen stimulation of the endometrium, which can lead to excessive and irregular shedding, causing heavy menstrual bleeding.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bleeding disorder:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although bleeding disorders, such as von Willebrand disease, can present with heavy menstrual bleeding, they are less common than <strong>anovulation</strong> in adolescents. Bleeding disorders should be considered if there is a history of prolonged bleeding, easy bruising, or a family history of bleeding disorders.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Endometriosis:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis is less common in adolescents, especially as a cause of menorrhagia soon after menarche. It is typically associated with dysmenorrhea (painful periods) and chronic pelvic pain rather than isolated heavy menstrual bleeding.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Uterine malignancy:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine malignancy is extremely rare in adolescents and is not a typical cause of menorrhagia in this age group. Other causes, such as <strong>anovulation</strong>, are far more common and should be considered first.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anovulation&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the most common cause of <strong>puberty menorrhagia</strong> in adolescent girls, occurring due to the immaturity of the hypothalamic-pituitary-ovarian axis.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245239,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61460,
      "choices": [
        {
          "id": 245117,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct tissue invasion</span></span></span></span></p>"
        },
        {
          "id": 245118,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Release of inflammatory cytokines</span></span></span></span></p>"
        },
        {
          "id": 245119,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cross-reactivity with bacterial antigens</span></span></span></span></p>"
        },
        {
          "id": 245120,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Toxin production by Streptococcus</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 10-year-old boy presents with fever, joint pain, and a newly detected heart murmur. He had a sore throat about 3 weeks prior that went untreated, and a throat swab culture at that time showed presence of Streptococcus pyogenes. Which mechanism is most responsible for the development of his current condition?<strong> </strong></span></span></p>",
      "unique_key": "Q2386476",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Cross-reactivity with bacterial antigens</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute Rheumatic Fever (ARF) results from an autoimmune response triggered by a prior infection with <strong>Streptococcus pyogenes</strong> (Group A Streptococcus). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The immune system produces antibodies against streptococcal M proteins, which mistakenly cross-react with proteins in the heart, joints, and other tissues, causing inflammation. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This process is known as <strong>molecular mimicry</strong> and is the primary mechanism behind ARF.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Direct tissue invasion</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> </strong>ARF is not caused by the direct invasion of tissues by <em>Streptococcus</em> but rather by the immune system&#39;s response to the bacterial infection.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Release of inflammatory cytokines</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While cytokines play a role in inflammation, they are not directly responsible for the autoimmune nature of ARF.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Toxin production by Streptococcus</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Streptococcal toxins can cause conditions like scarlet fever but are not the cause of the autoimmune response seen in ARF.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute Rheumatic Fever (ARF) is an autoimmune reaction where antibodies against Streptococcus pyogenes cross-react with host tissues, leading to inflammation in organs such as the heart and joints.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245119,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61317,
      "choices": [
        {
          "id": 244549,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubal blockage</span></span></span></span></p>"
        },
        {
          "id": 244550,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis</span></span></span></span></p>"
        },
        {
          "id": 244551,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenomyosis</span></span></span></span></p>"
        },
        {
          "id": 244552,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ovarian cyst</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman presents with chronic pelvic pain, dysmenorrhea, and difficulty conceiving. Pelvic ultrasound is performed, and the image below is noted. What is the most likely diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-170456.png\" style=\"height:185px; width:300px\" /></p>",
      "unique_key": "Q8666823",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B) Endometriosis</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ultrasound image provided shows a characteristic &quot;ground-glass&quot; appearance of an endometrioma, which is commonly associated with endometriosis. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis is a condition where endometrial tissue is present outside the uterus, often causing symptoms such as <strong>dysmenorrhea, chronic pelvic pain, and infertility</strong>.&nbsp; </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These findings, along with the patient&#39;s clinical history, make endometriosis the most likely diagnosis.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Tubal blockage:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubal blockages can contribute to infertility, but they are not typically associated with the characteristic ultrasound appearance seen here, nor do they cause the &quot;ground-glass&quot; appearance.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Adenomyosis:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenomyosis involves the invasion of endometrial tissue into the myometrium of the uterus, leading to a &quot;globular&quot; uterine appearance on ultrasound. It does not present with an isolated cystic structure as seen in the image.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ovarian cyst:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While ovarian cysts can be seen on ultrasound, the specific appearance of a homogenous, ground-glass appearance points more towards an endometrioma rather than a simple cyst.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">often presents with <strong>dysmenorrhea, chronic pelvic pain, and infertility</strong>. On ultrasound, <strong>endometriomas</strong> (associated with endometriosis) appear with a <strong>homogenous ground-glass echotexture</strong>. </span></span></span></span></p>",
      "correct_choice_id": 244550,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61451,
      "choices": [
        {
          "id": 245081,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">45%&nbsp;</span></span></p>"
        },
        {
          "id": 245082,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">27%&nbsp;</span></span></p>"
        },
        {
          "id": 245083,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">36%</span></span></p>"
        },
        {
          "id": 245084,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">31.5%&nbsp;</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calculate the Burn Surface Area (BSA) for a patient with a&nbsp;burn involving the chest abdomen, right upper limb, and right thigh up to knee (circumferential): </span></span></p>",
      "unique_key": "Q2511718",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) 36%&nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">According to the &lsquo;Rule of Nine&rsquo;, BSA is calculated as: </span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chest and Abdomen = 18%</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Right Upper limb = 9%</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Right Thigh = 9%</span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Total = 18% + 9% + 9% = 36%</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Rule of Nines is a method used to estimate the total body surface area affected by burns. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It divides the body into sections that represent approximately 9% of the total surface area, facilitating quick and effective assessment and treatment planning for burn patients.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245083,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61221,
      "choices": [
        {
          "id": 244165,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mapleson A</span></span></p>"
        },
        {
          "id": 244166,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mapleson B</span></span></p>"
        },
        {
          "id": 244167,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mapleson C</span></span></p>"
        },
        {
          "id": 244168,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mapleson D</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old man is being ventilated in the ICU following severe head trauma. The anesthesiologist uses the breathing circuit as shown in the image below. It features an inner tube that delivers fresh gas to the patient and an outer tube for exhalation through an adjustable pressure limiting (APL) valve. Which type of Mapleson circuit does this belong to? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/18/screenshot-2024-10-18-130158_enhanced.jpg\" style=\"height:366px; width:500px\" /></p>",
      "unique_key": "Q8660486",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Mapleson D</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The circuit shown in the image is the <strong>Bain&#39;s circuit</strong>, which is a <strong>coaxial modification of the Mapleson D circuit</strong>. It consists of two tubes: an inner inspiratory tube that delivers fresh gas to the patient, and an outer expiratory tube that allows exhaled gases to exit through an adjustable pressure limiting (APL) valve. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The coaxial design makes it efficient for maintaining warm and humidified air, which is especially useful in clinical settings where controlled ventilation is required.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Mapleson A</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This circuit is more efficient for spontaneous ventilation but not suitable for controlled ventilation as it requires higher fresh gas flow. It has a different design and tubing arrangement than the Bain&rsquo;s circuit.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Mapleson B</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is an uncommon circuit, and it is less efficient in terms of fresh gas flow requirements compared to the Bain&rsquo;s circuit.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Mapleson C</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This circuit is typically used for short-term ventilation in the operating room. It lacks the coaxial arrangement seen in the Bain&rsquo;s circuit.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Bain&#39;s circuit</strong> is a modified <strong>Mapleson D circuit</strong>, featuring a <strong>coaxial design</strong> that allows efficient ventilation with controlled fresh gas flow, making it suitable for both spontaneous and controlled ventilation scenarios.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244168,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61271,
      "choices": [
        {
          "id": 244365,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased lysosomal trafficking</span></span></p>"
        },
        {
          "id": 244366,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defective phagolysosome fusion</span></span></p>"
        },
        {
          "id": 244367,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defective chemotaxis</span></span></p>"
        },
        {
          "id": 244368,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in RAG gene</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 2-year-old boy presents with a history of recurrent fevers and a recent episode of severe pneumonia. Physical examination reveals mild pallor, oral thrush, micrognathia, low-set right ear, and areas of patchy hypopigmentation on the face, trunk, and extremities, along with silver-gray hair. The peripheral blood smear reveals abnormal inclusions as shown in the image. What is the underlying defect associated with this condition?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162724.jpg\" style=\"height:344px; width:400px\" /></span></span></p>",
      "unique_key": "Q8236466",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Defective phagolysosome fusion</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation, including recurrent infections, hypopigmentation, and the presence of abnormal inclusions on the peripheral smear, is suggestive of <strong>Chediak-Higashi syndrome.</strong> </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This rare genetic disorder is characterized by a defect in the <em>LYST</em> gene, leading to impaired phagolysosome fusion within phagocytes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The inability of lysosomes to fuse properly results in the accumulation of large granules in neutrophils and other immune cells, leading to recurrent infections due to impaired microbial killing.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Increased lysosomal trafficking:&nbsp;</span></strong><span style=\"font-size:14.0pt\">While defects in lysosomal trafficking could impair cell function, the increased lysosomal trafficking is not likely to cause the characteristic giant granules in neutrophils or the skin and hair abnormalities seen in Chediak-Higashi syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Defective chemotaxis:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Defective chemotaxis can lead to conditions like leukocyte adhesion deficiency, which results in severe bacterial infections but does not present with abnormal granules in neutrophils or the hypopigmentation seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Defect in RAG gene:&nbsp;</span></strong><span style=\"font-size:14.0pt\">A defect in the <em>RAG</em> gene affects lymphocyte development, leading to conditions like SCID (Severe Combined Immunodeficiency), which presents with recurrent infections but not with the specific abnormal granules or hypopigmentation seen in Chediak-Higashi syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chediak-Higashi syndrome is caused by defective phagolysosome fusion due to mutations in the LYST gene, leading to characteristic giant granules in neutrophils, hypopigmentation, and recurrent infections. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244366,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61472,
      "choices": [
        {
          "id": 245165,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">42 mg/hour</span></span></p>"
        },
        {
          "id": 245166,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">39 mg/hour</span></span></p>"
        },
        {
          "id": 245167,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">30 mg/hour</span></span></p>"
        },
        {
          "id": 245168,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">60 mg/hour</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 72-year-old man with chronic kidney disease is being treated with Drug Y, which is typically administered at a rate of 60 mg/hour. The drug is eliminated through the following pathways: 70% by renal excretion, 15% by hepatic metabolism, and 15% by biliary secretion. His current GFR is 45 mL/min (normal GFR is 90 mL/min), and his liver and biliary functions are normal. What should be the adjusted dose rate of Drug Y for this patient?</span></span></p>",
      "unique_key": "Q1540983",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) 39 mg/hour</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In this scenario, <strong>70%</strong> of Drug Y is eliminated through the <strong>renal route</strong>, and <strong>30%</strong> is eliminated by <strong>non-renal routes</strong> (15% hepatic metabolism and 15% biliary secretion).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s <strong>GFR is reduced to 45 mL/min</strong>, which is <strong>50%</strong> of normal renal function (normal being 90 mL/min). This means that the renal clearance capacity is also <strong>reduced by 50%</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To calculate the new dose:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">30% of the drug&nbsp;</span></strong><span style=\"font-size:14.0pt\">is eliminated by <strong>non-renal routes</strong>, which remains unchanged.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">70%&nbsp;</span></strong><span style=\"font-size:14.0pt\">of the drug is eliminated renally, but due to the reduced GFR, this is adjusted to <strong>50% of the renal capacity</strong>, resulting in <strong>35%</strong> renal elimination.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thus, the total effective elimination in this patient is:</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">30%&thinsp;(non-renal)+35%&thinsp;(adjusted&nbsp;renal&nbsp;function)=65%</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, the adjusted dose rate should be <strong>65%</strong> of the original dose:</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">60&thinsp;mg/hour&times;0.65=39&thinsp;mg/hour</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For drugs with significant <strong>renal clearance</strong>, dose adjustments are necessary when <strong>GFR</strong> is decreased.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calculate the adjusted dose by considering both the <strong>non-renal elimination</strong> and the reduced <strong>renal elimination capacity</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients with <strong>50% renal function</strong>, the new dose rate is adjusted proportionally when <strong>70%</strong> of the drug&#39;s clearance is renal.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245166,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61315,
      "choices": [
        {
          "id": 244541,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retained placenta</span></span></p>"
        },
        {
          "id": 244542,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postpartum hemorrhage</span></span></p>"
        },
        {
          "id": 244543,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine inversion</span></span></p>"
        },
        {
          "id": 244544,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine atony</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which clinical scenario would most likely warrant the use of this instrument? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-173439.png\" style=\"height:209px; width:300px\" /></p>",
      "unique_key": "Q1116374",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Postpartum hemorrhage</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image shows a Bakri balloon, which is commonly used in the management of postpartum hemorrhage (PPH), particularly when bleeding is due to uterine atony. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The balloon is inserted into the uterine cavity and inflated with sterile saline, creating pressure against the uterine walls to control bleeding. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This mechanical compression helps tamponade bleeding from the uterine surface, especially when medications like oxytocin are insufficient.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Retained placenta:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management of retained placenta involves manual removal or surgical intervention rather than the use of a Bakri balloon. The instrument in the image does not aid in the extraction of retained placental tissue directly.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Uterine inversion:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine inversion is a rare but serious complication where the uterus turns inside out after childbirth. It requires immediate repositioning of the uterus, often manually or surgically. A Bakri balloon is not used in this scenario, as it does not help reposition the inverted uterus.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Uterine atony:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine atony refers to the failure of the uterus to contract adequately after delivery, leading to excessive bleeding. While a Bakri balloon can be used to control bleeding from uterine atony, it is specifically indicated when atony results in severe postpartum hemorrhage, making the broader indication of PPH more accurate in this context.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Bakri balloon is a mechanical tamponade device used in the management of postpartum hemorrhage when uterine atony or other causes lead to significant bleeding that cannot be controlled with uterotonic agents alone. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244542,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61229,
      "choices": [
        {
          "id": 244197,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of glycoprotein IIb/IIIa</span></span></span></span></p>"
        },
        {
          "id": 244198,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of von Willebrand factor</span></span></span></span></p>"
        },
        {
          "id": 244199,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of glycoprotein Ib-IX-V complex</span></span></span></span></p>"
        },
        {
          "id": 244200,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autoantibodies against platelets</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man presents with a lifelong history of easy bruising and prolonged bleeding from minor cuts. Recently, he has experienced frequent nosebleeds and gum bleeding while brushing his teeth. Physical examination reveals petechiae on his lower extremities, but there is no hepatosplenomegaly. Laboratory tests reveal a normal platelet count, but the peripheral smear shows abnormally large platelets. Bleeding time is prolonged, while prothrombin time (PT) and activated partial thromboplastin time (aPTT) are within normal limits. Platelet aggregation studies show a poor response to ristocetin but normal aggregation in response to ADP and collagen. Given these findings, which molecular abnormality is most likely present in this patient&#39;s condition?</span></span></p>",
      "unique_key": "Q6387578",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) Deficiency of glycoprotein Ib-IX-V complex</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient&#39;s clinical presentation and laboratory findings are characteristic of <strong>Bernard-Soulier syndrome</strong>, a rare inherited platelet disorder. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The disease is caused by a deficiency or dysfunction of the glycoprotein Ib-IX-V complex, which is crucial for platelet adhesion to the vessel wall by binding to von Willebrand factor. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This defect results in impaired platelet aggregation in response to ristocetin, while aggregation in response to ADP and collagen remains normal. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of abnormally large platelets and a normal platelet count, along with prolonged bleeding time, further supports the diagnosis of Bernard-Soulier syndrome.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Deficiency of glycoprotein IIb/IIIa:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This describes <strong>Glanzmann thrombasthenia</strong>, which results in defective platelet aggregation in response to ADP, collagen, and other agonists. However, in this condition, platelets typically respond to ristocetin, unlike in Bernard-Soulier syndrome.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Deficiency of von Willebrand factor:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This describes <strong>von Willebrand disease</strong>, which is characterized by a defect in platelet adhesion and may present with prolonged bleeding time and an abnormal response to ristocetin. However, it typically does not show abnormally large platelets on a smear or normal platelet counts with defective glycoprotein Ib-IX-V complex.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Autoantibodies against platelets:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is associated with <strong>immune thrombocytopenic purpura (ITP)</strong>, which results in thrombocytopenia (low platelet count) rather than a defect in platelet aggregation. ITP would not result in the normal aggregation studies seen here except with ristocetin.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bernard-Soulier syndrome is characterized by a deficiency of the glycoprotein Ib-IX-V complex, resulting in defective platelet adhesion, large platelets, and a poor aggregation response to ristocetin. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognizing the specific laboratory features helps differentiate it from other platelet disorders.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244199,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61289,
      "choices": [
        {
          "id": 244437,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mediastinal lymphadenopathy compressing the esophagus</span></span></p>"
        },
        {
          "id": 244438,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peptic stricture</span></span></p>"
        },
        {
          "id": 244439,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal carcinoma</span></span></p>"
        },
        {
          "id": 244440,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal web</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old man presents with progressive dysphagia, predominantly for solid foods over the past 6 months. He also reports significant unintentional weight loss during this period. A barium swallow study is performed, and the radiographic image is shown below. Based on these clinical findings and the image, what is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-163042.jpg\" style=\"height:275px; width:300px\" /></span></span></p>",
      "unique_key": "Q9729956",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Esophageal carcinoma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s presentation of progressive dysphagia, especially for solids, alongside significant unintentional weight loss, is highly suggestive of esophageal carcinoma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The barium swallow image displays a narrowed segment with irregular contours, which is consistent with a malignant process. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Progressive dysphagia starting with difficulty swallowing solids before liquids is typical of an obstructive lesion, such as esophageal cancer.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Mediastinal lymphadenopathy compressing the esophagus:</span></strong><span style=\"font-size:14.0pt\"> This condition can cause external pressure on the esophagus, leading to dysphagia. However, it is less likely to present with irregular intraluminal narrowing as seen in this case. Additionally, the clinical presentation here aligns more closely with an intrinsic malignant process rather than extrinsic compression.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Peptic stricture:</span></strong><span style=\"font-size:14.0pt\"> Peptic strictures arise from chronic gastroesophageal reflux disease (GERD) and result in smooth, tapered narrowing of the esophagus. They typically do not present with significant weight loss, nor do they cause the irregular narrowing shown in the radiograph, which is more indicative of malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Esophageal web:</span></strong><span style=\"font-size:14.0pt\"> Esophageal webs are thin, membranous structures within the esophagus that cause dysphagia, often affecting the proximal esophagus. They are not associated with significant weight loss and do not present with the irregular, constricting lesion seen in the barium swallow image of this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients presenting with progressive dysphagia, particularly when accompanied by unintentional weight loss, esophageal carcinoma should be considered as a likely diagnosis. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244439,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61336,
      "choices": [
        {
          "id": 244625,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-4, B-1, C-3, D-2</span></span></span></span></p>"
        },
        {
          "id": 244626,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1, B-4, C-2, D-3</span></span></span></span></p>"
        },
        {
          "id": 244627,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-5, B-3, C-1, D-4</span></span></span></span></p>"
        },
        {
          "id": 244628,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-4, B-5, C-2, D-1</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following regarding the transmission of Japanese Encephalitis (JE):</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-175906.png\" style=\"height:344px; width:1000px\" /></span></span></p>",
      "unique_key": "Q9633540",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) A-4, B-1, C-3, D-2</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Culex mosquitoes (A-4)&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">act as the <strong>vector</strong> for the transmission of Japanese Encephalitis. They bite infected animals or birds and transmit the virus to humans and other animals.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Man (B-1)&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is considered an <strong>accidental host</strong> in the lifecycle of the Japanese Encephalitis virus because humans do not develop sufficient viremia to infect mosquitoes, thus playing no role in the maintenance of the virus.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pigs (C-3)&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are considered the <strong>amplifier host</strong> because they develop a high viremia which helps to sustain and amplify the virus in the environment.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ardeid birds (D-2)&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(such as herons and egrets) serve as the <strong>reservoir hosts</strong> for Japanese Encephalitis, where the virus can persist in the natural environment.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JE Epidemiology</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vector: Culex triteniorhynchus</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amplifier host: Pigs</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accidental host: Man</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reservoir host: Ardied birds (Herons, ducks, fowls)</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244625,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61464,
      "choices": [
        {
          "id": 245133,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubular adenoma</span></span></p>"
        },
        {
          "id": 245134,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubulo-villous adenoma</span></span></p>"
        },
        {
          "id": 245135,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperplastic polyp</span></span></p>"
        },
        {
          "id": 245136,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Villous adenoma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old male undergoes a colonoscopy as part of routine screening. During the procedure, a polyp is discovered and removed. Histological analysis of the polyp reveals the image below. Which of the following is the most accurate description for this type of polyp?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180227.jpg\" style=\"height:279px; width:400px\" /></span></span></p>",
      "unique_key": "Q2697468",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Tubulo-villous adenoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tubulo-villous adenomas have histological features that include a combination of tubular and villous structures, which is evident in the provided image. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This type of polyp has an intermediate risk of developing into colorectal cancer compared to purely tubular adenomas (lower risk) and villous adenomas (higher risk). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The mixed histological pattern seen here is characteristic of tubulo-villous adenoma.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Tubular adenoma:</span></strong><span style=\"font-size:14.0pt\"> Tubular adenomas consist primarily of tubular structures with a lower malignant potential than tubulo-villous adenomas. They do not have the mixture of villous structures seen in the provided image, making this option incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hyperplastic polyp:</span></strong><span style=\"font-size:14.0pt\"> Hyperplastic polyps are benign polyps with a serrated architecture and are typically not considered pre-malignant. They do not have the glandular or villous structures that characterize tubulo-villous adenomas, as seen in the histological image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Villous adenoma:</span></strong><span style=\"font-size:14.0pt\"> Villous adenomas have a higher proportion of villous structures and are associated with a higher risk of malignancy than tubulo-villous adenomas. While villous structures are present in the image, the mixture of both tubular and villous components is more consistent with a tubulo-villous adenoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tubulo-villous adenomas are characterized by a mixture of tubular and villous structures, with an intermediate risk of progression to colorectal cancer compared to tubular adenomas and villous adenomas.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245134,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61290,
      "choices": [
        {
          "id": 244441,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous abdominal surgery</span></span></p>"
        },
        {
          "id": 244442,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">History of pelvic infection</span></span></p>"
        },
        {
          "id": 244443,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignancy</span></span></p>"
        },
        {
          "id": 244444,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endometriosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 27-year-old woman presents with acute pelvic pain and is diagnosed with an ectopic pregnancy. During a laparoscopic procedure, the following image is observed showing adhesions around the liver. What is the most likely underlying cause of this ectopic pregnancy?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-163122.jpg\" style=\"height:229px; width:400px\" /></span></span></p>",
      "unique_key": "Q5498271",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) History of pelvic infection</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The image depicts adhesions near the liver, which can be suggestive of <strong>Fitz-Hugh-Curtis syndrome</strong>, a complication of pelvic inflammatory disease (PID) that leads to adhesions between the liver and the peritoneum. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">PID</span></strong><span style=\"font-size:14.0pt\"> is a significant risk factor for developing ectopic pregnancy, as the inflammation and scarring from infection can lead to tubal damage, increasing the likelihood of an ectopic implantation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Previous abdominal surgery:</span></strong><span style=\"font-size:14.0pt\"> Abdominal surgery can lead to adhesions, but it is not the most common cause in this scenario. Adhesions from surgery usually form around the site of operation and are not typically seen with Fitz-Hugh-Curtis syndrome, which is directly related to pelvic infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Malignancy:</span></strong><span style=\"font-size:14.0pt\"> Malignancies do not typically cause the kind of adhesions shown in the image. While they can cause masses or changes in abdominal organs, they are not a common cause of ectopic pregnancies due to adhesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Endometriosis:</span></strong><span style=\"font-size:14.0pt\"> Endometriosis can cause adhesions, but these typically present as chocolate cysts or patches of endometrial-like tissue in the pelvis. The adhesions in the liver area are more characteristic of PID-associated complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Pelvic inflammatory disease (PID)&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a key risk factor for <strong>ectopic pregnancy</strong> due to the potential for tubal scarring and adhesions, which can impair the normal movement of the fertilized egg.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244442,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61329,
      "choices": [
        {
          "id": 244597,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1, B-2, C-3, D-4</span></span></span></span></p>"
        },
        {
          "id": 244598,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-4, B-3, C-2, D-1</span></span></span></span></p>"
        },
        {
          "id": 244599,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-4, C-2, D-1</span></span></span></span></p>"
        },
        {
          "id": 244600,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-3, C-1, D-4</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the following instruments which are used for the measurement of the nutritional status of the child?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-174611.png\" style=\"height:218px; width:300px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1. Harpenden caliper</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2. Salters Scale</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3. Shakir&rsquo;s Tape</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4. Infantometer</span></span></span></span></p>",
      "unique_key": "Q7428715",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans. C)</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A-3, B-4, C-2, D-1</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">A - Shakir&#39;s Tape (A-3):</span></strong><span style=\"font-size:14.0pt\"> Shakir&#39;s tape is a simple tool used to measure mid-upper arm circumference (MUAC) in children. It helps in assessing malnutrition by measuring the circumference of the arm, which is an indicator of muscle mass and fat stores in children. It is particularly useful in community health settings for the early detection of malnutrition.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">B - Infantometer (B-4):</span></strong><span style=\"font-size:14.0pt\"> An infantometer is a device used to measure the length or height of infants who are below two years old. It is crucial for assessing linear growth and identifying stunting, which is a sign of chronic malnutrition.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">C - Salter&#39;s Scale (C-2):</span></strong><span style=\"font-size:14.0pt\"> Salter&#39;s scale is a portable weighing scale commonly used to measure the weight of infants and young children. It is used to assess weight-for-age, which is an important parameter in evaluating the nutritional status of a child.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">D - Harpenden Caliper (D-1):</span></strong><span style=\"font-size:14.0pt\"> A Harpenden caliper is used to measure skinfold thickness, which helps in estimating body fat percentage. It is particularly useful for assessing body composition and nutritional status in clinical and research settings.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Different tools are used to measure various aspects of a child&#39;s nutritional status, such as body weight, height, arm circumference, and skinfold thickness. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Each tool has a specific purpose and is essential for the comprehensive assessment of growth and nutrition in children. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understanding the correct usage of these tools helps in the early detection and management of malnutrition.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244599,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61292,
      "choices": [
        {
          "id": 244449,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-B, 2-C, 3-D, 4-A</span></span></p>"
        },
        {
          "id": 244450,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-A, 2-D, 3-C, 4-B</span></span></p>"
        },
        {
          "id": 244451,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-D, 2-B, 3-A, 4-C</span></span></p>"
        },
        {
          "id": 244452,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-C, 2-A, 3-D, 4-B</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the mode of inheritance with the corresponding disorder in the appropriate column:<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-171306.png\" style=\"height:181px; width:700px\" /></p>",
      "unique_key": "Q9660957",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1-B, 2-C, 3-D, 4-A</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-B: Huntington&#39;s disease&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is inherited in an <strong>autosomal dominant</strong> manner. A single copy of the mutant gene from an affected parent can lead to the condition.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2-C: Hemophilia A&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">follows an <strong>X-linked recessive</strong> inheritance pattern, typically affecting males as they have only one X chromosome inherited from their mother.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3-D: Cystic fibrosis&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>autosomal recessive</strong> disorder, meaning that two copies of the mutated gene (one from each parent) are necessary for the condition to manifest.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4-A: Leber&#39;s disease&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>mitochondrially inherited</strong> condition, which means it is passed down through the mitochondria present in the egg cell, hence inherited from the mother.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-171413.png\" style=\"height:232px; width:900px\" /></span></span></strong></span></span></p>",
      "correct_choice_id": 244449,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61313,
      "choices": [
        {
          "id": 244533,
          "text": "<p><span style=\"font-size:18px;\">Chorionic villous sampling (CVS)</span></p>"
        },
        {
          "id": 244534,
          "text": "<p><span style=\"font-size:18px;\">Cell-free DNA testing</span></p>"
        },
        {
          "id": 244535,
          "text": "<p><span style=\"font-size:18px;\">Quadruple screening test</span></p>"
        },
        {
          "id": 244536,
          "text": "<p><span style=\"font-size:18px;\">Nuchal translucency scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 38-year-old woman in her first pregnancy is identified as having a high risk of fetal Down syndrome based on her age. She seeks a screening test with the highest possible detection rate for chromosomal abnormalities. Which of the following would be the most appropriate recommendation for her?</span></p>",
      "unique_key": "Q4831171",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cell-free DNA testing</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Cell-free DNA testing&nbsp;</strong>(cfDNA) is a non-invasive prenatal screening (NIPS) method that analyzes small fragments of fetal DNA circulating in the maternal blood.</span></li><li><span style=\"font-size:14.0pt;\">It has a high detection rate for Down syndrome, approaching <strong>99% sensitivity</strong> and <strong>specificity</strong>, making it the ideal choice for screening in high-risk pregnancies, such as those associated with advanced maternal age.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Chorionic villous sampling (CVS):&nbsp;</strong>This is an invasive diagnostic procedure that carries a risk of miscarriage. While it provides definitive diagnostic results, it is not considered a first-line screening test.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Quadruple screening test:&nbsp;</strong>The quadruple test is performed in the second trimester and assesses the levels of four serum markers to estimate the risk of Down syndrome. Its detection rate is lower than that of cfDNA testing, making it less suitable in high-risk cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Nuchal translucency scan:&nbsp;</strong>Nuchal translucency measurement is part of the first-trimester screening but is not as comprehensive as cfDNA testing. While it can help identify chromosomal abnormalities, it is less accurate than cfDNA testing when used alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Cell-free DNA testing is recommended for high-risk pregnancies due to its superior accuracy and non-invasive nature compared to other screening methods.</span></li></ul>",
      "correct_choice_id": 244534,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61443,
      "choices": [
        {
          "id": 245049,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple myeloma</span></span></p>"
        },
        {
          "id": 245050,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Waldenstr&ouml;m macroglobulinemia</span></span></p>"
        },
        {
          "id": 245051,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monoclonal gammopathy of undetermined significance (MGUS)</span></span></p>"
        },
        {
          "id": 245052,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary amyloidosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">65-year-old woman is evaluated during a routine check-up. She reports feeling well overall, with no significant symptoms other than mild fatigue. Physical examination is unremarkable. Routine laboratory tests reveal a hemoglobin level of 12.5 g/dL, calcium level of 9.2 mg/dL, and serum creatinine of 1.0 mg/dL. Serum protein electrophoresis identifies a monoclonal spike (M-spike) with an IgG concentration of 1.2 g/dL. Urine protein electrophoresis is negative for Bence Jones proteins. Bone marrow biopsy shows plasma cells comprising less than 10% of the total cellularity. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q8541181",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Monoclonal gammopathy of undetermined significance (MGUS)</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MGUS is characterized by the presence of a monoclonal protein (M-protein) in the blood without the signs and symptoms of multiple myeloma or other related disorders. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnostic criteria for MGUS include an M-spike of less than 3 g/dL, bone marrow plasma cells comprising less than 10% of cellularity, and the absence of CRAB (hypercalcemia, renal insufficiency, anemia, or bone lesions) features. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s findings, including a small M-spike, normal calcium and renal function, and plasma cells less than 10% on bone marrow biopsy, are consistent with MGUS.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Multiple myeloma</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Characterized by a higher M-spike, bone marrow plasma cells greater than 10%, and the presence of CRAB features. This patient does not meet these criteria.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Waldenstr&ouml;m macroglobulinemia</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Typically involves an IgM monoclonal protein and presents with symptoms related to hyperviscosity, such as vision changes or neurologic symptoms, which are not seen in this patient.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Primary amyloidosis</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Associated with organ involvement due to amyloid deposits, which is not evident in this patient&#39;s presentation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MGUS is an asymptomatic condition identified by the presence of a monoclonal protein in the blood, with a low M-spike, fewer than 10% plasma cells in the bone marrow, and no evidence of organ damage or other features of multiple myeloma.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245051,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61272,
      "choices": [
        {
          "id": 244369,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-2, C-4, D-1</span></span></span></span></p>"
        },
        {
          "id": 244370,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-4, B-1, C-2, D-3</span></span></span></span></p>"
        },
        {
          "id": 244371,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-3, C-1, D-4</span></span></span></span></p>"
        },
        {
          "id": 244372,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-1, B-4, C-3, D-2</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-165952.png\" style=\"height:384px; width:1000px\" /></p>",
      "unique_key": "Q9448616",
      "difficulty_level": "beginner",
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) A-3, B-2, C-4, D-1</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Borderline Personality Disorder - 3. Unstable relationships and fear of abandonment</span></span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Individuals with Borderline Personality Disorder (BPD) often experience intense fears of abandonment, unstable interpersonal relationships, and rapid mood shifts.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Antisocial Personality Disorder - 2. Lack of empathy and exploitation of others</span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antisocial Personality Disorder is characterized by a disregard for the rights of others, a lack of empathy, and often manipulative or exploitative behavior.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Narcissistic Personality Disorder - 4. Grandiose sense of self-importance</span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Individuals with Narcissistic Personality Disorder tend to have an inflated sense of their own importance and a need for admiration, often coupled with a lack of empathy for others.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Schizoid Personality Disorder - 1. Preference for solitary activities</span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">People with Schizoid Personality Disorder tend to be socially detached, preferring solitary activities and displaying little interest in forming close relationships.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 244369,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61260,
      "choices": [
        {
          "id": 244321,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enterobius vermicularis</span></span></p>"
        },
        {
          "id": 244322,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trichuris trichiura</span></span></p>"
        },
        {
          "id": 244323,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ascaris lumbricoides</span></span></p>"
        },
        {
          "id": 244324,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Necator americanus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 5-year-old girl presents with her mother, who is concerned about her child experiencing intense perianal itching, particularly at night. On further questioning, the mother also reports that her daughter is having difficulty sleeping and is being irritable. A stool sample examination was performed, and</span></span> <span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">the egg was seen in the picture below</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Which of the following is the most likely organism responsible for this presentation?</span></span><strong> </strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162533.jpg\" style=\"height:399px; width:400px\" /></span></span></p>",
      "unique_key": "Q7758680",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Enterobius vermicularis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The image shows an <strong>elongated egg</strong> with a <strong>flattened side</strong> and a <strong>thick shell</strong>, characteristic of <strong>Enterobius vermicularis</strong>, commonly known as <strong>pinworm</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Enterobius vermicularis eggs are laid around the perianal region, causing intense <strong>perianal itching</strong>, especially at night when the female worm emerges to deposit eggs. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The itching often leads to difficulty sleeping, and in some cases, secondary bacterial infection due to scratching. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diagnosis is usually confirmed by identifying eggs either in the stool or using the <strong>Scotch tape test</strong> to collect eggs from the perianal region.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Trichuris trichiura</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Also known as <strong>whipworm</strong>, these eggs are <strong>barrel-shaped</strong> with <strong>bipolar plugs</strong> at each end. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162547.jpg\" style=\"height:255px; width:400px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Ascaris lumbricoides</span></strong><span style=\"font-size:14.0pt\">: Ascaris eggs are <strong>round</strong> or <strong>oval</strong> with a <strong>rough, thick shell</strong> and lack the characteristic flattened side seen in Enterobius eggs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162559.jpg\" style=\"height:395px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Necator americanus</span></strong><span style=\"font-size:14.0pt\">: This is a type of <strong>hookworm</strong>, and its eggs are <strong>oval</strong> with visible <strong>blastomeres</strong>, but they do not have the flattened side as seen in Enterobius eggs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-162621.jpg\" style=\"height:403px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Enterobius vermicularis (pinworm)&nbsp;</span></strong><span style=\"font-size:14.0pt\">causes <strong>perianal itching</strong>, particularly at night. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The eggs are <strong>elongated with a flattened side</strong>, and diagnosis can be made through stool microscopy or the <strong>Scotch tape test</strong>. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244321,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61225,
      "choices": [
        {
          "id": 244181,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Measure serum 25-hydroxyvitamin D levels</span></span></span></span></p>"
        },
        {
          "id": 244182,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obtain a skeletal survey to evaluate for multiple myeloma</span></span></span></span></p>"
        },
        {
          "id": 244183,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perform a breast ultrasound to screen for metastatic disease</span></span></span></span></p>"
        },
        {
          "id": 244184,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Perform a parathyroid scintigraphy scan (Sestamibi scan)</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 37-year-old woman presents to the clinic with diffuse bone pain, primarily affecting her right arm and left thigh. She also reports worsening constipation and mild fatigue. On physical examination, there is tenderness over the left thigh. Laboratory tests reveal a serum calcium level of 13.2 mg/dL, phosphate level of 1.3 mg/dL, and creatinine level of 1.1 mg/dL. Additional laboratory findings include an elevated parathyroid hormone (PTH) level. A bone biopsy reveals cystic changes, fibrosis, and hemosiderin-laden macrophages. An X-ray of the left femur demonstrates subperiosteal bone resorption. Based on these findings, what is the most appropriate initial intervention to confirm the underlying cause of this patient&#39;s condition?<strong> </strong></span></span></p>",
      "unique_key": "Q1126789",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D) Perform a parathyroid scintigraphy scan (Sestamibi scan)</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation, laboratory findings, and imaging studies strongly suggest primary hyperparathyroidism, most likely due to a parathyroid adenoma. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypercalcemia, hypophosphatemia, and elevated PTH levels are hallmarks of this condition. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The bone biopsy showing cystic changes, fibrosis, and hemosiderin-laden macrophages is indicative of osteitis fibrosa cystica, a skeletal manifestation of severe hyperparathyroidism. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subperiosteal bone resorption on X-ray is another classic finding. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most appropriate next step is to localize the source of excessive PTH secretion, typically a parathyroid adenoma, using a parathyroid scintigraphy (Sestamibi scan) for surgical planning.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Measure serum 25-hydroxyvitamin D levels:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While vitamin D deficiency can exacerbate hyperparathyroidism, the constellation of symptoms and lab findings here (marked hypercalcemia, bone resorption) points directly to primary hyperparathyroidism rather than a simple vitamin D deficiency.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Obtain a skeletal survey to evaluate for multiple myeloma:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple myeloma can cause bone pain and hypercalcemia, but it usually presents with other features like anemia, elevated creatinine, and characteristic lytic bone lesions. The patient&#39;s bone biopsy findings and subperiosteal bone resorption are more consistent with primary hyperparathyroidism.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Perform a breast ultrasound to screen for metastatic disease:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypercalcemia can occur in metastatic breast cancer; however, this patient&#39;s specific skeletal findings (subperiosteal resorption and cystic bone lesions) are more typical of hyperparathyroidism. Additionally, there are no clinical signs pointing to a primary breast malignancy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary hyperparathyroidism is a common cause of hypercalcemia with characteristic skeletal manifestations, including osteitis fibrosa cystica and subperiosteal bone resorption. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most definitive diagnostic step involves localization of a parathyroid adenoma, typically through parathyroid scintigraphy.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244184,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61474,
      "choices": [
        {
          "id": 245173,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Denosumab</span></span></span></p>"
        },
        {
          "id": 245174,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Teriparatide</span></span></span></p>"
        },
        {
          "id": 245175,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Raloxifene</span></span></span></p>"
        },
        {
          "id": 245176,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calcitonin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old woman with a history of osteoporosis presents to her physician to discuss treatment options. She has already tried bisphosphonates, but they caused severe gastrointestinal discomfort. The physician considers a medication that directly stimulates osteoblast activity to promote bone formation. Which of the following drugs is most appropriate for this purpose?</span></span></p>",
      "unique_key": "Q4705724",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Teriparatide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Teriparatide&nbsp;</span></strong><span style=\"font-size:14.0pt\">is a recombinant form of parathyroid hormone (PTH) that directly stimulates <strong>osteoblast activity</strong>, leading to increased bone formation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is specifically used in patients with severe osteoporosis who are at high risk for fractures and in those who may not tolerate other therapies.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;<strong>Abaloparatide</strong> is another drug in the same class that also stimulates osteoblasts.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Other Options:</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Denosumab</span></strong><span style=\"font-size:14.0pt\">: This drug is a monoclonal antibody that <strong>inhibits osteoclast activity</strong> by targeting RANKL, leading to decreased bone resorption. It does not directly stimulate osteoblasts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Raloxifene</span></strong><span style=\"font-size:14.0pt\">: Raloxifene is a selective estrogen receptor modulator (SERM) that <strong>inhibits osteoclast activity</strong>, reducing bone resorption. It is used to prevent bone loss but does not stimulate osteoblasts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Calcitonin</span></strong><span style=\"font-size:14.0pt\">: Calcitonin works by <strong>inhibiting osteoclasts</strong>, reducing bone resorption and decreasing calcium levels. It is not used for stimulating osteoblast activity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">DRUGS USED IN OSTEOPOROSIS</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-15-180346.jpg\" style=\"height:372px; width:700px\" /></span></strong></span></span></p>",
      "correct_choice_id": 245174,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61495,
      "choices": [
        {
          "id": 245257,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anconeus is supplied by a branch arising in the axilla.</span></span></span></span></p>"
        },
        {
          "id": 245258,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The lateral head of the triceps is paralyzed in a lesion of the radial nerve in the lower spiral groove.</span></span></span></span></p>"
        },
        {
          "id": 245259,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It leaves the axilla by passing through the quadrangular space.</span></span></span></span></p>"
        },
        {
          "id": 245260,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the arm, it travels along the brachial artery.</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old man presents with wrist drop and sensory loss over the dorsum of the hand after a humeral shaft fracture, suggesting a radial nerve injury. Which of the following statements about the radial nerve is most accurate?<strong> </strong></span></span></p>",
      "unique_key": "Q1750833",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></span></strong><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B) The lateral head of the triceps is paralyzed in a lesion of the radial nerve in the lower spiral groove.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The radial nerve runs along the spiral groove of the humerus and supplies the triceps brachii muscle. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a mid-shaft humeral fracture, the radial nerve may be injured, affecting the lateral head of the triceps. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This can result in weakness or paralysis of the lateral head along with wrist drop and sensory loss over the dorsum of the hand.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Anconeus is supplied by a branch arising in the axilla:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is incorrect. The anconeus muscle is innervated by a branch of the radial nerve that arises in the arm, not the axilla.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It leaves the axilla by passing through the quadrangular space:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is incorrect. The axillary nerve, not the radial nerve, exits the axilla through the quadrangular space. The radial nerve exits the axilla via the triangular interval and enters the posterior compartment of the arm.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. In the arm, it travels along the brachial artery:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is incorrect. The radial nerve travels with the deep brachial artery in the posterior compartment, not along the main brachial artery, which is found in the anterior compartment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The radial nerve runs along the spiral groove of the humerus and can be injured in mid-shaft humeral fractures. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lesions in this area can cause paralysis of the lateral head of the triceps and wrist drop. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245258,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61218,
      "choices": [
        {
          "id": 244153,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To check the depth of anesthesia</span></span></p>"
        },
        {
          "id": 244154,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To look for hypotension</span></span></p>"
        },
        {
          "id": 244155,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To see if there was bradycardia</span></span></p>"
        },
        {
          "id": 244156,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To ensure there were no ventricular arrhythmias</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old boy is undergoing surgery to correct a congenital ptosis. The induction of anesthesia is smooth, and the procedure proceeds without complications. As the surgeon begins to manipulate the extraocular muscles, the anesthesiologist looks at the monitor. Why is the anesthesiologist doing this? </span></span></p>",
      "unique_key": "Q3838429",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) To see if there was bradycardia</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The anesthesiologist monitors the cardiac rhythm closely during manipulation of the extraocular muscles to detect the <strong>oculocardiac reflex</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This reflex is a <strong>trigemino-vagal reflex</strong> where afferent signals are carried by the <strong>trigeminal nerve</strong> and efferent signals by the <strong>vagus nerve</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is triggered when traction is applied to the extraocular muscles, especially during surgeries involving these muscles, like strabismus or ptosis correction.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The reflex can cause <strong>bradycardia</strong> (most common), <strong>asystole</strong>, or other types of arrhythmias due to increased parasympathetic activity. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Awareness of this potential complication allows the anesthesiologist to respond quickly, usually by ceasing manipulation of the muscle or administering <strong>antimuscarinic agents</strong> like <strong>atropine</strong> or <strong>glycopyrrolate</strong> to counteract the bradycardia.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. To check the depth of anesthesia</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While depth of anesthesia is important, it is not specifically related to the need for monitoring the heart rate during eye muscle manipulation. The concern here is primarily the <strong>oculocardiac reflex</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. To look for hypotension</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hypotension is not directly related to the manipulation of the extraocular muscles or the triggering of the oculocardiac reflex. Bradycardia is the primary manifestation of this reflex.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. To ensure there were no ventricular arrhythmias</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While arrhythmias can occur as a result of the oculocardiac reflex, the initial concern during eye muscle manipulation is <strong>bradycardia</strong> due to the reflex arc involving the trigeminal and vagus nerves.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>oculocardiac reflex</strong> is a common occurrence during eye surgeries involving manipulation of the extraocular muscles, leading to <strong>bradycardia</strong> through the <strong>trigemino-vagal pathway</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Awareness and prompt management are crucial to avoid severe complications during these procedures.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244155,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61236,
      "choices": [
        {
          "id": 244225,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glatiramer acetate</span></span></span></span></p>"
        },
        {
          "id": 244226,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Corticosteroids</span></span></span></span></p>"
        },
        {
          "id": 244227,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inactivated virus vaccine</span></span></span></span></p>"
        },
        {
          "id": 244228,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Riluzole</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man presents with progressive muscle weakness and difficulty swallowing over the past 6 months. He also reports episodes of choking while eating and frequent coughing, particularly at night. On examination, there is spasticity in the lower limbs, hyperreflexia, and fasciculations in the tongue and arms. His speech is slurred, and there is notable muscle atrophy in the hands. Over time, his symptoms worsen, and he develops respiratory difficulty. Which of the following medications could slow the progression of his disease?<strong> </strong></span></span></p>",
      "unique_key": "Q7836283",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Riluzole</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s symptoms, including progressive muscle weakness, dysphagia, spasticity, fasciculations, and muscle atrophy, are characteristic of amyotrophic lateral sclerosis (ALS). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ALS is a neurodegenerative disease that affects both upper and lower motor neurons. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Riluzole is the only medication approved to slow the progression of ALS. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It works by inhibiting glutamate release, which reduces excitotoxic damage to neurons.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Glatiramer acetate</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: An immunomodulator used in multiple sclerosis (MS). It has no therapeutic effect in ALS.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Corticosteroids</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Used in inflammatory conditions, such as autoimmune diseases, but they do not impact the progression of ALS, which is a neurodegenerative disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Inactivated virus vaccine</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vaccines are preventative measures against infections and do not have a role in treating neurodegenerative conditions like ALS.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Riluzole is an approved medication that can slow the progression of amyotrophic lateral sclerosis (ALS) by reducing glutamate-induced neuronal damage.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244228,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61261,
      "choices": [
        {
          "id": 244325,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Timolol</span></span></span></p>"
        },
        {
          "id": 244326,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brimonidine</span></span></span></p>"
        },
        {
          "id": 244327,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Latanoprost</span></span></span></p>"
        },
        {
          "id": 244328,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dorzolamide</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-month-old infant is diagnosed with congenital glaucoma and needs to start medical treatment. Which of the following antiglaucoma medications is considered unsafe for use in infants?<strong> </strong></span></span></p>",
      "unique_key": "Q8640022",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) Brimonidine</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brimonidine is an alpha-2 adrenergic agonist used in the treatment of glaucoma to reduce intraocular pressure.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;However, it is contraindicated in infants due to the risk of central nervous system depression, including apnea, bradycardia, and lethargy.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Therefore, it is considered unsafe in pediatric patients, particularly those under the age of two years.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Timolol</span></strong><span style=\"font-size:14.0pt\">: Timolol is a non-selective beta-blocker that is used to lower intraocular pressure in glaucoma. While it can be used cautiously in pediatric patients, it may require monitoring for potential side effects like bradycardia and bronchospasm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Latanoprost</span></strong><span style=\"font-size:14.0pt\">: Latanoprost is a prostaglandin analog that increases the outflow of aqueous humor. It is generally considered safe for use in children and is often prescribed in pediatric glaucoma management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Dorzolamide</span></strong><span style=\"font-size:14.0pt\">: Dorzolamide is a carbonic anhydrase inhibitor used to reduce intraocular pressure. It can be used in pediatric patients, and its side effects are generally mild, including ocular irritation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brimonidine is unsafe for infants due to the risk of serious central nervous system side effects.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Other medications like timolol, latanoprost, and dorzolamide can be used cautiously in pediatric patients with appropriate monitoring.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244326,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61255,
      "choices": [
        {
          "id": 244301,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV 7</span></span></span></span></p>"
        },
        {
          "id": 244302,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV 16, 18</span></span></span></span></p>"
        },
        {
          "id": 244303,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV 6, 11</span></span></span></span></p>"
        },
        {
          "id": 244304,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV 2, 4, 27</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 11-year-old boy presents to the clinic with small, raised, rough lesions on his hands and fingers. His mother reports that the lesions have been slowly increasing in number over the past several months. The child is otherwise healthy with no history of significant illness. On examination, the lesions are firm with a rough surface. What types of human papillomavirus (HPV) are most commonly associated with these cutaneous lesions?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-164954.png\" style=\"height:221px; width:300px\" /></p>",
      "unique_key": "Q3877727",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D) HPV 2, 4, 27</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These types of human papillomavirus (HPV) are most commonly associated with <strong>cutaneous warts</strong>, particularly <strong>common warts</strong> (verrucae vulgaris), which are often found on the hands and fingers in children. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common warts are firm, rough, and raised, which matches the description of the lesions in this patient. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV 2, 4, and 27 are responsible for the majority of these benign skin lesions, which are transmitted through direct contact.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. HPV 7:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV 7 is associated with a specific form of warts known as <strong>butcher&rsquo;s warts</strong>, typically seen in individuals who handle meat, poultry, or fish. This HPV type is less common and is not typically implicated in warts seen in the general population, particularly in children with no occupational exposure.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. HPV 16, 18:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV types 16 and 18 are associated with <strong>anogenital warts</strong> and are high-risk types for the development of <strong>cervical and other anogenital cancers</strong>. These types of HPV are not associated with cutaneous warts on the hands and fingers, but instead cause lesions on mucosal surfaces. Hence, this option is incorrect for the scenario described.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. HPV 6, 11:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV types 6 and 11 are most commonly linked with <strong>anogenital warts (condyloma acuminata)</strong> and low-risk for malignancy. These types may also cause respiratory papillomatosis but are not responsible for common cutaneous warts, making this option incorrect.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Human papillomavirus types <strong>2, 4, and 27</strong> are the most common causes of <strong>cutaneous warts</strong> (verrucae vulgaris), especially on the hands and fingers. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These warts are firm, raised, and rough-surfaced, and are often seen in children due to direct contact transmission of HPV.</span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244304,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61302,
      "choices": [
        {
          "id": 244489,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spring balance</span></span></span></p>"
        },
        {
          "id": 244490,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Beam balance</span></span></span></p>"
        },
        {
          "id": 244491,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Electronic weighing scale</span></span></span></p>"
        },
        {
          "id": 244492,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Salter scale</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the instrument shown.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/15/screenshot-2024-10-15-163317.jpg\" style=\"height:370px; width:300px\" /></span></span></p>",
      "unique_key": "Q9169518",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) Salter scale</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The instrument shown is a <em>Salter scale</em>. It is a mechanical device used specifically for weighing infants and young children, particularly those aged 1-5 years. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The child is placed in a sling that is then attached to the scale, allowing for a weight measurement when suspended. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Salter scale is widely used in various health programs, including those sponsored by UNICEF, especially in remote or resource-limited settings. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It aids in monitoring the growth and development of children by providing accurate weight measurements.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Spring balance:</span></strong><span style=\"font-size:14.0pt\"> This instrument measures weight based on the tension of a spring, but it is not typically used for weighing infants in healthcare settings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Beam balance:</span></strong><span style=\"font-size:14.0pt\"> A beam balance is used for precise weight measurements in laboratories or for educational purposes but is not practical for weighing children.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Electronic weighing scale:</span></strong><span style=\"font-size:14.0pt\"> This is a common tool for weighing patients, but it is usually used for older children or adults. It requires a flat surface and electricity or batteries, unlike the Salter scale, which can be used in field settings without electricity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Salter scale is a key instrument for measuring the weight of infants in field settings, often used by healthcare workers and programs like UNICEF for growth monitoring and nutritional assessments.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244492,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61494,
      "choices": [
        {
          "id": 245253,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marginal sulcus</span></span></p>"
        },
        {
          "id": 245254,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcarine sulcus</span></span></p>"
        },
        {
          "id": 245255,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parieto-occipital sulcus</span></span></p>"
        },
        {
          "id": 245256,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lingual sulcus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 51-year-old man presents with visual disturbances affecting the central field of vision. An MRI of the brain is performed, revealing the involvement of a specific sulcus in the occipital lobe, as indicated by the arrow in the provided image. Which of the following sulci is identified in the given coronal section?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/16/screenshot-2024-10-16-113446.png\" style=\"height:259px; width:300px\" /></p>",
      "unique_key": "Q7744844",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong>&nbsp;</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>B) Calcarine sulcus</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The calcarine sulcus is a prominent sulcus located in the occipital lobe, extending from the parieto-occipital sulcus to the posterior pole of the brain. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It plays a crucial role in the primary visual cortex (V1), which is responsible for processing visual information, including central vision. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this MRI, the arrow points to a location consistent with the calcarine sulcus, making this the correct answer.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Marginal sulcus:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The marginal sulcus is part of the cingulate sulcus that extends to the medial aspect of the brain. It is not involved in the visual processing of central vision and is located more anteriorly compared to the calcarine sulcus.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Parieto-occipital sulcus:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This sulcus separates the parietal and occipital lobes but is not directly involved in the processing of visual information in the primary visual cortex. It is located more anteriorly relative to the calcarine sulcus.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Lingual sulcus:&nbsp;</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The lingual sulcus is related to the lingual gyrus, which is also involved in visual processing but is not the primary visual cortex like the calcarine sulcus. The sulcus identified in the image is more consistent with the location of the calcarine sulcus.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The calcarine sulcus is located in the occipital lobe and is integral to the function of the primary visual cortex. </span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 245254,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61276,
      "choices": [
        {
          "id": 244385,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sorbitol dehydrogenase</span></span></p>"
        },
        {
          "id": 244386,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aldose reductase</span></span></p>"
        },
        {
          "id": 244387,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucokinase</span></span></p>"
        },
        {
          "id": 244388,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hexokinase</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old man with a 20-year history of poorly controlled type 1 diabetes presents with blurred vision and is found to have a developing cataract. Which of the following enzymes is most closely linked to the underlying mechanism in this patient&#39;s cataract condition?</span></span></p>",
      "unique_key": "Q8251411",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) Aldose reductase</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Aldose reductase is the key enzyme involved in the conversion of glucose to sorbitol, particularly in tissues where glucose uptake is insulin-independent, such as the lens, retina, and peripheral nerves. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients with long-standing diabetes, high blood glucose levels lead to an increased flux of glucose through the polyol pathway. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Aldose reductase reduces glucose to sorbitol. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Since sorbitol is a sugar alcohol that accumulates in tissues with low levels of sorbitol dehydrogenase, it causes osmotic stress, leading to water accumulation in the lens, resulting in cataract formation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Sorbitol dehydrogenase:</span></strong><span style=\"font-size:14.0pt\"> While sorbitol dehydrogenase converts sorbitol into fructose, it is not the primary enzyme involved in the initial accumulation of sorbitol in the lens. The lens has relatively low sorbitol dehydrogenase activity, which contributes to sorbitol build-up when glucose is converted to sorbitol by aldose reductase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Glucokinase:</span></strong><span style=\"font-size:14.0pt\"> Glucokinase is involved in the conversion of glucose to glucose-6-phosphate in the liver and pancreatic beta cells. It is not related to the polyol pathway or the development of diabetic cataracts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Hexokinase:</span></strong><span style=\"font-size:14.0pt\"> Hexokinase is responsible for the phosphorylation of glucose to glucose-6-phosphate in most tissues. It is not directly involved in the conversion of glucose to sorbitol, which is mediated by aldose reductase.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Aldose reductase plays a crucial role in the conversion of glucose to sorbitol in the polyol pathway, especially under hyperglycemic conditions. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In patients with diabetes, the accumulation of sorbitol in tissues with limited sorbitol dehydrogenase activity can lead to osmotic stress, contributing to complications like cataract formation in the lens. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 244386,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}